{
 "cells": [
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Authors: Phu Dang and Diane Dinh\n",
    "\n",
    "Purpose: Pedal ROI Data Analysis\n",
    "\n",
    "Date: 05.11.2023\n",
    "\n",
    "Number of projects per investment pillar (AG-AK) (Phu & Diane) (done in Tableau) \\\n",
    "Name of project title and clinical trials(DA-DG) (Phu & Diane) (done in Tableau) \\\n",
    "Number of peer-reviewed publications (DM) (Phu & Diane) \\\n",
    "Name of project titles that will lead to improvements in health policy (FD, FL) (Phu & Diane)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 139,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "The autoreload extension is already loaded. To reload it, use:\n",
      "  %reload_ext autoreload\n"
     ]
    }
   ],
   "source": [
    "# Importing libraries and packages\n",
    "\n",
    "%load_ext autoreload\n",
    "%autoreload 2\n",
    "\n",
    "import pandas as pd\n",
    "import numpy as np \n",
    "import matplotlib.pyplot as plt \n",
    "import seaborn as sns\n",
    "import plotly.express as px\n",
    "import os\n",
    "import re\n",
    "from sklearn.preprocessing import Binarizer\n",
    "from phu_util import *\n",
    "\n",
    "# pd.set_option('display.max_rows', None)\n",
    "# Adjust dataframe display options to view full output\n",
    "pd.set_option('display.max_columns', None)\n",
    "pd.set_option('display.width', None)\n",
    "\n",
    "# Reset to default ~ comment 2 lines above and \n",
    "# uncomment 2 lines below, run all before pushing to GitHub\n",
    "# pd.set_option('display.max_columns', 20)\n",
    "# pd.set_option('display.width', 80)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'c:\\\\Users\\\\phuro\\\\Biokind\\\\curebound-team\\\\curebound\\\\notebooks'"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "working_directory()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Read datasets\n",
    "\n",
    "os.chdir('../data')\n",
    "fp = os.path.join('interim', '2022_Pedal_Progress_Report.csv').replace(\"\\\\\",\"/\")\n",
    "pr = pd.read_csv(fp, index_col=0)\n",
    "\n",
    "fp = os.path.join('interim', '2022_Pedal_ROI.csv').replace(\"\\\\\",\"/\")\n",
    "roi = pd.read_csv(fp, index_col=0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Publication Status 4</th>\n",
       "      <th>Fourth DOI #</th>\n",
       "      <th>Publication Status 5</th>\n",
       "      <th>Fifth DOI #</th>\n",
       "      <th>Publication Status 6</th>\n",
       "      <th>Sixth DOI #</th>\n",
       "      <th>Publication Status 7</th>\n",
       "      <th>Seventh DOI #</th>\n",
       "      <th>Publication Status 8</th>\n",
       "      <th>Eighth DOI #</th>\n",
       "      <th>Publication Status 9</th>\n",
       "      <th>Ninth DOI #</th>\n",
       "      <th>Publication Status 10</th>\n",
       "      <th>Tenth DOI #</th>\n",
       "      <th>Pedal Non-Peer Pubs</th>\n",
       "      <th>Other Accomplishments</th>\n",
       "      <th>Health Benefits</th>\n",
       "      <th>International</th>\n",
       "      <th>National</th>\n",
       "      <th>Local</th>\n",
       "      <th>General Public</th>\n",
       "      <th>Healthcare Professionals</th>\n",
       "      <th>Patients</th>\n",
       "      <th>Patient Families</th>\n",
       "      <th>Health Benefits Description</th>\n",
       "      <th>Policy Influence</th>\n",
       "      <th>International (pol)</th>\n",
       "      <th>National (pol)</th>\n",
       "      <th>Local (pol)</th>\n",
       "      <th>General Public (pol)</th>\n",
       "      <th>Healthcare Professionals (pol)</th>\n",
       "      <th>Patients (pol)</th>\n",
       "      <th>Patient Families (pol)</th>\n",
       "      <th>Policy Benefits Description</th>\n",
       "      <th>Economic Benefits</th>\n",
       "      <th>International (econ)</th>\n",
       "      <th>National (econ)</th>\n",
       "      <th>Local (econ)</th>\n",
       "      <th>General Public (econ)</th>\n",
       "      <th>Healthcare Professionals (econ)</th>\n",
       "      <th>Patients (econ)</th>\n",
       "      <th>Patient Families (econ)</th>\n",
       "      <th>Economic Benefits Description</th>\n",
       "      <th>Equity Benefits</th>\n",
       "      <th>International (equity)</th>\n",
       "      <th>National (equity)</th>\n",
       "      <th>Local (equity)</th>\n",
       "      <th>General Public (equity)</th>\n",
       "      <th>Healthcare Professionals (equity)</th>\n",
       "      <th>Patients (equity)</th>\n",
       "      <th>Patient Families (equity)</th>\n",
       "      <th>Equity Benefits Description</th>\n",
       "      <th>Additional Funding Achieved</th>\n",
       "      <th>First AFS Status</th>\n",
       "      <th>First AFS Name and Project Title</th>\n",
       "      <th>First AFS Amount</th>\n",
       "      <th>Second AFS Status</th>\n",
       "      <th>Second AFS Name and Project Title</th>\n",
       "      <th>Second AFS Amount</th>\n",
       "      <th>Third AFS Status</th>\n",
       "      <th>Third AFS Name and Project Title</th>\n",
       "      <th>Third AGS Amount</th>\n",
       "      <th>Fourth AFS Status</th>\n",
       "      <th>Fourth AFS Name and Project Title</th>\n",
       "      <th>Fourth AFS Amount</th>\n",
       "      <th>Additional Funding Source #5 Agency/Sponsor Name and Project Title</th>\n",
       "      <th>Fifth AFS Status</th>\n",
       "      <th>Fifth AFS Amount</th>\n",
       "      <th>Additional Pedal Funding Impact</th>\n",
       "      <th>Additional Funding Benefits Description</th>\n",
       "      <th>Additional Pedal Funding Impact (clinical stages)</th>\n",
       "      <th>Additional Funding Benefits Description (clinical stages)</th>\n",
       "      <th>Participated in Pedal</th>\n",
       "      <th>Further Research Contributions</th>\n",
       "      <th>Success Stories</th>\n",
       "      <th>Major Scientific Breakthroughs</th>\n",
       "      <th>Additional Comments</th>\n",
       "      <th>Complete</th>\n",
       "      <th>Publication Status 1</th>\n",
       "      <th>First DOI #</th>\n",
       "      <th>Publication Status 2</th>\n",
       "      <th>Second DOI #</th>\n",
       "      <th>Publication Status 3</th>\n",
       "      <th>Third DOI #</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>3.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>We have identified some genes that are recurre...</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>NIH R35HG011315 Using genomic perturbations to...</td>\n",
       "      <td>1500000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding would enable the applicatio...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>In addition, funding could allow us to do more...</td>\n",
       "      <td>Yes, I have participated as a rider every year...</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>4.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Adam K. Fuhs S, Meisenhelder J,  Lesperan...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>We expect our results will confirm the critica...</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Five</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>the Hartwell Foundation</td>\n",
       "      <td>300000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Padres Pedal the Cause</td>\n",
       "      <td>100000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>Pediatric Cancer Research Foundation</td>\n",
       "      <td>750000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>NIH R03CA273629-01</td>\n",
       "      <td>150000.0</td>\n",
       "      <td>Tower Cancer Research Foundation</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>500000.0</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to p...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to p...</td>\n",
       "      <td>I have participated as both a virtual particip...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Funding from Padres Pedal the Cause has been i...</td>\n",
       "      <td>True</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>5.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None to date</td>\n",
       "      <td>additional funding provided by Padres Pedal th...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>We expect our results will support the use of ...</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>The combination of cabozantinib with 13-cis-re...</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Exelixis, Inc.</td>\n",
       "      <td>250000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to e...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to p...</td>\n",
       "      <td>I have participated as both a virtual particip...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Funding from Padres Pedal the Cause has been i...</td>\n",
       "      <td>True</td>\n",
       "      <td>Published</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>6.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>See above in the progress report.</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>oral cancer prevention in at risk individuals</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>Oral cancer prevention and the consequent redu...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>At risk oral cancer patients are often part of...</td>\n",
       "      <td>One</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>NIH R01, will likely be funded soon</td>\n",
       "      <td>2500000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>For advancing the planned clinical trial and c...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Identification of biomarkers predicting clinic...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Many thanks for all your support!!!</td>\n",
       "      <td>True</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>8.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>8.Ghali F, Patel D, Jamieson C, Parsons JK, Mc...</td>\n",
       "      <td>2019-present Member, Wnt Signaling in Prostate...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Trial is testing a therapeutic combination for...</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Trial focused on all demographic of prostate c...</td>\n",
       "      <td>One</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Oncternal</td>\n",
       "      <td>377000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>This is a grass roots project. It is a single ...</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes, runner.</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    ID          Event Name Publication Status 4 Fourth DOI #  \\\n",
       "0  3.0  Progress Report #1                  NaN          NaN   \n",
       "1  4.0  Progress Report #1                  NaN          NaN   \n",
       "2  5.0  Progress Report #1                  NaN          NaN   \n",
       "3  6.0  Progress Report #1                  NaN          NaN   \n",
       "4  8.0  Progress Report #1                  NaN          NaN   \n",
       "\n",
       "  Publication Status 5 Fifth DOI # Publication Status 6 Sixth DOI #  \\\n",
       "0                  NaN         NaN                  NaN         NaN   \n",
       "1                  NaN         NaN                  NaN         NaN   \n",
       "2                  NaN         NaN                  NaN         NaN   \n",
       "3                  NaN         NaN                  NaN         NaN   \n",
       "4                  NaN         NaN                  NaN         NaN   \n",
       "\n",
       "  Publication Status 7 Seventh DOI # Publication Status 8 Eighth DOI #  \\\n",
       "0                  NaN           NaN                  NaN          NaN   \n",
       "1                  NaN           NaN                  NaN          NaN   \n",
       "2                  NaN           NaN                  NaN          NaN   \n",
       "3                  NaN           NaN                  NaN          NaN   \n",
       "4                  NaN           NaN                  NaN          NaN   \n",
       "\n",
       "  Publication Status 9 Ninth DOI # Publication Status 10 Tenth DOI #  \\\n",
       "0                  NaN         NaN                   NaN         NaN   \n",
       "1                  NaN         NaN                   NaN         NaN   \n",
       "2                  NaN         NaN                   NaN         NaN   \n",
       "3                  NaN         NaN                   NaN         NaN   \n",
       "4                  NaN         NaN                   NaN         NaN   \n",
       "\n",
       "                                 Pedal Non-Peer Pubs  \\\n",
       "0                                                NaN   \n",
       "1       Adam K. Fuhs S, Meisenhelder J,  Lesperan...   \n",
       "2                                       None to date   \n",
       "3                                                NaN   \n",
       "4  8.Ghali F, Patel D, Jamieson C, Parsons JK, Mc...   \n",
       "\n",
       "                               Other Accomplishments Health Benefits  \\\n",
       "0                                                NaN             Yes   \n",
       "1                                                NaN             Yes   \n",
       "2  additional funding provided by Padres Pedal th...             Yes   \n",
       "3                  See above in the progress report.             Yes   \n",
       "4  2019-present Member, Wnt Signaling in Prostate...             Yes   \n",
       "\n",
       "   International  National  Local  General Public  Healthcare Professionals  \\\n",
       "0          False     False  False           False                     False   \n",
       "1           True     False  False           False                     False   \n",
       "2           True     False  False           False                     False   \n",
       "3           True      True  False           False                     False   \n",
       "4          False     False  False           False                     False   \n",
       "\n",
       "   Patients  Patient Families  \\\n",
       "0      True             False   \n",
       "1     False             False   \n",
       "2     False             False   \n",
       "3      True              True   \n",
       "4      True             False   \n",
       "\n",
       "                         Health Benefits Description Policy Influence  \\\n",
       "0  We have identified some genes that are recurre...               No   \n",
       "1  We expect our results will confirm the critica...               No   \n",
       "2  We expect our results will support the use of ...               No   \n",
       "3      oral cancer prevention in at risk individuals               No   \n",
       "4  Trial is testing a therapeutic combination for...               No   \n",
       "\n",
       "   International (pol)  National (pol)  Local (pol)  General Public (pol)  \\\n",
       "0                False           False        False                 False   \n",
       "1                False           False        False                 False   \n",
       "2                False           False        False                 False   \n",
       "3                False           False        False                 False   \n",
       "4                False           False        False                 False   \n",
       "\n",
       "   Healthcare Professionals (pol)  Patients (pol)  Patient Families (pol)  \\\n",
       "0                           False           False                   False   \n",
       "1                           False           False                   False   \n",
       "2                           False           False                   False   \n",
       "3                           False           False                   False   \n",
       "4                           False           False                   False   \n",
       "\n",
       "  Policy Benefits Description Economic Benefits  International (econ)  \\\n",
       "0                         NaN                No                 False   \n",
       "1                         NaN                No                 False   \n",
       "2                         NaN               Yes                 False   \n",
       "3                         NaN               Yes                  True   \n",
       "4                         NaN                No                 False   \n",
       "\n",
       "   National (econ)  Local (econ)  General Public (econ)  \\\n",
       "0            False         False                  False   \n",
       "1            False         False                  False   \n",
       "2             True         False                  False   \n",
       "3             True         False                  False   \n",
       "4            False         False                  False   \n",
       "\n",
       "   Healthcare Professionals (econ)  Patients (econ)  Patient Families (econ)  \\\n",
       "0                            False            False                    False   \n",
       "1                            False            False                    False   \n",
       "2                            False            False                    False   \n",
       "3                            False             True                     True   \n",
       "4                            False            False                    False   \n",
       "\n",
       "                       Economic Benefits Description Equity Benefits  \\\n",
       "0                                                NaN              No   \n",
       "1                                                NaN              No   \n",
       "2  The combination of cabozantinib with 13-cis-re...              No   \n",
       "3  Oral cancer prevention and the consequent redu...             Yes   \n",
       "4                                                NaN             Yes   \n",
       "\n",
       "   International (equity)  National (equity)  Local (equity)  \\\n",
       "0                   False              False           False   \n",
       "1                   False              False           False   \n",
       "2                   False              False           False   \n",
       "3                    True               True           False   \n",
       "4                   False              False           False   \n",
       "\n",
       "   General Public (equity)  Healthcare Professionals (equity)  \\\n",
       "0                    False                              False   \n",
       "1                    False                              False   \n",
       "2                    False                              False   \n",
       "3                    False                              False   \n",
       "4                    False                              False   \n",
       "\n",
       "   Patients (equity)  Patient Families (equity)  \\\n",
       "0              False                      False   \n",
       "1              False                      False   \n",
       "2              False                      False   \n",
       "3               True                       True   \n",
       "4               True                      False   \n",
       "\n",
       "                         Equity Benefits Description  \\\n",
       "0                                                NaN   \n",
       "1                                                NaN   \n",
       "2                                                NaN   \n",
       "3  At risk oral cancer patients are often part of...   \n",
       "4  Trial focused on all demographic of prostate c...   \n",
       "\n",
       "  Additional Funding Achieved First AFS Status  \\\n",
       "0                         One          Awarded   \n",
       "1                        Five          Awarded   \n",
       "2                         One          Awarded   \n",
       "3                         One        Submitted   \n",
       "4                         One          Awarded   \n",
       "\n",
       "                    First AFS Name and Project Title  First AFS Amount  \\\n",
       "0  NIH R35HG011315 Using genomic perturbations to...         1500000.0   \n",
       "1                            the Hartwell Foundation          300000.0   \n",
       "2                                     Exelixis, Inc.          250000.0   \n",
       "3                NIH R01, will likely be funded soon         2500000.0   \n",
       "4                                         Oncternal           377000.0   \n",
       "\n",
       "  Second AFS Status Second AFS Name and Project Title  Second AFS Amount  \\\n",
       "0               NaN                               NaN                NaN   \n",
       "1           Awarded            Padres Pedal the Cause           100000.0   \n",
       "2               NaN                               NaN                NaN   \n",
       "3               NaN                               NaN                NaN   \n",
       "4               NaN                               NaN                NaN   \n",
       "\n",
       "  Third AFS Status      Third AFS Name and Project Title  Third AGS Amount  \\\n",
       "0              NaN                                   NaN               NaN   \n",
       "1        Submitted  Pediatric Cancer Research Foundation          750000.0   \n",
       "2              NaN                                   NaN               NaN   \n",
       "3              NaN                                   NaN               NaN   \n",
       "4              NaN                                   NaN               NaN   \n",
       "\n",
       "  Fourth AFS Status Fourth AFS Name and Project Title  Fourth AFS Amount  \\\n",
       "0               NaN                               NaN                NaN   \n",
       "1         Submitted                NIH R03CA273629-01           150000.0   \n",
       "2               NaN                               NaN                NaN   \n",
       "3               NaN                               NaN                NaN   \n",
       "4               NaN                               NaN                NaN   \n",
       "\n",
       "  Additional Funding Source #5 Agency/Sponsor Name and Project Title  \\\n",
       "0                                                NaN                   \n",
       "1                   Tower Cancer Research Foundation                   \n",
       "2                                                NaN                   \n",
       "3                                                NaN                   \n",
       "4                                                NaN                   \n",
       "\n",
       "  Fifth AFS Status  Fifth AFS Amount Additional Pedal Funding Impact  \\\n",
       "0              NaN               NaN                             Yes   \n",
       "1        Submitted          500000.0                             Yes   \n",
       "2              NaN               NaN                             Yes   \n",
       "3              NaN               NaN                             Yes   \n",
       "4              NaN               NaN                             Yes   \n",
       "\n",
       "             Additional Funding Benefits Description  \\\n",
       "0  Additional funding would enable the applicatio...   \n",
       "1  Additional funding support would allow us to p...   \n",
       "2  Additional funding support would allow us to e...   \n",
       "3  For advancing the planned clinical trial and c...   \n",
       "4  This is a grass roots project. It is a single ...   \n",
       "\n",
       "  Additional Pedal Funding Impact (clinical stages)  \\\n",
       "0                                               Yes   \n",
       "1                                               Yes   \n",
       "2                                               Yes   \n",
       "3                                               Yes   \n",
       "4                                                No   \n",
       "\n",
       "  Additional Funding Benefits Description (clinical stages)  \\\n",
       "0  In addition, funding could allow us to do more...          \n",
       "1  Additional funding support would allow us to p...          \n",
       "2  Additional funding support would allow us to p...          \n",
       "3  Identification of biomarkers predicting clinic...          \n",
       "4                                                NaN          \n",
       "\n",
       "                               Participated in Pedal  \\\n",
       "0  Yes, I have participated as a rider every year...   \n",
       "1  I have participated as both a virtual particip...   \n",
       "2  I have participated as both a virtual particip...   \n",
       "3                                                Yes   \n",
       "4                                      Yes, runner.    \n",
       "\n",
       "  Further Research Contributions Success Stories  \\\n",
       "0                             No              No   \n",
       "1                            Yes              No   \n",
       "2                            Yes             Yes   \n",
       "3                             No              No   \n",
       "4                            Yes              No   \n",
       "\n",
       "  Major Scientific Breakthroughs  \\\n",
       "0                            NaN   \n",
       "1                            NaN   \n",
       "2                            Yes   \n",
       "3                            NaN   \n",
       "4                            NaN   \n",
       "\n",
       "                                 Additional Comments  Complete  \\\n",
       "0                                                NaN      True   \n",
       "1  Funding from Padres Pedal the Cause has been i...      True   \n",
       "2  Funding from Padres Pedal the Cause has been i...      True   \n",
       "3                Many thanks for all your support!!!      True   \n",
       "4                                                NaN      True   \n",
       "\n",
       "  Publication Status 1 First DOI # Publication Status 2 Second DOI #  \\\n",
       "0             Accepted         NaN                  NaN          NaN   \n",
       "1             Accepted         NaN            Submitted          NaN   \n",
       "2            Published         NaN                  NaN          NaN   \n",
       "3          In progress         NaN          In progress          NaN   \n",
       "4                  NaN         NaN                  NaN          NaN   \n",
       "\n",
       "  Publication Status 3 Third DOI #  \n",
       "0                  NaN         NaN  \n",
       "1                  NaN         NaN  \n",
       "2                  NaN         NaN  \n",
       "3                  NaN         NaN  \n",
       "4                  NaN         NaN  "
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pr.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Award ID</th>\n",
       "      <th>Project Title</th>\n",
       "      <th>PI Institution</th>\n",
       "      <th>Other Institution</th>\n",
       "      <th>Prevention and diagnostic tools</th>\n",
       "      <th>Novel approaches and new therapeutic platforms</th>\n",
       "      <th>Immunotherapies and personalized vaccines</th>\n",
       "      <th>Addressing cancer disparities</th>\n",
       "      <th>Pediatric cancers</th>\n",
       "      <th>Specific Aims</th>\n",
       "      <th>Aim 1</th>\n",
       "      <th>Aim 2</th>\n",
       "      <th>Aim 3</th>\n",
       "      <th>Aim 4</th>\n",
       "      <th>Aim 5</th>\n",
       "      <th>Aim 6</th>\n",
       "      <th>Public Health Significance</th>\n",
       "      <th>Award Amount</th>\n",
       "      <th>Grant Start Date:</th>\n",
       "      <th>Grant End Date:</th>\n",
       "      <th>Complete</th>\n",
       "      <th>SR - None</th>\n",
       "      <th>SR - Biobehaviorial MCC</th>\n",
       "      <th>SR - Biorepository &amp; Tissue Tech. MCC</th>\n",
       "      <th>SR - Biostatistics MCC</th>\n",
       "      <th>SR - Clinical Trials Office MCC</th>\n",
       "      <th>SR - Flow Cytometry MCC</th>\n",
       "      <th>SR - Genomics &amp; Computational Bio. MCC</th>\n",
       "      <th>SR - In Vivo Imaging MCC</th>\n",
       "      <th>SR - Microscopy MCC</th>\n",
       "      <th>SR - Radiation Medicine MCC</th>\n",
       "      <th>SR - Transgenic Mouse MCC</th>\n",
       "      <th>SR - Gene Transfer/Targeting/Therap Salk</th>\n",
       "      <th>SR - Transgenic Salk</th>\n",
       "      <th>SR - Mass Spect - Proteom/Metabol Salk</th>\n",
       "      <th>SR - Chemical Library Screening SBPMDI</th>\n",
       "      <th>SR - Functional Genomics SBPMDI</th>\n",
       "      <th>Cancer Metabolism SBPMDI</th>\n",
       "      <th>Pedal Importance (recruitment, retention, advancement)</th>\n",
       "      <th>If yes, please specify</th>\n",
       "      <th>If no, please specify</th>\n",
       "      <th>Clinical Trials Resulted</th>\n",
       "      <th>First Clinical Trial</th>\n",
       "      <th>First Clinical Trial Patient Count</th>\n",
       "      <th>Second Clinical Trial</th>\n",
       "      <th>Second Clinical Trial Patient Count</th>\n",
       "      <th>Companies Founded</th>\n",
       "      <th>Patents Filed</th>\n",
       "      <th>Patent Details</th>\n",
       "      <th>Peer-Reviewed Publications Count</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>3.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>3.1</td>\n",
       "      <td>Detecting dysregulated genes in neuroblastoma ...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Identify genes that are dysregulated in neurob...</td>\n",
       "      <td>Identify and characterize de novo germline and...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Improved knowledge of the genetic mutations th...</td>\n",
       "      <td>100000.0</td>\n",
       "      <td>2019-07-15</td>\n",
       "      <td>2021-07-14</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The PPTC funding allowed a postdoctoral resear...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No Trials</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>4.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>4.1</td>\n",
       "      <td>Functional Roles for Histidine Kinase Signalin...</td>\n",
       "      <td>Rady Children's</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Evaluate the functional role of NME1 expressio...</td>\n",
       "      <td>Evaluate the functional role of NME1 histidine...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Children with aggressive neuroblastoma have po...</td>\n",
       "      <td>100000.0</td>\n",
       "      <td>2019-07-15</td>\n",
       "      <td>2020-07-14</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The availability of funding from Padres Pedal ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No Trials</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>none</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>5.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>5.1</td>\n",
       "      <td>A National Phase I Study of Cabozantinib in Co...</td>\n",
       "      <td>Rady Children's</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine the safety, dose-limiting toxicities...</td>\n",
       "      <td>Identify biomarkers predictive of patient resp...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Children with high-risk and recurrent solid tu...</td>\n",
       "      <td>200000.0</td>\n",
       "      <td>2021-07-01</td>\n",
       "      <td>2023-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The availability of funding from Padres Pedal ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One Trial</td>\n",
       "      <td>A National Phase I Study of Cabozantinib in Co...</td>\n",
       "      <td>6.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>6.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>6.1</td>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Improve outcomes for HNSCC by expanding our un...</td>\n",
       "      <td>Leverage our administrative, biostatistics, co...</td>\n",
       "      <td>Develop emerging, novel, high quality translat...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cancer immunotherapies have led to major treat...</td>\n",
       "      <td>200000.0</td>\n",
       "      <td>2021-07-01</td>\n",
       "      <td>2022-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Opportunity to develop an immune modulatory ap...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One Trial</td>\n",
       "      <td>Metformin for oral cancer prevention 2.0</td>\n",
       "      <td>80.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>8.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>8.1</td>\n",
       "      <td>A Phase 1B, Nonrandomized Trial Investigating ...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>To investigate the safety and tolerability of ...</td>\n",
       "      <td>To evaluate the anti-tumor activity of cirmtuz...</td>\n",
       "      <td>To prospectively interrogate the Wnt signaling...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Metastatic castration resistant prostate cance...</td>\n",
       "      <td>150000.0</td>\n",
       "      <td>2020-01-01</td>\n",
       "      <td>2021-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes this grant was supporting the infrastructu...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One Trial</td>\n",
       "      <td>Phase 1B, Nonrandomized Trial Investigating Do...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Oncternal</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Zero</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    ID Event Name  Award ID  \\\n",
       "0  3.0    Initial       3.1   \n",
       "2  4.0    Initial       4.1   \n",
       "4  5.0    Initial       5.1   \n",
       "6  6.0    Initial       6.1   \n",
       "8  8.0    Initial       8.1   \n",
       "\n",
       "                                       Project Title        PI Institution  \\\n",
       "0  Detecting dysregulated genes in neuroblastoma ...        Salk Institute   \n",
       "2  Functional Roles for Histidine Kinase Signalin...       Rady Children's   \n",
       "4  A National Phase I Study of Cabozantinib in Co...       Rady Children's   \n",
       "6  UCSD-UCSF Specialized Program of Research Exce...  Moores Cancer Center   \n",
       "8  A Phase 1B, Nonrandomized Trial Investigating ...  Moores Cancer Center   \n",
       "\n",
       "  Other Institution  Prevention and diagnostic tools  \\\n",
       "0               NaN                            False   \n",
       "2               NaN                            False   \n",
       "4               NaN                            False   \n",
       "6               NaN                            False   \n",
       "8               NaN                            False   \n",
       "\n",
       "   Novel approaches and new therapeutic platforms  \\\n",
       "0                                           False   \n",
       "2                                           False   \n",
       "4                                           False   \n",
       "6                                           False   \n",
       "8                                            True   \n",
       "\n",
       "   Immunotherapies and personalized vaccines  Addressing cancer disparities  \\\n",
       "0                                      False                          False   \n",
       "2                                      False                          False   \n",
       "4                                      False                          False   \n",
       "6                                      False                          False   \n",
       "8                                      False                          False   \n",
       "\n",
       "   Pediatric cancers        Specific Aims  \\\n",
       "0               True    Two Specific Aims   \n",
       "2               True    Two Specific Aims   \n",
       "4               True    Two Specific Aims   \n",
       "6              False  Three Specific Aims   \n",
       "8              False  Three Specific Aims   \n",
       "\n",
       "                                               Aim 1  \\\n",
       "0  Identify genes that are dysregulated in neurob...   \n",
       "2  Evaluate the functional role of NME1 expressio...   \n",
       "4  Determine the safety, dose-limiting toxicities...   \n",
       "6  Improve outcomes for HNSCC by expanding our un...   \n",
       "8  To investigate the safety and tolerability of ...   \n",
       "\n",
       "                                               Aim 2  \\\n",
       "0  Identify and characterize de novo germline and...   \n",
       "2  Evaluate the functional role of NME1 histidine...   \n",
       "4  Identify biomarkers predictive of patient resp...   \n",
       "6  Leverage our administrative, biostatistics, co...   \n",
       "8  To evaluate the anti-tumor activity of cirmtuz...   \n",
       "\n",
       "                                               Aim 3 Aim 4 Aim 5 Aim 6  \\\n",
       "0                                                NaN   NaN   NaN   NaN   \n",
       "2                                                NaN   NaN   NaN   NaN   \n",
       "4                                                NaN   NaN   NaN   NaN   \n",
       "6  Develop emerging, novel, high quality translat...   NaN   NaN   NaN   \n",
       "8  To prospectively interrogate the Wnt signaling...   NaN   NaN   NaN   \n",
       "\n",
       "                          Public Health Significance  Award Amount  \\\n",
       "0  Improved knowledge of the genetic mutations th...      100000.0   \n",
       "2  Children with aggressive neuroblastoma have po...      100000.0   \n",
       "4  Children with high-risk and recurrent solid tu...      200000.0   \n",
       "6  Cancer immunotherapies have led to major treat...      200000.0   \n",
       "8  Metastatic castration resistant prostate cance...      150000.0   \n",
       "\n",
       "  Grant Start Date: Grant End Date:  Complete SR - None  \\\n",
       "0        2019-07-15      2021-07-14  Complete      True   \n",
       "2        2019-07-15      2020-07-14  Complete     False   \n",
       "4        2021-07-01      2023-06-30  Complete     False   \n",
       "6        2021-07-01      2022-06-30  Complete     False   \n",
       "8        2020-01-01      2021-12-31  Complete     False   \n",
       "\n",
       "  SR - Biobehaviorial MCC SR - Biorepository & Tissue Tech. MCC  \\\n",
       "0                   False                                 False   \n",
       "2                   False                                 False   \n",
       "4                   False                                 False   \n",
       "6                   False                                  True   \n",
       "8                   False                                  True   \n",
       "\n",
       "  SR - Biostatistics MCC SR - Clinical Trials Office MCC  \\\n",
       "0                  False                           False   \n",
       "2                   True                           False   \n",
       "4                   True                           False   \n",
       "6                  False                            True   \n",
       "8                   True                            True   \n",
       "\n",
       "  SR - Flow Cytometry MCC SR - Genomics & Computational Bio. MCC  \\\n",
       "0                   False                                  False   \n",
       "2                   False                                  False   \n",
       "4                   False                                  False   \n",
       "6                   False                                   True   \n",
       "8                   False                                   True   \n",
       "\n",
       "  SR - In Vivo Imaging MCC SR - Microscopy MCC SR - Radiation Medicine MCC  \\\n",
       "0                    False               False                       False   \n",
       "2                    False               False                       False   \n",
       "4                    False               False                       False   \n",
       "6                    False               False                       False   \n",
       "8                    False               False                       False   \n",
       "\n",
       "  SR - Transgenic Mouse MCC SR - Gene Transfer/Targeting/Therap Salk  \\\n",
       "0                     False                                    False   \n",
       "2                     False                                    False   \n",
       "4                     False                                    False   \n",
       "6                     False                                    False   \n",
       "8                     False                                    False   \n",
       "\n",
       "  SR - Transgenic Salk SR - Mass Spect - Proteom/Metabol Salk  \\\n",
       "0                False                                  False   \n",
       "2                False                                  False   \n",
       "4                False                                  False   \n",
       "6                False                                  False   \n",
       "8                False                                  False   \n",
       "\n",
       "  SR - Chemical Library Screening SBPMDI SR - Functional Genomics SBPMDI  \\\n",
       "0                                  False                           False   \n",
       "2                                   True                           False   \n",
       "4                                  False                           False   \n",
       "6                                  False                           False   \n",
       "8                                  False                           False   \n",
       "\n",
       "  Cancer Metabolism SBPMDI  \\\n",
       "0                    False   \n",
       "2                    False   \n",
       "4                    False   \n",
       "6                    False   \n",
       "8                    False   \n",
       "\n",
       "  Pedal Importance (recruitment, retention, advancement)  \\\n",
       "0                                                Yes       \n",
       "2                                                Yes       \n",
       "4                                                Yes       \n",
       "6                                                Yes       \n",
       "8                                                Yes       \n",
       "\n",
       "                              If yes, please specify If no, please specify  \\\n",
       "0  The PPTC funding allowed a postdoctoral resear...                   NaN   \n",
       "2  The availability of funding from Padres Pedal ...                   NaN   \n",
       "4  The availability of funding from Padres Pedal ...                   NaN   \n",
       "6  Opportunity to develop an immune modulatory ap...                   NaN   \n",
       "8  Yes this grant was supporting the infrastructu...                   NaN   \n",
       "\n",
       "  Clinical Trials Resulted                               First Clinical Trial  \\\n",
       "0                No Trials                                                NaN   \n",
       "2                No Trials                                                NaN   \n",
       "4                One Trial  A National Phase I Study of Cabozantinib in Co...   \n",
       "6                One Trial           Metformin for oral cancer prevention 2.0   \n",
       "8                One Trial  Phase 1B, Nonrandomized Trial Investigating Do...   \n",
       "\n",
       "   First Clinical Trial Patient Count Second Clinical Trial  \\\n",
       "0                                 NaN                   NaN   \n",
       "2                                 NaN                   NaN   \n",
       "4                                 6.0                   NaN   \n",
       "6                                80.0                   NaN   \n",
       "8                                 0.0                   NaN   \n",
       "\n",
       "   Second Clinical Trial Patient Count Companies Founded Patents Filed  \\\n",
       "0                                  NaN              None            No   \n",
       "2                                  NaN              none            No   \n",
       "4                                  NaN              None            No   \n",
       "6                                  NaN                No            No   \n",
       "8                                  NaN         Oncternal            No   \n",
       "\n",
       "  Patent Details Peer-Reviewed Publications Count  \n",
       "0            NaN                              One  \n",
       "2            NaN                              Two  \n",
       "4            NaN                              One  \n",
       "6            NaN                              Two  \n",
       "8            NaN                             Zero  "
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "roi.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "roi['Project Title'] = roi['Project Title'].apply(lambda x: re.sub(r\"[\\s]{2}\", \" \", x))\\\n",
    "    .apply(lambda x: re.sub(\"pacreatic\", \"pancreatic\", x))\\\n",
    "    .apply(lambda x: re.sub(\"Rhabdoid\", \"rhabdoid\", x))\\\n",
    "    .replace('Transcriptomic and epigenomic profiling to reveal TIL and microglia functional phenotype and clonality in pediatric brain tumors',\n",
    "    'Transcriptomic, epigenomic profiling to reveal TIL, microglia functional phenotype, and clonality in pediatric brain tumors')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['A National Phase I Study of Cabozantinib in Combination with 13-cis-Retinoic Acid in Children with Relapsed or Refractory Solid Tumors',\n",
       "       'A Novel Role for Histidine Kinase Activity in Neuroblastoma Pathogenesis',\n",
       "       'A Phase 1B, Nonrandomized Trial Investigating Docetaxel Combined with Cirmtuzumab in Patients with Metastatic Castration Resistant Prostate Cancer',\n",
       "       'A Phase 1b Safety and Feasibility Study of Personalized Immunotherapy in Adults with Advanced Cancers',\n",
       "       'A Phase 1b pilot clinical trial of cirmtuzumab, an anti-ROR1 monoclonal antibody, in combination with paclitaxel for the treatment of patients with metastatic, or locally advanced, unresectable breast cancer',\n",
       "       'A pilot trial to test the benefit of real time drug screening to determine individualized treatment plans for children and young adults with relapsed or refractory medulloblastoma',\n",
       "       'An Open-Label, Phase 2 Efficacy Study of Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)',\n",
       "       'An over-expressed GPCR in pancreatic cancer associated fibroblasts as a novel therapeutic target',\n",
       "       'Applying p38 MAPK inhibitors to tackle breast cancer metastasis',\n",
       "       'Characterization of a GOLPH3 Pathway Inhibitor to Enable a Hit-to-Lead Grant to Develop a Novel Cancer Therapeutic',\n",
       "       'Cytotoxic Breast Cancer Treatment Effects on Aging',\n",
       "       'Deciphering the role of RNA editing in leukemia stem cell generation and pediatric acute leukemia relapse',\n",
       "       'Decoding Colon Cancers Using Boolean Principles',\n",
       "       'Defining the mechanisms of pancreatic cancer susceptibility in patient-derived organoid models',\n",
       "       'Demonstrating the Clinical Utility of Whole Exome Sequencing for Cancer Patients',\n",
       "       'Detecting Correlates of Vaccine Responses in Allogeneic Hematopoietic Stem Cell Transplant Recipients ',\n",
       "       'Detecting dysregulated genes in neuroblastoma using allele-specific expression',\n",
       "       'Developing targeted therapy for Ewing sarcoma metastasis',\n",
       "       'Development and Implementation of a Peer-Navigation Intervention to Improve Research Literacy in Pediatric Cancer Trials',\n",
       "       'Discovery of non-coding oncogenic mutations in pediatric acute lymphoblastic leukemia using ATAC-seq and Hi-C',\n",
       "       'Elucidating the role of Syk kinase and Syk inhibitors combined with Radiation therapy in Neuroblastoma',\n",
       "       'Enhanced Breast Cancer Risk Prediction from Imputed Gene Expression',\n",
       "       'Epigenetic basis of platinum drug resistance in ovarian cancer',\n",
       "       'Epigenetic profiling of endometrial cancer',\n",
       "       'Evaluation of carcinogen exposure via genome-wide DNA-adduct signatures',\n",
       "       'Examination of inhibitors of the ULK1 autophagy kinase as therapeutics in NSCLC',\n",
       "       'FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma',\n",
       "       'Fake Project to Test',\n",
       "       'Functional Roles for Histidine Kinase Signaling in Neuroblastoma',\n",
       "       'Highly selective, synthetic, cleavage specificity-based nanobiosensors for tumorigenic and anti-tumorigenic MMPs',\n",
       "       'Identification of genes critical for the production of T cells from human pluripotent stem cells for development of \"off-the-shelf\" T cell immunotherapies',\n",
       "       'Identification of regulatory programs for glioblastoma cellular hierarchy using single-cell multi-omic profiling',\n",
       "       'Identification of therapeutic targets of B-ALL using Boolean logic',\n",
       "       'Impact of Metformin on Clonal Hematopoiesis and Clinical Outcomes in Breast Cancer',\n",
       "       'Improved Echocardiographic Diagnosis of Anthracycline-Related Cardiac Dysfunction Using Global Longitudinal Strain',\n",
       "       'In Vivo Modeling of Anti-Tumor Responses of Human Melanoma Patients and their Responses to Checkpoint Immunotherapy',\n",
       "       'Inducing Cytosolic Chromatin Fragments in Cancer Cells to Turn Cold Tumors Hot',\n",
       "       'Inhibiting Liver Cancer Stem Cells to Improve Response to Thermal Ablation',\n",
       "       'Investigating the Efficacy of radium-223 with Olaparib in Men with Metastatic Castration-resistant Prostate Cancer',\n",
       "       'Irreversible electroporation as an In Situ vaccine for pancreatic cancer',\n",
       "       'Junk', 'Junk2',\n",
       "       'KRAS Addiction and Protein Biomarkers of Response to anti-KRAS Therapy in NSCLC Patient Derived Xenografts',\n",
       "       'Knowledge-based planning and treatment decision-making for gynecologic brachytherapy',\n",
       "       'Low Dose Chemotherapy for Immuno-activation in Lung Cancer',\n",
       "       'Mechanisms Linking Prolonged Nightly Fasting with Cancer Risk',\n",
       "       'Microbe-Associated Colorectal Cancer (M.A.C.S)',\n",
       "       'Natural Killer Cells for Treatment of Medulloblastoma',\n",
       "       'Neoantigen-specific T cell responses in exceptional responders to immunotherapy in NSCLC',\n",
       "       'New Therapies for Myeloid Leukemia',\n",
       "       'Novel Pathways Regulated by NME1 in Neuroblastoma',\n",
       "       'Novel kinase inhibitors in combination with retinoic acide for neuroblastoma',\n",
       "       'Oncogenic Regulation of B-Lymphomagenesis by the Chromatin Modulator DOT1L',\n",
       "       'Peptide Targeted Delivery of Epigenetic Therapies in Pancreatic Cancer',\n",
       "       'Precision Interception of Gastric Cancers',\n",
       "       'Protein Kinase C as a Novel Biomarker and Target in Pancreatic Cancer',\n",
       "       'Responses of Melanoma Patients to Checkpoint Immunotherapy',\n",
       "       'Science',\n",
       "       'Small molecule screen for inhibitors of the GOLPH3 pathway',\n",
       "       'Stromal reprogramming to enhance the effectiveness of pancreatic cancer therapy',\n",
       "       'Targeting A Therapeutic Vulnerability in PTEN-Deficient Brain Tumors',\n",
       "       'Targeting CD114 Signaling in Pediatric Medulloblastoma',\n",
       "       'Targeting FZD7 in human cancers',\n",
       "       'Targeting KRAS mutant lung cancer with biphosphonated/statins and rapamycin analogs',\n",
       "       'Targeting Stem Cell Signals in Cancer Development and Progression',\n",
       "       'Targeting cellular mechanotransduction in breast cancer metastasis',\n",
       "       'Targeting fibroblast heterogeneity to improve surgical outcomes in pancreatic cancer',\n",
       "       'Targeting imatinib-resistant, KIT-negative cells in human GISTs',\n",
       "       'Test title',\n",
       "       'The GNAS-PKA Onco-Signaling Network in Colorectal Malignancies',\n",
       "       'Therapeutic Reprogramming of Pancreatic Cancer Stroma Via Modulation of p62 and p53 (YEAR 1)',\n",
       "       'Tissue-specific role of SMARCB1 in pediatric rhabdoid tumors',\n",
       "       'Transcriptomic, epigenomic profiling to reveal TIL, microglia functional phenotype, and clonality in pediatric brain tumors',\n",
       "       'UCSD-UCSF Specialized Program of Research Excellence (SPORE) in Head and Neck Cancer',\n",
       "       'Understanding and Targeting NRF2 in Pancreatic Cancer'],\n",
       "      dtype=object)"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "test = roi['Project Title'].unique()\n",
    "test.sort()\n",
    "test\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "five_pillars = ['Prevention and diagnostic tools', \n",
    "                'Novel approaches and new therapeutic platforms',\n",
    "                'Immunotherapies and personalized vaccines',\n",
    "                'Addressing cancer disparities',\n",
    "                'Pediatric cancers']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "190\n",
      "False    153\n",
      "True      37\n",
      "Name: Prevention and diagnostic tools, dtype: int64\n",
      "\n",
      "190\n",
      "False    123\n",
      "True      67\n",
      "Name: Novel approaches and new therapeutic platforms, dtype: int64\n",
      "\n",
      "190\n",
      "False    154\n",
      "True      36\n",
      "Name: Immunotherapies and personalized vaccines, dtype: int64\n",
      "\n",
      "190\n",
      "False    187\n",
      "True       3\n",
      "Name: Addressing cancer disparities, dtype: int64\n",
      "\n",
      "190\n",
      "False    143\n",
      "True      47\n",
      "Name: Pediatric cancers, dtype: int64\n",
      "\n"
     ]
    }
   ],
   "source": [
    "for col in five_pillars:\n",
    "    print(roi[col].value_counts().sum())\n",
    "    print(roi[col].value_counts())\n",
    "    print()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Prevention and diagnostic tools                   0\n",
       "Novel approaches and new therapeutic platforms    0\n",
       "Immunotherapies and personalized vaccines         0\n",
       "Addressing cancer disparities                     0\n",
       "Pediatric cancers                                 0\n",
       "dtype: int64"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "roi[five_pillars].isna().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "190\n",
      "190\n"
     ]
    }
   ],
   "source": [
    "print(len(roi['ID'].unique()))\n",
    "print(roi.shape[0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "No Trials     87\n",
       "One Trial     15\n",
       "Two Trials     1\n",
       "Name: Clinical Trials Resulted, dtype: int64"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "roi['Clinical Trials Resulted'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [],
   "source": [
    "value_map = {'No Trials': 0, 'One Trial': 1, 'Two Trials': 2, np.nan: 0}\n",
    "\n",
    "roi['Clinical Trials Resulted'] = roi['Clinical Trials Resulted'].replace(\n",
    "    value_map\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "A National Phase I Study of Cabozantinib in Combination with 13-cis-Retinoic Acid in Children with Relapsed or Refractory Solid Tumors                                                                               2\n",
       "Metformin for oral cancer prevention 2.0                                                                                                                                                                             1\n",
       "Phase 1B, Nonrandomized Trial Investigating Docetaxel Combined with Cirmtuzumab in Patients with Metastatic Castration Resistant Prostate Cancer                                                                     1\n",
       "Individualized therapy for refractory medulloblastoma                                                                                                                                                                1\n",
       "NCT05153304  Protocol PCV-001  A Phase I/II Safety and Feasibility Study of Personalized Immunotherapy in Adults with Upper Gastrointestinal Tract Cancers.                                                          1\n",
       "Trial Name:    Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor  NCT#: NCT03556384                                                                       1\n",
       "A Phase 1/2 Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer with Bone Metastases (COMRADE)                                                                  1\n",
       "Nivolumab and Ipilimumab in Combination With Immunogenic Chemotherapy for Patients With Advanced NSCLC (NSCLC)    NCT04043195                                                                                        1\n",
       "Ruxolitinib with or without navitoxlax (Abbvie)                                                                                                                                                                      1\n",
       "Neoadjuvant Immunoradiotherapy in Head & Neck Cancer                                                                                                                                                                 1\n",
       "A Phase 1b Trial of Cirmtuzumab and Paclitaxel in Metastatic or Locally Advanced, Unresectable Breast Cancer                                                                                                         1\n",
       "An Open-Label, Phase 2 Efficacy Study of Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)                                                         1\n",
       "NCI10096 ClinicalTrials.gov Identifier:  NCT03317392  Title:  A Phase 1/2 Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer with Bone Metastases (COMRADE)    1\n",
       "NIVOLUMAB (ANTI-PD1 ANTIBODY) AND IPILIMUMAB (ANTI-CTLA4 ANTIBODY) IN COMBINATION WITH IMMUNOGENIC CHEMOTHERAPY FOR PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER                                                1\n",
       "Discovery and translation of precursor B-cell Acute Lymphoblastic Leukemia (B-ALL) stem cell targets                                                                                                                 1\n",
       "Name: First Clinical Trial, dtype: int64"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "roi[\"First Clinical Trial\"].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "A National Phase I Study of Cabozantinib in Combination with 13-cis-Retinoic Acid in Children with Relapsed or Refractory Solid Tumors                                                                               2\n",
       "Metformin for oral cancer prevention 2.0                                                                                                                                                                             1\n",
       "Phase 1B, Nonrandomized Trial Investigating Docetaxel Combined with Cirmtuzumab in Patients with Metastatic Castration Resistant Prostate Cancer                                                                     1\n",
       "Individualized therapy for refractory medulloblastoma                                                                                                                                                                1\n",
       "NCT05153304  Protocol PCV-001  A Phase I/II Safety and Feasibility Study of Personalized Immunotherapy in Adults with Upper Gastrointestinal Tract Cancers.                                                          1\n",
       "Trial Name:    Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor  NCT#: NCT03556384                                                                       1\n",
       "A Phase 1/2 Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer with Bone Metastases (COMRADE)                                                                  1\n",
       "Nivolumab and Ipilimumab in Combination With Immunogenic Chemotherapy for Patients With Advanced NSCLC (NSCLC)    NCT04043195                                                                                        1\n",
       "Ruxolitinib with or without navitoxlax (Abbvie)                                                                                                                                                                      1\n",
       "Neoadjuvant Immunoradiotherapy in Head & Neck Cancer                                                                                                                                                                 1\n",
       "A Phase 1b Trial of Cirmtuzumab and Paclitaxel in Metastatic or Locally Advanced, Unresectable Breast Cancer                                                                                                         1\n",
       "An Open-Label, Phase 2 Efficacy Study of Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)                                                         1\n",
       "NCI10096 ClinicalTrials.gov Identifier:  NCT03317392  Title:  A Phase 1/2 Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer with Bone Metastases (COMRADE)    1\n",
       "NIVOLUMAB (ANTI-PD1 ANTIBODY) AND IPILIMUMAB (ANTI-CTLA4 ANTIBODY) IN COMBINATION WITH IMMUNOGENIC CHEMOTHERAPY FOR PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER                                                1\n",
       "Discovery and translation of precursor B-cell Acute Lymphoblastic Leukemia (B-ALL) stem cell targets                                                                                                                 1\n",
       "Name: First Clinical Trial, dtype: int64"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "roi[\"First Clinical Trial\"].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0      Detecting dysregulated genes in neuroblastoma ...\n",
       "2      Functional Roles for Histidine Kinase Signalin...\n",
       "10                    New Therapies for Myeloid Leukemia\n",
       "12     Peptide Targeted Delivery of Epigenetic Therap...\n",
       "14             Precision Interception of Gastric Cancers\n",
       "                             ...                        \n",
       "289    Identification of therapeutic targets of B-ALL...\n",
       "290    Identification of therapeutic targets of B-ALL...\n",
       "291    Developing targeted therapy for Ewing sarcoma ...\n",
       "292    Developing targeted therapy for Ewing sarcoma ...\n",
       "293                                              Science\n",
       "Name: Project Title, Length: 174, dtype: object"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "roi[roi['First Clinical Trial'].isna()]['Project Title']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "dtype('float64')"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "roi.dtypes['Clinical Trials Resulted']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Readjust the clinical trials name columns to plot in Tableau\n",
    "\n",
    "def adjust_cli_trials_names(data, title):\n",
    "\n",
    "    \"\"\"\n",
    "        df (DataFrame): subject dataframe\n",
    "        title (str): the title of the project to adjust clinical trials names\n",
    "\n",
    "    \"\"\"\n",
    "\n",
    "    df = data[data['Project Title'] == title].reset_index(drop=True)\n",
    "    num_trials = df['Clinical Trials Resulted'].sum()\n",
    "    first = df['First Clinical Trial'].reset_index(drop=True)\n",
    "    second = df['Second Clinical Trial'].reset_index(drop=True)\n",
    "\n",
    "    if num_trials <= 1:\n",
    "        return df\n",
    "\n",
    "    while len(first[~first.isna()]) > 1:\n",
    "        first_nonnull_index = first[~first.isna()].index[-1]\n",
    "        to_move = first.iloc[first_nonnull_index]\n",
    "        first_null_index = second[second.isna()].index[0]\n",
    "        second.iloc[first_null_index] = to_move\n",
    "        first[first_nonnull_index] = np.NaN\n",
    "\n",
    "    df['First Clinical Trial'] = first\n",
    "    df['Second Clinical Trial'] = second\n",
    "    return df\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Award ID</th>\n",
       "      <th>Project Title</th>\n",
       "      <th>PI Institution</th>\n",
       "      <th>Other Institution</th>\n",
       "      <th>Prevention and diagnostic tools</th>\n",
       "      <th>Novel approaches and new therapeutic platforms</th>\n",
       "      <th>Immunotherapies and personalized vaccines</th>\n",
       "      <th>Addressing cancer disparities</th>\n",
       "      <th>Pediatric cancers</th>\n",
       "      <th>Specific Aims</th>\n",
       "      <th>Aim 1</th>\n",
       "      <th>Aim 2</th>\n",
       "      <th>Aim 3</th>\n",
       "      <th>Aim 4</th>\n",
       "      <th>Aim 5</th>\n",
       "      <th>Aim 6</th>\n",
       "      <th>Public Health Significance</th>\n",
       "      <th>Award Amount</th>\n",
       "      <th>Grant Start Date:</th>\n",
       "      <th>Grant End Date:</th>\n",
       "      <th>Complete</th>\n",
       "      <th>SR - None</th>\n",
       "      <th>SR - Biobehaviorial MCC</th>\n",
       "      <th>SR - Biorepository &amp; Tissue Tech. MCC</th>\n",
       "      <th>SR - Biostatistics MCC</th>\n",
       "      <th>SR - Clinical Trials Office MCC</th>\n",
       "      <th>SR - Flow Cytometry MCC</th>\n",
       "      <th>SR - Genomics &amp; Computational Bio. MCC</th>\n",
       "      <th>SR - In Vivo Imaging MCC</th>\n",
       "      <th>SR - Microscopy MCC</th>\n",
       "      <th>SR - Radiation Medicine MCC</th>\n",
       "      <th>SR - Transgenic Mouse MCC</th>\n",
       "      <th>SR - Gene Transfer/Targeting/Therap Salk</th>\n",
       "      <th>SR - Transgenic Salk</th>\n",
       "      <th>SR - Mass Spect - Proteom/Metabol Salk</th>\n",
       "      <th>SR - Chemical Library Screening SBPMDI</th>\n",
       "      <th>SR - Functional Genomics SBPMDI</th>\n",
       "      <th>Cancer Metabolism SBPMDI</th>\n",
       "      <th>Pedal Importance (recruitment, retention, advancement)</th>\n",
       "      <th>If yes, please specify</th>\n",
       "      <th>If no, please specify</th>\n",
       "      <th>Clinical Trials Resulted</th>\n",
       "      <th>First Clinical Trial</th>\n",
       "      <th>First Clinical Trial Patient Count</th>\n",
       "      <th>Second Clinical Trial</th>\n",
       "      <th>Second Clinical Trial Patient Count</th>\n",
       "      <th>Companies Founded</th>\n",
       "      <th>Patents Filed</th>\n",
       "      <th>Patent Details</th>\n",
       "      <th>Peer-Reviewed Publications Count</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>6.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>6.1</td>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Improve outcomes for HNSCC by expanding our un...</td>\n",
       "      <td>Leverage our administrative, biostatistics, co...</td>\n",
       "      <td>Develop emerging, novel, high quality translat...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cancer immunotherapies have led to major treat...</td>\n",
       "      <td>200000.0</td>\n",
       "      <td>2021-07-01</td>\n",
       "      <td>2022-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Opportunity to develop an immune modulatory ap...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>Metformin for oral cancer prevention 2.0</td>\n",
       "      <td>80.0</td>\n",
       "      <td>Neoadjuvant Immunoradiotherapy in Head &amp; Neck ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>61.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>6.2</td>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Improve outcomes for HNSCC by expanding out un...</td>\n",
       "      <td>Leverage our administrative, biostatistics, co...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cancer immunotherapies have led to major treat...</td>\n",
       "      <td>200000.0</td>\n",
       "      <td>2021-07-01</td>\n",
       "      <td>2022-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>62.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>6.3</td>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Leverage our administrative, biostatistics, co...</td>\n",
       "      <td>Develop emerging, novel, high quality translat...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cancer immunotherapies have led to major treat...</td>\n",
       "      <td>200000.0</td>\n",
       "      <td>2021-07-01</td>\n",
       "      <td>2022-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     ID Event Name  Award ID  \\\n",
       "0   6.0    Initial       6.1   \n",
       "1  61.0    Initial       6.2   \n",
       "2  62.0    Initial       6.3   \n",
       "\n",
       "                                       Project Title        PI Institution  \\\n",
       "0  UCSD-UCSF Specialized Program of Research Exce...  Moores Cancer Center   \n",
       "1  UCSD-UCSF Specialized Program of Research Exce...  Moores Cancer Center   \n",
       "2  UCSD-UCSF Specialized Program of Research Exce...  Moores Cancer Center   \n",
       "\n",
       "  Other Institution  Prevention and diagnostic tools  \\\n",
       "0               NaN                            False   \n",
       "1               NaN                            False   \n",
       "2               NaN                            False   \n",
       "\n",
       "   Novel approaches and new therapeutic platforms  \\\n",
       "0                                           False   \n",
       "1                                           False   \n",
       "2                                           False   \n",
       "\n",
       "   Immunotherapies and personalized vaccines  Addressing cancer disparities  \\\n",
       "0                                      False                          False   \n",
       "1                                       True                          False   \n",
       "2                                       True                          False   \n",
       "\n",
       "   Pediatric cancers        Specific Aims  \\\n",
       "0              False  Three Specific Aims   \n",
       "1              False    Two Specific Aims   \n",
       "2              False    Two Specific Aims   \n",
       "\n",
       "                                               Aim 1  \\\n",
       "0  Improve outcomes for HNSCC by expanding our un...   \n",
       "1  Improve outcomes for HNSCC by expanding out un...   \n",
       "2  Leverage our administrative, biostatistics, co...   \n",
       "\n",
       "                                               Aim 2  \\\n",
       "0  Leverage our administrative, biostatistics, co...   \n",
       "1  Leverage our administrative, biostatistics, co...   \n",
       "2  Develop emerging, novel, high quality translat...   \n",
       "\n",
       "                                               Aim 3 Aim 4 Aim 5 Aim 6  \\\n",
       "0  Develop emerging, novel, high quality translat...   NaN   NaN   NaN   \n",
       "1                                                NaN   NaN   NaN   NaN   \n",
       "2                                                NaN   NaN   NaN   NaN   \n",
       "\n",
       "                          Public Health Significance  Award Amount  \\\n",
       "0  Cancer immunotherapies have led to major treat...      200000.0   \n",
       "1  Cancer immunotherapies have led to major treat...      200000.0   \n",
       "2  Cancer immunotherapies have led to major treat...      200000.0   \n",
       "\n",
       "  Grant Start Date: Grant End Date:  Complete SR - None  \\\n",
       "0        2021-07-01      2022-06-30  Complete     False   \n",
       "1        2021-07-01      2022-06-30  Complete     False   \n",
       "2        2021-07-01      2022-06-30  Complete       NaN   \n",
       "\n",
       "  SR - Biobehaviorial MCC SR - Biorepository & Tissue Tech. MCC  \\\n",
       "0                   False                                  True   \n",
       "1                   False                                  True   \n",
       "2                     NaN                                   NaN   \n",
       "\n",
       "  SR - Biostatistics MCC SR - Clinical Trials Office MCC  \\\n",
       "0                  False                            True   \n",
       "1                   True                            True   \n",
       "2                    NaN                             NaN   \n",
       "\n",
       "  SR - Flow Cytometry MCC SR - Genomics & Computational Bio. MCC  \\\n",
       "0                   False                                   True   \n",
       "1                    True                                  False   \n",
       "2                     NaN                                    NaN   \n",
       "\n",
       "  SR - In Vivo Imaging MCC SR - Microscopy MCC SR - Radiation Medicine MCC  \\\n",
       "0                    False               False                       False   \n",
       "1                    False                True                        True   \n",
       "2                      NaN                 NaN                         NaN   \n",
       "\n",
       "  SR - Transgenic Mouse MCC SR - Gene Transfer/Targeting/Therap Salk  \\\n",
       "0                     False                                    False   \n",
       "1                      True                                    False   \n",
       "2                       NaN                                      NaN   \n",
       "\n",
       "  SR - Transgenic Salk SR - Mass Spect - Proteom/Metabol Salk  \\\n",
       "0                False                                  False   \n",
       "1                False                                  False   \n",
       "2                  NaN                                    NaN   \n",
       "\n",
       "  SR - Chemical Library Screening SBPMDI SR - Functional Genomics SBPMDI  \\\n",
       "0                                  False                           False   \n",
       "1                                  False                           False   \n",
       "2                                    NaN                             NaN   \n",
       "\n",
       "  Cancer Metabolism SBPMDI  \\\n",
       "0                    False   \n",
       "1                    False   \n",
       "2                      NaN   \n",
       "\n",
       "  Pedal Importance (recruitment, retention, advancement)  \\\n",
       "0                                                Yes       \n",
       "1                                                 No       \n",
       "2                                                NaN       \n",
       "\n",
       "                              If yes, please specify If no, please specify  \\\n",
       "0  Opportunity to develop an immune modulatory ap...                   NaN   \n",
       "1                                                NaN                   NaN   \n",
       "2                                                NaN                   NaN   \n",
       "\n",
       "   Clinical Trials Resulted                      First Clinical Trial  \\\n",
       "0                       1.0  Metformin for oral cancer prevention 2.0   \n",
       "1                       1.0                                       NaN   \n",
       "2                       0.0                                       NaN   \n",
       "\n",
       "   First Clinical Trial Patient Count  \\\n",
       "0                                80.0   \n",
       "1                                 0.0   \n",
       "2                                 NaN   \n",
       "\n",
       "                               Second Clinical Trial  \\\n",
       "0  Neoadjuvant Immunoradiotherapy in Head & Neck ...   \n",
       "1                                                NaN   \n",
       "2                                                NaN   \n",
       "\n",
       "   Second Clinical Trial Patient Count Companies Founded Patents Filed  \\\n",
       "0                                  NaN                No            No   \n",
       "1                                  NaN               NaN            No   \n",
       "2                                  NaN               NaN           NaN   \n",
       "\n",
       "  Patent Details Peer-Reviewed Publications Count  \n",
       "0            NaN                              Two  \n",
       "1            NaN                              Two  \n",
       "2            NaN                              NaN  "
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "adjust_cli_trials_names(roi, 'UCSD-UCSF Specialized Program of Research Excellence (SPORE) in Head and Neck Cancer')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Discovery of non-coding oncogenic mutations in pediatric acute lymphoblastic leukemia using ATAC-seq and Hi-C\n",
      "Decoding Colon Cancers Using Boolean Principles\n",
      "Irreversible electroporation as an In Situ vaccine for pancreatic cancer\n",
      "Tissue-specific role of SMARCB1 in pediatric rhabdoid tumors\n",
      "Therapeutic Reprogramming of Pancreatic Cancer Stroma Via Modulation of p62 and p53 (YEAR 1)\n",
      "Deciphering the role of RNA editing in leukemia stem cell generation and pediatric acute leukemia relapse\n",
      "Identification of therapeutic targets of B-ALL using Boolean logic\n",
      "Developing targeted therapy for Ewing sarcoma metastasis\n",
      "Oncogenic Regulation of B-Lymphomagenesis by the Chromatin Modulator DOT1L\n",
      "An over-expressed GPCR in pancreatic cancer associated fibroblasts as a novel therapeutic target\n",
      "Targeting cellular mechanotransduction in breast cancer metastasis\n",
      "FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma\n",
      "Identification of genes critical for the production of T cells from human pluripotent stem cells for development of \"off-the-shelf\" T cell immunotherapies\n",
      "A Phase 1b Safety and Feasibility Study of Personalized Immunotherapy in Adults with Advanced Cancers\n",
      "Understanding and Targeting NRF2 in Pancreatic Cancer\n",
      "Highly selective, synthetic, cleavage specificity-based nanobiosensors for tumorigenic and anti-tumorigenic MMPs\n",
      "Targeting CD114 Signaling in Pediatric Medulloblastoma\n",
      "Inhibiting Liver Cancer Stem Cells to Improve Response to Thermal Ablation\n",
      "Knowledge-based planning and treatment decision-making for gynecologic brachytherapy\n",
      "Identification of regulatory programs for glioblastoma cellular hierarchy using single-cell multi-omic profiling\n",
      "The GNAS-PKA Onco-Signaling Network in Colorectal Malignancies\n",
      "UCSD-UCSF Specialized Program of Research Excellence (SPORE) in Head and Neck Cancer\n",
      "Improved Echocardiographic Diagnosis of Anthracycline-Related Cardiac Dysfunction Using Global Longitudinal Strain\n",
      "New Therapies for Myeloid Leukemia\n",
      "Mechanisms Linking Prolonged Nightly Fasting with Cancer Risk\n",
      "Precision Interception of Gastric Cancers\n",
      "Epigenetic basis of platinum drug resistance in ovarian cancer\n",
      "Examination of inhibitors of the ULK1 autophagy kinase as therapeutics in NSCLC\n",
      "Neoantigen-specific T cell responses in exceptional responders to immunotherapy in NSCLC\n",
      "Defining the mechanisms of pancreatic cancer susceptibility in patient-derived organoid models\n",
      "Cytotoxic Breast Cancer Treatment Effects on Aging\n",
      "Targeting Stem Cell Signals in Cancer Development and Progression\n",
      "Detecting Correlates of Vaccine Responses in Allogeneic Hematopoietic Stem Cell Transplant Recipients \n",
      "Targeting fibroblast heterogeneity to improve surgical outcomes in pancreatic cancer\n",
      "A Novel Role for Histidine Kinase Activity in Neuroblastoma Pathogenesis\n",
      "In Vivo Modeling of Anti-Tumor Responses of Human Melanoma Patients and their Responses to Checkpoint Immunotherapy\n",
      "Protein Kinase C as a Novel Biomarker and Target in Pancreatic Cancer\n",
      "Small molecule screen for inhibitors of the GOLPH3 pathway\n",
      "Applying p38 MAPK inhibitors to tackle breast cancer metastasis\n",
      "Stromal reprogramming to enhance the effectiveness of pancreatic cancer therapy\n",
      "Targeting imatinib-resistant, KIT-negative cells in human GISTs\n",
      "Demonstrating the Clinical Utility of Whole Exome Sequencing for Cancer Patients\n",
      "Targeting KRAS mutant lung cancer with biphosphonated/statins and rapamycin analogs\n",
      "KRAS Addiction and Protein Biomarkers of Response to anti-KRAS Therapy in NSCLC Patient Derived Xenografts\n",
      "Detecting dysregulated genes in neuroblastoma using allele-specific expression\n",
      "Investigating the Efficacy of radium-223 with Olaparib in Men with Metastatic Castration-resistant Prostate Cancer\n",
      "Low Dose Chemotherapy for Immuno-activation in Lung Cancer\n",
      "Functional Roles for Histidine Kinase Signaling in Neuroblastoma\n",
      "A National Phase I Study of Cabozantinib in Combination with 13-cis-Retinoic Acid in Children with Relapsed or Refractory Solid Tumors\n",
      "Peptide Targeted Delivery of Epigenetic Therapies in Pancreatic Cancer\n",
      "Elucidating the role of Syk kinase and Syk inhibitors combined with Radiation therapy in Neuroblastoma\n",
      "A pilot trial to test the benefit of real time drug screening to determine individualized treatment plans for children and young adults with relapsed or refractory medulloblastoma\n",
      "Novel Pathways Regulated by NME1 in Neuroblastoma\n",
      "Characterization of a GOLPH3 Pathway Inhibitor to Enable a Hit-to-Lead Grant to Develop a Novel Cancer Therapeutic\n",
      "Microbe-Associated Colorectal Cancer (M.A.C.S)\n",
      "Evaluation of carcinogen exposure via genome-wide DNA-adduct signatures\n",
      "Impact of Metformin on Clonal Hematopoiesis and Clinical Outcomes in Breast Cancer\n",
      "Natural Killer Cells for Treatment of Medulloblastoma\n",
      "Targeting FZD7 in human cancers\n",
      "Inducing Cytosolic Chromatin Fragments in Cancer Cells to Turn Cold Tumors Hot\n",
      "Responses of Melanoma Patients to Checkpoint Immunotherapy\n",
      "Enhanced Breast Cancer Risk Prediction from Imputed Gene Expression\n",
      "Targeting A Therapeutic Vulnerability in PTEN-Deficient Brain Tumors\n",
      "Epigenetic profiling of endometrial cancer\n",
      "Development and Implementation of a Peer-Navigation Intervention to Improve Research Literacy in Pediatric Cancer Trials\n",
      "Transcriptomic, epigenomic profiling to reveal TIL, microglia functional phenotype, and clonality in pediatric brain tumors\n",
      "A Phase 1b pilot clinical trial of cirmtuzumab, an anti-ROR1 monoclonal antibody, in combination with paclitaxel for the treatment of patients with metastatic, or locally advanced, unresectable breast cancer\n",
      "An Open-Label, Phase 2 Efficacy Study of Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)\n",
      "Junk2\n",
      "Junk\n",
      "Fake Project to Test\n",
      "Test title\n",
      "Novel kinase inhibitors in combination with retinoic acide for neuroblastoma\n",
      "A Phase 1B, Nonrandomized Trial Investigating Docetaxel Combined with Cirmtuzumab in Patients with Metastatic Castration Resistant Prostate Cancer\n",
      "Science\n"
     ]
    }
   ],
   "source": [
    "for i in roi['Project Title'].value_counts().index:\n",
    "    print(i)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Remove dummy/test projects\n",
    "\n",
    "roi = roi[~roi['Project Title'].isin(['Junk2', 'Junk', 'Fake Project to Test', 'Test title'])]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['Discovery of non-coding oncogenic mutations in pediatric acute lymphoblastic leukemia using ATAC-seq and Hi-C',\n",
       "       'Decoding Colon Cancers Using Boolean Principles',\n",
       "       'Irreversible electroporation as an In Situ vaccine for pancreatic cancer',\n",
       "       'Tissue-specific role of SMARCB1 in pediatric rhabdoid tumors',\n",
       "       'Therapeutic Reprogramming of Pancreatic Cancer Stroma Via Modulation of p62 and p53 (YEAR 1)',\n",
       "       'Deciphering the role of RNA editing in leukemia stem cell generation and pediatric acute leukemia relapse',\n",
       "       'Identification of therapeutic targets of B-ALL using Boolean logic',\n",
       "       'Developing targeted therapy for Ewing sarcoma metastasis',\n",
       "       'Oncogenic Regulation of B-Lymphomagenesis by the Chromatin Modulator DOT1L',\n",
       "       'An over-expressed GPCR in pancreatic cancer associated fibroblasts as a novel therapeutic target',\n",
       "       'Targeting cellular mechanotransduction in breast cancer metastasis',\n",
       "       'FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma',\n",
       "       'Identification of genes critical for the production of T cells from human pluripotent stem cells for development of \"off-the-shelf\" T cell immunotherapies',\n",
       "       'A Phase 1b Safety and Feasibility Study of Personalized Immunotherapy in Adults with Advanced Cancers',\n",
       "       'Understanding and Targeting NRF2 in Pancreatic Cancer',\n",
       "       'Highly selective, synthetic, cleavage specificity-based nanobiosensors for tumorigenic and anti-tumorigenic MMPs',\n",
       "       'Targeting CD114 Signaling in Pediatric Medulloblastoma',\n",
       "       'Inhibiting Liver Cancer Stem Cells to Improve Response to Thermal Ablation',\n",
       "       'Knowledge-based planning and treatment decision-making for gynecologic brachytherapy',\n",
       "       'Identification of regulatory programs for glioblastoma cellular hierarchy using single-cell multi-omic profiling',\n",
       "       'The GNAS-PKA Onco-Signaling Network in Colorectal Malignancies',\n",
       "       'UCSD-UCSF Specialized Program of Research Excellence (SPORE) in Head and Neck Cancer',\n",
       "       'Improved Echocardiographic Diagnosis of Anthracycline-Related Cardiac Dysfunction Using Global Longitudinal Strain',\n",
       "       'New Therapies for Myeloid Leukemia',\n",
       "       'Mechanisms Linking Prolonged Nightly Fasting with Cancer Risk',\n",
       "       'Precision Interception of Gastric Cancers',\n",
       "       'Epigenetic basis of platinum drug resistance in ovarian cancer',\n",
       "       'Examination of inhibitors of the ULK1 autophagy kinase as therapeutics in NSCLC',\n",
       "       'Neoantigen-specific T cell responses in exceptional responders to immunotherapy in NSCLC',\n",
       "       'Defining the mechanisms of pancreatic cancer susceptibility in patient-derived organoid models',\n",
       "       'Cytotoxic Breast Cancer Treatment Effects on Aging',\n",
       "       'Targeting Stem Cell Signals in Cancer Development and Progression',\n",
       "       'Detecting Correlates of Vaccine Responses in Allogeneic Hematopoietic Stem Cell Transplant Recipients ',\n",
       "       'Targeting fibroblast heterogeneity to improve surgical outcomes in pancreatic cancer',\n",
       "       'A Novel Role for Histidine Kinase Activity in Neuroblastoma Pathogenesis',\n",
       "       'In Vivo Modeling of Anti-Tumor Responses of Human Melanoma Patients and their Responses to Checkpoint Immunotherapy',\n",
       "       'Protein Kinase C as a Novel Biomarker and Target in Pancreatic Cancer',\n",
       "       'Small molecule screen for inhibitors of the GOLPH3 pathway',\n",
       "       'Applying p38 MAPK inhibitors to tackle breast cancer metastasis',\n",
       "       'Stromal reprogramming to enhance the effectiveness of pancreatic cancer therapy',\n",
       "       'Targeting imatinib-resistant, KIT-negative cells in human GISTs',\n",
       "       'Demonstrating the Clinical Utility of Whole Exome Sequencing for Cancer Patients',\n",
       "       'Targeting KRAS mutant lung cancer with biphosphonated/statins and rapamycin analogs',\n",
       "       'KRAS Addiction and Protein Biomarkers of Response to anti-KRAS Therapy in NSCLC Patient Derived Xenografts',\n",
       "       'Detecting dysregulated genes in neuroblastoma using allele-specific expression',\n",
       "       'A Phase 1b pilot clinical trial of cirmtuzumab, an anti-ROR1 monoclonal antibody, in combination with paclitaxel for the treatment of patients with metastatic, or locally advanced, unresectable breast cancer',\n",
       "       'Low Dose Chemotherapy for Immuno-activation in Lung Cancer',\n",
       "       'Investigating the Efficacy of radium-223 with Olaparib in Men with Metastatic Castration-resistant Prostate Cancer',\n",
       "       'A National Phase I Study of Cabozantinib in Combination with 13-cis-Retinoic Acid in Children with Relapsed or Refractory Solid Tumors',\n",
       "       'Peptide Targeted Delivery of Epigenetic Therapies in Pancreatic Cancer',\n",
       "       'Elucidating the role of Syk kinase and Syk inhibitors combined with Radiation therapy in Neuroblastoma',\n",
       "       'A pilot trial to test the benefit of real time drug screening to determine individualized treatment plans for children and young adults with relapsed or refractory medulloblastoma',\n",
       "       'Novel Pathways Regulated by NME1 in Neuroblastoma',\n",
       "       'Characterization of a GOLPH3 Pathway Inhibitor to Enable a Hit-to-Lead Grant to Develop a Novel Cancer Therapeutic',\n",
       "       'Microbe-Associated Colorectal Cancer (M.A.C.S)',\n",
       "       'Evaluation of carcinogen exposure via genome-wide DNA-adduct signatures',\n",
       "       'Impact of Metformin on Clonal Hematopoiesis and Clinical Outcomes in Breast Cancer',\n",
       "       'Natural Killer Cells for Treatment of Medulloblastoma',\n",
       "       'Targeting FZD7 in human cancers',\n",
       "       'Inducing Cytosolic Chromatin Fragments in Cancer Cells to Turn Cold Tumors Hot',\n",
       "       'Responses of Melanoma Patients to Checkpoint Immunotherapy',\n",
       "       'Enhanced Breast Cancer Risk Prediction from Imputed Gene Expression',\n",
       "       'Targeting A Therapeutic Vulnerability in PTEN-Deficient Brain Tumors',\n",
       "       'Epigenetic profiling of endometrial cancer',\n",
       "       'Development and Implementation of a Peer-Navigation Intervention to Improve Research Literacy in Pediatric Cancer Trials',\n",
       "       'Transcriptomic, epigenomic profiling to reveal TIL, microglia functional phenotype, and clonality in pediatric brain tumors',\n",
       "       'Functional Roles for Histidine Kinase Signaling in Neuroblastoma',\n",
       "       'An Open-Label, Phase 2 Efficacy Study of Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)',\n",
       "       'Novel kinase inhibitors in combination with retinoic acide for neuroblastoma',\n",
       "       'A Phase 1B, Nonrandomized Trial Investigating Docetaxel Combined with Cirmtuzumab in Patients with Metastatic Castration Resistant Prostate Cancer',\n",
       "       'Science'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "roi['Project Title'].value_counts().index"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Award ID</th>\n",
       "      <th>Project Title</th>\n",
       "      <th>PI Institution</th>\n",
       "      <th>Other Institution</th>\n",
       "      <th>Prevention and diagnostic tools</th>\n",
       "      <th>Novel approaches and new therapeutic platforms</th>\n",
       "      <th>Immunotherapies and personalized vaccines</th>\n",
       "      <th>Addressing cancer disparities</th>\n",
       "      <th>Pediatric cancers</th>\n",
       "      <th>Specific Aims</th>\n",
       "      <th>Aim 1</th>\n",
       "      <th>Aim 2</th>\n",
       "      <th>Aim 3</th>\n",
       "      <th>Aim 4</th>\n",
       "      <th>Aim 5</th>\n",
       "      <th>Aim 6</th>\n",
       "      <th>Public Health Significance</th>\n",
       "      <th>Award Amount</th>\n",
       "      <th>Grant Start Date:</th>\n",
       "      <th>Grant End Date:</th>\n",
       "      <th>Complete</th>\n",
       "      <th>SR - None</th>\n",
       "      <th>SR - Biobehaviorial MCC</th>\n",
       "      <th>SR - Biorepository &amp; Tissue Tech. MCC</th>\n",
       "      <th>SR - Biostatistics MCC</th>\n",
       "      <th>SR - Clinical Trials Office MCC</th>\n",
       "      <th>SR - Flow Cytometry MCC</th>\n",
       "      <th>SR - Genomics &amp; Computational Bio. MCC</th>\n",
       "      <th>SR - In Vivo Imaging MCC</th>\n",
       "      <th>SR - Microscopy MCC</th>\n",
       "      <th>SR - Radiation Medicine MCC</th>\n",
       "      <th>SR - Transgenic Mouse MCC</th>\n",
       "      <th>SR - Gene Transfer/Targeting/Therap Salk</th>\n",
       "      <th>SR - Transgenic Salk</th>\n",
       "      <th>SR - Mass Spect - Proteom/Metabol Salk</th>\n",
       "      <th>SR - Chemical Library Screening SBPMDI</th>\n",
       "      <th>SR - Functional Genomics SBPMDI</th>\n",
       "      <th>Cancer Metabolism SBPMDI</th>\n",
       "      <th>Pedal Importance (recruitment, retention, advancement)</th>\n",
       "      <th>If yes, please specify</th>\n",
       "      <th>If no, please specify</th>\n",
       "      <th>Clinical Trials Resulted</th>\n",
       "      <th>First Clinical Trial</th>\n",
       "      <th>First Clinical Trial Patient Count</th>\n",
       "      <th>Second Clinical Trial</th>\n",
       "      <th>Second Clinical Trial Patient Count</th>\n",
       "      <th>Companies Founded</th>\n",
       "      <th>Patents Filed</th>\n",
       "      <th>Patent Details</th>\n",
       "      <th>Peer-Reviewed Publications Count</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>50.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>50.1</td>\n",
       "      <td>Tissue-specific role of SMARCB1 in pediatric r...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine cellular constraints on the ability ...</td>\n",
       "      <td>Investigate mechanisms underlying tissue-speci...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>This project aims to identify the mechanisms u...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>This grant and the publication that resulted (...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>none</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>129.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>50.2</td>\n",
       "      <td>Tissue-specific role of SMARCB1 in pediatric r...</td>\n",
       "      <td>Rady Children's</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine cellular constraints on the ability ...</td>\n",
       "      <td>Investigate mechanisms underlying tissue-speci...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>This project aims to identify the mechanisms u...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>196.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>196.1</td>\n",
       "      <td>Tissue-specific role of SMARCB1 in pediatric r...</td>\n",
       "      <td>UCSD - not a member of Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine cellular constraints on the ability...</td>\n",
       "      <td>Investigate mechanisms underlying tissue-speci...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>This project aims to identify the mechanisms u...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>197.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>196.2</td>\n",
       "      <td>Tissue-specific role of SMARCB1 in pediatric r...</td>\n",
       "      <td>UCSD - not a member of Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine cellular constraints on the ability ...</td>\n",
       "      <td>Investigate mechanisms underlying tissue-speci...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>This project aims to identify the mechanisms u...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "      ID Event Name  Award ID  \\\n",
       "0   50.0    Initial      50.1   \n",
       "1  129.0    Initial      50.2   \n",
       "2  196.0    Initial     196.1   \n",
       "3  197.0    Initial     196.2   \n",
       "\n",
       "                                       Project Title  \\\n",
       "0  Tissue-specific role of SMARCB1 in pediatric r...   \n",
       "1  Tissue-specific role of SMARCB1 in pediatric r...   \n",
       "2  Tissue-specific role of SMARCB1 in pediatric r...   \n",
       "3  Tissue-specific role of SMARCB1 in pediatric r...   \n",
       "\n",
       "                                PI Institution Other Institution  \\\n",
       "0                         Moores Cancer Center               NaN   \n",
       "1                              Rady Children's               NaN   \n",
       "2  UCSD - not a member of Moores Cancer Center               NaN   \n",
       "3  UCSD - not a member of Moores Cancer Center               NaN   \n",
       "\n",
       "   Prevention and diagnostic tools  \\\n",
       "0                            False   \n",
       "1                            False   \n",
       "2                            False   \n",
       "3                            False   \n",
       "\n",
       "   Novel approaches and new therapeutic platforms  \\\n",
       "0                                           False   \n",
       "1                                           False   \n",
       "2                                           False   \n",
       "3                                           False   \n",
       "\n",
       "   Immunotherapies and personalized vaccines  Addressing cancer disparities  \\\n",
       "0                                      False                          False   \n",
       "1                                      False                          False   \n",
       "2                                      False                          False   \n",
       "3                                      False                          False   \n",
       "\n",
       "   Pediatric cancers      Specific Aims  \\\n",
       "0               True  Two Specific Aims   \n",
       "1               True  Two Specific Aims   \n",
       "2               True  Two Specific Aims   \n",
       "3               True  Two Specific Aims   \n",
       "\n",
       "                                               Aim 1  \\\n",
       "0  Determine cellular constraints on the ability ...   \n",
       "1  Determine cellular constraints on the ability ...   \n",
       "2   Determine cellular constraints on the ability...   \n",
       "3  Determine cellular constraints on the ability ...   \n",
       "\n",
       "                                               Aim 2 Aim 3 Aim 4 Aim 5 Aim 6  \\\n",
       "0  Investigate mechanisms underlying tissue-speci...   NaN   NaN   NaN   NaN   \n",
       "1  Investigate mechanisms underlying tissue-speci...   NaN   NaN   NaN   NaN   \n",
       "2  Investigate mechanisms underlying tissue-speci...   NaN   NaN   NaN   NaN   \n",
       "3  Investigate mechanisms underlying tissue-speci...   NaN   NaN   NaN   NaN   \n",
       "\n",
       "                          Public Health Significance  Award Amount  \\\n",
       "0  This project aims to identify the mechanisms u...       75000.0   \n",
       "1  This project aims to identify the mechanisms u...       75000.0   \n",
       "2  This project aims to identify the mechanisms u...       75000.0   \n",
       "3  This project aims to identify the mechanisms u...       75000.0   \n",
       "\n",
       "  Grant Start Date: Grant End Date:  Complete SR - None  \\\n",
       "0        2017-06-01      2018-05-31  Complete     False   \n",
       "1        2017-06-01      2018-05-31  Complete      True   \n",
       "2        2017-06-01      2018-05-31  Complete       NaN   \n",
       "3        2017-06-01      2018-05-31  Complete       NaN   \n",
       "\n",
       "  SR - Biobehaviorial MCC SR - Biorepository & Tissue Tech. MCC  \\\n",
       "0                   False                                 False   \n",
       "1                   False                                 False   \n",
       "2                     NaN                                   NaN   \n",
       "3                     NaN                                   NaN   \n",
       "\n",
       "  SR - Biostatistics MCC SR - Clinical Trials Office MCC  \\\n",
       "0                  False                           False   \n",
       "1                  False                           False   \n",
       "2                    NaN                             NaN   \n",
       "3                    NaN                             NaN   \n",
       "\n",
       "  SR - Flow Cytometry MCC SR - Genomics & Computational Bio. MCC  \\\n",
       "0                   False                                   True   \n",
       "1                   False                                  False   \n",
       "2                     NaN                                    NaN   \n",
       "3                     NaN                                    NaN   \n",
       "\n",
       "  SR - In Vivo Imaging MCC SR - Microscopy MCC SR - Radiation Medicine MCC  \\\n",
       "0                    False                True                       False   \n",
       "1                    False               False                       False   \n",
       "2                      NaN                 NaN                         NaN   \n",
       "3                      NaN                 NaN                         NaN   \n",
       "\n",
       "  SR - Transgenic Mouse MCC SR - Gene Transfer/Targeting/Therap Salk  \\\n",
       "0                     False                                    False   \n",
       "1                     False                                    False   \n",
       "2                       NaN                                      NaN   \n",
       "3                       NaN                                      NaN   \n",
       "\n",
       "  SR - Transgenic Salk SR - Mass Spect - Proteom/Metabol Salk  \\\n",
       "0                False                                  False   \n",
       "1                False                                  False   \n",
       "2                  NaN                                    NaN   \n",
       "3                  NaN                                    NaN   \n",
       "\n",
       "  SR - Chemical Library Screening SBPMDI SR - Functional Genomics SBPMDI  \\\n",
       "0                                  False                           False   \n",
       "1                                  False                           False   \n",
       "2                                    NaN                             NaN   \n",
       "3                                    NaN                             NaN   \n",
       "\n",
       "  Cancer Metabolism SBPMDI  \\\n",
       "0                    False   \n",
       "1                    False   \n",
       "2                      NaN   \n",
       "3                      NaN   \n",
       "\n",
       "  Pedal Importance (recruitment, retention, advancement)  \\\n",
       "0                                                Yes       \n",
       "1                                                 No       \n",
       "2                                                NaN       \n",
       "3                                                NaN       \n",
       "\n",
       "                              If yes, please specify If no, please specify  \\\n",
       "0  This grant and the publication that resulted (...                   NaN   \n",
       "1                                                NaN                   NaN   \n",
       "2                                                NaN                   NaN   \n",
       "3                                                NaN                   NaN   \n",
       "\n",
       "   Clinical Trials Resulted First Clinical Trial  \\\n",
       "0                       0.0                  NaN   \n",
       "1                       0.0                  NaN   \n",
       "2                       0.0                  NaN   \n",
       "3                       0.0                  NaN   \n",
       "\n",
       "   First Clinical Trial Patient Count Second Clinical Trial  \\\n",
       "0                                 NaN                   NaN   \n",
       "1                                 NaN                   NaN   \n",
       "2                                 NaN                   NaN   \n",
       "3                                 NaN                   NaN   \n",
       "\n",
       "   Second Clinical Trial Patient Count Companies Founded Patents Filed  \\\n",
       "0                                  NaN              none            No   \n",
       "1                                  NaN               NaN            No   \n",
       "2                                  NaN               NaN           NaN   \n",
       "3                                  NaN               NaN           NaN   \n",
       "\n",
       "  Patent Details Peer-Reviewed Publications Count  \n",
       "0            NaN                              One  \n",
       "1            NaN                              One  \n",
       "2            NaN                              NaN  \n",
       "3            NaN                              NaN  "
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Apply clinical trial names adjustment function to all projects\n",
    "\n",
    "projs = roi['Project Title'].value_counts().index\n",
    "proj_data = []\n",
    "for p in projs:\n",
    "    df = adjust_cli_trials_names(roi, p)\n",
    "    proj_data.append(df)\n",
    "proj_data[3]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Award ID</th>\n",
       "      <th>Project Title</th>\n",
       "      <th>PI Institution</th>\n",
       "      <th>Other Institution</th>\n",
       "      <th>Prevention and diagnostic tools</th>\n",
       "      <th>Novel approaches and new therapeutic platforms</th>\n",
       "      <th>Immunotherapies and personalized vaccines</th>\n",
       "      <th>Addressing cancer disparities</th>\n",
       "      <th>Pediatric cancers</th>\n",
       "      <th>Specific Aims</th>\n",
       "      <th>Aim 1</th>\n",
       "      <th>Aim 2</th>\n",
       "      <th>Aim 3</th>\n",
       "      <th>Aim 4</th>\n",
       "      <th>Aim 5</th>\n",
       "      <th>Aim 6</th>\n",
       "      <th>Public Health Significance</th>\n",
       "      <th>Award Amount</th>\n",
       "      <th>Grant Start Date:</th>\n",
       "      <th>Grant End Date:</th>\n",
       "      <th>Complete</th>\n",
       "      <th>SR - None</th>\n",
       "      <th>SR - Biobehaviorial MCC</th>\n",
       "      <th>SR - Biorepository &amp; Tissue Tech. MCC</th>\n",
       "      <th>SR - Biostatistics MCC</th>\n",
       "      <th>SR - Clinical Trials Office MCC</th>\n",
       "      <th>SR - Flow Cytometry MCC</th>\n",
       "      <th>SR - Genomics &amp; Computational Bio. MCC</th>\n",
       "      <th>SR - In Vivo Imaging MCC</th>\n",
       "      <th>SR - Microscopy MCC</th>\n",
       "      <th>SR - Radiation Medicine MCC</th>\n",
       "      <th>SR - Transgenic Mouse MCC</th>\n",
       "      <th>SR - Gene Transfer/Targeting/Therap Salk</th>\n",
       "      <th>SR - Transgenic Salk</th>\n",
       "      <th>SR - Mass Spect - Proteom/Metabol Salk</th>\n",
       "      <th>SR - Chemical Library Screening SBPMDI</th>\n",
       "      <th>SR - Functional Genomics SBPMDI</th>\n",
       "      <th>Cancer Metabolism SBPMDI</th>\n",
       "      <th>Pedal Importance (recruitment, retention, advancement)</th>\n",
       "      <th>If yes, please specify</th>\n",
       "      <th>If no, please specify</th>\n",
       "      <th>Clinical Trials Resulted</th>\n",
       "      <th>First Clinical Trial</th>\n",
       "      <th>First Clinical Trial Patient Count</th>\n",
       "      <th>Second Clinical Trial</th>\n",
       "      <th>Second Clinical Trial Patient Count</th>\n",
       "      <th>Companies Founded</th>\n",
       "      <th>Patents Filed</th>\n",
       "      <th>Patent Details</th>\n",
       "      <th>Peer-Reviewed Publications Count</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>52.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>52.1</td>\n",
       "      <td>Discovery of non-coding oncogenic mutations in...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Discover non-coding regulatory mutations in AL...</td>\n",
       "      <td>Discover large-scale structural mutations and ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Acute Lymphoblastic Leukemia (ALL) is the most...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The funding for this project and the data gene...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>131.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>52.2</td>\n",
       "      <td>Discovery of non-coding oncogenic mutations in...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Discover non-coding regulatory mutations in AL...</td>\n",
       "      <td>Discover large-scale structural mutations and ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Acute Lymphoblastic Leukemia (ALL) is the most...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Obtaining funding is important for career adva...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>132.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>52.3</td>\n",
       "      <td>Discovery of non-coding oncogenic mutations in...</td>\n",
       "      <td>Rady Children's</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Discover non-coding regulatory mutations in AL...</td>\n",
       "      <td>Discover large-scale structural mutations and ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Acute Lymphoblastic Leukemia (ALL) is the most...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Funding for this project enhanced innovative c...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>200.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>200.1</td>\n",
       "      <td>Discovery of non-coding oncogenic mutations in...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Discover non-coding regulatory mutations in AL...</td>\n",
       "      <td>Discover large-scale structural mutations and ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Acute Lymphoblastic Leukemia (ALL) is the most...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>201.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>200.2</td>\n",
       "      <td>Discovery of non-coding oncogenic mutations in...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Discover non-coding regulatory mutations in AL...</td>\n",
       "      <td>Discover large-scale structural mutations and ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Acute Lymphoblastic Leukemia (ALL) is the most...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>181</th>\n",
       "      <td>41.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>41.1</td>\n",
       "      <td>An Open-Label, Phase 2 Efficacy Study of Temoz...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Primary objective: To determine overall respon...</td>\n",
       "      <td>Secondary objective: To determine progression-...</td>\n",
       "      <td>Exploratory objective: To investigate serum me...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Gastrointestinal stromal tumor (GIST) caused b...</td>\n",
       "      <td>300000.0</td>\n",
       "      <td>2019-01-01</td>\n",
       "      <td>2020-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The PTC funding lead to preliminary data for a...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>Trial Name:    Temozolomide (TMZ) In Advanced ...</td>\n",
       "      <td>13.0</td>\n",
       "      <td>An Open-Label, Phase 2 Efficacy Study of Temoz...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Three</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>182</th>\n",
       "      <td>118.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>41.2</td>\n",
       "      <td>An Open-Label, Phase 2 Efficacy Study of Temoz...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Primary objective: To determine overall respon...</td>\n",
       "      <td>Secondary objective: To determine progression-...</td>\n",
       "      <td>Exploratory objective: To investigate serum me...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Gastrointestinal stromal tumor (GIST) caused b...</td>\n",
       "      <td>300000.0</td>\n",
       "      <td>2019-01-01</td>\n",
       "      <td>2020-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>183</th>\n",
       "      <td>55.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>55.1</td>\n",
       "      <td>Novel kinase inhibitors in combination with re...</td>\n",
       "      <td>Rady Children's</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine the efficacy of CRA treatment combin...</td>\n",
       "      <td>Evaluate the functional role of the RAS-MAPK p...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Children with aggressive neuroblastoma have po...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The availability of funding from Padres Pedal ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>A National Phase I Study of Cabozantinib in Co...</td>\n",
       "      <td>6.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>none</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Three</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>184</th>\n",
       "      <td>8.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>8.1</td>\n",
       "      <td>A Phase 1B, Nonrandomized Trial Investigating ...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>To investigate the safety and tolerability of ...</td>\n",
       "      <td>To evaluate the anti-tumor activity of cirmtuz...</td>\n",
       "      <td>To prospectively interrogate the Wnt signaling...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Metastatic castration resistant prostate cance...</td>\n",
       "      <td>150000.0</td>\n",
       "      <td>2020-01-01</td>\n",
       "      <td>2021-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes this grant was supporting the infrastructu...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>Phase 1B, Nonrandomized Trial Investigating Do...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Oncternal</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Zero</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>185</th>\n",
       "      <td>207.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Science</td>\n",
       "      <td>UCSD - not a member of Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>science project</td>\n",
       "      <td>Health Project</td>\n",
       "      <td>Both</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>diana</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2022-08-01</td>\n",
       "      <td>2022-08-31</td>\n",
       "      <td>Incomplete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>186 rows × 52 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "        ID Event Name  Award ID  \\\n",
       "0     52.0    Initial      52.1   \n",
       "1    131.0    Initial      52.2   \n",
       "2    132.0    Initial      52.3   \n",
       "3    200.0    Initial     200.1   \n",
       "4    201.0    Initial     200.2   \n",
       "..     ...        ...       ...   \n",
       "181   41.0    Initial      41.1   \n",
       "182  118.0    Initial      41.2   \n",
       "183   55.0    Initial      55.1   \n",
       "184    8.0    Initial       8.1   \n",
       "185  207.0    Initial       NaN   \n",
       "\n",
       "                                         Project Title  \\\n",
       "0    Discovery of non-coding oncogenic mutations in...   \n",
       "1    Discovery of non-coding oncogenic mutations in...   \n",
       "2    Discovery of non-coding oncogenic mutations in...   \n",
       "3    Discovery of non-coding oncogenic mutations in...   \n",
       "4    Discovery of non-coding oncogenic mutations in...   \n",
       "..                                                 ...   \n",
       "181  An Open-Label, Phase 2 Efficacy Study of Temoz...   \n",
       "182  An Open-Label, Phase 2 Efficacy Study of Temoz...   \n",
       "183  Novel kinase inhibitors in combination with re...   \n",
       "184  A Phase 1B, Nonrandomized Trial Investigating ...   \n",
       "185                                            Science   \n",
       "\n",
       "                                  PI Institution Other Institution  \\\n",
       "0                                 Salk Institute               NaN   \n",
       "1                                 Salk Institute               NaN   \n",
       "2                                Rady Children's               NaN   \n",
       "3                                 Salk Institute               NaN   \n",
       "4                                 Salk Institute               NaN   \n",
       "..                                           ...               ...   \n",
       "181                         Moores Cancer Center               NaN   \n",
       "182                         Moores Cancer Center               NaN   \n",
       "183                              Rady Children's               NaN   \n",
       "184                         Moores Cancer Center               NaN   \n",
       "185  UCSD - not a member of Moores Cancer Center               NaN   \n",
       "\n",
       "     Prevention and diagnostic tools  \\\n",
       "0                              False   \n",
       "1                              False   \n",
       "2                              False   \n",
       "3                              False   \n",
       "4                              False   \n",
       "..                               ...   \n",
       "181                            False   \n",
       "182                            False   \n",
       "183                            False   \n",
       "184                            False   \n",
       "185                            False   \n",
       "\n",
       "     Novel approaches and new therapeutic platforms  \\\n",
       "0                                             False   \n",
       "1                                             False   \n",
       "2                                             False   \n",
       "3                                             False   \n",
       "4                                             False   \n",
       "..                                              ...   \n",
       "181                                            True   \n",
       "182                                            True   \n",
       "183                                           False   \n",
       "184                                            True   \n",
       "185                                           False   \n",
       "\n",
       "     Immunotherapies and personalized vaccines  Addressing cancer disparities  \\\n",
       "0                                        False                          False   \n",
       "1                                        False                          False   \n",
       "2                                        False                          False   \n",
       "3                                        False                          False   \n",
       "4                                        False                          False   \n",
       "..                                         ...                            ...   \n",
       "181                                      False                          False   \n",
       "182                                      False                          False   \n",
       "183                                      False                          False   \n",
       "184                                      False                          False   \n",
       "185                                      False                           True   \n",
       "\n",
       "     Pediatric cancers        Specific Aims  \\\n",
       "0                 True    Two Specific Aims   \n",
       "1                 True    Two Specific Aims   \n",
       "2                 True    Two Specific Aims   \n",
       "3                 True    Two Specific Aims   \n",
       "4                 True    Two Specific Aims   \n",
       "..                 ...                  ...   \n",
       "181              False  Three Specific Aims   \n",
       "182              False  Three Specific Aims   \n",
       "183               True    Two Specific Aims   \n",
       "184              False  Three Specific Aims   \n",
       "185              False  Three Specific Aims   \n",
       "\n",
       "                                                 Aim 1  \\\n",
       "0    Discover non-coding regulatory mutations in AL...   \n",
       "1    Discover non-coding regulatory mutations in AL...   \n",
       "2    Discover non-coding regulatory mutations in AL...   \n",
       "3    Discover non-coding regulatory mutations in AL...   \n",
       "4    Discover non-coding regulatory mutations in AL...   \n",
       "..                                                 ...   \n",
       "181  Primary objective: To determine overall respon...   \n",
       "182  Primary objective: To determine overall respon...   \n",
       "183  Determine the efficacy of CRA treatment combin...   \n",
       "184  To investigate the safety and tolerability of ...   \n",
       "185                                    science project   \n",
       "\n",
       "                                                 Aim 2  \\\n",
       "0    Discover large-scale structural mutations and ...   \n",
       "1    Discover large-scale structural mutations and ...   \n",
       "2    Discover large-scale structural mutations and ...   \n",
       "3    Discover large-scale structural mutations and ...   \n",
       "4    Discover large-scale structural mutations and ...   \n",
       "..                                                 ...   \n",
       "181  Secondary objective: To determine progression-...   \n",
       "182  Secondary objective: To determine progression-...   \n",
       "183  Evaluate the functional role of the RAS-MAPK p...   \n",
       "184  To evaluate the anti-tumor activity of cirmtuz...   \n",
       "185                                     Health Project   \n",
       "\n",
       "                                                 Aim 3 Aim 4 Aim 5 Aim 6  \\\n",
       "0                                                  NaN   NaN   NaN   NaN   \n",
       "1                                                  NaN   NaN   NaN   NaN   \n",
       "2                                                  NaN   NaN   NaN   NaN   \n",
       "3                                                  NaN   NaN   NaN   NaN   \n",
       "4                                                  NaN   NaN   NaN   NaN   \n",
       "..                                                 ...   ...   ...   ...   \n",
       "181  Exploratory objective: To investigate serum me...   NaN   NaN   NaN   \n",
       "182  Exploratory objective: To investigate serum me...   NaN   NaN   NaN   \n",
       "183                                                NaN   NaN   NaN   NaN   \n",
       "184  To prospectively interrogate the Wnt signaling...   NaN   NaN   NaN   \n",
       "185                                               Both   NaN   NaN   NaN   \n",
       "\n",
       "                            Public Health Significance  Award Amount  \\\n",
       "0    Acute Lymphoblastic Leukemia (ALL) is the most...       75000.0   \n",
       "1    Acute Lymphoblastic Leukemia (ALL) is the most...       75000.0   \n",
       "2    Acute Lymphoblastic Leukemia (ALL) is the most...       75000.0   \n",
       "3    Acute Lymphoblastic Leukemia (ALL) is the most...       75000.0   \n",
       "4    Acute Lymphoblastic Leukemia (ALL) is the most...       75000.0   \n",
       "..                                                 ...           ...   \n",
       "181  Gastrointestinal stromal tumor (GIST) caused b...      300000.0   \n",
       "182  Gastrointestinal stromal tumor (GIST) caused b...      300000.0   \n",
       "183  Children with aggressive neuroblastoma have po...       75000.0   \n",
       "184  Metastatic castration resistant prostate cance...      150000.0   \n",
       "185                                              diana       75000.0   \n",
       "\n",
       "    Grant Start Date: Grant End Date:    Complete SR - None  \\\n",
       "0          2017-06-01      2018-05-31    Complete      True   \n",
       "1          2017-06-01      2018-05-31    Complete      True   \n",
       "2          2017-06-01      2018-05-31    Complete      True   \n",
       "3          2017-06-01      2018-05-31    Complete       NaN   \n",
       "4          2017-06-01      2018-05-31    Complete       NaN   \n",
       "..                ...             ...         ...       ...   \n",
       "181        2019-01-01      2020-12-31    Complete     False   \n",
       "182        2019-01-01      2020-12-31    Complete     False   \n",
       "183        2017-06-01      2018-05-31    Complete     False   \n",
       "184        2020-01-01      2021-12-31    Complete     False   \n",
       "185        2022-08-01      2022-08-31  Incomplete       NaN   \n",
       "\n",
       "    SR - Biobehaviorial MCC SR - Biorepository & Tissue Tech. MCC  \\\n",
       "0                     False                                 False   \n",
       "1                     False                                 False   \n",
       "2                     False                                 False   \n",
       "3                       NaN                                   NaN   \n",
       "4                       NaN                                   NaN   \n",
       "..                      ...                                   ...   \n",
       "181                   False                                  True   \n",
       "182                   False                                  True   \n",
       "183                   False                                  True   \n",
       "184                   False                                  True   \n",
       "185                     NaN                                   NaN   \n",
       "\n",
       "    SR - Biostatistics MCC SR - Clinical Trials Office MCC  \\\n",
       "0                    False                           False   \n",
       "1                    False                           False   \n",
       "2                    False                           False   \n",
       "3                      NaN                             NaN   \n",
       "4                      NaN                             NaN   \n",
       "..                     ...                             ...   \n",
       "181                   True                            True   \n",
       "182                   True                            True   \n",
       "183                   True                           False   \n",
       "184                   True                            True   \n",
       "185                    NaN                             NaN   \n",
       "\n",
       "    SR - Flow Cytometry MCC SR - Genomics & Computational Bio. MCC  \\\n",
       "0                     False                                  False   \n",
       "1                     False                                  False   \n",
       "2                     False                                  False   \n",
       "3                       NaN                                    NaN   \n",
       "4                       NaN                                    NaN   \n",
       "..                      ...                                    ...   \n",
       "181                   False                                  False   \n",
       "182                   False                                  False   \n",
       "183                   False                                  False   \n",
       "184                   False                                   True   \n",
       "185                     NaN                                    NaN   \n",
       "\n",
       "    SR - In Vivo Imaging MCC SR - Microscopy MCC SR - Radiation Medicine MCC  \\\n",
       "0                      False               False                       False   \n",
       "1                      False               False                       False   \n",
       "2                      False               False                       False   \n",
       "3                        NaN                 NaN                         NaN   \n",
       "4                        NaN                 NaN                         NaN   \n",
       "..                       ...                 ...                         ...   \n",
       "181                    False               False                       False   \n",
       "182                    False               False                       False   \n",
       "183                     True               False                       False   \n",
       "184                    False               False                       False   \n",
       "185                      NaN                 NaN                         NaN   \n",
       "\n",
       "    SR - Transgenic Mouse MCC SR - Gene Transfer/Targeting/Therap Salk  \\\n",
       "0                       False                                    False   \n",
       "1                       False                                    False   \n",
       "2                       False                                    False   \n",
       "3                         NaN                                      NaN   \n",
       "4                         NaN                                      NaN   \n",
       "..                        ...                                      ...   \n",
       "181                     False                                    False   \n",
       "182                     False                                    False   \n",
       "183                     False                                    False   \n",
       "184                     False                                    False   \n",
       "185                       NaN                                      NaN   \n",
       "\n",
       "    SR - Transgenic Salk SR - Mass Spect - Proteom/Metabol Salk  \\\n",
       "0                  False                                  False   \n",
       "1                  False                                  False   \n",
       "2                  False                                  False   \n",
       "3                    NaN                                    NaN   \n",
       "4                    NaN                                    NaN   \n",
       "..                   ...                                    ...   \n",
       "181                False                                  False   \n",
       "182                False                                  False   \n",
       "183                False                                  False   \n",
       "184                False                                  False   \n",
       "185                  NaN                                    NaN   \n",
       "\n",
       "    SR - Chemical Library Screening SBPMDI SR - Functional Genomics SBPMDI  \\\n",
       "0                                    False                           False   \n",
       "1                                    False                           False   \n",
       "2                                    False                           False   \n",
       "3                                      NaN                             NaN   \n",
       "4                                      NaN                             NaN   \n",
       "..                                     ...                             ...   \n",
       "181                                  False                           False   \n",
       "182                                  False                           False   \n",
       "183                                  False                           False   \n",
       "184                                  False                           False   \n",
       "185                                    NaN                             NaN   \n",
       "\n",
       "    Cancer Metabolism SBPMDI  \\\n",
       "0                      False   \n",
       "1                      False   \n",
       "2                      False   \n",
       "3                        NaN   \n",
       "4                        NaN   \n",
       "..                       ...   \n",
       "181                    False   \n",
       "182                    False   \n",
       "183                    False   \n",
       "184                    False   \n",
       "185                      NaN   \n",
       "\n",
       "    Pedal Importance (recruitment, retention, advancement)  \\\n",
       "0                                                  Yes       \n",
       "1                                                  Yes       \n",
       "2                                                  Yes       \n",
       "3                                                  NaN       \n",
       "4                                                  NaN       \n",
       "..                                                 ...       \n",
       "181                                                Yes       \n",
       "182                                                 No       \n",
       "183                                                Yes       \n",
       "184                                                Yes       \n",
       "185                                                NaN       \n",
       "\n",
       "                                If yes, please specify If no, please specify  \\\n",
       "0    The funding for this project and the data gene...                   NaN   \n",
       "1    Obtaining funding is important for career adva...                   NaN   \n",
       "2    Funding for this project enhanced innovative c...                   NaN   \n",
       "3                                                  NaN                   NaN   \n",
       "4                                                  NaN                   NaN   \n",
       "..                                                 ...                   ...   \n",
       "181  The PTC funding lead to preliminary data for a...                   NaN   \n",
       "182                                                NaN                   NaN   \n",
       "183  The availability of funding from Padres Pedal ...                   NaN   \n",
       "184  Yes this grant was supporting the infrastructu...                   NaN   \n",
       "185                                                NaN                   NaN   \n",
       "\n",
       "     Clinical Trials Resulted  \\\n",
       "0                         0.0   \n",
       "1                         0.0   \n",
       "2                         0.0   \n",
       "3                         0.0   \n",
       "4                         0.0   \n",
       "..                        ...   \n",
       "181                       1.0   \n",
       "182                       1.0   \n",
       "183                       1.0   \n",
       "184                       1.0   \n",
       "185                       0.0   \n",
       "\n",
       "                                  First Clinical Trial  \\\n",
       "0                                                  NaN   \n",
       "1                                                  NaN   \n",
       "2                                                  NaN   \n",
       "3                                                  NaN   \n",
       "4                                                  NaN   \n",
       "..                                                 ...   \n",
       "181  Trial Name:    Temozolomide (TMZ) In Advanced ...   \n",
       "182                                                NaN   \n",
       "183  A National Phase I Study of Cabozantinib in Co...   \n",
       "184  Phase 1B, Nonrandomized Trial Investigating Do...   \n",
       "185                                                NaN   \n",
       "\n",
       "     First Clinical Trial Patient Count  \\\n",
       "0                                   NaN   \n",
       "1                                   NaN   \n",
       "2                                   NaN   \n",
       "3                                   NaN   \n",
       "4                                   NaN   \n",
       "..                                  ...   \n",
       "181                                13.0   \n",
       "182                                18.0   \n",
       "183                                 6.0   \n",
       "184                                 0.0   \n",
       "185                                 NaN   \n",
       "\n",
       "                                 Second Clinical Trial  \\\n",
       "0                                                  NaN   \n",
       "1                                                  NaN   \n",
       "2                                                  NaN   \n",
       "3                                                  NaN   \n",
       "4                                                  NaN   \n",
       "..                                                 ...   \n",
       "181  An Open-Label, Phase 2 Efficacy Study of Temoz...   \n",
       "182                                                NaN   \n",
       "183                                                NaN   \n",
       "184                                                NaN   \n",
       "185                                                NaN   \n",
       "\n",
       "     Second Clinical Trial Patient Count Companies Founded Patents Filed  \\\n",
       "0                                    NaN              None            No   \n",
       "1                                    NaN              None            No   \n",
       "2                                    NaN              None            No   \n",
       "3                                    NaN               NaN           NaN   \n",
       "4                                    NaN               NaN           NaN   \n",
       "..                                   ...               ...           ...   \n",
       "181                                  NaN              None            No   \n",
       "182                                  NaN               NaN            No   \n",
       "183                                  NaN              none            No   \n",
       "184                                  NaN         Oncternal            No   \n",
       "185                                  NaN               NaN           NaN   \n",
       "\n",
       "    Patent Details Peer-Reviewed Publications Count  \n",
       "0              NaN                              Two  \n",
       "1              NaN                              One  \n",
       "2              NaN                              Two  \n",
       "3              NaN                              NaN  \n",
       "4              NaN                              NaN  \n",
       "..             ...                              ...  \n",
       "181            NaN                            Three  \n",
       "182            NaN                              One  \n",
       "183            NaN                            Three  \n",
       "184            NaN                             Zero  \n",
       "185            NaN                              NaN  \n",
       "\n",
       "[186 rows x 52 columns]"
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Concatenate adjusted dataframes into one\n",
    "\n",
    "roi_adj = pd.concat(proj_data, ignore_index=True)\n",
    "roi_adj"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Award ID</th>\n",
       "      <th>Project Title</th>\n",
       "      <th>PI Institution</th>\n",
       "      <th>Other Institution</th>\n",
       "      <th>Prevention and diagnostic tools</th>\n",
       "      <th>Novel approaches and new therapeutic platforms</th>\n",
       "      <th>Immunotherapies and personalized vaccines</th>\n",
       "      <th>Addressing cancer disparities</th>\n",
       "      <th>Pediatric cancers</th>\n",
       "      <th>Specific Aims</th>\n",
       "      <th>Aim 1</th>\n",
       "      <th>Aim 2</th>\n",
       "      <th>Aim 3</th>\n",
       "      <th>Aim 4</th>\n",
       "      <th>Aim 5</th>\n",
       "      <th>Aim 6</th>\n",
       "      <th>Public Health Significance</th>\n",
       "      <th>Award Amount</th>\n",
       "      <th>Grant Start Date:</th>\n",
       "      <th>Grant End Date:</th>\n",
       "      <th>Complete</th>\n",
       "      <th>SR - None</th>\n",
       "      <th>SR - Biobehaviorial MCC</th>\n",
       "      <th>SR - Biorepository &amp; Tissue Tech. MCC</th>\n",
       "      <th>SR - Biostatistics MCC</th>\n",
       "      <th>SR - Clinical Trials Office MCC</th>\n",
       "      <th>SR - Flow Cytometry MCC</th>\n",
       "      <th>SR - Genomics &amp; Computational Bio. MCC</th>\n",
       "      <th>SR - In Vivo Imaging MCC</th>\n",
       "      <th>SR - Microscopy MCC</th>\n",
       "      <th>SR - Radiation Medicine MCC</th>\n",
       "      <th>SR - Transgenic Mouse MCC</th>\n",
       "      <th>SR - Gene Transfer/Targeting/Therap Salk</th>\n",
       "      <th>SR - Transgenic Salk</th>\n",
       "      <th>SR - Mass Spect - Proteom/Metabol Salk</th>\n",
       "      <th>SR - Chemical Library Screening SBPMDI</th>\n",
       "      <th>SR - Functional Genomics SBPMDI</th>\n",
       "      <th>Cancer Metabolism SBPMDI</th>\n",
       "      <th>Pedal Importance (recruitment, retention, advancement)</th>\n",
       "      <th>If yes, please specify</th>\n",
       "      <th>If no, please specify</th>\n",
       "      <th>Clinical Trials Resulted</th>\n",
       "      <th>First Clinical Trial</th>\n",
       "      <th>First Clinical Trial Patient Count</th>\n",
       "      <th>Second Clinical Trial</th>\n",
       "      <th>Second Clinical Trial Patient Count</th>\n",
       "      <th>Companies Founded</th>\n",
       "      <th>Patents Filed</th>\n",
       "      <th>Patent Details</th>\n",
       "      <th>Peer-Reviewed Publications Count</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>181</th>\n",
       "      <td>41.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>41.1</td>\n",
       "      <td>An Open-Label, Phase 2 Efficacy Study of Temoz...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Primary objective: To determine overall respon...</td>\n",
       "      <td>Secondary objective: To determine progression-...</td>\n",
       "      <td>Exploratory objective: To investigate serum me...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Gastrointestinal stromal tumor (GIST) caused b...</td>\n",
       "      <td>300000.0</td>\n",
       "      <td>2019-01-01</td>\n",
       "      <td>2020-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The PTC funding lead to preliminary data for a...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>Trial Name:    Temozolomide (TMZ) In Advanced ...</td>\n",
       "      <td>13.0</td>\n",
       "      <td>An Open-Label, Phase 2 Efficacy Study of Temoz...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Three</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>182</th>\n",
       "      <td>118.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>41.2</td>\n",
       "      <td>An Open-Label, Phase 2 Efficacy Study of Temoz...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Primary objective: To determine overall respon...</td>\n",
       "      <td>Secondary objective: To determine progression-...</td>\n",
       "      <td>Exploratory objective: To investigate serum me...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Gastrointestinal stromal tumor (GIST) caused b...</td>\n",
       "      <td>300000.0</td>\n",
       "      <td>2019-01-01</td>\n",
       "      <td>2020-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        ID Event Name  Award ID  \\\n",
       "181   41.0    Initial      41.1   \n",
       "182  118.0    Initial      41.2   \n",
       "\n",
       "                                         Project Title        PI Institution  \\\n",
       "181  An Open-Label, Phase 2 Efficacy Study of Temoz...  Moores Cancer Center   \n",
       "182  An Open-Label, Phase 2 Efficacy Study of Temoz...  Moores Cancer Center   \n",
       "\n",
       "    Other Institution  Prevention and diagnostic tools  \\\n",
       "181               NaN                            False   \n",
       "182               NaN                            False   \n",
       "\n",
       "     Novel approaches and new therapeutic platforms  \\\n",
       "181                                            True   \n",
       "182                                            True   \n",
       "\n",
       "     Immunotherapies and personalized vaccines  Addressing cancer disparities  \\\n",
       "181                                      False                          False   \n",
       "182                                      False                          False   \n",
       "\n",
       "     Pediatric cancers        Specific Aims  \\\n",
       "181              False  Three Specific Aims   \n",
       "182              False  Three Specific Aims   \n",
       "\n",
       "                                                 Aim 1  \\\n",
       "181  Primary objective: To determine overall respon...   \n",
       "182  Primary objective: To determine overall respon...   \n",
       "\n",
       "                                                 Aim 2  \\\n",
       "181  Secondary objective: To determine progression-...   \n",
       "182  Secondary objective: To determine progression-...   \n",
       "\n",
       "                                                 Aim 3 Aim 4 Aim 5 Aim 6  \\\n",
       "181  Exploratory objective: To investigate serum me...   NaN   NaN   NaN   \n",
       "182  Exploratory objective: To investigate serum me...   NaN   NaN   NaN   \n",
       "\n",
       "                            Public Health Significance  Award Amount  \\\n",
       "181  Gastrointestinal stromal tumor (GIST) caused b...      300000.0   \n",
       "182  Gastrointestinal stromal tumor (GIST) caused b...      300000.0   \n",
       "\n",
       "    Grant Start Date: Grant End Date:  Complete SR - None  \\\n",
       "181        2019-01-01      2020-12-31  Complete     False   \n",
       "182        2019-01-01      2020-12-31  Complete     False   \n",
       "\n",
       "    SR - Biobehaviorial MCC SR - Biorepository & Tissue Tech. MCC  \\\n",
       "181                   False                                  True   \n",
       "182                   False                                  True   \n",
       "\n",
       "    SR - Biostatistics MCC SR - Clinical Trials Office MCC  \\\n",
       "181                   True                            True   \n",
       "182                   True                            True   \n",
       "\n",
       "    SR - Flow Cytometry MCC SR - Genomics & Computational Bio. MCC  \\\n",
       "181                   False                                  False   \n",
       "182                   False                                  False   \n",
       "\n",
       "    SR - In Vivo Imaging MCC SR - Microscopy MCC SR - Radiation Medicine MCC  \\\n",
       "181                    False               False                       False   \n",
       "182                    False               False                       False   \n",
       "\n",
       "    SR - Transgenic Mouse MCC SR - Gene Transfer/Targeting/Therap Salk  \\\n",
       "181                     False                                    False   \n",
       "182                     False                                    False   \n",
       "\n",
       "    SR - Transgenic Salk SR - Mass Spect - Proteom/Metabol Salk  \\\n",
       "181                False                                  False   \n",
       "182                False                                  False   \n",
       "\n",
       "    SR - Chemical Library Screening SBPMDI SR - Functional Genomics SBPMDI  \\\n",
       "181                                  False                           False   \n",
       "182                                  False                           False   \n",
       "\n",
       "    Cancer Metabolism SBPMDI  \\\n",
       "181                    False   \n",
       "182                    False   \n",
       "\n",
       "    Pedal Importance (recruitment, retention, advancement)  \\\n",
       "181                                                Yes       \n",
       "182                                                 No       \n",
       "\n",
       "                                If yes, please specify If no, please specify  \\\n",
       "181  The PTC funding lead to preliminary data for a...                   NaN   \n",
       "182                                                NaN                   NaN   \n",
       "\n",
       "     Clinical Trials Resulted  \\\n",
       "181                       1.0   \n",
       "182                       1.0   \n",
       "\n",
       "                                  First Clinical Trial  \\\n",
       "181  Trial Name:    Temozolomide (TMZ) In Advanced ...   \n",
       "182                                                NaN   \n",
       "\n",
       "     First Clinical Trial Patient Count  \\\n",
       "181                                13.0   \n",
       "182                                18.0   \n",
       "\n",
       "                                 Second Clinical Trial  \\\n",
       "181  An Open-Label, Phase 2 Efficacy Study of Temoz...   \n",
       "182                                                NaN   \n",
       "\n",
       "     Second Clinical Trial Patient Count Companies Founded Patents Filed  \\\n",
       "181                                  NaN              None            No   \n",
       "182                                  NaN               NaN            No   \n",
       "\n",
       "    Patent Details Peer-Reviewed Publications Count  \n",
       "181            NaN                            Three  \n",
       "182            NaN                              One  "
      ]
     },
     "execution_count": 25,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# sanity checks\n",
    "\n",
    "roi_adj.loc[\n",
    "    roi_adj['Project Title'].apply(lambda x: True if re.match(r'^An Open-Label', x) else False), :\n",
    "]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Project Title</th>\n",
       "      <th>First Clinical Trial</th>\n",
       "      <th>Second Clinical Trial</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>169</th>\n",
       "      <td>Understanding and Targeting NRF2 in Pancreatic...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>171</th>\n",
       "      <td>Understanding and Targeting NRF2 in Pancreatic...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>Understanding and Targeting NRF2 in Pancreatic...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>103</th>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "      <td>Neoadjuvant Immunoradiotherapy in Head &amp; Neck ...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "      <td>Metformin for oral cancer prevention 2.0</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>A Phase 1B, Nonrandomized Trial Investigating ...</td>\n",
       "      <td>Phase 1B, Nonrandomized Trial Investigating Do...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>222</th>\n",
       "      <td>A Novel Role for Histidine Kinase Activity in ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>224</th>\n",
       "      <td>A Novel Role for Histidine Kinase Activity in ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>A National Phase I Study of Cabozantinib in Co...</td>\n",
       "      <td>A National Phase I Study of Cabozantinib in Co...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>102</th>\n",
       "      <td>A National Phase I Study of Cabozantinib in Co...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>186 rows × 3 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                         Project Title  \\\n",
       "169  Understanding and Targeting NRF2 in Pancreatic...   \n",
       "171  Understanding and Targeting NRF2 in Pancreatic...   \n",
       "57   Understanding and Targeting NRF2 in Pancreatic...   \n",
       "103  UCSD-UCSF Specialized Program of Research Exce...   \n",
       "6    UCSD-UCSF Specialized Program of Research Exce...   \n",
       "..                                                 ...   \n",
       "8    A Phase 1B, Nonrandomized Trial Investigating ...   \n",
       "222  A Novel Role for Histidine Kinase Activity in ...   \n",
       "224  A Novel Role for Histidine Kinase Activity in ...   \n",
       "4    A National Phase I Study of Cabozantinib in Co...   \n",
       "102  A National Phase I Study of Cabozantinib in Co...   \n",
       "\n",
       "                                  First Clinical Trial Second Clinical Trial  \n",
       "169                                                NaN                   NaN  \n",
       "171                                                NaN                   NaN  \n",
       "57                                                 NaN                   NaN  \n",
       "103  Neoadjuvant Immunoradiotherapy in Head & Neck ...                   NaN  \n",
       "6             Metformin for oral cancer prevention 2.0                   NaN  \n",
       "..                                                 ...                   ...  \n",
       "8    Phase 1B, Nonrandomized Trial Investigating Do...                   NaN  \n",
       "222                                                NaN                   NaN  \n",
       "224                                                NaN                   NaN  \n",
       "4    A National Phase I Study of Cabozantinib in Co...                   NaN  \n",
       "102                                                NaN                   NaN  \n",
       "\n",
       "[186 rows x 3 columns]"
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pd.set_option('display.max_rows', 22)\n",
    "roi[['Project Title', 'First Clinical Trial', 'Second Clinical Trial']].sort_values(by='Project Title', ascending=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Save cleaned dataframes to csv files in interim\n",
    "# Caution: examine directory before uncomment/run this cell to prevent duplicate\n",
    "# files or unintentional modifications to files\n",
    "\n",
    "wp = os.path.join('interim', 'tableau-datasets', '2022_Pedal_ROI.csv')\n",
    "roi_adj.to_csv(wp)\n",
    "\n",
    "# wp = os.path.join('interim', '2022_Pedal_Progress_Report.csv')\n",
    "# prog_r.to_csv(wp)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Publication Status 4</th>\n",
       "      <th>Fourth DOI #</th>\n",
       "      <th>Publication Status 5</th>\n",
       "      <th>Fifth DOI #</th>\n",
       "      <th>Publication Status 6</th>\n",
       "      <th>Sixth DOI #</th>\n",
       "      <th>Publication Status 7</th>\n",
       "      <th>Seventh DOI #</th>\n",
       "      <th>Publication Status 8</th>\n",
       "      <th>Eighth DOI #</th>\n",
       "      <th>Publication Status 9</th>\n",
       "      <th>Ninth DOI #</th>\n",
       "      <th>Publication Status 10</th>\n",
       "      <th>Tenth DOI #</th>\n",
       "      <th>Pedal Non-Peer Pubs</th>\n",
       "      <th>Other Accomplishments</th>\n",
       "      <th>Health Benefits</th>\n",
       "      <th>International</th>\n",
       "      <th>National</th>\n",
       "      <th>Local</th>\n",
       "      <th>General Public</th>\n",
       "      <th>Healthcare Professionals</th>\n",
       "      <th>Patients</th>\n",
       "      <th>Patient Families</th>\n",
       "      <th>Health Benefits Description</th>\n",
       "      <th>Policy Influence</th>\n",
       "      <th>International (pol)</th>\n",
       "      <th>National (pol)</th>\n",
       "      <th>Local (pol)</th>\n",
       "      <th>General Public (pol)</th>\n",
       "      <th>Healthcare Professionals (pol)</th>\n",
       "      <th>Patients (pol)</th>\n",
       "      <th>Patient Families (pol)</th>\n",
       "      <th>Policy Benefits Description</th>\n",
       "      <th>Economic Benefits</th>\n",
       "      <th>International (econ)</th>\n",
       "      <th>National (econ)</th>\n",
       "      <th>Local (econ)</th>\n",
       "      <th>General Public (econ)</th>\n",
       "      <th>Healthcare Professionals (econ)</th>\n",
       "      <th>Patients (econ)</th>\n",
       "      <th>Patient Families (econ)</th>\n",
       "      <th>Economic Benefits Description</th>\n",
       "      <th>Equity Benefits</th>\n",
       "      <th>International (equity)</th>\n",
       "      <th>National (equity)</th>\n",
       "      <th>Local (equity)</th>\n",
       "      <th>General Public (equity)</th>\n",
       "      <th>Healthcare Professionals (equity)</th>\n",
       "      <th>Patients (equity)</th>\n",
       "      <th>Patient Families (equity)</th>\n",
       "      <th>Equity Benefits Description</th>\n",
       "      <th>Additional Funding Achieved</th>\n",
       "      <th>First AFS Status</th>\n",
       "      <th>First AFS Name and Project Title</th>\n",
       "      <th>First AFS Amount</th>\n",
       "      <th>Second AFS Status</th>\n",
       "      <th>Second AFS Name and Project Title</th>\n",
       "      <th>Second AFS Amount</th>\n",
       "      <th>Third AFS Status</th>\n",
       "      <th>Third AFS Name and Project Title</th>\n",
       "      <th>Third AGS Amount</th>\n",
       "      <th>Fourth AFS Status</th>\n",
       "      <th>Fourth AFS Name and Project Title</th>\n",
       "      <th>Fourth AFS Amount</th>\n",
       "      <th>Additional Funding Source #5 Agency/Sponsor Name and Project Title</th>\n",
       "      <th>Fifth AFS Status</th>\n",
       "      <th>Fifth AFS Amount</th>\n",
       "      <th>Additional Pedal Funding Impact</th>\n",
       "      <th>Additional Funding Benefits Description</th>\n",
       "      <th>Additional Pedal Funding Impact (clinical stages)</th>\n",
       "      <th>Additional Funding Benefits Description (clinical stages)</th>\n",
       "      <th>Participated in Pedal</th>\n",
       "      <th>Further Research Contributions</th>\n",
       "      <th>Success Stories</th>\n",
       "      <th>Major Scientific Breakthroughs</th>\n",
       "      <th>Additional Comments</th>\n",
       "      <th>Complete</th>\n",
       "      <th>Publication Status 1</th>\n",
       "      <th>First DOI #</th>\n",
       "      <th>Publication Status 2</th>\n",
       "      <th>Second DOI #</th>\n",
       "      <th>Publication Status 3</th>\n",
       "      <th>Third DOI #</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>3.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>We have identified some genes that are recurre...</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>NIH R35HG011315 Using genomic perturbations to...</td>\n",
       "      <td>1500000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding would enable the applicatio...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>In addition, funding could allow us to do more...</td>\n",
       "      <td>Yes, I have participated as a rider every year...</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>4.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Adam K. Fuhs S, Meisenhelder J,  Lesperan...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>We expect our results will confirm the critica...</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Five</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>the Hartwell Foundation</td>\n",
       "      <td>300000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Padres Pedal the Cause</td>\n",
       "      <td>100000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>Pediatric Cancer Research Foundation</td>\n",
       "      <td>750000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>NIH R03CA273629-01</td>\n",
       "      <td>150000.0</td>\n",
       "      <td>Tower Cancer Research Foundation</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>500000.0</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to p...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to p...</td>\n",
       "      <td>I have participated as both a virtual particip...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Funding from Padres Pedal the Cause has been i...</td>\n",
       "      <td>True</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>5.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None to date</td>\n",
       "      <td>additional funding provided by Padres Pedal th...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>We expect our results will support the use of ...</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>The combination of cabozantinib with 13-cis-re...</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Exelixis, Inc.</td>\n",
       "      <td>250000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to e...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to p...</td>\n",
       "      <td>I have participated as both a virtual particip...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Funding from Padres Pedal the Cause has been i...</td>\n",
       "      <td>True</td>\n",
       "      <td>Published</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>6.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>See above in the progress report.</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>oral cancer prevention in at risk individuals</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>Oral cancer prevention and the consequent redu...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>At risk oral cancer patients are often part of...</td>\n",
       "      <td>One</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>NIH R01, will likely be funded soon</td>\n",
       "      <td>2500000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>For advancing the planned clinical trial and c...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Identification of biomarkers predicting clinic...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Many thanks for all your support!!!</td>\n",
       "      <td>True</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>8.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>8.Ghali F, Patel D, Jamieson C, Parsons JK, Mc...</td>\n",
       "      <td>2019-present Member, Wnt Signaling in Prostate...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Trial is testing a therapeutic combination for...</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Trial focused on all demographic of prostate c...</td>\n",
       "      <td>One</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Oncternal</td>\n",
       "      <td>377000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>This is a grass roots project. It is a single ...</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes, runner.</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>98</th>\n",
       "      <td>132.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>The knowledge gained from this project will en...</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No additional funding sources</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding would enable the continued ...</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes, I have participated as a virtual rider ev...</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>doi.org/10.1093/nar/gkab621</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>99</th>\n",
       "      <td>133.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Not applicable</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>The study may identify genes that are associat...</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No additional funding sources</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>True</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>100</th>\n",
       "      <td>134.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>My project identified potential tumor markers ...</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No additional funding sources</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>Published</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>101</th>\n",
       "      <td>136.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Pancreatitis biology is poorly understood due ...</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No additional funding sources</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funds would enable our team to cont...</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes, in May 2021 I participated virtually.</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>102</th>\n",
       "      <td>138.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Adam K. Fuhs S, Meisenhelder J,  Lesperan...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>We expect our results will confirm the critica...</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Five</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>the Hartwell Foundation</td>\n",
       "      <td>300000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Padres Pedal the Cause</td>\n",
       "      <td>100000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Padres Pedal the Cause</td>\n",
       "      <td>100000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>Pediatric Cancer Research Foundation</td>\n",
       "      <td>750000.0</td>\n",
       "      <td>NIH R03CA273629-01</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>150000.0</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to p...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to p...</td>\n",
       "      <td>I have participated as both a virtual particip...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Funding from Padres Pedal the Cause has  been ...</td>\n",
       "      <td>True</td>\n",
       "      <td>Published</td>\n",
       "      <td>NaN</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>102 rows × 86 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "        ID          Event Name Publication Status 4 Fourth DOI #  \\\n",
       "0      3.0  Progress Report #1                  NaN          NaN   \n",
       "1      4.0  Progress Report #1                  NaN          NaN   \n",
       "2      5.0  Progress Report #1                  NaN          NaN   \n",
       "3      6.0  Progress Report #1                  NaN          NaN   \n",
       "4      8.0  Progress Report #1                  NaN          NaN   \n",
       "..     ...                 ...                  ...          ...   \n",
       "98   132.0  Progress Report #1                  NaN          NaN   \n",
       "99   133.0  Progress Report #1                  NaN          NaN   \n",
       "100  134.0  Progress Report #1                  NaN          NaN   \n",
       "101  136.0  Progress Report #1                  NaN          NaN   \n",
       "102  138.0  Progress Report #1                  NaN          NaN   \n",
       "\n",
       "    Publication Status 5 Fifth DOI # Publication Status 6 Sixth DOI #  \\\n",
       "0                    NaN         NaN                  NaN         NaN   \n",
       "1                    NaN         NaN                  NaN         NaN   \n",
       "2                    NaN         NaN                  NaN         NaN   \n",
       "3                    NaN         NaN                  NaN         NaN   \n",
       "4                    NaN         NaN                  NaN         NaN   \n",
       "..                   ...         ...                  ...         ...   \n",
       "98                   NaN         NaN                  NaN         NaN   \n",
       "99                   NaN         NaN                  NaN         NaN   \n",
       "100                  NaN         NaN                  NaN         NaN   \n",
       "101                  NaN         NaN                  NaN         NaN   \n",
       "102                  NaN         NaN                  NaN         NaN   \n",
       "\n",
       "    Publication Status 7 Seventh DOI # Publication Status 8 Eighth DOI #  \\\n",
       "0                    NaN           NaN                  NaN          NaN   \n",
       "1                    NaN           NaN                  NaN          NaN   \n",
       "2                    NaN           NaN                  NaN          NaN   \n",
       "3                    NaN           NaN                  NaN          NaN   \n",
       "4                    NaN           NaN                  NaN          NaN   \n",
       "..                   ...           ...                  ...          ...   \n",
       "98                   NaN           NaN                  NaN          NaN   \n",
       "99                   NaN           NaN                  NaN          NaN   \n",
       "100                  NaN           NaN                  NaN          NaN   \n",
       "101                  NaN           NaN                  NaN          NaN   \n",
       "102                  NaN           NaN                  NaN          NaN   \n",
       "\n",
       "    Publication Status 9 Ninth DOI # Publication Status 10 Tenth DOI #  \\\n",
       "0                    NaN         NaN                   NaN         NaN   \n",
       "1                    NaN         NaN                   NaN         NaN   \n",
       "2                    NaN         NaN                   NaN         NaN   \n",
       "3                    NaN         NaN                   NaN         NaN   \n",
       "4                    NaN         NaN                   NaN         NaN   \n",
       "..                   ...         ...                   ...         ...   \n",
       "98                   NaN         NaN                   NaN         NaN   \n",
       "99                   NaN         NaN                   NaN         NaN   \n",
       "100                  NaN         NaN                   NaN         NaN   \n",
       "101                  NaN         NaN                   NaN         NaN   \n",
       "102                  NaN         NaN                   NaN         NaN   \n",
       "\n",
       "                                   Pedal Non-Peer Pubs  \\\n",
       "0                                                  NaN   \n",
       "1         Adam K. Fuhs S, Meisenhelder J,  Lesperan...   \n",
       "2                                         None to date   \n",
       "3                                                  NaN   \n",
       "4    8.Ghali F, Patel D, Jamieson C, Parsons JK, Mc...   \n",
       "..                                                 ...   \n",
       "98                                                 NaN   \n",
       "99                                                 NaN   \n",
       "100                                                NaN   \n",
       "101                                                NaN   \n",
       "102       Adam K. Fuhs S, Meisenhelder J,  Lesperan...   \n",
       "\n",
       "                                 Other Accomplishments Health Benefits  \\\n",
       "0                                                  NaN             Yes   \n",
       "1                                                  NaN             Yes   \n",
       "2    additional funding provided by Padres Pedal th...             Yes   \n",
       "3                    See above in the progress report.             Yes   \n",
       "4    2019-present Member, Wnt Signaling in Prostate...             Yes   \n",
       "..                                                 ...             ...   \n",
       "98                                                 NaN             Yes   \n",
       "99                                      Not applicable             Yes   \n",
       "100                                                NaN             Yes   \n",
       "101                                                NaN             Yes   \n",
       "102                                                NaN             Yes   \n",
       "\n",
       "     International  National  Local  General Public  Healthcare Professionals  \\\n",
       "0            False     False  False           False                     False   \n",
       "1             True     False  False           False                     False   \n",
       "2             True     False  False           False                     False   \n",
       "3             True      True  False           False                     False   \n",
       "4            False     False  False           False                     False   \n",
       "..             ...       ...    ...             ...                       ...   \n",
       "98           False     False  False           False                     False   \n",
       "99           False     False  False           False                     False   \n",
       "100          False     False  False           False                     False   \n",
       "101          False     False  False           False                     False   \n",
       "102           True     False  False           False                     False   \n",
       "\n",
       "     Patients  Patient Families  \\\n",
       "0        True             False   \n",
       "1       False             False   \n",
       "2       False             False   \n",
       "3        True              True   \n",
       "4        True             False   \n",
       "..        ...               ...   \n",
       "98       True             False   \n",
       "99       True             False   \n",
       "100      True             False   \n",
       "101      True             False   \n",
       "102     False             False   \n",
       "\n",
       "                           Health Benefits Description  Policy Influence  \\\n",
       "0    We have identified some genes that are recurre...              True   \n",
       "1    We expect our results will confirm the critica...              True   \n",
       "2    We expect our results will support the use of ...              True   \n",
       "3        oral cancer prevention in at risk individuals              True   \n",
       "4    Trial is testing a therapeutic combination for...              True   \n",
       "..                                                 ...               ...   \n",
       "98   The knowledge gained from this project will en...              True   \n",
       "99   The study may identify genes that are associat...              True   \n",
       "100  My project identified potential tumor markers ...              True   \n",
       "101  Pancreatitis biology is poorly understood due ...              True   \n",
       "102  We expect our results will confirm the critica...              True   \n",
       "\n",
       "     International (pol)  National (pol)  Local (pol)  General Public (pol)  \\\n",
       "0                  False           False        False                 False   \n",
       "1                  False           False        False                 False   \n",
       "2                  False           False        False                 False   \n",
       "3                  False           False        False                 False   \n",
       "4                  False           False        False                 False   \n",
       "..                   ...             ...          ...                   ...   \n",
       "98                 False           False        False                 False   \n",
       "99                 False           False        False                 False   \n",
       "100                False           False        False                 False   \n",
       "101                False           False        False                 False   \n",
       "102                False           False        False                 False   \n",
       "\n",
       "     Healthcare Professionals (pol)  Patients (pol)  Patient Families (pol)  \\\n",
       "0                             False           False                   False   \n",
       "1                             False           False                   False   \n",
       "2                             False           False                   False   \n",
       "3                             False           False                   False   \n",
       "4                             False           False                   False   \n",
       "..                              ...             ...                     ...   \n",
       "98                            False           False                   False   \n",
       "99                            False           False                   False   \n",
       "100                           False           False                   False   \n",
       "101                           False           False                   False   \n",
       "102                           False           False                   False   \n",
       "\n",
       "    Policy Benefits Description Economic Benefits  International (econ)  \\\n",
       "0                           NaN                No                 False   \n",
       "1                           NaN                No                 False   \n",
       "2                           NaN               Yes                 False   \n",
       "3                           NaN               Yes                  True   \n",
       "4                           NaN                No                 False   \n",
       "..                          ...               ...                   ...   \n",
       "98                          NaN                No                 False   \n",
       "99                          NaN                No                 False   \n",
       "100                         NaN                No                 False   \n",
       "101                         NaN                No                 False   \n",
       "102                         NaN                No                 False   \n",
       "\n",
       "     National (econ)  Local (econ)  General Public (econ)  \\\n",
       "0              False         False                  False   \n",
       "1              False         False                  False   \n",
       "2               True         False                  False   \n",
       "3               True         False                  False   \n",
       "4              False         False                  False   \n",
       "..               ...           ...                    ...   \n",
       "98             False         False                  False   \n",
       "99             False         False                  False   \n",
       "100            False         False                  False   \n",
       "101            False         False                  False   \n",
       "102            False         False                  False   \n",
       "\n",
       "     Healthcare Professionals (econ)  Patients (econ)  \\\n",
       "0                              False            False   \n",
       "1                              False            False   \n",
       "2                              False            False   \n",
       "3                              False             True   \n",
       "4                              False            False   \n",
       "..                               ...              ...   \n",
       "98                             False            False   \n",
       "99                             False            False   \n",
       "100                            False            False   \n",
       "101                            False            False   \n",
       "102                            False            False   \n",
       "\n",
       "     Patient Families (econ)  \\\n",
       "0                      False   \n",
       "1                      False   \n",
       "2                      False   \n",
       "3                       True   \n",
       "4                      False   \n",
       "..                       ...   \n",
       "98                     False   \n",
       "99                     False   \n",
       "100                    False   \n",
       "101                    False   \n",
       "102                    False   \n",
       "\n",
       "                         Economic Benefits Description Equity Benefits  \\\n",
       "0                                                  NaN              No   \n",
       "1                                                  NaN              No   \n",
       "2    The combination of cabozantinib with 13-cis-re...              No   \n",
       "3    Oral cancer prevention and the consequent redu...             Yes   \n",
       "4                                                  NaN             Yes   \n",
       "..                                                 ...             ...   \n",
       "98                                                 NaN              No   \n",
       "99                                                 NaN              No   \n",
       "100                                                NaN              No   \n",
       "101                                                NaN              No   \n",
       "102                                                NaN              No   \n",
       "\n",
       "     International (equity)  National (equity)  Local (equity)  \\\n",
       "0                     False              False           False   \n",
       "1                     False              False           False   \n",
       "2                     False              False           False   \n",
       "3                      True               True           False   \n",
       "4                     False              False           False   \n",
       "..                      ...                ...             ...   \n",
       "98                    False              False           False   \n",
       "99                    False              False           False   \n",
       "100                   False              False           False   \n",
       "101                   False              False           False   \n",
       "102                   False              False           False   \n",
       "\n",
       "     General Public (equity)  Healthcare Professionals (equity)  \\\n",
       "0                      False                              False   \n",
       "1                      False                              False   \n",
       "2                      False                              False   \n",
       "3                      False                              False   \n",
       "4                      False                              False   \n",
       "..                       ...                                ...   \n",
       "98                     False                              False   \n",
       "99                     False                              False   \n",
       "100                    False                              False   \n",
       "101                    False                              False   \n",
       "102                    False                              False   \n",
       "\n",
       "     Patients (equity)  Patient Families (equity)  \\\n",
       "0                False                      False   \n",
       "1                False                      False   \n",
       "2                False                      False   \n",
       "3                 True                       True   \n",
       "4                 True                      False   \n",
       "..                 ...                        ...   \n",
       "98               False                      False   \n",
       "99               False                      False   \n",
       "100              False                      False   \n",
       "101              False                      False   \n",
       "102              False                      False   \n",
       "\n",
       "                           Equity Benefits Description  \\\n",
       "0                                                  NaN   \n",
       "1                                                  NaN   \n",
       "2                                                  NaN   \n",
       "3    At risk oral cancer patients are often part of...   \n",
       "4    Trial focused on all demographic of prostate c...   \n",
       "..                                                 ...   \n",
       "98                                                 NaN   \n",
       "99                                                 NaN   \n",
       "100                                                NaN   \n",
       "101                                                NaN   \n",
       "102                                                NaN   \n",
       "\n",
       "       Additional Funding Achieved First AFS Status  \\\n",
       "0                              One          Awarded   \n",
       "1                             Five          Awarded   \n",
       "2                              One          Awarded   \n",
       "3                              One        Submitted   \n",
       "4                              One          Awarded   \n",
       "..                             ...              ...   \n",
       "98   No additional funding sources              NaN   \n",
       "99   No additional funding sources              NaN   \n",
       "100  No additional funding sources              NaN   \n",
       "101  No additional funding sources              NaN   \n",
       "102                           Five          Awarded   \n",
       "\n",
       "                      First AFS Name and Project Title  First AFS Amount  \\\n",
       "0    NIH R35HG011315 Using genomic perturbations to...         1500000.0   \n",
       "1                              the Hartwell Foundation          300000.0   \n",
       "2                                       Exelixis, Inc.          250000.0   \n",
       "3                  NIH R01, will likely be funded soon         2500000.0   \n",
       "4                                           Oncternal           377000.0   \n",
       "..                                                 ...               ...   \n",
       "98                                                 NaN               NaN   \n",
       "99                                                 NaN               NaN   \n",
       "100                                                NaN               NaN   \n",
       "101                                                NaN               NaN   \n",
       "102                            the Hartwell Foundation          300000.0   \n",
       "\n",
       "    Second AFS Status Second AFS Name and Project Title  Second AFS Amount  \\\n",
       "0                 NaN                               NaN                NaN   \n",
       "1             Awarded            Padres Pedal the Cause           100000.0   \n",
       "2                 NaN                               NaN                NaN   \n",
       "3                 NaN                               NaN                NaN   \n",
       "4                 NaN                               NaN                NaN   \n",
       "..                ...                               ...                ...   \n",
       "98                NaN                               NaN                NaN   \n",
       "99                NaN                               NaN                NaN   \n",
       "100               NaN                               NaN                NaN   \n",
       "101               NaN                               NaN                NaN   \n",
       "102           Awarded            Padres Pedal the Cause           100000.0   \n",
       "\n",
       "    Third AFS Status      Third AFS Name and Project Title  Third AGS Amount  \\\n",
       "0                NaN                                   NaN               NaN   \n",
       "1          Submitted  Pediatric Cancer Research Foundation          750000.0   \n",
       "2                NaN                                   NaN               NaN   \n",
       "3                NaN                                   NaN               NaN   \n",
       "4                NaN                                   NaN               NaN   \n",
       "..               ...                                   ...               ...   \n",
       "98               NaN                                   NaN               NaN   \n",
       "99               NaN                                   NaN               NaN   \n",
       "100              NaN                                   NaN               NaN   \n",
       "101              NaN                                   NaN               NaN   \n",
       "102          Awarded                Padres Pedal the Cause          100000.0   \n",
       "\n",
       "    Fourth AFS Status     Fourth AFS Name and Project Title  \\\n",
       "0                 NaN                                   NaN   \n",
       "1           Submitted                    NIH R03CA273629-01   \n",
       "2                 NaN                                   NaN   \n",
       "3                 NaN                                   NaN   \n",
       "4                 NaN                                   NaN   \n",
       "..                ...                                   ...   \n",
       "98                NaN                                   NaN   \n",
       "99                NaN                                   NaN   \n",
       "100               NaN                                   NaN   \n",
       "101               NaN                                   NaN   \n",
       "102         Submitted  Pediatric Cancer Research Foundation   \n",
       "\n",
       "     Fourth AFS Amount  \\\n",
       "0                  NaN   \n",
       "1             150000.0   \n",
       "2                  NaN   \n",
       "3                  NaN   \n",
       "4                  NaN   \n",
       "..                 ...   \n",
       "98                 NaN   \n",
       "99                 NaN   \n",
       "100                NaN   \n",
       "101                NaN   \n",
       "102           750000.0   \n",
       "\n",
       "    Additional Funding Source #5 Agency/Sponsor Name and Project Title  \\\n",
       "0                                                  NaN                   \n",
       "1                     Tower Cancer Research Foundation                   \n",
       "2                                                  NaN                   \n",
       "3                                                  NaN                   \n",
       "4                                                  NaN                   \n",
       "..                                                 ...                   \n",
       "98                                                 NaN                   \n",
       "99                                                 NaN                   \n",
       "100                                                NaN                   \n",
       "101                                                NaN                   \n",
       "102                                 NIH R03CA273629-01                   \n",
       "\n",
       "    Fifth AFS Status  Fifth AFS Amount Additional Pedal Funding Impact  \\\n",
       "0                NaN               NaN                             Yes   \n",
       "1          Submitted          500000.0                             Yes   \n",
       "2                NaN               NaN                             Yes   \n",
       "3                NaN               NaN                             Yes   \n",
       "4                NaN               NaN                             Yes   \n",
       "..               ...               ...                             ...   \n",
       "98               NaN               NaN                             Yes   \n",
       "99               NaN               NaN                              No   \n",
       "100              NaN               NaN                              No   \n",
       "101              NaN               NaN                             Yes   \n",
       "102        Submitted          150000.0                             Yes   \n",
       "\n",
       "               Additional Funding Benefits Description  \\\n",
       "0    Additional funding would enable the applicatio...   \n",
       "1    Additional funding support would allow us to p...   \n",
       "2    Additional funding support would allow us to e...   \n",
       "3    For advancing the planned clinical trial and c...   \n",
       "4    This is a grass roots project. It is a single ...   \n",
       "..                                                 ...   \n",
       "98   Additional funding would enable the continued ...   \n",
       "99                                                 NaN   \n",
       "100                                                NaN   \n",
       "101  Additional funds would enable our team to cont...   \n",
       "102  Additional funding support would allow us to p...   \n",
       "\n",
       "    Additional Pedal Funding Impact (clinical stages)  \\\n",
       "0                                                 Yes   \n",
       "1                                                 Yes   \n",
       "2                                                 Yes   \n",
       "3                                                 Yes   \n",
       "4                                                  No   \n",
       "..                                                ...   \n",
       "98                                                 No   \n",
       "99                                                 No   \n",
       "100                                                No   \n",
       "101                                                No   \n",
       "102                                               Yes   \n",
       "\n",
       "    Additional Funding Benefits Description (clinical stages)  \\\n",
       "0    In addition, funding could allow us to do more...          \n",
       "1    Additional funding support would allow us to p...          \n",
       "2    Additional funding support would allow us to p...          \n",
       "3    Identification of biomarkers predicting clinic...          \n",
       "4                                                  NaN          \n",
       "..                                                 ...          \n",
       "98                                                 NaN          \n",
       "99                                                 NaN          \n",
       "100                                                NaN          \n",
       "101                                                NaN          \n",
       "102  Additional funding support would allow us to p...          \n",
       "\n",
       "                                 Participated in Pedal  \\\n",
       "0    Yes, I have participated as a rider every year...   \n",
       "1    I have participated as both a virtual particip...   \n",
       "2    I have participated as both a virtual particip...   \n",
       "3                                                  Yes   \n",
       "4                                        Yes, runner.    \n",
       "..                                                 ...   \n",
       "98   Yes, I have participated as a virtual rider ev...   \n",
       "99                                                  No   \n",
       "100                                                NaN   \n",
       "101         Yes, in May 2021 I participated virtually.   \n",
       "102  I have participated as both a virtual particip...   \n",
       "\n",
       "    Further Research Contributions Success Stories  \\\n",
       "0                               No              No   \n",
       "1                              Yes              No   \n",
       "2                              Yes             Yes   \n",
       "3                               No              No   \n",
       "4                              Yes              No   \n",
       "..                             ...             ...   \n",
       "98                              No              No   \n",
       "99                              No              No   \n",
       "100                            NaN             NaN   \n",
       "101                             No              No   \n",
       "102                            Yes              No   \n",
       "\n",
       "    Major Scientific Breakthroughs  \\\n",
       "0                              NaN   \n",
       "1                              NaN   \n",
       "2                              Yes   \n",
       "3                              NaN   \n",
       "4                              NaN   \n",
       "..                             ...   \n",
       "98                             NaN   \n",
       "99                             NaN   \n",
       "100                            NaN   \n",
       "101                            NaN   \n",
       "102                            NaN   \n",
       "\n",
       "                                   Additional Comments  Complete  \\\n",
       "0                                                  NaN      True   \n",
       "1    Funding from Padres Pedal the Cause has been i...      True   \n",
       "2    Funding from Padres Pedal the Cause has been i...      True   \n",
       "3                  Many thanks for all your support!!!      True   \n",
       "4                                                  NaN      True   \n",
       "..                                                 ...       ...   \n",
       "98                                                 NaN      True   \n",
       "99                                                  No      True   \n",
       "100                                                NaN      True   \n",
       "101                                                NaN      True   \n",
       "102  Funding from Padres Pedal the Cause has  been ...      True   \n",
       "\n",
       "    Publication Status 1                  First DOI # Publication Status 2  \\\n",
       "0               Accepted                          NaN                  NaN   \n",
       "1               Accepted                          NaN            Submitted   \n",
       "2              Published                          NaN                  NaN   \n",
       "3            In progress                          NaN          In progress   \n",
       "4                    NaN                          NaN                  NaN   \n",
       "..                   ...                          ...                  ...   \n",
       "98              Accepted  doi.org/10.1093/nar/gkab621          In progress   \n",
       "99           In progress                          NaN                  NaN   \n",
       "100            Published                          NaN                  NaN   \n",
       "101          In progress                          NaN                  NaN   \n",
       "102            Published                          NaN          In progress   \n",
       "\n",
       "    Second DOI # Publication Status 3 Third DOI #  \n",
       "0            NaN                  NaN         NaN  \n",
       "1            NaN                  NaN         NaN  \n",
       "2            NaN                  NaN         NaN  \n",
       "3            NaN                  NaN         NaN  \n",
       "4            NaN                  NaN         NaN  \n",
       "..           ...                  ...         ...  \n",
       "98           NaN                  NaN         NaN  \n",
       "99           NaN                  NaN         NaN  \n",
       "100          NaN                  NaN         NaN  \n",
       "101          NaN                  NaN         NaN  \n",
       "102          NaN                  NaN         NaN  \n",
       "\n",
       "[102 rows x 86 columns]"
      ]
     },
     "execution_count": 28,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pr['Policy Influence'] = pr['Policy Influence'].fillna(False).astype(bool)\n",
    "\n",
    "pr[pr['Policy Influence']]"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Number of peer-reviewed publications (DM)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Published      30\n",
      "In progress    28\n",
      "Accepted       16\n",
      "Submitted       2\n",
      "Name: Publication Status 1, dtype: int64\n",
      "\n",
      "In progress    21\n",
      "Published      11\n",
      "Submitted       5\n",
      "Accepted        4\n",
      "Name: Publication Status 2, dtype: int64\n",
      "\n",
      "Published      6\n",
      "In progress    5\n",
      "Accepted       3\n",
      "Submitted      1\n",
      "Name: Publication Status 3, dtype: int64\n",
      "\n",
      "Published      6\n",
      "In progress    2\n",
      "Accepted       1\n",
      "Name: Publication Status 4, dtype: int64\n",
      "\n",
      "Accepted     2\n",
      "Published    2\n",
      "Submitted    1\n",
      "Name: Publication Status 5, dtype: int64\n",
      "\n",
      "Submitted    2\n",
      "Accepted     1\n",
      "Published    1\n",
      "Name: Publication Status 6, dtype: int64\n",
      "\n",
      "Submitted    2\n",
      "Accepted     1\n",
      "Published    1\n",
      "Name: Publication Status 7, dtype: int64\n",
      "\n",
      "Accepted       1\n",
      "Submitted      1\n",
      "In progress    1\n",
      "Published      1\n",
      "Name: Publication Status 8, dtype: int64\n",
      "\n",
      "In progress    2\n",
      "Accepted       1\n",
      "Published      1\n",
      "Name: Publication Status 9, dtype: int64\n",
      "\n",
      "In progress    2\n",
      "Accepted       1\n",
      "Published      1\n",
      "Name: Publication Status 10, dtype: int64\n",
      "\n"
     ]
    }
   ],
   "source": [
    "for i in range(1, 11):\n",
    "    print(pr[f'Publication Status {i}'].value_counts())\n",
    "    print()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Published      30\n",
       "In progress    28\n",
       "Accepted       16\n",
       "Submitted       2\n",
       "Name: Publication Status 1, dtype: int64"
      ]
     },
     "execution_count": 30,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "to_plot = pr['Publication Status 1'].value_counts()\n",
    "to_plot"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.plotly.v1+json": {
       "config": {
        "plotlyServerURL": "https://plot.ly"
       },
       "data": [
        {
         "alignmentgroup": "True",
         "hovertemplate": "variable=Publication Status 1<br>index=%{x}<br>value=%{y}<extra></extra>",
         "legendgroup": "Publication Status 1",
         "marker": {
          "color": "#636efa",
          "pattern": {
           "shape": ""
          }
         },
         "name": "Publication Status 1",
         "offsetgroup": "Publication Status 1",
         "orientation": "v",
         "showlegend": true,
         "textposition": "auto",
         "type": "bar",
         "x": [
          "Published",
          "In progress",
          "Accepted",
          "Submitted"
         ],
         "xaxis": "x",
         "y": [
          30,
          28,
          16,
          2
         ],
         "yaxis": "y"
        }
       ],
       "layout": {
        "barmode": "relative",
        "legend": {
         "title": {
          "text": "variable"
         },
         "tracegroupgap": 0
        },
        "margin": {
         "t": 60
        },
        "template": {
         "data": {
          "bar": [
           {
            "error_x": {
             "color": "#2a3f5f"
            },
            "error_y": {
             "color": "#2a3f5f"
            },
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "bar"
           }
          ],
          "barpolar": [
           {
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "barpolar"
           }
          ],
          "carpet": [
           {
            "aaxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "baxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "type": "carpet"
           }
          ],
          "choropleth": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "choropleth"
           }
          ],
          "contour": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "contour"
           }
          ],
          "contourcarpet": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "contourcarpet"
           }
          ],
          "heatmap": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "heatmap"
           }
          ],
          "heatmapgl": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "heatmapgl"
           }
          ],
          "histogram": [
           {
            "marker": {
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "histogram"
           }
          ],
          "histogram2d": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "histogram2d"
           }
          ],
          "histogram2dcontour": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "histogram2dcontour"
           }
          ],
          "mesh3d": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "mesh3d"
           }
          ],
          "parcoords": [
           {
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "parcoords"
           }
          ],
          "pie": [
           {
            "automargin": true,
            "type": "pie"
           }
          ],
          "scatter": [
           {
            "fillpattern": {
             "fillmode": "overlay",
             "size": 10,
             "solidity": 0.2
            },
            "type": "scatter"
           }
          ],
          "scatter3d": [
           {
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatter3d"
           }
          ],
          "scattercarpet": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattercarpet"
           }
          ],
          "scattergeo": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattergeo"
           }
          ],
          "scattergl": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattergl"
           }
          ],
          "scattermapbox": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattermapbox"
           }
          ],
          "scatterpolar": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterpolar"
           }
          ],
          "scatterpolargl": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterpolargl"
           }
          ],
          "scatterternary": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterternary"
           }
          ],
          "surface": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "surface"
           }
          ],
          "table": [
           {
            "cells": {
             "fill": {
              "color": "#EBF0F8"
             },
             "line": {
              "color": "white"
             }
            },
            "header": {
             "fill": {
              "color": "#C8D4E3"
             },
             "line": {
              "color": "white"
             }
            },
            "type": "table"
           }
          ]
         },
         "layout": {
          "annotationdefaults": {
           "arrowcolor": "#2a3f5f",
           "arrowhead": 0,
           "arrowwidth": 1
          },
          "autotypenumbers": "strict",
          "coloraxis": {
           "colorbar": {
            "outlinewidth": 0,
            "ticks": ""
           }
          },
          "colorscale": {
           "diverging": [
            [
             0,
             "#8e0152"
            ],
            [
             0.1,
             "#c51b7d"
            ],
            [
             0.2,
             "#de77ae"
            ],
            [
             0.3,
             "#f1b6da"
            ],
            [
             0.4,
             "#fde0ef"
            ],
            [
             0.5,
             "#f7f7f7"
            ],
            [
             0.6,
             "#e6f5d0"
            ],
            [
             0.7,
             "#b8e186"
            ],
            [
             0.8,
             "#7fbc41"
            ],
            [
             0.9,
             "#4d9221"
            ],
            [
             1,
             "#276419"
            ]
           ],
           "sequential": [
            [
             0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1,
             "#f0f921"
            ]
           ],
           "sequentialminus": [
            [
             0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1,
             "#f0f921"
            ]
           ]
          },
          "colorway": [
           "#636efa",
           "#EF553B",
           "#00cc96",
           "#ab63fa",
           "#FFA15A",
           "#19d3f3",
           "#FF6692",
           "#B6E880",
           "#FF97FF",
           "#FECB52"
          ],
          "font": {
           "color": "#2a3f5f"
          },
          "geo": {
           "bgcolor": "white",
           "lakecolor": "white",
           "landcolor": "#E5ECF6",
           "showlakes": true,
           "showland": true,
           "subunitcolor": "white"
          },
          "hoverlabel": {
           "align": "left"
          },
          "hovermode": "closest",
          "mapbox": {
           "style": "light"
          },
          "paper_bgcolor": "white",
          "plot_bgcolor": "#E5ECF6",
          "polar": {
           "angularaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "bgcolor": "#E5ECF6",
           "radialaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "scene": {
           "xaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           },
           "yaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           },
           "zaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           }
          },
          "shapedefaults": {
           "line": {
            "color": "#2a3f5f"
           }
          },
          "ternary": {
           "aaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "baxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "bgcolor": "#E5ECF6",
           "caxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "title": {
           "x": 0.05
          },
          "xaxis": {
           "automargin": true,
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "zerolinewidth": 2
          },
          "yaxis": {
           "automargin": true,
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "zerolinewidth": 2
          }
         }
        },
        "xaxis": {
         "anchor": "y",
         "domain": [
          0,
          1
         ],
         "title": {
          "text": "index"
         }
        },
        "yaxis": {
         "anchor": "x",
         "domain": [
          0,
          1
         ],
         "title": {
          "text": "value"
         }
        }
       }
      }
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "px.bar(to_plot)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Publication Status 1</th>\n",
       "      <th>Publication Status 2</th>\n",
       "      <th>Publication Status 3</th>\n",
       "      <th>Publication Status 4</th>\n",
       "      <th>Publication Status 5</th>\n",
       "      <th>Publication Status 6</th>\n",
       "      <th>Publication Status 7</th>\n",
       "      <th>Publication Status 8</th>\n",
       "      <th>Publication Status 9</th>\n",
       "      <th>Publication Status 10</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Accepted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Accepted</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Published</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>In progress</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>99</th>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>100</th>\n",
       "      <td>Published</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>101</th>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>102</th>\n",
       "      <td>Published</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>103</th>\n",
       "      <td>Published</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>104 rows × 10 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    Publication Status 1 Publication Status 2 Publication Status 3  \\\n",
       "0               Accepted                  NaN                  NaN   \n",
       "1               Accepted            Submitted                  NaN   \n",
       "2              Published                  NaN                  NaN   \n",
       "3            In progress          In progress                  NaN   \n",
       "4                    NaN                  NaN                  NaN   \n",
       "..                   ...                  ...                  ...   \n",
       "99           In progress                  NaN                  NaN   \n",
       "100            Published                  NaN                  NaN   \n",
       "101          In progress                  NaN                  NaN   \n",
       "102            Published          In progress                  NaN   \n",
       "103            Published                  NaN                  NaN   \n",
       "\n",
       "    Publication Status 4 Publication Status 5 Publication Status 6  \\\n",
       "0                    NaN                  NaN                  NaN   \n",
       "1                    NaN                  NaN                  NaN   \n",
       "2                    NaN                  NaN                  NaN   \n",
       "3                    NaN                  NaN                  NaN   \n",
       "4                    NaN                  NaN                  NaN   \n",
       "..                   ...                  ...                  ...   \n",
       "99                   NaN                  NaN                  NaN   \n",
       "100                  NaN                  NaN                  NaN   \n",
       "101                  NaN                  NaN                  NaN   \n",
       "102                  NaN                  NaN                  NaN   \n",
       "103                  NaN                  NaN                  NaN   \n",
       "\n",
       "    Publication Status 7 Publication Status 8 Publication Status 9  \\\n",
       "0                    NaN                  NaN                  NaN   \n",
       "1                    NaN                  NaN                  NaN   \n",
       "2                    NaN                  NaN                  NaN   \n",
       "3                    NaN                  NaN                  NaN   \n",
       "4                    NaN                  NaN                  NaN   \n",
       "..                   ...                  ...                  ...   \n",
       "99                   NaN                  NaN                  NaN   \n",
       "100                  NaN                  NaN                  NaN   \n",
       "101                  NaN                  NaN                  NaN   \n",
       "102                  NaN                  NaN                  NaN   \n",
       "103                  NaN                  NaN                  NaN   \n",
       "\n",
       "    Publication Status 10  \n",
       "0                     NaN  \n",
       "1                     NaN  \n",
       "2                     NaN  \n",
       "3                     NaN  \n",
       "4                     NaN  \n",
       "..                    ...  \n",
       "99                    NaN  \n",
       "100                   NaN  \n",
       "101                   NaN  \n",
       "102                   NaN  \n",
       "103                   NaN  \n",
       "\n",
       "[104 rows x 10 columns]"
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Get all peer-reviewed publication statuses\n",
    "\n",
    "pubs = pr.filter(regex=(r'Publication Status\\s\\d{1}'))\n",
    "pubs = pubs[pubs.columns[-3:].tolist() + pubs.columns[:7].tolist()]\n",
    "pubs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Publication 1</th>\n",
       "      <th>Publication 2</th>\n",
       "      <th>Publication 3</th>\n",
       "      <th>Publication 4</th>\n",
       "      <th>Publication 5</th>\n",
       "      <th>Publication 6</th>\n",
       "      <th>Publication 7</th>\n",
       "      <th>Publication 8</th>\n",
       "      <th>Publication 9</th>\n",
       "      <th>Publication 10</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Accepted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Accepted</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Published</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>In progress</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  Publication 1 Publication 2 Publication 3 Publication 4 Publication 5  \\\n",
       "0      Accepted           NaN           NaN           NaN           NaN   \n",
       "1      Accepted     Submitted           NaN           NaN           NaN   \n",
       "2     Published           NaN           NaN           NaN           NaN   \n",
       "3   In progress   In progress           NaN           NaN           NaN   \n",
       "4           NaN           NaN           NaN           NaN           NaN   \n",
       "\n",
       "  Publication 6 Publication 7 Publication 8 Publication 9 Publication 10  \n",
       "0           NaN           NaN           NaN           NaN            NaN  \n",
       "1           NaN           NaN           NaN           NaN            NaN  \n",
       "2           NaN           NaN           NaN           NaN            NaN  \n",
       "3           NaN           NaN           NaN           NaN            NaN  \n",
       "4           NaN           NaN           NaN           NaN            NaN  "
      ]
     },
     "execution_count": 33,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Remove \"Status\" from pubs column names\n",
    "\n",
    "new_cols = []\n",
    "for col in pubs.columns:\n",
    "    new_col = re.sub(r' Status', '', col)\n",
    "    new_cols.append(new_col)\n",
    "\n",
    "pubs.columns = new_cols\n",
    "pubs.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [],
   "source": [
    "pubs_color_palette = px.colors.qualitative.Bold"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.plotly.v1+json": {
       "config": {
        "plotlyServerURL": "https://plot.ly"
       },
       "data": [
        {
         "alignmentgroup": "True",
         "bingroup": "x",
         "histnorm": "percent",
         "hovertemplate": "publication #=Publication 1<br>status=%{x}<br>percent=%{y}<extra></extra>",
         "legendgroup": "Publication 1",
         "marker": {
          "color": "rgb(127, 60, 141)",
          "pattern": {
           "shape": ""
          }
         },
         "name": "Publication 1",
         "offsetgroup": "Publication 1",
         "orientation": "v",
         "showlegend": true,
         "type": "histogram",
         "x": [
          "Accepted",
          "Accepted",
          "Published",
          "In progress",
          null,
          null,
          "In progress",
          "In progress",
          "In progress",
          null,
          null,
          "Published",
          "In progress",
          "Accepted",
          "Published",
          "Published",
          "Accepted",
          null,
          null,
          "In progress",
          null,
          "In progress",
          "Published",
          "Accepted",
          "Published",
          null,
          "Submitted",
          "In progress",
          "Published",
          "Published",
          "In progress",
          "Accepted",
          "In progress",
          "Published",
          "In progress",
          "Accepted",
          null,
          "In progress",
          "Published",
          "In progress",
          "Published",
          "Accepted",
          "Accepted",
          "Accepted",
          null,
          "Accepted",
          "In progress",
          "Published",
          "Published",
          null,
          "In progress",
          null,
          null,
          "In progress",
          null,
          "Accepted",
          "Published",
          "Published",
          null,
          "In progress",
          "Published",
          null,
          "In progress",
          "Accepted",
          null,
          null,
          null,
          "In progress",
          null,
          null,
          null,
          null,
          "Published",
          "Published",
          "Published",
          null,
          "Published",
          null,
          "Submitted",
          "In progress",
          "Published",
          null,
          "In progress",
          "Published",
          "In progress",
          "In progress",
          "Published",
          "In progress",
          "Published",
          "Accepted",
          "In progress",
          "Published",
          null,
          "Published",
          "Published",
          null,
          "Accepted",
          "In progress",
          "Accepted",
          "In progress",
          "Published",
          "In progress",
          "Published",
          "Published"
         ],
         "xaxis": "x",
         "yaxis": "y"
        },
        {
         "alignmentgroup": "True",
         "bingroup": "x",
         "histnorm": "percent",
         "hovertemplate": "publication #=Publication 2<br>status=%{x}<br>percent=%{y}<extra></extra>",
         "legendgroup": "Publication 2",
         "marker": {
          "color": "rgb(17, 165, 121)",
          "pattern": {
           "shape": ""
          }
         },
         "name": "Publication 2",
         "offsetgroup": "Publication 2",
         "orientation": "v",
         "showlegend": true,
         "type": "histogram",
         "x": [
          null,
          "Submitted",
          null,
          "In progress",
          null,
          null,
          "In progress",
          null,
          null,
          null,
          null,
          "Published",
          null,
          "Accepted",
          "Submitted",
          "Submitted",
          "In progress",
          null,
          null,
          null,
          null,
          "In progress",
          "Published",
          "In progress",
          "Published",
          null,
          null,
          null,
          "Submitted",
          null,
          "In progress",
          "Accepted",
          "In progress",
          "Published",
          "In progress",
          "In progress",
          null,
          null,
          "In progress",
          null,
          "Published",
          null,
          "Accepted",
          null,
          null,
          "In progress",
          null,
          null,
          "Published",
          null,
          "In progress",
          null,
          null,
          "In progress",
          null,
          "In progress",
          "In progress",
          "In progress",
          null,
          null,
          "In progress",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Published",
          "Accepted",
          null,
          null,
          "Published",
          null,
          null,
          null,
          "Submitted",
          null,
          null,
          "Published",
          "In progress",
          null,
          null,
          null,
          null,
          "In progress",
          null,
          "Published",
          null,
          null,
          "Published",
          null,
          null,
          null,
          "In progress",
          null,
          null,
          null,
          "In progress",
          null
         ],
         "xaxis": "x",
         "yaxis": "y"
        },
        {
         "alignmentgroup": "True",
         "bingroup": "x",
         "histnorm": "percent",
         "hovertemplate": "publication #=Publication 3<br>status=%{x}<br>percent=%{y}<extra></extra>",
         "legendgroup": "Publication 3",
         "marker": {
          "color": "rgb(57, 105, 172)",
          "pattern": {
           "shape": ""
          }
         },
         "name": "Publication 3",
         "offsetgroup": "Publication 3",
         "orientation": "v",
         "showlegend": true,
         "type": "histogram",
         "x": [
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "In progress",
          null,
          "In progress",
          null,
          "In progress",
          null,
          null,
          null,
          null,
          null,
          null,
          "Published",
          null,
          null,
          null,
          null,
          null,
          "In progress",
          null,
          null,
          "Accepted",
          null,
          "Published",
          null,
          "In progress",
          null,
          null,
          null,
          null,
          "Published",
          null,
          "Accepted",
          null,
          null,
          null,
          null,
          null,
          "Submitted",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Published",
          "Accepted",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Published",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Published",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null
         ],
         "xaxis": "x",
         "yaxis": "y"
        },
        {
         "alignmentgroup": "True",
         "bingroup": "x",
         "histnorm": "percent",
         "hovertemplate": "publication #=Publication 4<br>status=%{x}<br>percent=%{y}<extra></extra>",
         "legendgroup": "Publication 4",
         "marker": {
          "color": "rgb(242, 183, 1)",
          "pattern": {
           "shape": ""
          }
         },
         "name": "Publication 4",
         "offsetgroup": "Publication 4",
         "orientation": "v",
         "showlegend": true,
         "type": "histogram",
         "x": [
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "In progress",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Published",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "In progress",
          null,
          "Published",
          null,
          null,
          null,
          null,
          null,
          null,
          "Published",
          null,
          "Accepted",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Published",
          "Published",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Published",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null
         ],
         "xaxis": "x",
         "yaxis": "y"
        },
        {
         "alignmentgroup": "True",
         "bingroup": "x",
         "histnorm": "percent",
         "hovertemplate": "publication #=Publication 5<br>status=%{x}<br>percent=%{y}<extra></extra>",
         "legendgroup": "Publication 5",
         "marker": {
          "color": "rgb(231, 63, 116)",
          "pattern": {
           "shape": ""
          }
         },
         "name": "Publication 5",
         "offsetgroup": "Publication 5",
         "orientation": "v",
         "showlegend": true,
         "type": "histogram",
         "x": [
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Accepted",
          null,
          "Submitted",
          null,
          null,
          null,
          null,
          null,
          null,
          "Published",
          null,
          "Accepted",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Published",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null
         ],
         "xaxis": "x",
         "yaxis": "y"
        },
        {
         "alignmentgroup": "True",
         "bingroup": "x",
         "histnorm": "percent",
         "hovertemplate": "publication #=Publication 6<br>status=%{x}<br>percent=%{y}<extra></extra>",
         "legendgroup": "Publication 6",
         "marker": {
          "color": "rgb(128, 186, 90)",
          "pattern": {
           "shape": ""
          }
         },
         "name": "Publication 6",
         "offsetgroup": "Publication 6",
         "orientation": "v",
         "showlegend": true,
         "type": "histogram",
         "x": [
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Accepted",
          null,
          "Submitted",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Submitted",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Published",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null
         ],
         "xaxis": "x",
         "yaxis": "y"
        },
        {
         "alignmentgroup": "True",
         "bingroup": "x",
         "histnorm": "percent",
         "hovertemplate": "publication #=Publication 7<br>status=%{x}<br>percent=%{y}<extra></extra>",
         "legendgroup": "Publication 7",
         "marker": {
          "color": "rgb(230, 131, 16)",
          "pattern": {
           "shape": ""
          }
         },
         "name": "Publication 7",
         "offsetgroup": "Publication 7",
         "orientation": "v",
         "showlegend": true,
         "type": "histogram",
         "x": [
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Accepted",
          null,
          "Submitted",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Submitted",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Published",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null
         ],
         "xaxis": "x",
         "yaxis": "y"
        },
        {
         "alignmentgroup": "True",
         "bingroup": "x",
         "histnorm": "percent",
         "hovertemplate": "publication #=Publication 8<br>status=%{x}<br>percent=%{y}<extra></extra>",
         "legendgroup": "Publication 8",
         "marker": {
          "color": "rgb(0, 134, 149)",
          "pattern": {
           "shape": ""
          }
         },
         "name": "Publication 8",
         "offsetgroup": "Publication 8",
         "orientation": "v",
         "showlegend": true,
         "type": "histogram",
         "x": [
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Accepted",
          null,
          "Submitted",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "In progress",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Published",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null
         ],
         "xaxis": "x",
         "yaxis": "y"
        },
        {
         "alignmentgroup": "True",
         "bingroup": "x",
         "histnorm": "percent",
         "hovertemplate": "publication #=Publication 9<br>status=%{x}<br>percent=%{y}<extra></extra>",
         "legendgroup": "Publication 9",
         "marker": {
          "color": "rgb(207, 28, 144)",
          "pattern": {
           "shape": ""
          }
         },
         "name": "Publication 9",
         "offsetgroup": "Publication 9",
         "orientation": "v",
         "showlegend": true,
         "type": "histogram",
         "x": [
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Accepted",
          null,
          "In progress",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "In progress",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Published",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null
         ],
         "xaxis": "x",
         "yaxis": "y"
        },
        {
         "alignmentgroup": "True",
         "bingroup": "x",
         "histnorm": "percent",
         "hovertemplate": "publication #=Publication 10<br>status=%{x}<br>percent=%{y}<extra></extra>",
         "legendgroup": "Publication 10",
         "marker": {
          "color": "rgb(249, 123, 114)",
          "pattern": {
           "shape": ""
          }
         },
         "name": "Publication 10",
         "offsetgroup": "Publication 10",
         "orientation": "v",
         "showlegend": true,
         "type": "histogram",
         "x": [
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Accepted",
          null,
          "In progress",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "In progress",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Published",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null
         ],
         "xaxis": "x",
         "yaxis": "y"
        }
       ],
       "layout": {
        "barmode": "relative",
        "legend": {
         "title": {
          "text": "publication #"
         },
         "tracegroupgap": 0
        },
        "template": {
         "data": {
          "bar": [
           {
            "error_x": {
             "color": "#2a3f5f"
            },
            "error_y": {
             "color": "#2a3f5f"
            },
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "bar"
           }
          ],
          "barpolar": [
           {
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "barpolar"
           }
          ],
          "carpet": [
           {
            "aaxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "baxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "type": "carpet"
           }
          ],
          "choropleth": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "choropleth"
           }
          ],
          "contour": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "contour"
           }
          ],
          "contourcarpet": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "contourcarpet"
           }
          ],
          "heatmap": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "heatmap"
           }
          ],
          "heatmapgl": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "heatmapgl"
           }
          ],
          "histogram": [
           {
            "marker": {
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "histogram"
           }
          ],
          "histogram2d": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "histogram2d"
           }
          ],
          "histogram2dcontour": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "histogram2dcontour"
           }
          ],
          "mesh3d": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "mesh3d"
           }
          ],
          "parcoords": [
           {
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "parcoords"
           }
          ],
          "pie": [
           {
            "automargin": true,
            "type": "pie"
           }
          ],
          "scatter": [
           {
            "fillpattern": {
             "fillmode": "overlay",
             "size": 10,
             "solidity": 0.2
            },
            "type": "scatter"
           }
          ],
          "scatter3d": [
           {
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatter3d"
           }
          ],
          "scattercarpet": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattercarpet"
           }
          ],
          "scattergeo": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattergeo"
           }
          ],
          "scattergl": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattergl"
           }
          ],
          "scattermapbox": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattermapbox"
           }
          ],
          "scatterpolar": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterpolar"
           }
          ],
          "scatterpolargl": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterpolargl"
           }
          ],
          "scatterternary": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterternary"
           }
          ],
          "surface": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "surface"
           }
          ],
          "table": [
           {
            "cells": {
             "fill": {
              "color": "#EBF0F8"
             },
             "line": {
              "color": "white"
             }
            },
            "header": {
             "fill": {
              "color": "#C8D4E3"
             },
             "line": {
              "color": "white"
             }
            },
            "type": "table"
           }
          ]
         },
         "layout": {
          "annotationdefaults": {
           "arrowcolor": "#2a3f5f",
           "arrowhead": 0,
           "arrowwidth": 1
          },
          "autotypenumbers": "strict",
          "coloraxis": {
           "colorbar": {
            "outlinewidth": 0,
            "ticks": ""
           }
          },
          "colorscale": {
           "diverging": [
            [
             0,
             "#8e0152"
            ],
            [
             0.1,
             "#c51b7d"
            ],
            [
             0.2,
             "#de77ae"
            ],
            [
             0.3,
             "#f1b6da"
            ],
            [
             0.4,
             "#fde0ef"
            ],
            [
             0.5,
             "#f7f7f7"
            ],
            [
             0.6,
             "#e6f5d0"
            ],
            [
             0.7,
             "#b8e186"
            ],
            [
             0.8,
             "#7fbc41"
            ],
            [
             0.9,
             "#4d9221"
            ],
            [
             1,
             "#276419"
            ]
           ],
           "sequential": [
            [
             0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1,
             "#f0f921"
            ]
           ],
           "sequentialminus": [
            [
             0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1,
             "#f0f921"
            ]
           ]
          },
          "colorway": [
           "#636efa",
           "#EF553B",
           "#00cc96",
           "#ab63fa",
           "#FFA15A",
           "#19d3f3",
           "#FF6692",
           "#B6E880",
           "#FF97FF",
           "#FECB52"
          ],
          "font": {
           "color": "#2a3f5f"
          },
          "geo": {
           "bgcolor": "white",
           "lakecolor": "white",
           "landcolor": "#E5ECF6",
           "showlakes": true,
           "showland": true,
           "subunitcolor": "white"
          },
          "hoverlabel": {
           "align": "left"
          },
          "hovermode": "closest",
          "mapbox": {
           "style": "light"
          },
          "paper_bgcolor": "white",
          "plot_bgcolor": "#E5ECF6",
          "polar": {
           "angularaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "bgcolor": "#E5ECF6",
           "radialaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "scene": {
           "xaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           },
           "yaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           },
           "zaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           }
          },
          "shapedefaults": {
           "line": {
            "color": "#2a3f5f"
           }
          },
          "ternary": {
           "aaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "baxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "bgcolor": "#E5ECF6",
           "caxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "title": {
           "x": 0.05
          },
          "xaxis": {
           "automargin": true,
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "zerolinewidth": 2
          },
          "yaxis": {
           "automargin": true,
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "zerolinewidth": 2
          }
         }
        },
        "title": {
         "text": "2022 Peer-Reviewed Publication Percentages by Status"
        },
        "xaxis": {
         "anchor": "y",
         "domain": [
          0,
          1
         ],
         "title": {
          "text": "status"
         }
        },
        "yaxis": {
         "anchor": "x",
         "domain": [
          0,
          1
         ],
         "title": {
          "text": "percent"
         }
        }
       }
      }
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Plot the publication distribution, subset by status\n",
    "\n",
    "publications_fig = px.histogram(pubs, color_discrete_sequence=pubs_color_palette, \\\n",
    "    title='2022 Peer-Reviewed Publication Percentages by Status', histnorm='percent',\n",
    "    labels={'variable': 'publication #', 'value': 'status'})\n",
    "publications_fig.update_layout(xaxis_title='status')\n",
    "# publications_fig.update_traces(\n",
    "#     hovertemplate='publiction #: %{}<br>status: %{x}<br>percent: %{y:.2f}',\n",
    "# )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Export viz\n",
    "\n",
    "viz_dir = \"C:\\\\Users\\\\phuro\\\\Biokind\\\\curebound-team\\\\curebound\\\\src\\\\visualization\"\n",
    "wp = os.path.join(viz_dir, 'publications_fig.html')\n",
    "publications_fig.write_html(wp)#, include_plotlyjs='cdn')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "166"
      ]
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Get total number of peer-reviewed publications\n",
    "\n",
    "num_pubs = 0\n",
    "for col in pubs.columns:\n",
    "    num_pub = len(pubs[col]) - pubs[col].isna().sum()\n",
    "    num_pubs += num_pub\n",
    "\n",
    "num_pubs\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 38,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# sanity check\n",
    "\n",
    "pr.shape[0] == pr['ID'].nunique()"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Name of project titles that will lead to improvements in health policy (FD, FL)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Merge project titles to progress report\n",
    "\n",
    "titles = roi[['ID', 'Project Title']]\n",
    "pr = pr.merge(titles, on='ID')\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\phuro\\AppData\\Local\\Temp\\ipykernel_47384\\3271432832.py:4: SettingWithCopyWarning:\n",
      "\n",
      "\n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Policy Influence</th>\n",
       "      <th>International (pol)</th>\n",
       "      <th>National (pol)</th>\n",
       "      <th>Local (pol)</th>\n",
       "      <th>General Public (pol)</th>\n",
       "      <th>Healthcare Professionals (pol)</th>\n",
       "      <th>Patients (pol)</th>\n",
       "      <th>Patient Families (pol)</th>\n",
       "      <th>Policy Benefits Description</th>\n",
       "      <th>Project Title</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Detecting dysregulated genes in neuroblastoma ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Functional Roles for Histidine Kinase Signalin...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A National Phase I Study of Cabozantinib in Co...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A Phase 1B, Nonrandomized Trial Investigating ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Policy Influence  International (pol)  National (pol)  Local (pol)  \\\n",
       "0              True                False           False        False   \n",
       "1              True                False           False        False   \n",
       "2              True                False           False        False   \n",
       "3              True                False           False        False   \n",
       "4              True                False           False        False   \n",
       "\n",
       "   General Public (pol)  Healthcare Professionals (pol)  Patients (pol)  \\\n",
       "0                 False                           False           False   \n",
       "1                 False                           False           False   \n",
       "2                 False                           False           False   \n",
       "3                 False                           False           False   \n",
       "4                 False                           False           False   \n",
       "\n",
       "   Patient Families (pol) Policy Benefits Description  \\\n",
       "0                   False                         NaN   \n",
       "1                   False                         NaN   \n",
       "2                   False                         NaN   \n",
       "3                   False                         NaN   \n",
       "4                   False                         NaN   \n",
       "\n",
       "                                       Project Title  \n",
       "0  Detecting dysregulated genes in neuroblastoma ...  \n",
       "1  Functional Roles for Histidine Kinase Signalin...  \n",
       "2  A National Phase I Study of Cabozantinib in Co...  \n",
       "3  UCSD-UCSF Specialized Program of Research Exce...  \n",
       "4  A Phase 1B, Nonrandomized Trial Investigating ...  "
      ]
     },
     "execution_count": 40,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Get all columns related health policy / health decision making\n",
    "\n",
    "poli = pr.filter(regex=(r'pol|Pol'))\n",
    "poli['Project Title'] = pr['Project Title']\n",
    "poli.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Publication Status 4</th>\n",
       "      <th>Fourth DOI #</th>\n",
       "      <th>Publication Status 5</th>\n",
       "      <th>Fifth DOI #</th>\n",
       "      <th>Publication Status 6</th>\n",
       "      <th>Sixth DOI #</th>\n",
       "      <th>Publication Status 7</th>\n",
       "      <th>Seventh DOI #</th>\n",
       "      <th>Publication Status 8</th>\n",
       "      <th>Eighth DOI #</th>\n",
       "      <th>Publication Status 9</th>\n",
       "      <th>Ninth DOI #</th>\n",
       "      <th>Publication Status 10</th>\n",
       "      <th>Tenth DOI #</th>\n",
       "      <th>Pedal Non-Peer Pubs</th>\n",
       "      <th>Other Accomplishments</th>\n",
       "      <th>Health Benefits</th>\n",
       "      <th>International</th>\n",
       "      <th>National</th>\n",
       "      <th>Local</th>\n",
       "      <th>General Public</th>\n",
       "      <th>Healthcare Professionals</th>\n",
       "      <th>Patients</th>\n",
       "      <th>Patient Families</th>\n",
       "      <th>Health Benefits Description</th>\n",
       "      <th>Policy Influence</th>\n",
       "      <th>International (pol)</th>\n",
       "      <th>National (pol)</th>\n",
       "      <th>Local (pol)</th>\n",
       "      <th>General Public (pol)</th>\n",
       "      <th>Healthcare Professionals (pol)</th>\n",
       "      <th>Patients (pol)</th>\n",
       "      <th>Patient Families (pol)</th>\n",
       "      <th>Policy Benefits Description</th>\n",
       "      <th>Economic Benefits</th>\n",
       "      <th>International (econ)</th>\n",
       "      <th>National (econ)</th>\n",
       "      <th>Local (econ)</th>\n",
       "      <th>General Public (econ)</th>\n",
       "      <th>Healthcare Professionals (econ)</th>\n",
       "      <th>Patients (econ)</th>\n",
       "      <th>Patient Families (econ)</th>\n",
       "      <th>Economic Benefits Description</th>\n",
       "      <th>Equity Benefits</th>\n",
       "      <th>International (equity)</th>\n",
       "      <th>National (equity)</th>\n",
       "      <th>Local (equity)</th>\n",
       "      <th>General Public (equity)</th>\n",
       "      <th>Healthcare Professionals (equity)</th>\n",
       "      <th>Patients (equity)</th>\n",
       "      <th>Patient Families (equity)</th>\n",
       "      <th>Equity Benefits Description</th>\n",
       "      <th>Additional Funding Achieved</th>\n",
       "      <th>First AFS Status</th>\n",
       "      <th>First AFS Name and Project Title</th>\n",
       "      <th>First AFS Amount</th>\n",
       "      <th>Second AFS Status</th>\n",
       "      <th>Second AFS Name and Project Title</th>\n",
       "      <th>Second AFS Amount</th>\n",
       "      <th>Third AFS Status</th>\n",
       "      <th>Third AFS Name and Project Title</th>\n",
       "      <th>Third AGS Amount</th>\n",
       "      <th>Fourth AFS Status</th>\n",
       "      <th>Fourth AFS Name and Project Title</th>\n",
       "      <th>Fourth AFS Amount</th>\n",
       "      <th>Additional Funding Source #5 Agency/Sponsor Name and Project Title</th>\n",
       "      <th>Fifth AFS Status</th>\n",
       "      <th>Fifth AFS Amount</th>\n",
       "      <th>Additional Pedal Funding Impact</th>\n",
       "      <th>Additional Funding Benefits Description</th>\n",
       "      <th>Additional Pedal Funding Impact (clinical stages)</th>\n",
       "      <th>Additional Funding Benefits Description (clinical stages)</th>\n",
       "      <th>Participated in Pedal</th>\n",
       "      <th>Further Research Contributions</th>\n",
       "      <th>Success Stories</th>\n",
       "      <th>Major Scientific Breakthroughs</th>\n",
       "      <th>Additional Comments</th>\n",
       "      <th>Complete</th>\n",
       "      <th>Publication Status 1</th>\n",
       "      <th>First DOI #</th>\n",
       "      <th>Publication Status 2</th>\n",
       "      <th>Second DOI #</th>\n",
       "      <th>Publication Status 3</th>\n",
       "      <th>Third DOI #</th>\n",
       "      <th>Project Title</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>3.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>We have identified some genes that are recurre...</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>NIH R35HG011315 Using genomic perturbations to...</td>\n",
       "      <td>1500000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding would enable the applicatio...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>In addition, funding could allow us to do more...</td>\n",
       "      <td>Yes, I have participated as a rider every year...</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Detecting dysregulated genes in neuroblastoma ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>4.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Adam K. Fuhs S, Meisenhelder J,  Lesperan...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>We expect our results will confirm the critica...</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Five</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>the Hartwell Foundation</td>\n",
       "      <td>300000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Padres Pedal the Cause</td>\n",
       "      <td>100000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>Pediatric Cancer Research Foundation</td>\n",
       "      <td>750000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>NIH R03CA273629-01</td>\n",
       "      <td>150000.0</td>\n",
       "      <td>Tower Cancer Research Foundation</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>500000.0</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to p...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to p...</td>\n",
       "      <td>I have participated as both a virtual particip...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Funding from Padres Pedal the Cause has been i...</td>\n",
       "      <td>True</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Functional Roles for Histidine Kinase Signalin...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>5.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None to date</td>\n",
       "      <td>additional funding provided by Padres Pedal th...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>We expect our results will support the use of ...</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>The combination of cabozantinib with 13-cis-re...</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Exelixis, Inc.</td>\n",
       "      <td>250000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to e...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to p...</td>\n",
       "      <td>I have participated as both a virtual particip...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Funding from Padres Pedal the Cause has been i...</td>\n",
       "      <td>True</td>\n",
       "      <td>Published</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A National Phase I Study of Cabozantinib in Co...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>6.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>See above in the progress report.</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>oral cancer prevention in at risk individuals</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>Oral cancer prevention and the consequent redu...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>At risk oral cancer patients are often part of...</td>\n",
       "      <td>One</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>NIH R01, will likely be funded soon</td>\n",
       "      <td>2500000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>For advancing the planned clinical trial and c...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Identification of biomarkers predicting clinic...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Many thanks for all your support!!!</td>\n",
       "      <td>True</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>8.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>8.Ghali F, Patel D, Jamieson C, Parsons JK, Mc...</td>\n",
       "      <td>2019-present Member, Wnt Signaling in Prostate...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Trial is testing a therapeutic combination for...</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Trial focused on all demographic of prostate c...</td>\n",
       "      <td>One</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Oncternal</td>\n",
       "      <td>377000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>This is a grass roots project. It is a single ...</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes, runner.</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A Phase 1B, Nonrandomized Trial Investigating ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    ID          Event Name Publication Status 4 Fourth DOI #  \\\n",
       "0  3.0  Progress Report #1                  NaN          NaN   \n",
       "1  4.0  Progress Report #1                  NaN          NaN   \n",
       "2  5.0  Progress Report #1                  NaN          NaN   \n",
       "3  6.0  Progress Report #1                  NaN          NaN   \n",
       "4  8.0  Progress Report #1                  NaN          NaN   \n",
       "\n",
       "  Publication Status 5 Fifth DOI # Publication Status 6 Sixth DOI #  \\\n",
       "0                  NaN         NaN                  NaN         NaN   \n",
       "1                  NaN         NaN                  NaN         NaN   \n",
       "2                  NaN         NaN                  NaN         NaN   \n",
       "3                  NaN         NaN                  NaN         NaN   \n",
       "4                  NaN         NaN                  NaN         NaN   \n",
       "\n",
       "  Publication Status 7 Seventh DOI # Publication Status 8 Eighth DOI #  \\\n",
       "0                  NaN           NaN                  NaN          NaN   \n",
       "1                  NaN           NaN                  NaN          NaN   \n",
       "2                  NaN           NaN                  NaN          NaN   \n",
       "3                  NaN           NaN                  NaN          NaN   \n",
       "4                  NaN           NaN                  NaN          NaN   \n",
       "\n",
       "  Publication Status 9 Ninth DOI # Publication Status 10 Tenth DOI #  \\\n",
       "0                  NaN         NaN                   NaN         NaN   \n",
       "1                  NaN         NaN                   NaN         NaN   \n",
       "2                  NaN         NaN                   NaN         NaN   \n",
       "3                  NaN         NaN                   NaN         NaN   \n",
       "4                  NaN         NaN                   NaN         NaN   \n",
       "\n",
       "                                 Pedal Non-Peer Pubs  \\\n",
       "0                                                NaN   \n",
       "1       Adam K. Fuhs S, Meisenhelder J,  Lesperan...   \n",
       "2                                       None to date   \n",
       "3                                                NaN   \n",
       "4  8.Ghali F, Patel D, Jamieson C, Parsons JK, Mc...   \n",
       "\n",
       "                               Other Accomplishments Health Benefits  \\\n",
       "0                                                NaN             Yes   \n",
       "1                                                NaN             Yes   \n",
       "2  additional funding provided by Padres Pedal th...             Yes   \n",
       "3                  See above in the progress report.             Yes   \n",
       "4  2019-present Member, Wnt Signaling in Prostate...             Yes   \n",
       "\n",
       "   International  National  Local  General Public  Healthcare Professionals  \\\n",
       "0          False     False  False           False                     False   \n",
       "1           True     False  False           False                     False   \n",
       "2           True     False  False           False                     False   \n",
       "3           True      True  False           False                     False   \n",
       "4          False     False  False           False                     False   \n",
       "\n",
       "   Patients  Patient Families  \\\n",
       "0      True             False   \n",
       "1     False             False   \n",
       "2     False             False   \n",
       "3      True              True   \n",
       "4      True             False   \n",
       "\n",
       "                         Health Benefits Description  Policy Influence  \\\n",
       "0  We have identified some genes that are recurre...              True   \n",
       "1  We expect our results will confirm the critica...              True   \n",
       "2  We expect our results will support the use of ...              True   \n",
       "3      oral cancer prevention in at risk individuals              True   \n",
       "4  Trial is testing a therapeutic combination for...              True   \n",
       "\n",
       "   International (pol)  National (pol)  Local (pol)  General Public (pol)  \\\n",
       "0                False           False        False                 False   \n",
       "1                False           False        False                 False   \n",
       "2                False           False        False                 False   \n",
       "3                False           False        False                 False   \n",
       "4                False           False        False                 False   \n",
       "\n",
       "   Healthcare Professionals (pol)  Patients (pol)  Patient Families (pol)  \\\n",
       "0                           False           False                   False   \n",
       "1                           False           False                   False   \n",
       "2                           False           False                   False   \n",
       "3                           False           False                   False   \n",
       "4                           False           False                   False   \n",
       "\n",
       "  Policy Benefits Description Economic Benefits  International (econ)  \\\n",
       "0                         NaN                No                 False   \n",
       "1                         NaN                No                 False   \n",
       "2                         NaN               Yes                 False   \n",
       "3                         NaN               Yes                  True   \n",
       "4                         NaN                No                 False   \n",
       "\n",
       "   National (econ)  Local (econ)  General Public (econ)  \\\n",
       "0            False         False                  False   \n",
       "1            False         False                  False   \n",
       "2             True         False                  False   \n",
       "3             True         False                  False   \n",
       "4            False         False                  False   \n",
       "\n",
       "   Healthcare Professionals (econ)  Patients (econ)  Patient Families (econ)  \\\n",
       "0                            False            False                    False   \n",
       "1                            False            False                    False   \n",
       "2                            False            False                    False   \n",
       "3                            False             True                     True   \n",
       "4                            False            False                    False   \n",
       "\n",
       "                       Economic Benefits Description Equity Benefits  \\\n",
       "0                                                NaN              No   \n",
       "1                                                NaN              No   \n",
       "2  The combination of cabozantinib with 13-cis-re...              No   \n",
       "3  Oral cancer prevention and the consequent redu...             Yes   \n",
       "4                                                NaN             Yes   \n",
       "\n",
       "   International (equity)  National (equity)  Local (equity)  \\\n",
       "0                   False              False           False   \n",
       "1                   False              False           False   \n",
       "2                   False              False           False   \n",
       "3                    True               True           False   \n",
       "4                   False              False           False   \n",
       "\n",
       "   General Public (equity)  Healthcare Professionals (equity)  \\\n",
       "0                    False                              False   \n",
       "1                    False                              False   \n",
       "2                    False                              False   \n",
       "3                    False                              False   \n",
       "4                    False                              False   \n",
       "\n",
       "   Patients (equity)  Patient Families (equity)  \\\n",
       "0              False                      False   \n",
       "1              False                      False   \n",
       "2              False                      False   \n",
       "3               True                       True   \n",
       "4               True                      False   \n",
       "\n",
       "                         Equity Benefits Description  \\\n",
       "0                                                NaN   \n",
       "1                                                NaN   \n",
       "2                                                NaN   \n",
       "3  At risk oral cancer patients are often part of...   \n",
       "4  Trial focused on all demographic of prostate c...   \n",
       "\n",
       "  Additional Funding Achieved First AFS Status  \\\n",
       "0                         One          Awarded   \n",
       "1                        Five          Awarded   \n",
       "2                         One          Awarded   \n",
       "3                         One        Submitted   \n",
       "4                         One          Awarded   \n",
       "\n",
       "                    First AFS Name and Project Title  First AFS Amount  \\\n",
       "0  NIH R35HG011315 Using genomic perturbations to...         1500000.0   \n",
       "1                            the Hartwell Foundation          300000.0   \n",
       "2                                     Exelixis, Inc.          250000.0   \n",
       "3                NIH R01, will likely be funded soon         2500000.0   \n",
       "4                                         Oncternal           377000.0   \n",
       "\n",
       "  Second AFS Status Second AFS Name and Project Title  Second AFS Amount  \\\n",
       "0               NaN                               NaN                NaN   \n",
       "1           Awarded            Padres Pedal the Cause           100000.0   \n",
       "2               NaN                               NaN                NaN   \n",
       "3               NaN                               NaN                NaN   \n",
       "4               NaN                               NaN                NaN   \n",
       "\n",
       "  Third AFS Status      Third AFS Name and Project Title  Third AGS Amount  \\\n",
       "0              NaN                                   NaN               NaN   \n",
       "1        Submitted  Pediatric Cancer Research Foundation          750000.0   \n",
       "2              NaN                                   NaN               NaN   \n",
       "3              NaN                                   NaN               NaN   \n",
       "4              NaN                                   NaN               NaN   \n",
       "\n",
       "  Fourth AFS Status Fourth AFS Name and Project Title  Fourth AFS Amount  \\\n",
       "0               NaN                               NaN                NaN   \n",
       "1         Submitted                NIH R03CA273629-01           150000.0   \n",
       "2               NaN                               NaN                NaN   \n",
       "3               NaN                               NaN                NaN   \n",
       "4               NaN                               NaN                NaN   \n",
       "\n",
       "  Additional Funding Source #5 Agency/Sponsor Name and Project Title  \\\n",
       "0                                                NaN                   \n",
       "1                   Tower Cancer Research Foundation                   \n",
       "2                                                NaN                   \n",
       "3                                                NaN                   \n",
       "4                                                NaN                   \n",
       "\n",
       "  Fifth AFS Status  Fifth AFS Amount Additional Pedal Funding Impact  \\\n",
       "0              NaN               NaN                             Yes   \n",
       "1        Submitted          500000.0                             Yes   \n",
       "2              NaN               NaN                             Yes   \n",
       "3              NaN               NaN                             Yes   \n",
       "4              NaN               NaN                             Yes   \n",
       "\n",
       "             Additional Funding Benefits Description  \\\n",
       "0  Additional funding would enable the applicatio...   \n",
       "1  Additional funding support would allow us to p...   \n",
       "2  Additional funding support would allow us to e...   \n",
       "3  For advancing the planned clinical trial and c...   \n",
       "4  This is a grass roots project. It is a single ...   \n",
       "\n",
       "  Additional Pedal Funding Impact (clinical stages)  \\\n",
       "0                                               Yes   \n",
       "1                                               Yes   \n",
       "2                                               Yes   \n",
       "3                                               Yes   \n",
       "4                                                No   \n",
       "\n",
       "  Additional Funding Benefits Description (clinical stages)  \\\n",
       "0  In addition, funding could allow us to do more...          \n",
       "1  Additional funding support would allow us to p...          \n",
       "2  Additional funding support would allow us to p...          \n",
       "3  Identification of biomarkers predicting clinic...          \n",
       "4                                                NaN          \n",
       "\n",
       "                               Participated in Pedal  \\\n",
       "0  Yes, I have participated as a rider every year...   \n",
       "1  I have participated as both a virtual particip...   \n",
       "2  I have participated as both a virtual particip...   \n",
       "3                                                Yes   \n",
       "4                                      Yes, runner.    \n",
       "\n",
       "  Further Research Contributions Success Stories  \\\n",
       "0                             No              No   \n",
       "1                            Yes              No   \n",
       "2                            Yes             Yes   \n",
       "3                             No              No   \n",
       "4                            Yes              No   \n",
       "\n",
       "  Major Scientific Breakthroughs  \\\n",
       "0                            NaN   \n",
       "1                            NaN   \n",
       "2                            Yes   \n",
       "3                            NaN   \n",
       "4                            NaN   \n",
       "\n",
       "                                 Additional Comments  Complete  \\\n",
       "0                                                NaN      True   \n",
       "1  Funding from Padres Pedal the Cause has been i...      True   \n",
       "2  Funding from Padres Pedal the Cause has been i...      True   \n",
       "3                Many thanks for all your support!!!      True   \n",
       "4                                                NaN      True   \n",
       "\n",
       "  Publication Status 1 First DOI # Publication Status 2 Second DOI #  \\\n",
       "0             Accepted         NaN                  NaN          NaN   \n",
       "1             Accepted         NaN            Submitted          NaN   \n",
       "2            Published         NaN                  NaN          NaN   \n",
       "3          In progress         NaN          In progress          NaN   \n",
       "4                  NaN         NaN                  NaN          NaN   \n",
       "\n",
       "  Publication Status 3 Third DOI #  \\\n",
       "0                  NaN         NaN   \n",
       "1                  NaN         NaN   \n",
       "2                  NaN         NaN   \n",
       "3                  NaN         NaN   \n",
       "4                  NaN         NaN   \n",
       "\n",
       "                                       Project Title  \n",
       "0  Detecting dysregulated genes in neuroblastoma ...  \n",
       "1  Functional Roles for Histidine Kinase Signalin...  \n",
       "2  A National Phase I Study of Cabozantinib in Co...  \n",
       "3  UCSD-UCSF Specialized Program of Research Exce...  \n",
       "4  A Phase 1B, Nonrandomized Trial Investigating ...  "
      ]
     },
     "execution_count": 41,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pr.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Policy Influence</th>\n",
       "      <th>International (pol)</th>\n",
       "      <th>National (pol)</th>\n",
       "      <th>Local (pol)</th>\n",
       "      <th>General Public (pol)</th>\n",
       "      <th>Healthcare Professionals (pol)</th>\n",
       "      <th>Patients (pol)</th>\n",
       "      <th>Patient Families (pol)</th>\n",
       "      <th>Policy Benefits Description</th>\n",
       "      <th>Project Title</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Our project could improve guidelines as to how...</td>\n",
       "      <td>Neoantigen-specific T cell responses in except...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>WIll better delineate the burden of clonal hem...</td>\n",
       "      <td>Impact of Metformin on Clonal Hematopoiesis an...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>These tools can help healthcare professionals ...</td>\n",
       "      <td>Knowledge-based planning and treatment decisio...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>The navigation intervention could potentially ...</td>\n",
       "      <td>Development and Implementation of a Peer-Navig...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Potential to influence NCCN guidelines.</td>\n",
       "      <td>An Open-Label, Phase 2 Efficacy Study of Temoz...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>E cigarette related policies</td>\n",
       "      <td>Decoding Colon Cancers Using Boolean Principles</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Adding genomics to the EMR in Epic.</td>\n",
       "      <td>Deciphering the role of RNA editing in leukemi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>The development of tumor specific probes for g...</td>\n",
       "      <td>Precision Interception of Gastric Cancers</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Our project could improve guidelines as to how...</td>\n",
       "      <td>Neoantigen-specific T cell responses in except...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>59</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>N/a</td>\n",
       "      <td>A pilot trial to test the benefit of real time...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>These tools can help healthcare professionals ...</td>\n",
       "      <td>Knowledge-based planning and treatment decisio...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>71</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>To make brachy more automated and clinical</td>\n",
       "      <td>Knowledge-based planning and treatment decisio...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>81</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>The navigator intervention could potentially b...</td>\n",
       "      <td>Development and Implementation of a Peer-Navig...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>85</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>These studies on the immune compartment may le...</td>\n",
       "      <td>Investigating the Efficacy of radium-223 with ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    Policy Influence  International (pol)  National (pol)  Local (pol)  \\\n",
       "9               True                False           False        False   \n",
       "19              True                 True           False        False   \n",
       "22              True                 True            True         True   \n",
       "31              True                False            True         True   \n",
       "35              True                False            True        False   \n",
       "42              True                False           False        False   \n",
       "44              True                False           False        False   \n",
       "53              True                 True            True        False   \n",
       "56              True                False           False        False   \n",
       "59              True                 True            True         True   \n",
       "70              True                 True            True         True   \n",
       "71              True                 True            True         True   \n",
       "81              True                False            True         True   \n",
       "85              True                False            True        False   \n",
       "\n",
       "    General Public (pol)  Healthcare Professionals (pol)  Patients (pol)  \\\n",
       "9                   True                           False            True   \n",
       "19                 False                           False           False   \n",
       "22                 False                            True            True   \n",
       "31                  True                            True            True   \n",
       "35                 False                           False           False   \n",
       "42                  True                           False           False   \n",
       "44                 False                            True           False   \n",
       "53                 False                            True            True   \n",
       "56                  True                           False            True   \n",
       "59                 False                            True           False   \n",
       "70                 False                            True            True   \n",
       "71                  True                           False           False   \n",
       "81                  True                            True            True   \n",
       "85                 False                           False           False   \n",
       "\n",
       "    Patient Families (pol)                        Policy Benefits Description  \\\n",
       "9                    False  Our project could improve guidelines as to how...   \n",
       "19                   False  WIll better delineate the burden of clonal hem...   \n",
       "22                   False  These tools can help healthcare professionals ...   \n",
       "31                    True  The navigation intervention could potentially ...   \n",
       "35                   False            Potential to influence NCCN guidelines.   \n",
       "42                   False                       E cigarette related policies   \n",
       "44                   False                Adding genomics to the EMR in Epic.   \n",
       "53                   False  The development of tumor specific probes for g...   \n",
       "56                   False  Our project could improve guidelines as to how...   \n",
       "59                   False                                                N/a   \n",
       "70                   False  These tools can help healthcare professionals ...   \n",
       "71                   False        To make brachy more automated and clinical    \n",
       "81                    True  The navigator intervention could potentially b...   \n",
       "85                   False  These studies on the immune compartment may le...   \n",
       "\n",
       "                                        Project Title  \n",
       "9   Neoantigen-specific T cell responses in except...  \n",
       "19  Impact of Metformin on Clonal Hematopoiesis an...  \n",
       "22  Knowledge-based planning and treatment decisio...  \n",
       "31  Development and Implementation of a Peer-Navig...  \n",
       "35  An Open-Label, Phase 2 Efficacy Study of Temoz...  \n",
       "42    Decoding Colon Cancers Using Boolean Principles  \n",
       "44  Deciphering the role of RNA editing in leukemi...  \n",
       "53          Precision Interception of Gastric Cancers  \n",
       "56  Neoantigen-specific T cell responses in except...  \n",
       "59  A pilot trial to test the benefit of real time...  \n",
       "70  Knowledge-based planning and treatment decisio...  \n",
       "71  Knowledge-based planning and treatment decisio...  \n",
       "81  Development and Implementation of a Peer-Navig...  \n",
       "85  Investigating the Efficacy of radium-223 with ...  "
      ]
     },
     "execution_count": 42,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "poli[~poli['Policy Benefits Description'].isna()]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\phuro\\AppData\\Local\\Temp\\ipykernel_47384\\2581353454.py:3: SettingWithCopyWarning:\n",
      "\n",
      "\n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Policy Influence</th>\n",
       "      <th>International (pol)</th>\n",
       "      <th>National (pol)</th>\n",
       "      <th>Local (pol)</th>\n",
       "      <th>General Public (pol)</th>\n",
       "      <th>Healthcare Professionals (pol)</th>\n",
       "      <th>Patients (pol)</th>\n",
       "      <th>Patient Families (pol)</th>\n",
       "      <th>Policy Benefits Description</th>\n",
       "      <th>Project Title</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Detecting dysregulated genes in neuroblastoma ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Functional Roles for Histidine Kinase Signalin...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A National Phase I Study of Cabozantinib in Co...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A Phase 1B, Nonrandomized Trial Investigating ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Policy Influence  International (pol)  National (pol)  Local (pol)  \\\n",
       "0              True                False           False        False   \n",
       "1              True                False           False        False   \n",
       "2              True                False           False        False   \n",
       "3              True                False           False        False   \n",
       "4              True                False           False        False   \n",
       "\n",
       "   General Public (pol)  Healthcare Professionals (pol)  Patients (pol)  \\\n",
       "0                 False                           False           False   \n",
       "1                 False                           False           False   \n",
       "2                 False                           False           False   \n",
       "3                 False                           False           False   \n",
       "4                 False                           False           False   \n",
       "\n",
       "   Patient Families (pol) Policy Benefits Description  \\\n",
       "0                   False                         NaN   \n",
       "1                   False                         NaN   \n",
       "2                   False                         NaN   \n",
       "3                   False                         NaN   \n",
       "4                   False                         NaN   \n",
       "\n",
       "                                       Project Title  \n",
       "0  Detecting dysregulated genes in neuroblastoma ...  \n",
       "1  Functional Roles for Histidine Kinase Signalin...  \n",
       "2  A National Phase I Study of Cabozantinib in Co...  \n",
       "3  UCSD-UCSF Specialized Program of Research Exce...  \n",
       "4  A Phase 1B, Nonrandomized Trial Investigating ...  "
      ]
     },
     "execution_count": 43,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Replace an instance of 'N/a' in pol benefits descr. with nan\n",
    "\n",
    "poli['Policy Benefits Description'] = poli['Policy Benefits Description'].replace('N/a', np.nan)\n",
    "# poli = poli.loc[:, poli.columns[:8].tolist() + ['Description']]\n",
    "poli.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Policy Influence\n",
      "True     101\n",
      "False      1\n",
      "Name: Policy Influence, dtype: int64\n",
      "\n",
      "International (pol)\n",
      "False    96\n",
      "True      6\n",
      "Name: International (pol), dtype: int64\n",
      "\n",
      "National (pol)\n",
      "False    93\n",
      "True      9\n",
      "Name: National (pol), dtype: int64\n",
      "\n",
      "Local (pol)\n",
      "False    96\n",
      "True      6\n",
      "Name: Local (pol), dtype: int64\n",
      "\n",
      "General Public (pol)\n",
      "False    96\n",
      "True      6\n",
      "Name: General Public (pol), dtype: int64\n",
      "\n",
      "Healthcare Professionals (pol)\n",
      "False    95\n",
      "True      7\n",
      "Name: Healthcare Professionals (pol), dtype: int64\n",
      "\n",
      "Patients (pol)\n",
      "False    95\n",
      "True      7\n",
      "Name: Patients (pol), dtype: int64\n",
      "\n",
      "Patient Families (pol)\n",
      "False    100\n",
      "True       2\n",
      "Name: Patient Families (pol), dtype: int64\n",
      "\n",
      "Policy Benefits Description\n",
      "Our project could improve guidelines as to how patients are treated with immune checkpoint blockade treatment.                                                                                                                                                                                                1\n",
      "WIll better delineate the burden of clonal hematopoiesis in breast cancer patients, informing the risk of developing secondary malignancies and perhaps, risk of breast cancer recurrence associated with this novel biomarker.                                                                               1\n",
      "These tools can help healthcare professionals with decision-making that impacts the quality and length of patient treatments, by helping them select appropriate brachytherapy devices to implant                                                                                                             1\n",
      "The navigation intervention could potentially be translated to bedside clinical care and thus be included in training for all providers involved in informed consent processes for therapeutic and non-therapeutic clinical trials. Results can also be translated to adolescents and adults with cancer.     1\n",
      "Potential to influence NCCN guidelines.                                                                                                                                                                                                                                                                       1\n",
      "E cigarette related policies                                                                                                                                                                                                                                                                                  1\n",
      "Adding genomics to the EMR in Epic.                                                                                                                                                                                                                                                                           1\n",
      "The development of tumor specific probes for gastric cancer may lead to new clinical guidelines for detection and treatment of gastric cancer.                                                                                                                                                                1\n",
      "Our project could improve guidelines as to how patients are treated with immune checkpoint blockade  treatment.                                                                                                                                                                                               1\n",
      "These tools can help healthcare professionals with decision-making that impacts the quality and length  of patient treatments, by helping them select appropriate brachytherapy devices to implant                                                                                                            1\n",
      "To make brachy more automated and clinical                                                                                                                                                                                                                                                                    1\n",
      "The navigator intervention could potentially be translated to bedside clinical care and thus be included in training for all providers involved in informed consent processes for therapeutic and non-therapeutic clinical trials. Results can also be translated to adolescents and adults with cancer.      1\n",
      "These studies on the immune compartment may lead to support for adjusting clinical treatment guidelines for bone metastatic castration resistant prostate cancer to include the new combination treatment of Ra-223 plus olaparib.                                                                            1\n",
      "Name: Policy Benefits Description, dtype: int64\n",
      "\n",
      "Project Title\n",
      "Knowledge-based planning and treatment decision-making for gynecologic brachytherapy                                                                          3\n",
      "Discovery of non-coding oncogenic mutations in pediatric acute lymphoblastic leukemia using ATAC-seq and Hi-C                                                 3\n",
      "New Therapies for Myeloid Leukemia                                                                                                                            3\n",
      "Inhibiting Liver Cancer Stem Cells to Improve Response to Thermal Ablation                                                                                    3\n",
      "Decoding Colon Cancers Using Boolean Principles                                                                                                               3\n",
      "                                                                                                                                                             ..\n",
      "A National Phase I Study of Cabozantinib in Combination with 13-cis-Retinoic Acid in Children with Relapsed or Refractory Solid Tumors                        1\n",
      "Novel kinase inhibitors in combination with retinoic acide for neuroblastoma                                                                                  1\n",
      "Natural Killer Cells for Treatment of Medulloblastoma                                                                                                         1\n",
      "Identification of genes critical for the production of T cells from human pluripotent stem cells for development of \"off-the-shelf\" T cell immunotherapies    1\n",
      "Functional Roles for Histidine Kinase Signaling in Neuroblastoma                                                                                              1\n",
      "Name: Project Title, Length: 52, dtype: int64\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# Check columns values\n",
    "\n",
    "for col in poli.columns:\n",
    "    print(col)\n",
    "    print(poli[col].value_counts())\n",
    "    print()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\phuro\\AppData\\Local\\Temp\\ipykernel_47384\\801329202.py:4: FutureWarning:\n",
      "\n",
      "Dropping invalid columns in DataFrameGroupBy.max is deprecated. In a future version, a TypeError will be raised. Before calling .max, select only columns which should be valid for the function.\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "52"
      ]
     },
     "execution_count": 45,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Get total number of projects with improvements in health policy\n",
    "\n",
    "pd.set_option('display.max_rows', None)\n",
    "poli.groupby(by='Project Title').max()['Policy Influence'].sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Award ID</th>\n",
       "      <th>Project Title</th>\n",
       "      <th>PI Institution</th>\n",
       "      <th>Other Institution</th>\n",
       "      <th>Prevention and diagnostic tools</th>\n",
       "      <th>Novel approaches and new therapeutic platforms</th>\n",
       "      <th>Immunotherapies and personalized vaccines</th>\n",
       "      <th>Addressing cancer disparities</th>\n",
       "      <th>Pediatric cancers</th>\n",
       "      <th>Specific Aims</th>\n",
       "      <th>Aim 1</th>\n",
       "      <th>Aim 2</th>\n",
       "      <th>Aim 3</th>\n",
       "      <th>Aim 4</th>\n",
       "      <th>Aim 5</th>\n",
       "      <th>Aim 6</th>\n",
       "      <th>Public Health Significance</th>\n",
       "      <th>Award Amount</th>\n",
       "      <th>Grant Start Date:</th>\n",
       "      <th>Grant End Date:</th>\n",
       "      <th>Complete</th>\n",
       "      <th>SR - None</th>\n",
       "      <th>SR - Biobehaviorial MCC</th>\n",
       "      <th>SR - Biorepository &amp; Tissue Tech. MCC</th>\n",
       "      <th>SR - Biostatistics MCC</th>\n",
       "      <th>SR - Clinical Trials Office MCC</th>\n",
       "      <th>SR - Flow Cytometry MCC</th>\n",
       "      <th>SR - Genomics &amp; Computational Bio. MCC</th>\n",
       "      <th>SR - In Vivo Imaging MCC</th>\n",
       "      <th>SR - Microscopy MCC</th>\n",
       "      <th>SR - Radiation Medicine MCC</th>\n",
       "      <th>SR - Transgenic Mouse MCC</th>\n",
       "      <th>SR - Gene Transfer/Targeting/Therap Salk</th>\n",
       "      <th>SR - Transgenic Salk</th>\n",
       "      <th>SR - Mass Spect - Proteom/Metabol Salk</th>\n",
       "      <th>SR - Chemical Library Screening SBPMDI</th>\n",
       "      <th>SR - Functional Genomics SBPMDI</th>\n",
       "      <th>Cancer Metabolism SBPMDI</th>\n",
       "      <th>Pedal Importance (recruitment, retention, advancement)</th>\n",
       "      <th>If yes, please specify</th>\n",
       "      <th>If no, please specify</th>\n",
       "      <th>Clinical Trials Resulted</th>\n",
       "      <th>First Clinical Trial</th>\n",
       "      <th>First Clinical Trial Patient Count</th>\n",
       "      <th>Second Clinical Trial</th>\n",
       "      <th>Second Clinical Trial Patient Count</th>\n",
       "      <th>Companies Founded</th>\n",
       "      <th>Patents Filed</th>\n",
       "      <th>Patent Details</th>\n",
       "      <th>Peer-Reviewed Publications Count</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>50.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>50.1</td>\n",
       "      <td>Tissue-specific role of SMARCB1 in pediatric r...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine cellular constraints on the ability ...</td>\n",
       "      <td>Investigate mechanisms underlying tissue-speci...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>This project aims to identify the mechanisms u...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>This grant and the publication that resulted (...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>none</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>129.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>50.2</td>\n",
       "      <td>Tissue-specific role of SMARCB1 in pediatric r...</td>\n",
       "      <td>Rady Children's</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine cellular constraints on the ability ...</td>\n",
       "      <td>Investigate mechanisms underlying tissue-speci...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>This project aims to identify the mechanisms u...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>196.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>196.1</td>\n",
       "      <td>Tissue-specific role of SMARCB1 in pediatric r...</td>\n",
       "      <td>UCSD - not a member of Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine cellular constraints on the ability...</td>\n",
       "      <td>Investigate mechanisms underlying tissue-speci...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>This project aims to identify the mechanisms u...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>197.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>196.2</td>\n",
       "      <td>Tissue-specific role of SMARCB1 in pediatric r...</td>\n",
       "      <td>UCSD - not a member of Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine cellular constraints on the ability ...</td>\n",
       "      <td>Investigate mechanisms underlying tissue-speci...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>This project aims to identify the mechanisms u...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "       ID Event Name  Award ID  \\\n",
       "18   50.0    Initial      50.1   \n",
       "19  129.0    Initial      50.2   \n",
       "20  196.0    Initial     196.1   \n",
       "21  197.0    Initial     196.2   \n",
       "\n",
       "                                        Project Title  \\\n",
       "18  Tissue-specific role of SMARCB1 in pediatric r...   \n",
       "19  Tissue-specific role of SMARCB1 in pediatric r...   \n",
       "20  Tissue-specific role of SMARCB1 in pediatric r...   \n",
       "21  Tissue-specific role of SMARCB1 in pediatric r...   \n",
       "\n",
       "                                 PI Institution Other Institution  \\\n",
       "18                         Moores Cancer Center               NaN   \n",
       "19                              Rady Children's               NaN   \n",
       "20  UCSD - not a member of Moores Cancer Center               NaN   \n",
       "21  UCSD - not a member of Moores Cancer Center               NaN   \n",
       "\n",
       "    Prevention and diagnostic tools  \\\n",
       "18                            False   \n",
       "19                            False   \n",
       "20                            False   \n",
       "21                            False   \n",
       "\n",
       "    Novel approaches and new therapeutic platforms  \\\n",
       "18                                           False   \n",
       "19                                           False   \n",
       "20                                           False   \n",
       "21                                           False   \n",
       "\n",
       "    Immunotherapies and personalized vaccines  Addressing cancer disparities  \\\n",
       "18                                      False                          False   \n",
       "19                                      False                          False   \n",
       "20                                      False                          False   \n",
       "21                                      False                          False   \n",
       "\n",
       "    Pediatric cancers      Specific Aims  \\\n",
       "18               True  Two Specific Aims   \n",
       "19               True  Two Specific Aims   \n",
       "20               True  Two Specific Aims   \n",
       "21               True  Two Specific Aims   \n",
       "\n",
       "                                                Aim 1  \\\n",
       "18  Determine cellular constraints on the ability ...   \n",
       "19  Determine cellular constraints on the ability ...   \n",
       "20   Determine cellular constraints on the ability...   \n",
       "21  Determine cellular constraints on the ability ...   \n",
       "\n",
       "                                                Aim 2 Aim 3 Aim 4 Aim 5 Aim 6  \\\n",
       "18  Investigate mechanisms underlying tissue-speci...   NaN   NaN   NaN   NaN   \n",
       "19  Investigate mechanisms underlying tissue-speci...   NaN   NaN   NaN   NaN   \n",
       "20  Investigate mechanisms underlying tissue-speci...   NaN   NaN   NaN   NaN   \n",
       "21  Investigate mechanisms underlying tissue-speci...   NaN   NaN   NaN   NaN   \n",
       "\n",
       "                           Public Health Significance  Award Amount  \\\n",
       "18  This project aims to identify the mechanisms u...       75000.0   \n",
       "19  This project aims to identify the mechanisms u...       75000.0   \n",
       "20  This project aims to identify the mechanisms u...       75000.0   \n",
       "21  This project aims to identify the mechanisms u...       75000.0   \n",
       "\n",
       "   Grant Start Date: Grant End Date:  Complete SR - None  \\\n",
       "18        2017-06-01      2018-05-31  Complete     False   \n",
       "19        2017-06-01      2018-05-31  Complete      True   \n",
       "20        2017-06-01      2018-05-31  Complete       NaN   \n",
       "21        2017-06-01      2018-05-31  Complete       NaN   \n",
       "\n",
       "   SR - Biobehaviorial MCC SR - Biorepository & Tissue Tech. MCC  \\\n",
       "18                   False                                 False   \n",
       "19                   False                                 False   \n",
       "20                     NaN                                   NaN   \n",
       "21                     NaN                                   NaN   \n",
       "\n",
       "   SR - Biostatistics MCC SR - Clinical Trials Office MCC  \\\n",
       "18                  False                           False   \n",
       "19                  False                           False   \n",
       "20                    NaN                             NaN   \n",
       "21                    NaN                             NaN   \n",
       "\n",
       "   SR - Flow Cytometry MCC SR - Genomics & Computational Bio. MCC  \\\n",
       "18                   False                                   True   \n",
       "19                   False                                  False   \n",
       "20                     NaN                                    NaN   \n",
       "21                     NaN                                    NaN   \n",
       "\n",
       "   SR - In Vivo Imaging MCC SR - Microscopy MCC SR - Radiation Medicine MCC  \\\n",
       "18                    False                True                       False   \n",
       "19                    False               False                       False   \n",
       "20                      NaN                 NaN                         NaN   \n",
       "21                      NaN                 NaN                         NaN   \n",
       "\n",
       "   SR - Transgenic Mouse MCC SR - Gene Transfer/Targeting/Therap Salk  \\\n",
       "18                     False                                    False   \n",
       "19                     False                                    False   \n",
       "20                       NaN                                      NaN   \n",
       "21                       NaN                                      NaN   \n",
       "\n",
       "   SR - Transgenic Salk SR - Mass Spect - Proteom/Metabol Salk  \\\n",
       "18                False                                  False   \n",
       "19                False                                  False   \n",
       "20                  NaN                                    NaN   \n",
       "21                  NaN                                    NaN   \n",
       "\n",
       "   SR - Chemical Library Screening SBPMDI SR - Functional Genomics SBPMDI  \\\n",
       "18                                  False                           False   \n",
       "19                                  False                           False   \n",
       "20                                    NaN                             NaN   \n",
       "21                                    NaN                             NaN   \n",
       "\n",
       "   Cancer Metabolism SBPMDI  \\\n",
       "18                    False   \n",
       "19                    False   \n",
       "20                      NaN   \n",
       "21                      NaN   \n",
       "\n",
       "   Pedal Importance (recruitment, retention, advancement)  \\\n",
       "18                                                Yes       \n",
       "19                                                 No       \n",
       "20                                                NaN       \n",
       "21                                                NaN       \n",
       "\n",
       "                               If yes, please specify If no, please specify  \\\n",
       "18  This grant and the publication that resulted (...                   NaN   \n",
       "19                                                NaN                   NaN   \n",
       "20                                                NaN                   NaN   \n",
       "21                                                NaN                   NaN   \n",
       "\n",
       "    Clinical Trials Resulted First Clinical Trial  \\\n",
       "18                       0.0                  NaN   \n",
       "19                       0.0                  NaN   \n",
       "20                       0.0                  NaN   \n",
       "21                       0.0                  NaN   \n",
       "\n",
       "    First Clinical Trial Patient Count Second Clinical Trial  \\\n",
       "18                                 NaN                   NaN   \n",
       "19                                 NaN                   NaN   \n",
       "20                                 NaN                   NaN   \n",
       "21                                 NaN                   NaN   \n",
       "\n",
       "    Second Clinical Trial Patient Count Companies Founded Patents Filed  \\\n",
       "18                                  NaN              none            No   \n",
       "19                                  NaN               NaN            No   \n",
       "20                                  NaN               NaN           NaN   \n",
       "21                                  NaN               NaN           NaN   \n",
       "\n",
       "   Patent Details Peer-Reviewed Publications Count  \n",
       "18            NaN                              One  \n",
       "19            NaN                              One  \n",
       "20            NaN                              NaN  \n",
       "21            NaN                              NaN  "
      ]
     },
     "execution_count": 46,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# sanity check\n",
    "\n",
    "roi_adj[roi_adj['Project Title'].str.contains('Tissue-specific')]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Define color schemes\n",
    "\n",
    "red = px.colors.qualitative.Alphabet[17]\n",
    "blue = px.colors.qualitative.Alphabet[1]\n",
    "cyan = px.colors.qualitative.Alphabet[18]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'#3283FE'"
      ]
     },
     "execution_count": 48,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "blue"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\phuro\\AppData\\Local\\Temp\\ipykernel_47384\\135756109.py:3: FutureWarning:\n",
      "\n",
      "Dropping invalid columns in DataFrameGroupBy.max is deprecated. In a future version, a TypeError will be raised. Before calling .max, select only columns which should be valid for the function.\n",
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.plotly.v1+json": {
       "config": {
        "plotlyServerURL": "https://plot.ly"
       },
       "data": [
        {
         "alignmentgroup": "True",
         "bingroup": "x",
         "histfunc": "sum",
         "hovertemplate": "x=%{x}<br>sum of y=%{y}<extra></extra>",
         "legendgroup": "",
         "marker": {
          "color": "#3283FE",
          "opacity": 0.81,
          "pattern": {
           "shape": ""
          }
         },
         "name": "",
         "offsetgroup": "",
         "orientation": "v",
         "showlegend": false,
         "texttemplate": "%{value}",
         "type": "histogram",
         "x": [
          "National",
          "Healthcare Professionals",
          "International",
          "General Public",
          "Patients",
          "Local",
          "Patient Families"
         ],
         "xaxis": "x",
         "y": [
          6,
          5,
          4,
          4,
          4,
          3,
          1
         ],
         "yaxis": "y"
        }
       ],
       "layout": {
        "barmode": "relative",
        "legend": {
         "tracegroupgap": 0
        },
        "template": {
         "data": {
          "bar": [
           {
            "error_x": {
             "color": "#2a3f5f"
            },
            "error_y": {
             "color": "#2a3f5f"
            },
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "bar"
           }
          ],
          "barpolar": [
           {
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "barpolar"
           }
          ],
          "carpet": [
           {
            "aaxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "baxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "type": "carpet"
           }
          ],
          "choropleth": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "choropleth"
           }
          ],
          "contour": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "contour"
           }
          ],
          "contourcarpet": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "contourcarpet"
           }
          ],
          "heatmap": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "heatmap"
           }
          ],
          "heatmapgl": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "heatmapgl"
           }
          ],
          "histogram": [
           {
            "marker": {
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "histogram"
           }
          ],
          "histogram2d": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "histogram2d"
           }
          ],
          "histogram2dcontour": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "histogram2dcontour"
           }
          ],
          "mesh3d": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "mesh3d"
           }
          ],
          "parcoords": [
           {
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "parcoords"
           }
          ],
          "pie": [
           {
            "automargin": true,
            "type": "pie"
           }
          ],
          "scatter": [
           {
            "fillpattern": {
             "fillmode": "overlay",
             "size": 10,
             "solidity": 0.2
            },
            "type": "scatter"
           }
          ],
          "scatter3d": [
           {
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatter3d"
           }
          ],
          "scattercarpet": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattercarpet"
           }
          ],
          "scattergeo": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattergeo"
           }
          ],
          "scattergl": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattergl"
           }
          ],
          "scattermapbox": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattermapbox"
           }
          ],
          "scatterpolar": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterpolar"
           }
          ],
          "scatterpolargl": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterpolargl"
           }
          ],
          "scatterternary": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterternary"
           }
          ],
          "surface": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "surface"
           }
          ],
          "table": [
           {
            "cells": {
             "fill": {
              "color": "#EBF0F8"
             },
             "line": {
              "color": "white"
             }
            },
            "header": {
             "fill": {
              "color": "#C8D4E3"
             },
             "line": {
              "color": "white"
             }
            },
            "type": "table"
           }
          ]
         },
         "layout": {
          "annotationdefaults": {
           "arrowcolor": "#2a3f5f",
           "arrowhead": 0,
           "arrowwidth": 1
          },
          "autotypenumbers": "strict",
          "coloraxis": {
           "colorbar": {
            "outlinewidth": 0,
            "ticks": ""
           }
          },
          "colorscale": {
           "diverging": [
            [
             0,
             "#8e0152"
            ],
            [
             0.1,
             "#c51b7d"
            ],
            [
             0.2,
             "#de77ae"
            ],
            [
             0.3,
             "#f1b6da"
            ],
            [
             0.4,
             "#fde0ef"
            ],
            [
             0.5,
             "#f7f7f7"
            ],
            [
             0.6,
             "#e6f5d0"
            ],
            [
             0.7,
             "#b8e186"
            ],
            [
             0.8,
             "#7fbc41"
            ],
            [
             0.9,
             "#4d9221"
            ],
            [
             1,
             "#276419"
            ]
           ],
           "sequential": [
            [
             0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1,
             "#f0f921"
            ]
           ],
           "sequentialminus": [
            [
             0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1,
             "#f0f921"
            ]
           ]
          },
          "colorway": [
           "#636efa",
           "#EF553B",
           "#00cc96",
           "#ab63fa",
           "#FFA15A",
           "#19d3f3",
           "#FF6692",
           "#B6E880",
           "#FF97FF",
           "#FECB52"
          ],
          "font": {
           "color": "#2a3f5f"
          },
          "geo": {
           "bgcolor": "white",
           "lakecolor": "white",
           "landcolor": "#E5ECF6",
           "showlakes": true,
           "showland": true,
           "subunitcolor": "white"
          },
          "hoverlabel": {
           "align": "left"
          },
          "hovermode": "closest",
          "mapbox": {
           "style": "light"
          },
          "paper_bgcolor": "white",
          "plot_bgcolor": "#E5ECF6",
          "polar": {
           "angularaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "bgcolor": "#E5ECF6",
           "radialaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "scene": {
           "xaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           },
           "yaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           },
           "zaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           }
          },
          "shapedefaults": {
           "line": {
            "color": "#2a3f5f"
           }
          },
          "ternary": {
           "aaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "baxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "bgcolor": "#E5ECF6",
           "caxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "title": {
           "x": 0.05
          },
          "xaxis": {
           "automargin": true,
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "zerolinewidth": 2
          },
          "yaxis": {
           "automargin": true,
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "zerolinewidth": 2
          }
         }
        },
        "title": {
         "text": "Distribution of health policy improvements by impact level"
        },
        "xaxis": {
         "anchor": "y",
         "domain": [
          0,
          1
         ],
         "title": {
          "text": "impact level"
         }
        },
        "yaxis": {
         "anchor": "x",
         "domain": [
          0,
          1
         ],
         "title": {
          "text": "count"
         }
        }
       }
      }
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Plot distribution of policy impact\n",
    "\n",
    "poli_data = poli.groupby(by='Project Title').max().reset_index(drop=True)\\\n",
    "    .drop(columns=['Policy Influence'])\n",
    "poli_data.columns = poli_data.columns.map(lambda x: re.sub(r' \\(pol\\)', '', x))\n",
    "poli_data = poli_data.sum().sort_values(ascending=False)\n",
    "poli_fig = px.histogram(x=poli_data.index, y=poli_data, text_auto=True, \\\n",
    "    title='Distribution of health policy improvements by impact level', \n",
    "    color_discrete_sequence=[blue], opacity=0.81)\n",
    "poli_fig.update_yaxes(title='count')\n",
    "poli_fig.update_xaxes(title='impact level')\n",
    "poli_fig"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Successfully saved policy_impacts.html at: impacts\\policy_impacts.html\n"
     ]
    }
   ],
   "source": [
    "# Export figure\n",
    "\n",
    "os.chdir('C:\\\\Users\\\\phuro\\\\Biokind\\\\curebound-team\\\\curebound\\\\reports')\n",
    "export_fig('impacts', poli_fig, 'policy_impacts.html')\n",
    "os.chdir('C:\\\\Users\\\\phuro\\\\Biokind\\\\curebound-team\\\\curebound\\\\data')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\phuro\\AppData\\Local\\Temp\\ipykernel_47384\\795597267.py:1: FutureWarning:\n",
      "\n",
      "Dropping invalid columns in DataFrameGroupBy.max is deprecated. In a future version, a TypeError will be raised. Before calling .max, select only columns which should be valid for the function.\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Policy Influence</th>\n",
       "      <th>International (pol)</th>\n",
       "      <th>National (pol)</th>\n",
       "      <th>Local (pol)</th>\n",
       "      <th>General Public (pol)</th>\n",
       "      <th>Healthcare Professionals (pol)</th>\n",
       "      <th>Patients (pol)</th>\n",
       "      <th>Patient Families (pol)</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Project Title</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>A National Phase I Study of Cabozantinib in Combination with 13-cis-Retinoic Acid in Children with Relapsed or Refractory Solid Tumors</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>A Novel Role for Histidine Kinase Activity in Neuroblastoma Pathogenesis</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>A Phase 1B, Nonrandomized Trial Investigating Docetaxel Combined with Cirmtuzumab in Patients with Metastatic Castration Resistant Prostate Cancer</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>A Phase 1b Safety and Feasibility Study of Personalized Immunotherapy in Adults with Advanced Cancers</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>A Phase 1b pilot clinical trial of cirmtuzumab, an anti-ROR1 monoclonal antibody, in combination with paclitaxel for the treatment of patients with metastatic, or locally advanced, unresectable breast cancer</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>A pilot trial to test the benefit of real time drug screening to determine individualized treatment plans for children and young adults with relapsed or refractory medulloblastoma</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>An Open-Label, Phase 2 Efficacy Study of Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>An over-expressed GPCR in pancreatic cancer associated fibroblasts as a novel therapeutic target</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Characterization of a GOLPH3 Pathway Inhibitor to Enable a Hit-to-Lead Grant to Develop a Novel Cancer Therapeutic</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Deciphering the role of RNA editing in leukemia stem cell generation and pediatric acute leukemia relapse</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Decoding Colon Cancers Using Boolean Principles</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Defining the mechanisms of pancreatic cancer susceptibility in patient-derived organoid models</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Detecting dysregulated genes in neuroblastoma using allele-specific expression</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Developing targeted therapy for Ewing sarcoma metastasis</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Development and Implementation of a Peer-Navigation Intervention to Improve Research Literacy in Pediatric Cancer Trials</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Discovery of non-coding oncogenic mutations in pediatric acute lymphoblastic leukemia using ATAC-seq and Hi-C</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Elucidating the role of Syk kinase and Syk inhibitors combined with Radiation therapy in Neuroblastoma</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Enhanced Breast Cancer Risk Prediction from Imputed Gene Expression</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Epigenetic profiling of endometrial cancer</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Evaluation of carcinogen exposure via genome-wide DNA-adduct signatures</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Examination of inhibitors of the ULK1 autophagy kinase as therapeutics in NSCLC</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Functional Roles for Histidine Kinase Signaling in Neuroblastoma</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Identification of genes critical for the production of T cells from human pluripotent stem cells for development of \"off-the-shelf\" T cell immunotherapies</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Identification of regulatory programs for glioblastoma cellular hierarchy using single-cell multi-omic profiling</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Identification of therapeutic targets of B-ALL using Boolean logic</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Impact of Metformin on Clonal Hematopoiesis and Clinical Outcomes in Breast Cancer</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Improved Echocardiographic Diagnosis of Anthracycline-Related Cardiac Dysfunction Using Global Longitudinal Strain</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Inducing Cytosolic Chromatin Fragments in Cancer Cells to Turn Cold Tumors Hot</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Inhibiting Liver Cancer Stem Cells to Improve Response to Thermal Ablation</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Investigating the Efficacy of radium-223 with Olaparib in Men with Metastatic Castration-resistant Prostate Cancer</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Irreversible electroporation as an In Situ vaccine for pancreatic cancer</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Knowledge-based planning and treatment decision-making for gynecologic brachytherapy</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Low Dose Chemotherapy for Immuno-activation in Lung Cancer</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Microbe-Associated Colorectal Cancer (M.A.C.S)</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Natural Killer Cells for Treatment of Medulloblastoma</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Neoantigen-specific T cell responses in exceptional responders to immunotherapy in NSCLC</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>New Therapies for Myeloid Leukemia</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Novel Pathways Regulated by NME1 in Neuroblastoma</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Novel kinase inhibitors in combination with retinoic acide for neuroblastoma</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Oncogenic Regulation of B-Lymphomagenesis by the Chromatin Modulator DOT1L</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Peptide Targeted Delivery of Epigenetic Therapies in Pancreatic Cancer</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Precision Interception of Gastric Cancers</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Responses of Melanoma Patients to Checkpoint Immunotherapy</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Targeting A Therapeutic Vulnerability in PTEN-Deficient Brain Tumors</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Targeting CD114 Signaling in Pediatric Medulloblastoma</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Targeting FZD7 in human cancers</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Targeting cellular mechanotransduction in breast cancer metastasis</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Tissue-specific role of SMARCB1 in pediatric rhabdoid tumors</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Transcriptomic, epigenomic profiling to reveal TIL, microglia functional phenotype, and clonality in pediatric brain tumors</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>UCSD-UCSF Specialized Program of Research Excellence (SPORE) in Head and Neck Cancer</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Understanding and Targeting NRF2 in Pancreatic Cancer</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                    Policy Influence  \\\n",
       "Project Title                                                          \n",
       "A National Phase I Study of Cabozantinib in Com...              True   \n",
       "A Novel Role for Histidine Kinase Activity in N...              True   \n",
       "A Phase 1B, Nonrandomized Trial Investigating D...              True   \n",
       "A Phase 1b Safety and Feasibility Study of Pers...              True   \n",
       "A Phase 1b pilot clinical trial of cirmtuzumab,...              True   \n",
       "A pilot trial to test the benefit of real time ...              True   \n",
       "An Open-Label, Phase 2 Efficacy Study of Temozo...              True   \n",
       "An over-expressed GPCR in pancreatic cancer ass...              True   \n",
       "Characterization of a GOLPH3 Pathway Inhibitor ...              True   \n",
       "Deciphering the role of RNA editing in leukemia...              True   \n",
       "Decoding Colon Cancers Using Boolean Principles                 True   \n",
       "Defining the mechanisms of pancreatic cancer su...              True   \n",
       "Detecting dysregulated genes in neuroblastoma u...              True   \n",
       "Developing targeted therapy for Ewing sarcoma m...              True   \n",
       "Development and Implementation of a Peer-Naviga...              True   \n",
       "Discovery of non-coding oncogenic mutations in ...              True   \n",
       "Elucidating the role of Syk kinase and Syk inhi...              True   \n",
       "Enhanced Breast Cancer Risk Prediction from Imp...              True   \n",
       "Epigenetic profiling of endometrial cancer                      True   \n",
       "Evaluation of carcinogen exposure via genome-wi...              True   \n",
       "Examination of inhibitors of the ULK1 autophagy...              True   \n",
       "FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma                True   \n",
       "Functional Roles for Histidine Kinase Signaling...              True   \n",
       "Identification of genes critical for the produc...              True   \n",
       "Identification of regulatory programs for gliob...              True   \n",
       "Identification of therapeutic targets of B-ALL ...              True   \n",
       "Impact of Metformin on Clonal Hematopoiesis and...              True   \n",
       "Improved Echocardiographic Diagnosis of Anthrac...              True   \n",
       "Inducing Cytosolic Chromatin Fragments in Cance...              True   \n",
       "Inhibiting Liver Cancer Stem Cells to Improve R...              True   \n",
       "Investigating the Efficacy of radium-223 with O...              True   \n",
       "Irreversible electroporation as an In Situ vacc...              True   \n",
       "Knowledge-based planning and treatment decision...              True   \n",
       "Low Dose Chemotherapy for Immuno-activation in ...              True   \n",
       "Microbe-Associated Colorectal Cancer (M.A.C.S)                  True   \n",
       "Natural Killer Cells for Treatment of Medullobl...              True   \n",
       "Neoantigen-specific T cell responses in excepti...              True   \n",
       "New Therapies for Myeloid Leukemia                              True   \n",
       "Novel Pathways Regulated by NME1 in Neuroblastoma               True   \n",
       "Novel kinase inhibitors in combination with ret...              True   \n",
       "Oncogenic Regulation of B-Lymphomagenesis by th...              True   \n",
       "Peptide Targeted Delivery of Epigenetic Therapi...              True   \n",
       "Precision Interception of Gastric Cancers                       True   \n",
       "Responses of Melanoma Patients to Checkpoint Im...              True   \n",
       "Targeting A Therapeutic Vulnerability in PTEN-D...              True   \n",
       "Targeting CD114 Signaling in Pediatric Medullob...              True   \n",
       "Targeting FZD7 in human cancers                                 True   \n",
       "Targeting cellular mechanotransduction in breas...              True   \n",
       "Tissue-specific role of SMARCB1 in pediatric rh...              True   \n",
       "Transcriptomic, epigenomic profiling to reveal ...              True   \n",
       "UCSD-UCSF Specialized Program of Research Excel...              True   \n",
       "Understanding and Targeting NRF2 in Pancreatic ...              True   \n",
       "\n",
       "                                                    International (pol)  \\\n",
       "Project Title                                                             \n",
       "A National Phase I Study of Cabozantinib in Com...                False   \n",
       "A Novel Role for Histidine Kinase Activity in N...                False   \n",
       "A Phase 1B, Nonrandomized Trial Investigating D...                False   \n",
       "A Phase 1b Safety and Feasibility Study of Pers...                False   \n",
       "A Phase 1b pilot clinical trial of cirmtuzumab,...                False   \n",
       "A pilot trial to test the benefit of real time ...                 True   \n",
       "An Open-Label, Phase 2 Efficacy Study of Temozo...                False   \n",
       "An over-expressed GPCR in pancreatic cancer ass...                False   \n",
       "Characterization of a GOLPH3 Pathway Inhibitor ...                False   \n",
       "Deciphering the role of RNA editing in leukemia...                False   \n",
       "Decoding Colon Cancers Using Boolean Principles                   False   \n",
       "Defining the mechanisms of pancreatic cancer su...                False   \n",
       "Detecting dysregulated genes in neuroblastoma u...                False   \n",
       "Developing targeted therapy for Ewing sarcoma m...                False   \n",
       "Development and Implementation of a Peer-Naviga...                False   \n",
       "Discovery of non-coding oncogenic mutations in ...                False   \n",
       "Elucidating the role of Syk kinase and Syk inhi...                False   \n",
       "Enhanced Breast Cancer Risk Prediction from Imp...                False   \n",
       "Epigenetic profiling of endometrial cancer                        False   \n",
       "Evaluation of carcinogen exposure via genome-wi...                False   \n",
       "Examination of inhibitors of the ULK1 autophagy...                False   \n",
       "FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma                  False   \n",
       "Functional Roles for Histidine Kinase Signaling...                False   \n",
       "Identification of genes critical for the produc...                False   \n",
       "Identification of regulatory programs for gliob...                False   \n",
       "Identification of therapeutic targets of B-ALL ...                False   \n",
       "Impact of Metformin on Clonal Hematopoiesis and...                 True   \n",
       "Improved Echocardiographic Diagnosis of Anthrac...                False   \n",
       "Inducing Cytosolic Chromatin Fragments in Cance...                False   \n",
       "Inhibiting Liver Cancer Stem Cells to Improve R...                False   \n",
       "Investigating the Efficacy of radium-223 with O...                False   \n",
       "Irreversible electroporation as an In Situ vacc...                False   \n",
       "Knowledge-based planning and treatment decision...                 True   \n",
       "Low Dose Chemotherapy for Immuno-activation in ...                False   \n",
       "Microbe-Associated Colorectal Cancer (M.A.C.S)                    False   \n",
       "Natural Killer Cells for Treatment of Medullobl...                False   \n",
       "Neoantigen-specific T cell responses in excepti...                False   \n",
       "New Therapies for Myeloid Leukemia                                False   \n",
       "Novel Pathways Regulated by NME1 in Neuroblastoma                 False   \n",
       "Novel kinase inhibitors in combination with ret...                False   \n",
       "Oncogenic Regulation of B-Lymphomagenesis by th...                False   \n",
       "Peptide Targeted Delivery of Epigenetic Therapi...                False   \n",
       "Precision Interception of Gastric Cancers                          True   \n",
       "Responses of Melanoma Patients to Checkpoint Im...                False   \n",
       "Targeting A Therapeutic Vulnerability in PTEN-D...                False   \n",
       "Targeting CD114 Signaling in Pediatric Medullob...                False   \n",
       "Targeting FZD7 in human cancers                                   False   \n",
       "Targeting cellular mechanotransduction in breas...                False   \n",
       "Tissue-specific role of SMARCB1 in pediatric rh...                False   \n",
       "Transcriptomic, epigenomic profiling to reveal ...                False   \n",
       "UCSD-UCSF Specialized Program of Research Excel...                False   \n",
       "Understanding and Targeting NRF2 in Pancreatic ...                False   \n",
       "\n",
       "                                                    National (pol)  \\\n",
       "Project Title                                                        \n",
       "A National Phase I Study of Cabozantinib in Com...           False   \n",
       "A Novel Role for Histidine Kinase Activity in N...           False   \n",
       "A Phase 1B, Nonrandomized Trial Investigating D...           False   \n",
       "A Phase 1b Safety and Feasibility Study of Pers...           False   \n",
       "A Phase 1b pilot clinical trial of cirmtuzumab,...           False   \n",
       "A pilot trial to test the benefit of real time ...            True   \n",
       "An Open-Label, Phase 2 Efficacy Study of Temozo...            True   \n",
       "An over-expressed GPCR in pancreatic cancer ass...           False   \n",
       "Characterization of a GOLPH3 Pathway Inhibitor ...           False   \n",
       "Deciphering the role of RNA editing in leukemia...           False   \n",
       "Decoding Colon Cancers Using Boolean Principles              False   \n",
       "Defining the mechanisms of pancreatic cancer su...           False   \n",
       "Detecting dysregulated genes in neuroblastoma u...           False   \n",
       "Developing targeted therapy for Ewing sarcoma m...           False   \n",
       "Development and Implementation of a Peer-Naviga...            True   \n",
       "Discovery of non-coding oncogenic mutations in ...           False   \n",
       "Elucidating the role of Syk kinase and Syk inhi...           False   \n",
       "Enhanced Breast Cancer Risk Prediction from Imp...           False   \n",
       "Epigenetic profiling of endometrial cancer                   False   \n",
       "Evaluation of carcinogen exposure via genome-wi...           False   \n",
       "Examination of inhibitors of the ULK1 autophagy...           False   \n",
       "FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma             False   \n",
       "Functional Roles for Histidine Kinase Signaling...           False   \n",
       "Identification of genes critical for the produc...           False   \n",
       "Identification of regulatory programs for gliob...           False   \n",
       "Identification of therapeutic targets of B-ALL ...           False   \n",
       "Impact of Metformin on Clonal Hematopoiesis and...           False   \n",
       "Improved Echocardiographic Diagnosis of Anthrac...           False   \n",
       "Inducing Cytosolic Chromatin Fragments in Cance...           False   \n",
       "Inhibiting Liver Cancer Stem Cells to Improve R...           False   \n",
       "Investigating the Efficacy of radium-223 with O...            True   \n",
       "Irreversible electroporation as an In Situ vacc...           False   \n",
       "Knowledge-based planning and treatment decision...            True   \n",
       "Low Dose Chemotherapy for Immuno-activation in ...           False   \n",
       "Microbe-Associated Colorectal Cancer (M.A.C.S)               False   \n",
       "Natural Killer Cells for Treatment of Medullobl...           False   \n",
       "Neoantigen-specific T cell responses in excepti...           False   \n",
       "New Therapies for Myeloid Leukemia                           False   \n",
       "Novel Pathways Regulated by NME1 in Neuroblastoma            False   \n",
       "Novel kinase inhibitors in combination with ret...           False   \n",
       "Oncogenic Regulation of B-Lymphomagenesis by th...           False   \n",
       "Peptide Targeted Delivery of Epigenetic Therapi...           False   \n",
       "Precision Interception of Gastric Cancers                     True   \n",
       "Responses of Melanoma Patients to Checkpoint Im...           False   \n",
       "Targeting A Therapeutic Vulnerability in PTEN-D...           False   \n",
       "Targeting CD114 Signaling in Pediatric Medullob...           False   \n",
       "Targeting FZD7 in human cancers                              False   \n",
       "Targeting cellular mechanotransduction in breas...           False   \n",
       "Tissue-specific role of SMARCB1 in pediatric rh...           False   \n",
       "Transcriptomic, epigenomic profiling to reveal ...           False   \n",
       "UCSD-UCSF Specialized Program of Research Excel...           False   \n",
       "Understanding and Targeting NRF2 in Pancreatic ...           False   \n",
       "\n",
       "                                                    Local (pol)  \\\n",
       "Project Title                                                     \n",
       "A National Phase I Study of Cabozantinib in Com...        False   \n",
       "A Novel Role for Histidine Kinase Activity in N...        False   \n",
       "A Phase 1B, Nonrandomized Trial Investigating D...        False   \n",
       "A Phase 1b Safety and Feasibility Study of Pers...        False   \n",
       "A Phase 1b pilot clinical trial of cirmtuzumab,...        False   \n",
       "A pilot trial to test the benefit of real time ...         True   \n",
       "An Open-Label, Phase 2 Efficacy Study of Temozo...        False   \n",
       "An over-expressed GPCR in pancreatic cancer ass...        False   \n",
       "Characterization of a GOLPH3 Pathway Inhibitor ...        False   \n",
       "Deciphering the role of RNA editing in leukemia...        False   \n",
       "Decoding Colon Cancers Using Boolean Principles           False   \n",
       "Defining the mechanisms of pancreatic cancer su...        False   \n",
       "Detecting dysregulated genes in neuroblastoma u...        False   \n",
       "Developing targeted therapy for Ewing sarcoma m...        False   \n",
       "Development and Implementation of a Peer-Naviga...         True   \n",
       "Discovery of non-coding oncogenic mutations in ...        False   \n",
       "Elucidating the role of Syk kinase and Syk inhi...        False   \n",
       "Enhanced Breast Cancer Risk Prediction from Imp...        False   \n",
       "Epigenetic profiling of endometrial cancer                False   \n",
       "Evaluation of carcinogen exposure via genome-wi...        False   \n",
       "Examination of inhibitors of the ULK1 autophagy...        False   \n",
       "FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma          False   \n",
       "Functional Roles for Histidine Kinase Signaling...        False   \n",
       "Identification of genes critical for the produc...        False   \n",
       "Identification of regulatory programs for gliob...        False   \n",
       "Identification of therapeutic targets of B-ALL ...        False   \n",
       "Impact of Metformin on Clonal Hematopoiesis and...        False   \n",
       "Improved Echocardiographic Diagnosis of Anthrac...        False   \n",
       "Inducing Cytosolic Chromatin Fragments in Cance...        False   \n",
       "Inhibiting Liver Cancer Stem Cells to Improve R...        False   \n",
       "Investigating the Efficacy of radium-223 with O...        False   \n",
       "Irreversible electroporation as an In Situ vacc...        False   \n",
       "Knowledge-based planning and treatment decision...         True   \n",
       "Low Dose Chemotherapy for Immuno-activation in ...        False   \n",
       "Microbe-Associated Colorectal Cancer (M.A.C.S)            False   \n",
       "Natural Killer Cells for Treatment of Medullobl...        False   \n",
       "Neoantigen-specific T cell responses in excepti...        False   \n",
       "New Therapies for Myeloid Leukemia                        False   \n",
       "Novel Pathways Regulated by NME1 in Neuroblastoma         False   \n",
       "Novel kinase inhibitors in combination with ret...        False   \n",
       "Oncogenic Regulation of B-Lymphomagenesis by th...        False   \n",
       "Peptide Targeted Delivery of Epigenetic Therapi...        False   \n",
       "Precision Interception of Gastric Cancers                 False   \n",
       "Responses of Melanoma Patients to Checkpoint Im...        False   \n",
       "Targeting A Therapeutic Vulnerability in PTEN-D...        False   \n",
       "Targeting CD114 Signaling in Pediatric Medullob...        False   \n",
       "Targeting FZD7 in human cancers                           False   \n",
       "Targeting cellular mechanotransduction in breas...        False   \n",
       "Tissue-specific role of SMARCB1 in pediatric rh...        False   \n",
       "Transcriptomic, epigenomic profiling to reveal ...        False   \n",
       "UCSD-UCSF Specialized Program of Research Excel...        False   \n",
       "Understanding and Targeting NRF2 in Pancreatic ...        False   \n",
       "\n",
       "                                                    General Public (pol)  \\\n",
       "Project Title                                                              \n",
       "A National Phase I Study of Cabozantinib in Com...                 False   \n",
       "A Novel Role for Histidine Kinase Activity in N...                 False   \n",
       "A Phase 1B, Nonrandomized Trial Investigating D...                 False   \n",
       "A Phase 1b Safety and Feasibility Study of Pers...                 False   \n",
       "A Phase 1b pilot clinical trial of cirmtuzumab,...                 False   \n",
       "A pilot trial to test the benefit of real time ...                 False   \n",
       "An Open-Label, Phase 2 Efficacy Study of Temozo...                 False   \n",
       "An over-expressed GPCR in pancreatic cancer ass...                 False   \n",
       "Characterization of a GOLPH3 Pathway Inhibitor ...                 False   \n",
       "Deciphering the role of RNA editing in leukemia...                 False   \n",
       "Decoding Colon Cancers Using Boolean Principles                     True   \n",
       "Defining the mechanisms of pancreatic cancer su...                 False   \n",
       "Detecting dysregulated genes in neuroblastoma u...                 False   \n",
       "Developing targeted therapy for Ewing sarcoma m...                 False   \n",
       "Development and Implementation of a Peer-Naviga...                  True   \n",
       "Discovery of non-coding oncogenic mutations in ...                 False   \n",
       "Elucidating the role of Syk kinase and Syk inhi...                 False   \n",
       "Enhanced Breast Cancer Risk Prediction from Imp...                 False   \n",
       "Epigenetic profiling of endometrial cancer                         False   \n",
       "Evaluation of carcinogen exposure via genome-wi...                 False   \n",
       "Examination of inhibitors of the ULK1 autophagy...                 False   \n",
       "FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma                   False   \n",
       "Functional Roles for Histidine Kinase Signaling...                 False   \n",
       "Identification of genes critical for the produc...                 False   \n",
       "Identification of regulatory programs for gliob...                 False   \n",
       "Identification of therapeutic targets of B-ALL ...                 False   \n",
       "Impact of Metformin on Clonal Hematopoiesis and...                 False   \n",
       "Improved Echocardiographic Diagnosis of Anthrac...                 False   \n",
       "Inducing Cytosolic Chromatin Fragments in Cance...                 False   \n",
       "Inhibiting Liver Cancer Stem Cells to Improve R...                 False   \n",
       "Investigating the Efficacy of radium-223 with O...                 False   \n",
       "Irreversible electroporation as an In Situ vacc...                 False   \n",
       "Knowledge-based planning and treatment decision...                  True   \n",
       "Low Dose Chemotherapy for Immuno-activation in ...                 False   \n",
       "Microbe-Associated Colorectal Cancer (M.A.C.S)                     False   \n",
       "Natural Killer Cells for Treatment of Medullobl...                 False   \n",
       "Neoantigen-specific T cell responses in excepti...                  True   \n",
       "New Therapies for Myeloid Leukemia                                 False   \n",
       "Novel Pathways Regulated by NME1 in Neuroblastoma                  False   \n",
       "Novel kinase inhibitors in combination with ret...                 False   \n",
       "Oncogenic Regulation of B-Lymphomagenesis by th...                 False   \n",
       "Peptide Targeted Delivery of Epigenetic Therapi...                 False   \n",
       "Precision Interception of Gastric Cancers                          False   \n",
       "Responses of Melanoma Patients to Checkpoint Im...                 False   \n",
       "Targeting A Therapeutic Vulnerability in PTEN-D...                 False   \n",
       "Targeting CD114 Signaling in Pediatric Medullob...                 False   \n",
       "Targeting FZD7 in human cancers                                    False   \n",
       "Targeting cellular mechanotransduction in breas...                 False   \n",
       "Tissue-specific role of SMARCB1 in pediatric rh...                 False   \n",
       "Transcriptomic, epigenomic profiling to reveal ...                 False   \n",
       "UCSD-UCSF Specialized Program of Research Excel...                 False   \n",
       "Understanding and Targeting NRF2 in Pancreatic ...                 False   \n",
       "\n",
       "                                                    Healthcare Professionals (pol)  \\\n",
       "Project Title                                                                        \n",
       "A National Phase I Study of Cabozantinib in Com...                           False   \n",
       "A Novel Role for Histidine Kinase Activity in N...                           False   \n",
       "A Phase 1B, Nonrandomized Trial Investigating D...                           False   \n",
       "A Phase 1b Safety and Feasibility Study of Pers...                           False   \n",
       "A Phase 1b pilot clinical trial of cirmtuzumab,...                           False   \n",
       "A pilot trial to test the benefit of real time ...                            True   \n",
       "An Open-Label, Phase 2 Efficacy Study of Temozo...                           False   \n",
       "An over-expressed GPCR in pancreatic cancer ass...                           False   \n",
       "Characterization of a GOLPH3 Pathway Inhibitor ...                           False   \n",
       "Deciphering the role of RNA editing in leukemia...                            True   \n",
       "Decoding Colon Cancers Using Boolean Principles                              False   \n",
       "Defining the mechanisms of pancreatic cancer su...                           False   \n",
       "Detecting dysregulated genes in neuroblastoma u...                           False   \n",
       "Developing targeted therapy for Ewing sarcoma m...                           False   \n",
       "Development and Implementation of a Peer-Naviga...                            True   \n",
       "Discovery of non-coding oncogenic mutations in ...                           False   \n",
       "Elucidating the role of Syk kinase and Syk inhi...                           False   \n",
       "Enhanced Breast Cancer Risk Prediction from Imp...                           False   \n",
       "Epigenetic profiling of endometrial cancer                                   False   \n",
       "Evaluation of carcinogen exposure via genome-wi...                           False   \n",
       "Examination of inhibitors of the ULK1 autophagy...                           False   \n",
       "FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma                             False   \n",
       "Functional Roles for Histidine Kinase Signaling...                           False   \n",
       "Identification of genes critical for the produc...                           False   \n",
       "Identification of regulatory programs for gliob...                           False   \n",
       "Identification of therapeutic targets of B-ALL ...                           False   \n",
       "Impact of Metformin on Clonal Hematopoiesis and...                           False   \n",
       "Improved Echocardiographic Diagnosis of Anthrac...                           False   \n",
       "Inducing Cytosolic Chromatin Fragments in Cance...                           False   \n",
       "Inhibiting Liver Cancer Stem Cells to Improve R...                           False   \n",
       "Investigating the Efficacy of radium-223 with O...                           False   \n",
       "Irreversible electroporation as an In Situ vacc...                           False   \n",
       "Knowledge-based planning and treatment decision...                            True   \n",
       "Low Dose Chemotherapy for Immuno-activation in ...                           False   \n",
       "Microbe-Associated Colorectal Cancer (M.A.C.S)                               False   \n",
       "Natural Killer Cells for Treatment of Medullobl...                           False   \n",
       "Neoantigen-specific T cell responses in excepti...                           False   \n",
       "New Therapies for Myeloid Leukemia                                           False   \n",
       "Novel Pathways Regulated by NME1 in Neuroblastoma                            False   \n",
       "Novel kinase inhibitors in combination with ret...                           False   \n",
       "Oncogenic Regulation of B-Lymphomagenesis by th...                           False   \n",
       "Peptide Targeted Delivery of Epigenetic Therapi...                           False   \n",
       "Precision Interception of Gastric Cancers                                     True   \n",
       "Responses of Melanoma Patients to Checkpoint Im...                           False   \n",
       "Targeting A Therapeutic Vulnerability in PTEN-D...                           False   \n",
       "Targeting CD114 Signaling in Pediatric Medullob...                           False   \n",
       "Targeting FZD7 in human cancers                                              False   \n",
       "Targeting cellular mechanotransduction in breas...                           False   \n",
       "Tissue-specific role of SMARCB1 in pediatric rh...                           False   \n",
       "Transcriptomic, epigenomic profiling to reveal ...                           False   \n",
       "UCSD-UCSF Specialized Program of Research Excel...                           False   \n",
       "Understanding and Targeting NRF2 in Pancreatic ...                           False   \n",
       "\n",
       "                                                    Patients (pol)  \\\n",
       "Project Title                                                        \n",
       "A National Phase I Study of Cabozantinib in Com...           False   \n",
       "A Novel Role for Histidine Kinase Activity in N...           False   \n",
       "A Phase 1B, Nonrandomized Trial Investigating D...           False   \n",
       "A Phase 1b Safety and Feasibility Study of Pers...           False   \n",
       "A Phase 1b pilot clinical trial of cirmtuzumab,...           False   \n",
       "A pilot trial to test the benefit of real time ...           False   \n",
       "An Open-Label, Phase 2 Efficacy Study of Temozo...           False   \n",
       "An over-expressed GPCR in pancreatic cancer ass...           False   \n",
       "Characterization of a GOLPH3 Pathway Inhibitor ...           False   \n",
       "Deciphering the role of RNA editing in leukemia...           False   \n",
       "Decoding Colon Cancers Using Boolean Principles              False   \n",
       "Defining the mechanisms of pancreatic cancer su...           False   \n",
       "Detecting dysregulated genes in neuroblastoma u...           False   \n",
       "Developing targeted therapy for Ewing sarcoma m...           False   \n",
       "Development and Implementation of a Peer-Naviga...            True   \n",
       "Discovery of non-coding oncogenic mutations in ...           False   \n",
       "Elucidating the role of Syk kinase and Syk inhi...           False   \n",
       "Enhanced Breast Cancer Risk Prediction from Imp...           False   \n",
       "Epigenetic profiling of endometrial cancer                   False   \n",
       "Evaluation of carcinogen exposure via genome-wi...           False   \n",
       "Examination of inhibitors of the ULK1 autophagy...           False   \n",
       "FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma             False   \n",
       "Functional Roles for Histidine Kinase Signaling...           False   \n",
       "Identification of genes critical for the produc...           False   \n",
       "Identification of regulatory programs for gliob...           False   \n",
       "Identification of therapeutic targets of B-ALL ...           False   \n",
       "Impact of Metformin on Clonal Hematopoiesis and...           False   \n",
       "Improved Echocardiographic Diagnosis of Anthrac...           False   \n",
       "Inducing Cytosolic Chromatin Fragments in Cance...           False   \n",
       "Inhibiting Liver Cancer Stem Cells to Improve R...           False   \n",
       "Investigating the Efficacy of radium-223 with O...           False   \n",
       "Irreversible electroporation as an In Situ vacc...           False   \n",
       "Knowledge-based planning and treatment decision...            True   \n",
       "Low Dose Chemotherapy for Immuno-activation in ...           False   \n",
       "Microbe-Associated Colorectal Cancer (M.A.C.S)               False   \n",
       "Natural Killer Cells for Treatment of Medullobl...           False   \n",
       "Neoantigen-specific T cell responses in excepti...            True   \n",
       "New Therapies for Myeloid Leukemia                           False   \n",
       "Novel Pathways Regulated by NME1 in Neuroblastoma            False   \n",
       "Novel kinase inhibitors in combination with ret...           False   \n",
       "Oncogenic Regulation of B-Lymphomagenesis by th...           False   \n",
       "Peptide Targeted Delivery of Epigenetic Therapi...           False   \n",
       "Precision Interception of Gastric Cancers                     True   \n",
       "Responses of Melanoma Patients to Checkpoint Im...           False   \n",
       "Targeting A Therapeutic Vulnerability in PTEN-D...           False   \n",
       "Targeting CD114 Signaling in Pediatric Medullob...           False   \n",
       "Targeting FZD7 in human cancers                              False   \n",
       "Targeting cellular mechanotransduction in breas...           False   \n",
       "Tissue-specific role of SMARCB1 in pediatric rh...           False   \n",
       "Transcriptomic, epigenomic profiling to reveal ...           False   \n",
       "UCSD-UCSF Specialized Program of Research Excel...           False   \n",
       "Understanding and Targeting NRF2 in Pancreatic ...           False   \n",
       "\n",
       "                                                    Patient Families (pol)  \n",
       "Project Title                                                               \n",
       "A National Phase I Study of Cabozantinib in Com...                   False  \n",
       "A Novel Role for Histidine Kinase Activity in N...                   False  \n",
       "A Phase 1B, Nonrandomized Trial Investigating D...                   False  \n",
       "A Phase 1b Safety and Feasibility Study of Pers...                   False  \n",
       "A Phase 1b pilot clinical trial of cirmtuzumab,...                   False  \n",
       "A pilot trial to test the benefit of real time ...                   False  \n",
       "An Open-Label, Phase 2 Efficacy Study of Temozo...                   False  \n",
       "An over-expressed GPCR in pancreatic cancer ass...                   False  \n",
       "Characterization of a GOLPH3 Pathway Inhibitor ...                   False  \n",
       "Deciphering the role of RNA editing in leukemia...                   False  \n",
       "Decoding Colon Cancers Using Boolean Principles                      False  \n",
       "Defining the mechanisms of pancreatic cancer su...                   False  \n",
       "Detecting dysregulated genes in neuroblastoma u...                   False  \n",
       "Developing targeted therapy for Ewing sarcoma m...                   False  \n",
       "Development and Implementation of a Peer-Naviga...                    True  \n",
       "Discovery of non-coding oncogenic mutations in ...                   False  \n",
       "Elucidating the role of Syk kinase and Syk inhi...                   False  \n",
       "Enhanced Breast Cancer Risk Prediction from Imp...                   False  \n",
       "Epigenetic profiling of endometrial cancer                           False  \n",
       "Evaluation of carcinogen exposure via genome-wi...                   False  \n",
       "Examination of inhibitors of the ULK1 autophagy...                   False  \n",
       "FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma                     False  \n",
       "Functional Roles for Histidine Kinase Signaling...                   False  \n",
       "Identification of genes critical for the produc...                   False  \n",
       "Identification of regulatory programs for gliob...                   False  \n",
       "Identification of therapeutic targets of B-ALL ...                   False  \n",
       "Impact of Metformin on Clonal Hematopoiesis and...                   False  \n",
       "Improved Echocardiographic Diagnosis of Anthrac...                   False  \n",
       "Inducing Cytosolic Chromatin Fragments in Cance...                   False  \n",
       "Inhibiting Liver Cancer Stem Cells to Improve R...                   False  \n",
       "Investigating the Efficacy of radium-223 with O...                   False  \n",
       "Irreversible electroporation as an In Situ vacc...                   False  \n",
       "Knowledge-based planning and treatment decision...                   False  \n",
       "Low Dose Chemotherapy for Immuno-activation in ...                   False  \n",
       "Microbe-Associated Colorectal Cancer (M.A.C.S)                       False  \n",
       "Natural Killer Cells for Treatment of Medullobl...                   False  \n",
       "Neoantigen-specific T cell responses in excepti...                   False  \n",
       "New Therapies for Myeloid Leukemia                                   False  \n",
       "Novel Pathways Regulated by NME1 in Neuroblastoma                    False  \n",
       "Novel kinase inhibitors in combination with ret...                   False  \n",
       "Oncogenic Regulation of B-Lymphomagenesis by th...                   False  \n",
       "Peptide Targeted Delivery of Epigenetic Therapi...                   False  \n",
       "Precision Interception of Gastric Cancers                            False  \n",
       "Responses of Melanoma Patients to Checkpoint Im...                   False  \n",
       "Targeting A Therapeutic Vulnerability in PTEN-D...                   False  \n",
       "Targeting CD114 Signaling in Pediatric Medullob...                   False  \n",
       "Targeting FZD7 in human cancers                                      False  \n",
       "Targeting cellular mechanotransduction in breas...                   False  \n",
       "Tissue-specific role of SMARCB1 in pediatric rh...                   False  \n",
       "Transcriptomic, epigenomic profiling to reveal ...                   False  \n",
       "UCSD-UCSF Specialized Program of Research Excel...                   False  \n",
       "Understanding and Targeting NRF2 in Pancreatic ...                   False  "
      ]
     },
     "execution_count": 51,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "poli.groupby(by='Project Title').max()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Our project could improve guidelines as to how patients are treated with immune checkpoint blockade treatment.                                                                                                                                                                                                1\n",
       "WIll better delineate the burden of clonal hematopoiesis in breast cancer patients, informing the risk of developing secondary malignancies and perhaps, risk of breast cancer recurrence associated with this novel biomarker.                                                                               1\n",
       "These tools can help healthcare professionals with decision-making that impacts the quality and length of patient treatments, by helping them select appropriate brachytherapy devices to implant                                                                                                             1\n",
       "The navigation intervention could potentially be translated to bedside clinical care and thus be included in training for all providers involved in informed consent processes for therapeutic and non-therapeutic clinical trials. Results can also be translated to adolescents and adults with cancer.     1\n",
       "Potential to influence NCCN guidelines.                                                                                                                                                                                                                                                                       1\n",
       "E cigarette related policies                                                                                                                                                                                                                                                                                  1\n",
       "Adding genomics to the EMR in Epic.                                                                                                                                                                                                                                                                           1\n",
       "The development of tumor specific probes for gastric cancer may lead to new clinical guidelines for detection and treatment of gastric cancer.                                                                                                                                                                1\n",
       "Our project could improve guidelines as to how patients are treated with immune checkpoint blockade  treatment.                                                                                                                                                                                               1\n",
       "These tools can help healthcare professionals with decision-making that impacts the quality and length  of patient treatments, by helping them select appropriate brachytherapy devices to implant                                                                                                            1\n",
       "To make brachy more automated and clinical                                                                                                                                                                                                                                                                    1\n",
       "The navigator intervention could potentially be translated to bedside clinical care and thus be included in training for all providers involved in informed consent processes for therapeutic and non-therapeutic clinical trials. Results can also be translated to adolescents and adults with cancer.      1\n",
       "These studies on the immune compartment may lead to support for adjusting clinical treatment guidelines for bone metastatic castration resistant prostate cancer to include the new combination treatment of Ra-223 plus olaparib.                                                                            1\n",
       "Name: Policy Benefits Description, dtype: int64"
      ]
     },
     "execution_count": 52,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Pass columns back into pr (progress report) dataframe\n",
    "\n",
    "for col in poli.columns:\n",
    "    pr[col] = poli[col]\n",
    "\n",
    "pr['Policy Benefits Description'].value_counts()"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Health Benefits\n",
    "- HEALTH GAINS:  Will the findings from your project benefit health (e.g., prevention, detection, and/or treatment of cancer) and/or health behaviors? "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "metadata": {},
   "outputs": [],
   "source": [
    "hlth = pr.loc[:, ['Health Benefits', 'International', 'National', 'Local', \\\n",
    "    'General Public', 'Healthcare Professionals', 'Patients', 'Patient Families']]\n",
    "hlth['Project Title'] = pr['Project Title']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Health Benefits\n",
      "Yes    86\n",
      "No     15\n",
      "Name: Health Benefits, dtype: int64\n",
      "\n",
      "International\n",
      "False    52\n",
      "True     50\n",
      "Name: International, dtype: int64\n",
      "\n",
      "National\n",
      "False    80\n",
      "True     22\n",
      "Name: National, dtype: int64\n",
      "\n",
      "Local\n",
      "False    88\n",
      "True     14\n",
      "Name: Local, dtype: int64\n",
      "\n",
      "General Public\n",
      "False    88\n",
      "True     14\n",
      "Name: General Public, dtype: int64\n",
      "\n",
      "Healthcare Professionals\n",
      "False    91\n",
      "True     11\n",
      "Name: Healthcare Professionals, dtype: int64\n",
      "\n",
      "Patients\n",
      "False    54\n",
      "True     48\n",
      "Name: Patients, dtype: int64\n",
      "\n",
      "Patient Families\n",
      "False    98\n",
      "True      4\n",
      "Name: Patient Families, dtype: int64\n",
      "\n",
      "Project Title\n",
      "Knowledge-based planning and treatment decision-making for gynecologic brachytherapy                                                                                                                               3\n",
      "Discovery of non-coding oncogenic mutations in pediatric acute lymphoblastic leukemia using ATAC-seq and Hi-C                                                                                                      3\n",
      "New Therapies for Myeloid Leukemia                                                                                                                                                                                 3\n",
      "Inhibiting Liver Cancer Stem Cells to Improve Response to Thermal Ablation                                                                                                                                         3\n",
      "Decoding Colon Cancers Using Boolean Principles                                                                                                                                                                    3\n",
      "Examination of inhibitors of the ULK1 autophagy kinase as therapeutics in NSCLC                                                                                                                                    3\n",
      "FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma                                                                                                                                                                   3\n",
      "Defining the mechanisms of pancreatic cancer susceptibility in patient-derived organoid models                                                                                                                     3\n",
      "Detecting dysregulated genes in neuroblastoma using allele-specific expression                                                                                                                                     2\n",
      "Investigating the Efficacy of radium-223 with Olaparib in Men with Metastatic Castration-resistant Prostate Cancer                                                                                                 2\n",
      "Epigenetic profiling of endometrial cancer                                                                                                                                                                         2\n",
      "Development and Implementation of a Peer-Navigation Intervention to Improve Research Literacy in Pediatric Cancer Trials                                                                                           2\n",
      "Transcriptomic, epigenomic profiling to reveal TIL, microglia functional phenotype, and clonality in pediatric brain tumors                                                                                        2\n",
      "A Phase 1b pilot clinical trial of cirmtuzumab, an anti-ROR1 monoclonal antibody, in combination with paclitaxel for the treatment of patients with metastatic, or locally advanced, unresectable breast cancer    2\n",
      "An Open-Label, Phase 2 Efficacy Study of Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)                                                       2\n",
      "Oncogenic Regulation of B-Lymphomagenesis by the Chromatin Modulator DOT1L                                                                                                                                         2\n",
      "Low Dose Chemotherapy for Immuno-activation in Lung Cancer                                                                                                                                                         2\n",
      "Irreversible electroporation as an In Situ vaccine for pancreatic cancer                                                                                                                                           2\n",
      "Enhanced Breast Cancer Risk Prediction from Imputed Gene Expression                                                                                                                                                2\n",
      "An over-expressed GPCR in pancreatic cancer associated fibroblasts as a novel therapeutic target                                                                                                                   2\n",
      "Targeting cellular mechanotransduction in breast cancer metastasis                                                                                                                                                 2\n",
      "Tissue-specific role of SMARCB1 in pediatric rhabdoid tumors                                                                                                                                                       2\n",
      "Identification of therapeutic targets of B-ALL using Boolean logic                                                                                                                                                 2\n",
      "Developing targeted therapy for Ewing sarcoma metastasis                                                                                                                                                           2\n",
      "Understanding and Targeting NRF2 in Pancreatic Cancer                                                                                                                                                              2\n",
      "Responses of Melanoma Patients to Checkpoint Immunotherapy                                                                                                                                                         2\n",
      "A pilot trial to test the benefit of real time drug screening to determine individualized treatment plans for children and young adults with relapsed or refractory medulloblastoma                                2\n",
      "Characterization of a GOLPH3 Pathway Inhibitor to Enable a Hit-to-Lead Grant to Develop a Novel Cancer Therapeutic                                                                                                 2\n",
      "UCSD-UCSF Specialized Program of Research Excellence (SPORE) in Head and Neck Cancer                                                                                                                               2\n",
      "Peptide Targeted Delivery of Epigenetic Therapies in Pancreatic Cancer                                                                                                                                             2\n",
      "Precision Interception of Gastric Cancers                                                                                                                                                                          2\n",
      "Neoantigen-specific T cell responses in exceptional responders to immunotherapy in NSCLC                                                                                                                           2\n",
      "Elucidating the role of Syk kinase and Syk inhibitors combined with Radiation therapy in Neuroblastoma                                                                                                             2\n",
      "Inducing Cytosolic Chromatin Fragments in Cancer Cells to Turn Cold Tumors Hot                                                                                                                                     2\n",
      "Improved Echocardiographic Diagnosis of Anthracycline-Related Cardiac Dysfunction Using Global Longitudinal Strain                                                                                                 2\n",
      "A Novel Role for Histidine Kinase Activity in Neuroblastoma Pathogenesis                                                                                                                                           2\n",
      "Microbe-Associated Colorectal Cancer (M.A.C.S)                                                                                                                                                                     2\n",
      "Identification of regulatory programs for glioblastoma cellular hierarchy using single-cell multi-omic profiling                                                                                                   2\n",
      "Evaluation of carcinogen exposure via genome-wide DNA-adduct signatures                                                                                                                                            2\n",
      "Impact of Metformin on Clonal Hematopoiesis and Clinical Outcomes in Breast Cancer                                                                                                                                 2\n",
      "Targeting CD114 Signaling in Pediatric Medulloblastoma                                                                                                                                                             2\n",
      "Targeting FZD7 in human cancers                                                                                                                                                                                    2\n",
      "Novel Pathways Regulated by NME1 in Neuroblastoma                                                                                                                                                                  1\n",
      "A Phase 1b Safety and Feasibility Study of Personalized Immunotherapy in Adults with Advanced Cancers                                                                                                              1\n",
      "Targeting A Therapeutic Vulnerability in PTEN-Deficient Brain Tumors                                                                                                                                               1\n",
      "Deciphering the role of RNA editing in leukemia stem cell generation and pediatric acute leukemia relapse                                                                                                          1\n",
      "A Phase 1B, Nonrandomized Trial Investigating Docetaxel Combined with Cirmtuzumab in Patients with Metastatic Castration Resistant Prostate Cancer                                                                 1\n",
      "A National Phase I Study of Cabozantinib in Combination with 13-cis-Retinoic Acid in Children with Relapsed or Refractory Solid Tumors                                                                             1\n",
      "Novel kinase inhibitors in combination with retinoic acide for neuroblastoma                                                                                                                                       1\n",
      "Natural Killer Cells for Treatment of Medulloblastoma                                                                                                                                                              1\n",
      "Identification of genes critical for the production of T cells from human pluripotent stem cells for development of \"off-the-shelf\" T cell immunotherapies                                                         1\n",
      "Functional Roles for Histidine Kinase Signaling in Neuroblastoma                                                                                                                                                   1\n",
      "Name: Project Title, dtype: int64\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# Check columns values\n",
    "\n",
    "for col in hlth.columns:\n",
    "    print(col)\n",
    "    print(hlth[col].value_counts())\n",
    "    print()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Yes    86\n",
       "No     15\n",
       "Name: Health Benefits, dtype: int64"
      ]
     },
     "execution_count": 55,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pr['Health Benefits'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\phuro\\AppData\\Local\\Temp\\ipykernel_47384\\2409173555.py:3: FutureWarning:\n",
      "\n",
      "Dropping invalid columns in DataFrameGroupBy.max is deprecated. In a future version, a TypeError will be raised. Before calling .max, select only columns which should be valid for the function.\n",
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.plotly.v1+json": {
       "config": {
        "plotlyServerURL": "https://plot.ly"
       },
       "data": [
        {
         "alignmentgroup": "True",
         "bingroup": "x",
         "histfunc": "sum",
         "hovertemplate": "x=%{x}<br>sum of y=%{y}<extra></extra>",
         "legendgroup": "",
         "marker": {
          "color": "#3283FE",
          "opacity": 0.81,
          "pattern": {
           "shape": ""
          }
         },
         "name": "",
         "offsetgroup": "",
         "orientation": "v",
         "showlegend": false,
         "texttemplate": "%{value}",
         "type": "histogram",
         "x": [
          "International",
          "Patients",
          "National",
          "Local",
          "General Public",
          "Healthcare Professionals",
          "Patient Families"
         ],
         "xaxis": "x",
         "y": [
          36,
          34,
          17,
          10,
          10,
          8,
          3
         ],
         "yaxis": "y"
        }
       ],
       "layout": {
        "barmode": "relative",
        "legend": {
         "tracegroupgap": 0
        },
        "template": {
         "data": {
          "bar": [
           {
            "error_x": {
             "color": "#2a3f5f"
            },
            "error_y": {
             "color": "#2a3f5f"
            },
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "bar"
           }
          ],
          "barpolar": [
           {
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "barpolar"
           }
          ],
          "carpet": [
           {
            "aaxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "baxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "type": "carpet"
           }
          ],
          "choropleth": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "choropleth"
           }
          ],
          "contour": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "contour"
           }
          ],
          "contourcarpet": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "contourcarpet"
           }
          ],
          "heatmap": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "heatmap"
           }
          ],
          "heatmapgl": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "heatmapgl"
           }
          ],
          "histogram": [
           {
            "marker": {
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "histogram"
           }
          ],
          "histogram2d": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "histogram2d"
           }
          ],
          "histogram2dcontour": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "histogram2dcontour"
           }
          ],
          "mesh3d": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "mesh3d"
           }
          ],
          "parcoords": [
           {
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "parcoords"
           }
          ],
          "pie": [
           {
            "automargin": true,
            "type": "pie"
           }
          ],
          "scatter": [
           {
            "fillpattern": {
             "fillmode": "overlay",
             "size": 10,
             "solidity": 0.2
            },
            "type": "scatter"
           }
          ],
          "scatter3d": [
           {
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatter3d"
           }
          ],
          "scattercarpet": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattercarpet"
           }
          ],
          "scattergeo": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattergeo"
           }
          ],
          "scattergl": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattergl"
           }
          ],
          "scattermapbox": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattermapbox"
           }
          ],
          "scatterpolar": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterpolar"
           }
          ],
          "scatterpolargl": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterpolargl"
           }
          ],
          "scatterternary": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterternary"
           }
          ],
          "surface": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "surface"
           }
          ],
          "table": [
           {
            "cells": {
             "fill": {
              "color": "#EBF0F8"
             },
             "line": {
              "color": "white"
             }
            },
            "header": {
             "fill": {
              "color": "#C8D4E3"
             },
             "line": {
              "color": "white"
             }
            },
            "type": "table"
           }
          ]
         },
         "layout": {
          "annotationdefaults": {
           "arrowcolor": "#2a3f5f",
           "arrowhead": 0,
           "arrowwidth": 1
          },
          "autotypenumbers": "strict",
          "coloraxis": {
           "colorbar": {
            "outlinewidth": 0,
            "ticks": ""
           }
          },
          "colorscale": {
           "diverging": [
            [
             0,
             "#8e0152"
            ],
            [
             0.1,
             "#c51b7d"
            ],
            [
             0.2,
             "#de77ae"
            ],
            [
             0.3,
             "#f1b6da"
            ],
            [
             0.4,
             "#fde0ef"
            ],
            [
             0.5,
             "#f7f7f7"
            ],
            [
             0.6,
             "#e6f5d0"
            ],
            [
             0.7,
             "#b8e186"
            ],
            [
             0.8,
             "#7fbc41"
            ],
            [
             0.9,
             "#4d9221"
            ],
            [
             1,
             "#276419"
            ]
           ],
           "sequential": [
            [
             0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1,
             "#f0f921"
            ]
           ],
           "sequentialminus": [
            [
             0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1,
             "#f0f921"
            ]
           ]
          },
          "colorway": [
           "#636efa",
           "#EF553B",
           "#00cc96",
           "#ab63fa",
           "#FFA15A",
           "#19d3f3",
           "#FF6692",
           "#B6E880",
           "#FF97FF",
           "#FECB52"
          ],
          "font": {
           "color": "#2a3f5f"
          },
          "geo": {
           "bgcolor": "white",
           "lakecolor": "white",
           "landcolor": "#E5ECF6",
           "showlakes": true,
           "showland": true,
           "subunitcolor": "white"
          },
          "hoverlabel": {
           "align": "left"
          },
          "hovermode": "closest",
          "mapbox": {
           "style": "light"
          },
          "paper_bgcolor": "white",
          "plot_bgcolor": "#E5ECF6",
          "polar": {
           "angularaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "bgcolor": "#E5ECF6",
           "radialaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "scene": {
           "xaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           },
           "yaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           },
           "zaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           }
          },
          "shapedefaults": {
           "line": {
            "color": "#2a3f5f"
           }
          },
          "ternary": {
           "aaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "baxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "bgcolor": "#E5ECF6",
           "caxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "title": {
           "x": 0.05
          },
          "xaxis": {
           "automargin": true,
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "zerolinewidth": 2
          },
          "yaxis": {
           "automargin": true,
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "zerolinewidth": 2
          }
         }
        },
        "title": {
         "text": "Distribution of health gains by impact level"
        },
        "xaxis": {
         "anchor": "y",
         "domain": [
          0,
          1
         ],
         "title": {
          "text": "impact level"
         }
        },
        "yaxis": {
         "anchor": "x",
         "domain": [
          0,
          1
         ],
         "title": {
          "text": "count"
         }
        }
       }
      }
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Plot distribution of health benefits\n",
    "\n",
    "hlth_data = hlth.groupby(by='Project Title').max().reset_index(drop=True)\n",
    "hlth_data = hlth_data.sum().sort_values(ascending=False)\n",
    "hlth_fig = px.histogram(x=hlth_data.index, y=hlth_data, text_auto=True, \\\n",
    "    title='Distribution of health gains by impact level', \n",
    "    color_discrete_sequence=[blue], opacity=0.81)\n",
    "hlth_fig.update_yaxes(title='count')\n",
    "hlth_fig.update_xaxes(title='impact level')\n",
    "hlth_fig"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Successfully saved health_impacts.html at: impacts\\health_impacts.html\n"
     ]
    }
   ],
   "source": [
    "# Export figure\n",
    "\n",
    "os.chdir('C:\\\\Users\\\\phuro\\\\Biokind\\\\curebound-team\\\\curebound\\\\reports')\n",
    "export_fig('impacts', hlth_fig, 'health_impacts.html')\n",
    "os.chdir('C:\\\\Users\\\\phuro\\\\Biokind\\\\curebound-team\\\\curebound\\\\data')"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Economic Benefits\n",
    "- ECONOMIC BENEFITS:  Will the findings from your project lead to improvements in health care service cost and/or health care service delivery?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Economic Benefits</th>\n",
       "      <th>International (econ)</th>\n",
       "      <th>National (econ)</th>\n",
       "      <th>Local (econ)</th>\n",
       "      <th>General Public (econ)</th>\n",
       "      <th>Healthcare Professionals (econ)</th>\n",
       "      <th>Patients (econ)</th>\n",
       "      <th>Patient Families (econ)</th>\n",
       "      <th>Economic Benefits Description</th>\n",
       "      <th>Project Title</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Detecting dysregulated genes in neuroblastoma ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Functional Roles for Histidine Kinase Signalin...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>The combination of cabozantinib with 13-cis-re...</td>\n",
       "      <td>A National Phase I Study of Cabozantinib in Co...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>Oral cancer prevention and the consequent redu...</td>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A Phase 1B, Nonrandomized Trial Investigating ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  Economic Benefits  International (econ)  National (econ)  Local (econ)  \\\n",
       "0                No                 False            False         False   \n",
       "1                No                 False            False         False   \n",
       "2               Yes                 False             True         False   \n",
       "3               Yes                  True             True         False   \n",
       "4                No                 False            False         False   \n",
       "\n",
       "   General Public (econ)  Healthcare Professionals (econ)  Patients (econ)  \\\n",
       "0                  False                            False            False   \n",
       "1                  False                            False            False   \n",
       "2                  False                            False            False   \n",
       "3                  False                            False             True   \n",
       "4                  False                            False            False   \n",
       "\n",
       "   Patient Families (econ)                      Economic Benefits Description  \\\n",
       "0                    False                                                NaN   \n",
       "1                    False                                                NaN   \n",
       "2                    False  The combination of cabozantinib with 13-cis-re...   \n",
       "3                     True  Oral cancer prevention and the consequent redu...   \n",
       "4                    False                                                NaN   \n",
       "\n",
       "                                       Project Title  \n",
       "0  Detecting dysregulated genes in neuroblastoma ...  \n",
       "1  Functional Roles for Histidine Kinase Signalin...  \n",
       "2  A National Phase I Study of Cabozantinib in Co...  \n",
       "3  UCSD-UCSF Specialized Program of Research Exce...  \n",
       "4  A Phase 1B, Nonrandomized Trial Investigating ...  "
      ]
     },
     "execution_count": 58,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Get all columns related health economic benefits\n",
    "\n",
    "econ = pr.filter(regex=(r'econ|Econ'))\n",
    "econ = econ.loc[:, econ.columns[:9]]\n",
    "econ['Project Title'] = pr['Project Title']\n",
    "econ.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Economic Benefits</th>\n",
       "      <th>International (econ)</th>\n",
       "      <th>National (econ)</th>\n",
       "      <th>Local (econ)</th>\n",
       "      <th>General Public (econ)</th>\n",
       "      <th>Healthcare Professionals (econ)</th>\n",
       "      <th>Patients (econ)</th>\n",
       "      <th>Patient Families (econ)</th>\n",
       "      <th>Economic Benefits Description</th>\n",
       "      <th>Project Title</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>The combination of cabozantinib with 13-cis-re...</td>\n",
       "      <td>A National Phase I Study of Cabozantinib in Co...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>Oral cancer prevention and the consequent redu...</td>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Automated planning could reduce the time patie...</td>\n",
       "      <td>Knowledge-based planning and treatment decisio...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Reduced use of GCSF for supportive care for ch...</td>\n",
       "      <td>Targeting CD114 Signaling in Pediatric Medullo...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Potentially and in the long term. If our work ...</td>\n",
       "      <td>Enhanced Breast Cancer Risk Prediction from Im...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>The navigation intervention could potentially ...</td>\n",
       "      <td>Development and Implementation of a Peer-Navig...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>More effective therapies and predictive diagno...</td>\n",
       "      <td>Deciphering the role of RNA editing in leukemi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>The combination of tyrosine kinase inhibi...</td>\n",
       "      <td>Novel kinase inhibitors in combination with re...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>The treatment paradigm being proposed has the ...</td>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>If gastric cancer can be detected at an earlie...</td>\n",
       "      <td>Precision Interception of Gastric Cancers</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56</th>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>If we can provide a scientific basis for treat...</td>\n",
       "      <td>Neoantigen-specific T cell responses in except...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70</th>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Automated planning could reduce the time patie...</td>\n",
       "      <td>Knowledge-based planning and treatment decisio...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>81</th>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>The navigator intervention could potentially i...</td>\n",
       "      <td>Development and Implementation of a Peer-Navig...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Economic Benefits  International (econ)  National (econ)  Local (econ)  \\\n",
       "2                Yes                 False             True         False   \n",
       "3                Yes                  True             True         False   \n",
       "22               Yes                  True             True          True   \n",
       "23               Yes                 False             True         False   \n",
       "27               Yes                 False            False         False   \n",
       "31               Yes                 False             True          True   \n",
       "44               Yes                 False            False         False   \n",
       "48               Yes                 False             True         False   \n",
       "49               Yes                  True            False         False   \n",
       "53               Yes                  True             True         False   \n",
       "56               Yes                 False            False         False   \n",
       "70               Yes                  True             True          True   \n",
       "81               Yes                 False             True          True   \n",
       "\n",
       "    General Public (econ)  Healthcare Professionals (econ)  Patients (econ)  \\\n",
       "2                   False                            False            False   \n",
       "3                   False                            False             True   \n",
       "22                  False                             True             True   \n",
       "23                  False                            False            False   \n",
       "27                   True                            False            False   \n",
       "31                   True                             True             True   \n",
       "44                  False                            False             True   \n",
       "48                  False                            False            False   \n",
       "49                  False                            False            False   \n",
       "53                  False                             True             True   \n",
       "56                   True                            False             True   \n",
       "70                  False                             True             True   \n",
       "81                   True                             True             True   \n",
       "\n",
       "    Patient Families (econ)  \\\n",
       "2                     False   \n",
       "3                      True   \n",
       "22                    False   \n",
       "23                    False   \n",
       "27                    False   \n",
       "31                     True   \n",
       "44                    False   \n",
       "48                    False   \n",
       "49                    False   \n",
       "53                    False   \n",
       "56                    False   \n",
       "70                    False   \n",
       "81                     True   \n",
       "\n",
       "                        Economic Benefits Description  \\\n",
       "2   The combination of cabozantinib with 13-cis-re...   \n",
       "3   Oral cancer prevention and the consequent redu...   \n",
       "22  Automated planning could reduce the time patie...   \n",
       "23  Reduced use of GCSF for supportive care for ch...   \n",
       "27  Potentially and in the long term. If our work ...   \n",
       "31  The navigation intervention could potentially ...   \n",
       "44  More effective therapies and predictive diagno...   \n",
       "48       The combination of tyrosine kinase inhibi...   \n",
       "49  The treatment paradigm being proposed has the ...   \n",
       "53  If gastric cancer can be detected at an earlie...   \n",
       "56  If we can provide a scientific basis for treat...   \n",
       "70  Automated planning could reduce the time patie...   \n",
       "81  The navigator intervention could potentially i...   \n",
       "\n",
       "                                        Project Title  \n",
       "2   A National Phase I Study of Cabozantinib in Co...  \n",
       "3   UCSD-UCSF Specialized Program of Research Exce...  \n",
       "22  Knowledge-based planning and treatment decisio...  \n",
       "23  Targeting CD114 Signaling in Pediatric Medullo...  \n",
       "27  Enhanced Breast Cancer Risk Prediction from Im...  \n",
       "31  Development and Implementation of a Peer-Navig...  \n",
       "44  Deciphering the role of RNA editing in leukemi...  \n",
       "48  Novel kinase inhibitors in combination with re...  \n",
       "49  UCSD-UCSF Specialized Program of Research Exce...  \n",
       "53          Precision Interception of Gastric Cancers  \n",
       "56  Neoantigen-specific T cell responses in except...  \n",
       "70  Knowledge-based planning and treatment decisio...  \n",
       "81  Development and Implementation of a Peer-Navig...  "
      ]
     },
     "execution_count": 59,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "econ[~econ['Economic Benefits Description'].isna()]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Economic Benefits\n",
      "No     86\n",
      "Yes    15\n",
      "Name: Economic Benefits, dtype: int64\n",
      "\n",
      "International (econ)\n",
      "False    96\n",
      "True      6\n",
      "Name: International (econ), dtype: int64\n",
      "\n",
      "National (econ)\n",
      "False    92\n",
      "True     10\n",
      "Name: National (econ), dtype: int64\n",
      "\n",
      "Local (econ)\n",
      "False    97\n",
      "True      5\n",
      "Name: Local (econ), dtype: int64\n",
      "\n",
      "General Public (econ)\n",
      "False    97\n",
      "True      5\n",
      "Name: General Public (econ), dtype: int64\n",
      "\n",
      "Healthcare Professionals (econ)\n",
      "False    96\n",
      "True      6\n",
      "Name: Healthcare Professionals (econ), dtype: int64\n",
      "\n",
      "Patients (econ)\n",
      "False    93\n",
      "True      9\n",
      "Name: Patients (econ), dtype: int64\n",
      "\n",
      "Patient Families (econ)\n",
      "False    99\n",
      "True      3\n",
      "Name: Patient Families (econ), dtype: int64\n",
      "\n",
      "Economic Benefits Description\n",
      "The combination of cabozantinib with 13-cis-retinoic acid as a therapeutic option for patients with relapsed or refractory neuroblastoma represents a lower cost, outpatient therapy to reduce the overall cost of treatment                                                                                                                                                                     1\n",
      "Oral cancer prevention and the consequent reduction in morbidity, mortality, and patient related costs                                                                                                                                                                                                                                                                                           1\n",
      "Automated planning could reduce the time patients spend under anesthesia, which reduces hospital resource usage and could reduce costs of brachytherapy procedures                                                                                                                                                                                                                               1\n",
      "Reduced use of GCSF for supportive care for children with medulloblastoma would serve to both reduce costs of care and improve outcomes for children with medulloblastoma worldwide.                                                                                                                                                                                                             1\n",
      "Potentially and in the long term. If our work leads to better risk projection and earlier detection, this can reduce costs associated with managing late stage disease.                                                                                                                                                                                                                          1\n",
      "The navigation intervention could potentially increase clinical trials accrual and benefit more patients by providing equal access.  By increasing minority participation in clinical trials, we can effectively and equally translate discoveries and treatment benefits. Our results will inform clinical care and the design of a multi-site randomized clinical trial in a larger sample.    1\n",
      "More effective therapies and predictive diagnostics.                                                                                                                                                                                                                                                                                                                                             1\n",
      "     The combination of tyrosine kinase inhibitors with 13-cis-retinoic acid as a therapeutic option for patients with relapsed or refractory neuroblastoma represents a lower cost, outpatient therapy to reduce the overall cost of treatment for children with neuroblastoma                                                                                                                  1\n",
      "The treatment paradigm being proposed has the potential to dramatically decrease morbidity of HNSCC treatment                                                                                                                                                                                                                                                                                    1\n",
      "If gastric cancer can be detected at an earlier stage, then patient survival will be improved.                                                                                                                                                                                                                                                                                                   1\n",
      "If we can provide a scientific basis for treatment efficacy, it can save patient time and healthcare expenditures by avoiding treatments that are unlikely to be effective and potentially tailor these therapies to individual patients.                                                                                                                                                        1\n",
      "Automated planning could reduce the time patients spend under anesthesia, which reduces hospital  resource usage and could reduce costs of  brachytherapy procedures                                                                                                                                                                                                                             1\n",
      "The navigator intervention could potentially increase clinical trials accrual and benefit more patients by providing equal access.  By increasing minority participation in clinical trials, we can effectively and equally translate discoveries and treatment benefits. Our results will inform clinical care and the design of a multi-site randomized clinical trial in a larger sample.     1\n",
      "Name: Economic Benefits Description, dtype: int64\n",
      "\n",
      "Project Title\n",
      "Knowledge-based planning and treatment decision-making for gynecologic brachytherapy                                                                                                                               3\n",
      "Discovery of non-coding oncogenic mutations in pediatric acute lymphoblastic leukemia using ATAC-seq and Hi-C                                                                                                      3\n",
      "New Therapies for Myeloid Leukemia                                                                                                                                                                                 3\n",
      "Inhibiting Liver Cancer Stem Cells to Improve Response to Thermal Ablation                                                                                                                                         3\n",
      "Decoding Colon Cancers Using Boolean Principles                                                                                                                                                                    3\n",
      "Examination of inhibitors of the ULK1 autophagy kinase as therapeutics in NSCLC                                                                                                                                    3\n",
      "FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma                                                                                                                                                                   3\n",
      "Defining the mechanisms of pancreatic cancer susceptibility in patient-derived organoid models                                                                                                                     3\n",
      "Detecting dysregulated genes in neuroblastoma using allele-specific expression                                                                                                                                     2\n",
      "Investigating the Efficacy of radium-223 with Olaparib in Men with Metastatic Castration-resistant Prostate Cancer                                                                                                 2\n",
      "Epigenetic profiling of endometrial cancer                                                                                                                                                                         2\n",
      "Development and Implementation of a Peer-Navigation Intervention to Improve Research Literacy in Pediatric Cancer Trials                                                                                           2\n",
      "Transcriptomic, epigenomic profiling to reveal TIL, microglia functional phenotype, and clonality in pediatric brain tumors                                                                                        2\n",
      "A Phase 1b pilot clinical trial of cirmtuzumab, an anti-ROR1 monoclonal antibody, in combination with paclitaxel for the treatment of patients with metastatic, or locally advanced, unresectable breast cancer    2\n",
      "An Open-Label, Phase 2 Efficacy Study of Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)                                                       2\n",
      "Oncogenic Regulation of B-Lymphomagenesis by the Chromatin Modulator DOT1L                                                                                                                                         2\n",
      "Low Dose Chemotherapy for Immuno-activation in Lung Cancer                                                                                                                                                         2\n",
      "Irreversible electroporation as an In Situ vaccine for pancreatic cancer                                                                                                                                           2\n",
      "Enhanced Breast Cancer Risk Prediction from Imputed Gene Expression                                                                                                                                                2\n",
      "An over-expressed GPCR in pancreatic cancer associated fibroblasts as a novel therapeutic target                                                                                                                   2\n",
      "Targeting cellular mechanotransduction in breast cancer metastasis                                                                                                                                                 2\n",
      "Tissue-specific role of SMARCB1 in pediatric rhabdoid tumors                                                                                                                                                       2\n",
      "Identification of therapeutic targets of B-ALL using Boolean logic                                                                                                                                                 2\n",
      "Developing targeted therapy for Ewing sarcoma metastasis                                                                                                                                                           2\n",
      "Understanding and Targeting NRF2 in Pancreatic Cancer                                                                                                                                                              2\n",
      "Responses of Melanoma Patients to Checkpoint Immunotherapy                                                                                                                                                         2\n",
      "A pilot trial to test the benefit of real time drug screening to determine individualized treatment plans for children and young adults with relapsed or refractory medulloblastoma                                2\n",
      "Characterization of a GOLPH3 Pathway Inhibitor to Enable a Hit-to-Lead Grant to Develop a Novel Cancer Therapeutic                                                                                                 2\n",
      "UCSD-UCSF Specialized Program of Research Excellence (SPORE) in Head and Neck Cancer                                                                                                                               2\n",
      "Peptide Targeted Delivery of Epigenetic Therapies in Pancreatic Cancer                                                                                                                                             2\n",
      "Precision Interception of Gastric Cancers                                                                                                                                                                          2\n",
      "Neoantigen-specific T cell responses in exceptional responders to immunotherapy in NSCLC                                                                                                                           2\n",
      "Elucidating the role of Syk kinase and Syk inhibitors combined with Radiation therapy in Neuroblastoma                                                                                                             2\n",
      "Inducing Cytosolic Chromatin Fragments in Cancer Cells to Turn Cold Tumors Hot                                                                                                                                     2\n",
      "Improved Echocardiographic Diagnosis of Anthracycline-Related Cardiac Dysfunction Using Global Longitudinal Strain                                                                                                 2\n",
      "A Novel Role for Histidine Kinase Activity in Neuroblastoma Pathogenesis                                                                                                                                           2\n",
      "Microbe-Associated Colorectal Cancer (M.A.C.S)                                                                                                                                                                     2\n",
      "Identification of regulatory programs for glioblastoma cellular hierarchy using single-cell multi-omic profiling                                                                                                   2\n",
      "Evaluation of carcinogen exposure via genome-wide DNA-adduct signatures                                                                                                                                            2\n",
      "Impact of Metformin on Clonal Hematopoiesis and Clinical Outcomes in Breast Cancer                                                                                                                                 2\n",
      "Targeting CD114 Signaling in Pediatric Medulloblastoma                                                                                                                                                             2\n",
      "Targeting FZD7 in human cancers                                                                                                                                                                                    2\n",
      "Novel Pathways Regulated by NME1 in Neuroblastoma                                                                                                                                                                  1\n",
      "A Phase 1b Safety and Feasibility Study of Personalized Immunotherapy in Adults with Advanced Cancers                                                                                                              1\n",
      "Targeting A Therapeutic Vulnerability in PTEN-Deficient Brain Tumors                                                                                                                                               1\n",
      "Deciphering the role of RNA editing in leukemia stem cell generation and pediatric acute leukemia relapse                                                                                                          1\n",
      "A Phase 1B, Nonrandomized Trial Investigating Docetaxel Combined with Cirmtuzumab in Patients with Metastatic Castration Resistant Prostate Cancer                                                                 1\n",
      "A National Phase I Study of Cabozantinib in Combination with 13-cis-Retinoic Acid in Children with Relapsed or Refractory Solid Tumors                                                                             1\n",
      "Novel kinase inhibitors in combination with retinoic acide for neuroblastoma                                                                                                                                       1\n",
      "Natural Killer Cells for Treatment of Medulloblastoma                                                                                                                                                              1\n",
      "Identification of genes critical for the production of T cells from human pluripotent stem cells for development of \"off-the-shelf\" T cell immunotherapies                                                         1\n",
      "Functional Roles for Histidine Kinase Signaling in Neuroblastoma                                                                                                                                                   1\n",
      "Name: Project Title, dtype: int64\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# Check columns values\n",
    "\n",
    "for col in econ.columns:\n",
    "    print(col)\n",
    "    print(econ[col].value_counts())\n",
    "    print()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 61,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\phuro\\AppData\\Local\\Temp\\ipykernel_47384\\2172678298.py:3: FutureWarning:\n",
      "\n",
      "Dropping invalid columns in DataFrameGroupBy.max is deprecated. In a future version, a TypeError will be raised. Before calling .max, select only columns which should be valid for the function.\n",
      "\n"
     ]
    },
    {
     "data": {
      "application/vnd.plotly.v1+json": {
       "config": {
        "plotlyServerURL": "https://plot.ly"
       },
       "data": [
        {
         "alignmentgroup": "True",
         "bingroup": "x",
         "histfunc": "sum",
         "hovertemplate": "x=%{x}<br>sum of y=%{y}<extra></extra>",
         "legendgroup": "",
         "marker": {
          "color": "#3283FE",
          "opacity": 0.81,
          "pattern": {
           "shape": ""
          }
         },
         "name": "",
         "offsetgroup": "",
         "orientation": "v",
         "showlegend": false,
         "texttemplate": "%{value}",
         "type": "histogram",
         "x": [
          "National",
          "Patients",
          "International",
          "Healthcare Professionals",
          "Local",
          "General Public",
          "Patient Families"
         ],
         "xaxis": "x",
         "y": [
          8,
          6,
          4,
          4,
          3,
          3,
          2
         ],
         "yaxis": "y"
        }
       ],
       "layout": {
        "barmode": "relative",
        "legend": {
         "tracegroupgap": 0
        },
        "template": {
         "data": {
          "bar": [
           {
            "error_x": {
             "color": "#2a3f5f"
            },
            "error_y": {
             "color": "#2a3f5f"
            },
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "bar"
           }
          ],
          "barpolar": [
           {
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "barpolar"
           }
          ],
          "carpet": [
           {
            "aaxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "baxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "type": "carpet"
           }
          ],
          "choropleth": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "choropleth"
           }
          ],
          "contour": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "contour"
           }
          ],
          "contourcarpet": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "contourcarpet"
           }
          ],
          "heatmap": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "heatmap"
           }
          ],
          "heatmapgl": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "heatmapgl"
           }
          ],
          "histogram": [
           {
            "marker": {
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "histogram"
           }
          ],
          "histogram2d": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "histogram2d"
           }
          ],
          "histogram2dcontour": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "histogram2dcontour"
           }
          ],
          "mesh3d": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "mesh3d"
           }
          ],
          "parcoords": [
           {
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "parcoords"
           }
          ],
          "pie": [
           {
            "automargin": true,
            "type": "pie"
           }
          ],
          "scatter": [
           {
            "fillpattern": {
             "fillmode": "overlay",
             "size": 10,
             "solidity": 0.2
            },
            "type": "scatter"
           }
          ],
          "scatter3d": [
           {
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatter3d"
           }
          ],
          "scattercarpet": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattercarpet"
           }
          ],
          "scattergeo": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattergeo"
           }
          ],
          "scattergl": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattergl"
           }
          ],
          "scattermapbox": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattermapbox"
           }
          ],
          "scatterpolar": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterpolar"
           }
          ],
          "scatterpolargl": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterpolargl"
           }
          ],
          "scatterternary": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterternary"
           }
          ],
          "surface": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "surface"
           }
          ],
          "table": [
           {
            "cells": {
             "fill": {
              "color": "#EBF0F8"
             },
             "line": {
              "color": "white"
             }
            },
            "header": {
             "fill": {
              "color": "#C8D4E3"
             },
             "line": {
              "color": "white"
             }
            },
            "type": "table"
           }
          ]
         },
         "layout": {
          "annotationdefaults": {
           "arrowcolor": "#2a3f5f",
           "arrowhead": 0,
           "arrowwidth": 1
          },
          "autotypenumbers": "strict",
          "coloraxis": {
           "colorbar": {
            "outlinewidth": 0,
            "ticks": ""
           }
          },
          "colorscale": {
           "diverging": [
            [
             0,
             "#8e0152"
            ],
            [
             0.1,
             "#c51b7d"
            ],
            [
             0.2,
             "#de77ae"
            ],
            [
             0.3,
             "#f1b6da"
            ],
            [
             0.4,
             "#fde0ef"
            ],
            [
             0.5,
             "#f7f7f7"
            ],
            [
             0.6,
             "#e6f5d0"
            ],
            [
             0.7,
             "#b8e186"
            ],
            [
             0.8,
             "#7fbc41"
            ],
            [
             0.9,
             "#4d9221"
            ],
            [
             1,
             "#276419"
            ]
           ],
           "sequential": [
            [
             0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1,
             "#f0f921"
            ]
           ],
           "sequentialminus": [
            [
             0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1,
             "#f0f921"
            ]
           ]
          },
          "colorway": [
           "#636efa",
           "#EF553B",
           "#00cc96",
           "#ab63fa",
           "#FFA15A",
           "#19d3f3",
           "#FF6692",
           "#B6E880",
           "#FF97FF",
           "#FECB52"
          ],
          "font": {
           "color": "#2a3f5f"
          },
          "geo": {
           "bgcolor": "white",
           "lakecolor": "white",
           "landcolor": "#E5ECF6",
           "showlakes": true,
           "showland": true,
           "subunitcolor": "white"
          },
          "hoverlabel": {
           "align": "left"
          },
          "hovermode": "closest",
          "mapbox": {
           "style": "light"
          },
          "paper_bgcolor": "white",
          "plot_bgcolor": "#E5ECF6",
          "polar": {
           "angularaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "bgcolor": "#E5ECF6",
           "radialaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "scene": {
           "xaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           },
           "yaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           },
           "zaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           }
          },
          "shapedefaults": {
           "line": {
            "color": "#2a3f5f"
           }
          },
          "ternary": {
           "aaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "baxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "bgcolor": "#E5ECF6",
           "caxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "title": {
           "x": 0.05
          },
          "xaxis": {
           "automargin": true,
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "zerolinewidth": 2
          },
          "yaxis": {
           "automargin": true,
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "zerolinewidth": 2
          }
         }
        },
        "title": {
         "text": "Distribution of health cost/service improvements by impact level"
        },
        "xaxis": {
         "anchor": "y",
         "domain": [
          0,
          1
         ],
         "title": {
          "text": "impact level"
         }
        },
        "yaxis": {
         "anchor": "x",
         "domain": [
          0,
          1
         ],
         "title": {
          "text": "count"
         }
        }
       }
      }
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Plot distribution of economic impact\n",
    "\n",
    "econ_data = econ.groupby(by='Project Title').max().reset_index(drop=True)\n",
    "econ_data.columns = econ_data.columns.map(lambda x: re.sub(r' \\(econ\\)', '', x))\n",
    "econ_data = econ_data.sum().sort_values(ascending=False)\n",
    "econ_fig = px.histogram(x=econ_data.index, y=econ_data, text_auto=True, \\\n",
    "    title='Distribution of health cost/service improvements by impact level', \n",
    "    color_discrete_sequence=[blue], opacity=0.81)\n",
    "econ_fig.update_yaxes(title='count')\n",
    "econ_fig.update_xaxes(title='impact level')\n",
    "econ_fig"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Successfully saved economic_impacts.html at: impacts\\economic_impacts.html\n"
     ]
    }
   ],
   "source": [
    "# Export figure\n",
    "\n",
    "os.chdir('C:\\\\Users\\\\phuro\\\\Biokind\\\\curebound-team\\\\curebound\\\\reports')\n",
    "export_fig('impacts', econ_fig, 'economic_impacts.html')\n",
    "os.chdir('C:\\\\Users\\\\phuro\\\\Biokind\\\\curebound-team\\\\curebound\\\\data')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 63,
   "metadata": {},
   "outputs": [],
   "source": [
    "# sanity check\n",
    "\n",
    "roi_ids = roi_adj['ID'].tolist()\n",
    "roi_ids.sort()\n",
    "\n",
    "pr_ids = pr['ID'].tolist()\n",
    "pr_ids.sort()\n",
    "\n",
    "for i in pr_ids:\n",
    "    if i not in roi_ids:\n",
    "        print(i)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 64,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Award ID</th>\n",
       "      <th>Project Title</th>\n",
       "      <th>PI Institution</th>\n",
       "      <th>Other Institution</th>\n",
       "      <th>Prevention and diagnostic tools</th>\n",
       "      <th>Novel approaches and new therapeutic platforms</th>\n",
       "      <th>Immunotherapies and personalized vaccines</th>\n",
       "      <th>Addressing cancer disparities</th>\n",
       "      <th>Pediatric cancers</th>\n",
       "      <th>Specific Aims</th>\n",
       "      <th>Aim 1</th>\n",
       "      <th>Aim 2</th>\n",
       "      <th>Aim 3</th>\n",
       "      <th>Aim 4</th>\n",
       "      <th>Aim 5</th>\n",
       "      <th>Aim 6</th>\n",
       "      <th>Public Health Significance</th>\n",
       "      <th>Award Amount</th>\n",
       "      <th>Grant Start Date:</th>\n",
       "      <th>Grant End Date:</th>\n",
       "      <th>Complete</th>\n",
       "      <th>SR - None</th>\n",
       "      <th>SR - Biobehaviorial MCC</th>\n",
       "      <th>SR - Biorepository &amp; Tissue Tech. MCC</th>\n",
       "      <th>SR - Biostatistics MCC</th>\n",
       "      <th>SR - Clinical Trials Office MCC</th>\n",
       "      <th>SR - Flow Cytometry MCC</th>\n",
       "      <th>SR - Genomics &amp; Computational Bio. MCC</th>\n",
       "      <th>SR - In Vivo Imaging MCC</th>\n",
       "      <th>SR - Microscopy MCC</th>\n",
       "      <th>SR - Radiation Medicine MCC</th>\n",
       "      <th>SR - Transgenic Mouse MCC</th>\n",
       "      <th>SR - Gene Transfer/Targeting/Therap Salk</th>\n",
       "      <th>SR - Transgenic Salk</th>\n",
       "      <th>SR - Mass Spect - Proteom/Metabol Salk</th>\n",
       "      <th>SR - Chemical Library Screening SBPMDI</th>\n",
       "      <th>SR - Functional Genomics SBPMDI</th>\n",
       "      <th>Cancer Metabolism SBPMDI</th>\n",
       "      <th>Pedal Importance (recruitment, retention, advancement)</th>\n",
       "      <th>If yes, please specify</th>\n",
       "      <th>If no, please specify</th>\n",
       "      <th>Clinical Trials Resulted</th>\n",
       "      <th>First Clinical Trial</th>\n",
       "      <th>First Clinical Trial Patient Count</th>\n",
       "      <th>Second Clinical Trial</th>\n",
       "      <th>Second Clinical Trial Patient Count</th>\n",
       "      <th>Companies Founded</th>\n",
       "      <th>Patents Filed</th>\n",
       "      <th>Patent Details</th>\n",
       "      <th>Peer-Reviewed Publications Count</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>6.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>6.1</td>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Improve outcomes for HNSCC by expanding our un...</td>\n",
       "      <td>Leverage our administrative, biostatistics, co...</td>\n",
       "      <td>Develop emerging, novel, high quality translat...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cancer immunotherapies have led to major treat...</td>\n",
       "      <td>200000.0</td>\n",
       "      <td>2021-07-01</td>\n",
       "      <td>2022-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Opportunity to develop an immune modulatory ap...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>Metformin for oral cancer prevention 2.0</td>\n",
       "      <td>80.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>103</th>\n",
       "      <td>61.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>6.2</td>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Improve outcomes for HNSCC by expanding out un...</td>\n",
       "      <td>Leverage our administrative, biostatistics, co...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cancer immunotherapies have led to major treat...</td>\n",
       "      <td>200000.0</td>\n",
       "      <td>2021-07-01</td>\n",
       "      <td>2022-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>Neoadjuvant Immunoradiotherapy in Head &amp; Neck ...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>105</th>\n",
       "      <td>62.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>6.3</td>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Leverage our administrative, biostatistics, co...</td>\n",
       "      <td>Develop emerging, novel, high quality translat...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cancer immunotherapies have led to major treat...</td>\n",
       "      <td>200000.0</td>\n",
       "      <td>2021-07-01</td>\n",
       "      <td>2022-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "       ID Event Name  Award ID  \\\n",
       "6     6.0    Initial       6.1   \n",
       "103  61.0    Initial       6.2   \n",
       "105  62.0    Initial       6.3   \n",
       "\n",
       "                                         Project Title        PI Institution  \\\n",
       "6    UCSD-UCSF Specialized Program of Research Exce...  Moores Cancer Center   \n",
       "103  UCSD-UCSF Specialized Program of Research Exce...  Moores Cancer Center   \n",
       "105  UCSD-UCSF Specialized Program of Research Exce...  Moores Cancer Center   \n",
       "\n",
       "    Other Institution  Prevention and diagnostic tools  \\\n",
       "6                 NaN                            False   \n",
       "103               NaN                            False   \n",
       "105               NaN                            False   \n",
       "\n",
       "     Novel approaches and new therapeutic platforms  \\\n",
       "6                                             False   \n",
       "103                                           False   \n",
       "105                                           False   \n",
       "\n",
       "     Immunotherapies and personalized vaccines  Addressing cancer disparities  \\\n",
       "6                                        False                          False   \n",
       "103                                       True                          False   \n",
       "105                                       True                          False   \n",
       "\n",
       "     Pediatric cancers        Specific Aims  \\\n",
       "6                False  Three Specific Aims   \n",
       "103              False    Two Specific Aims   \n",
       "105              False    Two Specific Aims   \n",
       "\n",
       "                                                 Aim 1  \\\n",
       "6    Improve outcomes for HNSCC by expanding our un...   \n",
       "103  Improve outcomes for HNSCC by expanding out un...   \n",
       "105  Leverage our administrative, biostatistics, co...   \n",
       "\n",
       "                                                 Aim 2  \\\n",
       "6    Leverage our administrative, biostatistics, co...   \n",
       "103  Leverage our administrative, biostatistics, co...   \n",
       "105  Develop emerging, novel, high quality translat...   \n",
       "\n",
       "                                                 Aim 3 Aim 4 Aim 5 Aim 6  \\\n",
       "6    Develop emerging, novel, high quality translat...   NaN   NaN   NaN   \n",
       "103                                                NaN   NaN   NaN   NaN   \n",
       "105                                                NaN   NaN   NaN   NaN   \n",
       "\n",
       "                            Public Health Significance  Award Amount  \\\n",
       "6    Cancer immunotherapies have led to major treat...      200000.0   \n",
       "103  Cancer immunotherapies have led to major treat...      200000.0   \n",
       "105  Cancer immunotherapies have led to major treat...      200000.0   \n",
       "\n",
       "    Grant Start Date: Grant End Date:  Complete SR - None  \\\n",
       "6          2021-07-01      2022-06-30  Complete     False   \n",
       "103        2021-07-01      2022-06-30  Complete     False   \n",
       "105        2021-07-01      2022-06-30  Complete       NaN   \n",
       "\n",
       "    SR - Biobehaviorial MCC SR - Biorepository & Tissue Tech. MCC  \\\n",
       "6                     False                                  True   \n",
       "103                   False                                  True   \n",
       "105                     NaN                                   NaN   \n",
       "\n",
       "    SR - Biostatistics MCC SR - Clinical Trials Office MCC  \\\n",
       "6                    False                            True   \n",
       "103                   True                            True   \n",
       "105                    NaN                             NaN   \n",
       "\n",
       "    SR - Flow Cytometry MCC SR - Genomics & Computational Bio. MCC  \\\n",
       "6                     False                                   True   \n",
       "103                    True                                  False   \n",
       "105                     NaN                                    NaN   \n",
       "\n",
       "    SR - In Vivo Imaging MCC SR - Microscopy MCC SR - Radiation Medicine MCC  \\\n",
       "6                      False               False                       False   \n",
       "103                    False                True                        True   \n",
       "105                      NaN                 NaN                         NaN   \n",
       "\n",
       "    SR - Transgenic Mouse MCC SR - Gene Transfer/Targeting/Therap Salk  \\\n",
       "6                       False                                    False   \n",
       "103                      True                                    False   \n",
       "105                       NaN                                      NaN   \n",
       "\n",
       "    SR - Transgenic Salk SR - Mass Spect - Proteom/Metabol Salk  \\\n",
       "6                  False                                  False   \n",
       "103                False                                  False   \n",
       "105                  NaN                                    NaN   \n",
       "\n",
       "    SR - Chemical Library Screening SBPMDI SR - Functional Genomics SBPMDI  \\\n",
       "6                                    False                           False   \n",
       "103                                  False                           False   \n",
       "105                                    NaN                             NaN   \n",
       "\n",
       "    Cancer Metabolism SBPMDI  \\\n",
       "6                      False   \n",
       "103                    False   \n",
       "105                      NaN   \n",
       "\n",
       "    Pedal Importance (recruitment, retention, advancement)  \\\n",
       "6                                                  Yes       \n",
       "103                                                 No       \n",
       "105                                                NaN       \n",
       "\n",
       "                                If yes, please specify If no, please specify  \\\n",
       "6    Opportunity to develop an immune modulatory ap...                   NaN   \n",
       "103                                                NaN                   NaN   \n",
       "105                                                NaN                   NaN   \n",
       "\n",
       "     Clinical Trials Resulted  \\\n",
       "6                         1.0   \n",
       "103                       1.0   \n",
       "105                       0.0   \n",
       "\n",
       "                                  First Clinical Trial  \\\n",
       "6             Metformin for oral cancer prevention 2.0   \n",
       "103  Neoadjuvant Immunoradiotherapy in Head & Neck ...   \n",
       "105                                                NaN   \n",
       "\n",
       "     First Clinical Trial Patient Count Second Clinical Trial  \\\n",
       "6                                  80.0                   NaN   \n",
       "103                                 0.0                   NaN   \n",
       "105                                 NaN                   NaN   \n",
       "\n",
       "     Second Clinical Trial Patient Count Companies Founded Patents Filed  \\\n",
       "6                                    NaN                No            No   \n",
       "103                                  NaN               NaN            No   \n",
       "105                                  NaN               NaN           NaN   \n",
       "\n",
       "    Patent Details Peer-Reviewed Publications Count  \n",
       "6              NaN                              Two  \n",
       "103            NaN                              Two  \n",
       "105            NaN                              NaN  "
      ]
     },
     "execution_count": 64,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "roi[roi['Project Title'].str.contains('UCSD')]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Publication Status 4</th>\n",
       "      <th>Fourth DOI #</th>\n",
       "      <th>Publication Status 5</th>\n",
       "      <th>Fifth DOI #</th>\n",
       "      <th>Publication Status 6</th>\n",
       "      <th>Sixth DOI #</th>\n",
       "      <th>Publication Status 7</th>\n",
       "      <th>Seventh DOI #</th>\n",
       "      <th>Publication Status 8</th>\n",
       "      <th>Eighth DOI #</th>\n",
       "      <th>Publication Status 9</th>\n",
       "      <th>Ninth DOI #</th>\n",
       "      <th>Publication Status 10</th>\n",
       "      <th>Tenth DOI #</th>\n",
       "      <th>Pedal Non-Peer Pubs</th>\n",
       "      <th>Other Accomplishments</th>\n",
       "      <th>Health Benefits</th>\n",
       "      <th>International</th>\n",
       "      <th>National</th>\n",
       "      <th>Local</th>\n",
       "      <th>General Public</th>\n",
       "      <th>Healthcare Professionals</th>\n",
       "      <th>Patients</th>\n",
       "      <th>Patient Families</th>\n",
       "      <th>Health Benefits Description</th>\n",
       "      <th>Policy Influence</th>\n",
       "      <th>International (pol)</th>\n",
       "      <th>National (pol)</th>\n",
       "      <th>Local (pol)</th>\n",
       "      <th>General Public (pol)</th>\n",
       "      <th>Healthcare Professionals (pol)</th>\n",
       "      <th>Patients (pol)</th>\n",
       "      <th>Patient Families (pol)</th>\n",
       "      <th>Policy Benefits Description</th>\n",
       "      <th>Economic Benefits</th>\n",
       "      <th>International (econ)</th>\n",
       "      <th>National (econ)</th>\n",
       "      <th>Local (econ)</th>\n",
       "      <th>General Public (econ)</th>\n",
       "      <th>Healthcare Professionals (econ)</th>\n",
       "      <th>Patients (econ)</th>\n",
       "      <th>Patient Families (econ)</th>\n",
       "      <th>Economic Benefits Description</th>\n",
       "      <th>Equity Benefits</th>\n",
       "      <th>International (equity)</th>\n",
       "      <th>National (equity)</th>\n",
       "      <th>Local (equity)</th>\n",
       "      <th>General Public (equity)</th>\n",
       "      <th>Healthcare Professionals (equity)</th>\n",
       "      <th>Patients (equity)</th>\n",
       "      <th>Patient Families (equity)</th>\n",
       "      <th>Equity Benefits Description</th>\n",
       "      <th>Additional Funding Achieved</th>\n",
       "      <th>First AFS Status</th>\n",
       "      <th>First AFS Name and Project Title</th>\n",
       "      <th>First AFS Amount</th>\n",
       "      <th>Second AFS Status</th>\n",
       "      <th>Second AFS Name and Project Title</th>\n",
       "      <th>Second AFS Amount</th>\n",
       "      <th>Third AFS Status</th>\n",
       "      <th>Third AFS Name and Project Title</th>\n",
       "      <th>Third AGS Amount</th>\n",
       "      <th>Fourth AFS Status</th>\n",
       "      <th>Fourth AFS Name and Project Title</th>\n",
       "      <th>Fourth AFS Amount</th>\n",
       "      <th>Additional Funding Source #5 Agency/Sponsor Name and Project Title</th>\n",
       "      <th>Fifth AFS Status</th>\n",
       "      <th>Fifth AFS Amount</th>\n",
       "      <th>Additional Pedal Funding Impact</th>\n",
       "      <th>Additional Funding Benefits Description</th>\n",
       "      <th>Additional Pedal Funding Impact (clinical stages)</th>\n",
       "      <th>Additional Funding Benefits Description (clinical stages)</th>\n",
       "      <th>Participated in Pedal</th>\n",
       "      <th>Further Research Contributions</th>\n",
       "      <th>Success Stories</th>\n",
       "      <th>Major Scientific Breakthroughs</th>\n",
       "      <th>Additional Comments</th>\n",
       "      <th>Complete</th>\n",
       "      <th>Publication Status 1</th>\n",
       "      <th>First DOI #</th>\n",
       "      <th>Publication Status 2</th>\n",
       "      <th>Second DOI #</th>\n",
       "      <th>Publication Status 3</th>\n",
       "      <th>Third DOI #</th>\n",
       "      <th>Project Title</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>27.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>Published</td>\n",
       "      <td>10.1016/j.brachy.2021.07.001</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Oral presentations:  1.Kallis, K., Jyoti Mayad...</td>\n",
       "      <td>Using the preliminary data collected with the ...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>The tools developed from this work could resul...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>These tools can help healthcare professionals ...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Automated planning could reduce the time patie...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Currently, under-resourced centers (particular...</td>\n",
       "      <td>No additional funding sources</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>I would use the funding to hire personnel to d...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Once automated treatment planning has been val...</td>\n",
       "      <td>I participated in 2018 as a walker, 2019-20 as...</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The seed funding received from Padres Pedal th...</td>\n",
       "      <td>True</td>\n",
       "      <td>Published</td>\n",
       "      <td>10.1016/j.brachy.2020.04.008</td>\n",
       "      <td>Published</td>\n",
       "      <td>10.1016/j.semradonc.2020.05.009</td>\n",
       "      <td>Published</td>\n",
       "      <td>10.1016/j.brachy.2021.08.010</td>\n",
       "      <td>Knowledge-based planning and treatment decisio...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>37.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>How many additional funding sources did you re...</td>\n",
       "      <td>List your presentations, abstracts, book chapt...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>Findings could potentially benefit parents' ex...</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>The navigation intervention could potentially ...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>The navigation intervention could potentially ...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>The navigation intervention could potentially ...</td>\n",
       "      <td>Five</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>see below in box</td>\n",
       "      <td>1000000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>below</td>\n",
       "      <td>1000000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>below</td>\n",
       "      <td>125000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>below</td>\n",
       "      <td>125000.0</td>\n",
       "      <td>below</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>1250000.0</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Absolutely: Future CUREBOUND funding will be c...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes, if the navigation intervention is effecti...</td>\n",
       "      <td>yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Missing Cancer Control and Population Sciences...</td>\n",
       "      <td>True</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>10.1200/EDBK_320499</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>10.1001/jamanetworkopen.2021.9038</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>10.1002/pbc.28296</td>\n",
       "      <td>Development and Implementation of a Peer-Navig...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>51.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.Geron I, Savino AM, Fishman H, Tal N, Brown ...</td>\n",
       "      <td>Rell Sunn Award  Plenary Talk at AACR 2022  NA...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>We have identified a new method to</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Adding genomics to the EMR in Epic.</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>More effective therapies and predictive diagno...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Understanding ethnic and gender-related differ...</td>\n",
       "      <td>Three</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>LLS</td>\n",
       "      <td>600000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>NASA</td>\n",
       "      <td>2000000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>NIDDK RO1</td>\n",
       "      <td>1000000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>We would develop biomarkers for use in pediatr...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>It would help with development of Rebecsinib, ...</td>\n",
       "      <td>Yes as a rider.</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Thank you.</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Deciphering the role of RNA editing in leukemi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>69.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Turner MA, Amirfakhri S, Nishino H, Lwin TM, S...</td>\n",
       "      <td>GENOMICALLY SILENT REFRACTORY GASTRIC CANCER O...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>The labeling of gastric cancers will provide o...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>The development of tumor specific probes for g...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>If gastric cancer can be detected at an earlie...</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>NIH/NCI Bouvet (PI) 1R01CA256973-01A1 \"Molecul...</td>\n",
       "      <td>2264206.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding well help establish more mo...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional research will advance the technolog...</td>\n",
       "      <td>No.</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>10.21873</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Precision Interception of Gastric Cancers</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>59</th>\n",
       "      <td>77.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No additional funding sources</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A pilot trial to test the benefit of real time...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70</th>\n",
       "      <td>94.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>Published</td>\n",
       "      <td>10.1016/j.brachy.2021.07.001</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Oral presentations:  1. Kallis, K., Jyoti Maya...</td>\n",
       "      <td>Using the preliminary data collected with the ...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>The tools developed from this work could resul...</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>These tools can help healthcare professionals ...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Automated planning could reduce the time patie...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Currently, under-resourced centers (particular...</td>\n",
       "      <td>No additional funding sources</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Hire personnel and test the automated brachyth...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Once automated treatment planning has been val...</td>\n",
       "      <td>Participated as a rider before COVID</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>Published</td>\n",
       "      <td>10.1016/j.brachy.2020.04.008</td>\n",
       "      <td>Published</td>\n",
       "      <td>10.1016/j.semradonc.2020.05.009</td>\n",
       "      <td>Published</td>\n",
       "      <td>10.1016/j.brachy.2021.08.010</td>\n",
       "      <td>Knowledge-based planning and treatment decisio...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>81</th>\n",
       "      <td>112.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>Published</td>\n",
       "      <td>Please see Dr. Aristizabal's report</td>\n",
       "      <td>Published</td>\n",
       "      <td>Please see Dr. Aristizabal's report</td>\n",
       "      <td>Published</td>\n",
       "      <td>Please see Dr. Aristizabal's report</td>\n",
       "      <td>Published</td>\n",
       "      <td>Please see Dr. Aristizabal's report</td>\n",
       "      <td>Published</td>\n",
       "      <td>Please see Dr. Aristizabal's reprot</td>\n",
       "      <td>Published</td>\n",
       "      <td>Please see Dr. Aristizabal's reprot</td>\n",
       "      <td>Published</td>\n",
       "      <td>Please see Dr. Aristizabal's reprot</td>\n",
       "      <td>None.  Dr. Aristizabal has presented on behalf...</td>\n",
       "      <td>None.  Dr. Aristizabal has presented on behalf...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>Findings could potentially benefit parents' ex...</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>The navigator intervention could potentially b...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>The navigator intervention could potentially i...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>The navigator intervention could potentially i...</td>\n",
       "      <td>No additional funding sources</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Future Curebound funding will be critical to e...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes, if the navigator intervention is effectiv...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Please see Dr. Aristizabal's report.  She is t...</td>\n",
       "      <td>True</td>\n",
       "      <td>Published</td>\n",
       "      <td>Please see Dr. Aristizabal's report</td>\n",
       "      <td>Published</td>\n",
       "      <td>Please see Dr. Aristizabal's report</td>\n",
       "      <td>Published</td>\n",
       "      <td>Please see Dr. Aristizabal's report</td>\n",
       "      <td>Development and Implementation of a Peer-Navig...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "       ID          Event Name Publication Status 4  \\\n",
       "22   27.0  Progress Report #1            Published   \n",
       "31   37.0  Progress Report #1          In progress   \n",
       "44   51.0  Progress Report #1                  NaN   \n",
       "53   69.0  Progress Report #1                  NaN   \n",
       "59   77.0  Progress Report #1                  NaN   \n",
       "70   94.0  Progress Report #1            Published   \n",
       "81  112.0  Progress Report #1            Published   \n",
       "\n",
       "                           Fourth DOI # Publication Status 5  \\\n",
       "22         10.1016/j.brachy.2021.07.001                  NaN   \n",
       "31                                  NaN             Accepted   \n",
       "44                                  NaN                  NaN   \n",
       "53                                  NaN                  NaN   \n",
       "59                                  NaN                  NaN   \n",
       "70         10.1016/j.brachy.2021.07.001                  NaN   \n",
       "81  Please see Dr. Aristizabal's report            Published   \n",
       "\n",
       "                            Fifth DOI # Publication Status 6  \\\n",
       "22                                  NaN                  NaN   \n",
       "31                                  NaN             Accepted   \n",
       "44                                  NaN                  NaN   \n",
       "53                                  NaN                  NaN   \n",
       "59                                  NaN                  NaN   \n",
       "70                                  NaN                  NaN   \n",
       "81  Please see Dr. Aristizabal's report            Published   \n",
       "\n",
       "                            Sixth DOI # Publication Status 7  \\\n",
       "22                                  NaN                  NaN   \n",
       "31                                  NaN             Accepted   \n",
       "44                                  NaN                  NaN   \n",
       "53                                  NaN                  NaN   \n",
       "59                                  NaN                  NaN   \n",
       "70                                  NaN                  NaN   \n",
       "81  Please see Dr. Aristizabal's report            Published   \n",
       "\n",
       "                          Seventh DOI # Publication Status 8  \\\n",
       "22                                  NaN                  NaN   \n",
       "31                                  NaN             Accepted   \n",
       "44                                  NaN                  NaN   \n",
       "53                                  NaN                  NaN   \n",
       "59                                  NaN                  NaN   \n",
       "70                                  NaN                  NaN   \n",
       "81  Please see Dr. Aristizabal's report            Published   \n",
       "\n",
       "                           Eighth DOI # Publication Status 9  \\\n",
       "22                                  NaN                  NaN   \n",
       "31                                  NaN             Accepted   \n",
       "44                                  NaN                  NaN   \n",
       "53                                  NaN                  NaN   \n",
       "59                                  NaN                  NaN   \n",
       "70                                  NaN                  NaN   \n",
       "81  Please see Dr. Aristizabal's reprot            Published   \n",
       "\n",
       "                            Ninth DOI # Publication Status 10  \\\n",
       "22                                  NaN                   NaN   \n",
       "31                                  NaN              Accepted   \n",
       "44                                  NaN                   NaN   \n",
       "53                                  NaN                   NaN   \n",
       "59                                  NaN                   NaN   \n",
       "70                                  NaN                   NaN   \n",
       "81  Please see Dr. Aristizabal's reprot             Published   \n",
       "\n",
       "                            Tenth DOI #  \\\n",
       "22                                  NaN   \n",
       "31                                  NaN   \n",
       "44                                  NaN   \n",
       "53                                  NaN   \n",
       "59                                  NaN   \n",
       "70                                  NaN   \n",
       "81  Please see Dr. Aristizabal's reprot   \n",
       "\n",
       "                                  Pedal Non-Peer Pubs  \\\n",
       "22  Oral presentations:  1.Kallis, K., Jyoti Mayad...   \n",
       "31  How many additional funding sources did you re...   \n",
       "44  1.Geron I, Savino AM, Fishman H, Tal N, Brown ...   \n",
       "53  Turner MA, Amirfakhri S, Nishino H, Lwin TM, S...   \n",
       "59                                                NaN   \n",
       "70  Oral presentations:  1. Kallis, K., Jyoti Maya...   \n",
       "81  None.  Dr. Aristizabal has presented on behalf...   \n",
       "\n",
       "                                Other Accomplishments Health Benefits  \\\n",
       "22  Using the preliminary data collected with the ...             Yes   \n",
       "31  List your presentations, abstracts, book chapt...             Yes   \n",
       "44  Rell Sunn Award  Plenary Talk at AACR 2022  NA...             Yes   \n",
       "53  GENOMICALLY SILENT REFRACTORY GASTRIC CANCER O...             Yes   \n",
       "59                                                NaN             Yes   \n",
       "70  Using the preliminary data collected with the ...             Yes   \n",
       "81  None.  Dr. Aristizabal has presented on behalf...             Yes   \n",
       "\n",
       "    International  National  Local  General Public  Healthcare Professionals  \\\n",
       "22           True      True   True           False                      True   \n",
       "31          False      True   True            True                      True   \n",
       "44           True      True   True            True                      True   \n",
       "53           True      True   True            True                      True   \n",
       "59           True      True   True           False                      True   \n",
       "70           True      True   True           False                      True   \n",
       "81          False      True   True            True                      True   \n",
       "\n",
       "    Patients  Patient Families  \\\n",
       "22      True             False   \n",
       "31      True              True   \n",
       "44      True              True   \n",
       "53      True             False   \n",
       "59     False             False   \n",
       "70      True             False   \n",
       "81      True              True   \n",
       "\n",
       "                          Health Benefits Description  Policy Influence  \\\n",
       "22  The tools developed from this work could resul...              True   \n",
       "31  Findings could potentially benefit parents' ex...              True   \n",
       "44                We have identified a new method to               True   \n",
       "53  The labeling of gastric cancers will provide o...              True   \n",
       "59                                                NaN              True   \n",
       "70  The tools developed from this work could resul...              True   \n",
       "81  Findings could potentially benefit parents' ex...              True   \n",
       "\n",
       "    International (pol)  National (pol)  Local (pol)  General Public (pol)  \\\n",
       "22                 True            True         True                 False   \n",
       "31                False            True         True                  True   \n",
       "44                False           False        False                 False   \n",
       "53                 True            True        False                 False   \n",
       "59                 True            True         True                 False   \n",
       "70                 True            True         True                 False   \n",
       "81                False            True         True                  True   \n",
       "\n",
       "    Healthcare Professionals (pol)  Patients (pol)  Patient Families (pol)  \\\n",
       "22                            True            True                   False   \n",
       "31                            True            True                    True   \n",
       "44                            True           False                   False   \n",
       "53                            True            True                   False   \n",
       "59                            True           False                   False   \n",
       "70                            True            True                   False   \n",
       "81                            True            True                    True   \n",
       "\n",
       "                          Policy Benefits Description Economic Benefits  \\\n",
       "22  These tools can help healthcare professionals ...               Yes   \n",
       "31  The navigation intervention could potentially ...               Yes   \n",
       "44                Adding genomics to the EMR in Epic.               Yes   \n",
       "53  The development of tumor specific probes for g...               Yes   \n",
       "59                                                NaN               Yes   \n",
       "70  These tools can help healthcare professionals ...               Yes   \n",
       "81  The navigator intervention could potentially b...               Yes   \n",
       "\n",
       "    International (econ)  National (econ)  Local (econ)  \\\n",
       "22                  True             True          True   \n",
       "31                 False             True          True   \n",
       "44                 False            False         False   \n",
       "53                  True             True         False   \n",
       "59                  True             True          True   \n",
       "70                  True             True          True   \n",
       "81                 False             True          True   \n",
       "\n",
       "    General Public (econ)  Healthcare Professionals (econ)  Patients (econ)  \\\n",
       "22                  False                             True             True   \n",
       "31                   True                             True             True   \n",
       "44                  False                            False             True   \n",
       "53                  False                             True             True   \n",
       "59                  False                             True            False   \n",
       "70                  False                             True             True   \n",
       "81                   True                             True             True   \n",
       "\n",
       "    Patient Families (econ)  \\\n",
       "22                    False   \n",
       "31                     True   \n",
       "44                    False   \n",
       "53                    False   \n",
       "59                    False   \n",
       "70                    False   \n",
       "81                     True   \n",
       "\n",
       "                        Economic Benefits Description Equity Benefits  \\\n",
       "22  Automated planning could reduce the time patie...             Yes   \n",
       "31  The navigation intervention could potentially ...             Yes   \n",
       "44  More effective therapies and predictive diagno...             Yes   \n",
       "53  If gastric cancer can be detected at an earlie...              No   \n",
       "59                                                NaN              No   \n",
       "70  Automated planning could reduce the time patie...             Yes   \n",
       "81  The navigator intervention could potentially i...             Yes   \n",
       "\n",
       "    International (equity)  National (equity)  Local (equity)  \\\n",
       "22                    True               True            True   \n",
       "31                    True               True            True   \n",
       "44                   False              False           False   \n",
       "53                   False              False           False   \n",
       "59                   False              False           False   \n",
       "70                    True               True            True   \n",
       "81                   False               True            True   \n",
       "\n",
       "    General Public (equity)  Healthcare Professionals (equity)  \\\n",
       "22                    False                              False   \n",
       "31                     True                               True   \n",
       "44                    False                              False   \n",
       "53                    False                              False   \n",
       "59                    False                              False   \n",
       "70                    False                              False   \n",
       "81                     True                               True   \n",
       "\n",
       "    Patients (equity)  Patient Families (equity)  \\\n",
       "22              False                      False   \n",
       "31               True                       True   \n",
       "44               True                      False   \n",
       "53              False                      False   \n",
       "59              False                      False   \n",
       "70              False                      False   \n",
       "81               True                       True   \n",
       "\n",
       "                          Equity Benefits Description  \\\n",
       "22  Currently, under-resourced centers (particular...   \n",
       "31  The navigation intervention could potentially ...   \n",
       "44  Understanding ethnic and gender-related differ...   \n",
       "53                                                NaN   \n",
       "59                                                NaN   \n",
       "70  Currently, under-resourced centers (particular...   \n",
       "81  The navigator intervention could potentially i...   \n",
       "\n",
       "      Additional Funding Achieved First AFS Status  \\\n",
       "22  No additional funding sources              NaN   \n",
       "31                           Five          Awarded   \n",
       "44                          Three          Awarded   \n",
       "53                            One          Awarded   \n",
       "59  No additional funding sources              NaN   \n",
       "70  No additional funding sources              NaN   \n",
       "81  No additional funding sources              NaN   \n",
       "\n",
       "                     First AFS Name and Project Title  First AFS Amount  \\\n",
       "22                                                NaN               NaN   \n",
       "31                                   see below in box         1000000.0   \n",
       "44                                                LLS          600000.0   \n",
       "53  NIH/NCI Bouvet (PI) 1R01CA256973-01A1 \"Molecul...         2264206.0   \n",
       "59                                                NaN               NaN   \n",
       "70                                                NaN               NaN   \n",
       "81                                                NaN               NaN   \n",
       "\n",
       "   Second AFS Status Second AFS Name and Project Title  Second AFS Amount  \\\n",
       "22               NaN                               NaN                NaN   \n",
       "31         Submitted                             below          1000000.0   \n",
       "44           Awarded                              NASA          2000000.0   \n",
       "53               NaN                               NaN                NaN   \n",
       "59               NaN                               NaN                NaN   \n",
       "70               NaN                               NaN                NaN   \n",
       "81               NaN                               NaN                NaN   \n",
       "\n",
       "   Third AFS Status Third AFS Name and Project Title  Third AGS Amount  \\\n",
       "22              NaN                              NaN               NaN   \n",
       "31          Awarded                            below          125000.0   \n",
       "44          Awarded                        NIDDK RO1         1000000.0   \n",
       "53              NaN                              NaN               NaN   \n",
       "59              NaN                              NaN               NaN   \n",
       "70              NaN                              NaN               NaN   \n",
       "81              NaN                              NaN               NaN   \n",
       "\n",
       "   Fourth AFS Status Fourth AFS Name and Project Title  Fourth AFS Amount  \\\n",
       "22               NaN                               NaN                NaN   \n",
       "31           Awarded                             below           125000.0   \n",
       "44               NaN                               NaN                NaN   \n",
       "53               NaN                               NaN                NaN   \n",
       "59               NaN                               NaN                NaN   \n",
       "70               NaN                               NaN                NaN   \n",
       "81               NaN                               NaN                NaN   \n",
       "\n",
       "   Additional Funding Source #5 Agency/Sponsor Name and Project Title  \\\n",
       "22                                                NaN                   \n",
       "31                                              below                   \n",
       "44                                                NaN                   \n",
       "53                                                NaN                   \n",
       "59                                                NaN                   \n",
       "70                                                NaN                   \n",
       "81                                                NaN                   \n",
       "\n",
       "   Fifth AFS Status  Fifth AFS Amount Additional Pedal Funding Impact  \\\n",
       "22              NaN               NaN                             Yes   \n",
       "31          Awarded         1250000.0                             Yes   \n",
       "44              NaN               NaN                             Yes   \n",
       "53              NaN               NaN                             Yes   \n",
       "59              NaN               NaN                              No   \n",
       "70              NaN               NaN                             Yes   \n",
       "81              NaN               NaN                             Yes   \n",
       "\n",
       "              Additional Funding Benefits Description  \\\n",
       "22  I would use the funding to hire personnel to d...   \n",
       "31  Absolutely: Future CUREBOUND funding will be c...   \n",
       "44  We would develop biomarkers for use in pediatr...   \n",
       "53  Additional funding well help establish more mo...   \n",
       "59                                                NaN   \n",
       "70  Hire personnel and test the automated brachyth...   \n",
       "81  Future Curebound funding will be critical to e...   \n",
       "\n",
       "   Additional Pedal Funding Impact (clinical stages)  \\\n",
       "22                                               Yes   \n",
       "31                                               Yes   \n",
       "44                                               Yes   \n",
       "53                                               Yes   \n",
       "59                                                No   \n",
       "70                                               Yes   \n",
       "81                                               Yes   \n",
       "\n",
       "   Additional Funding Benefits Description (clinical stages)  \\\n",
       "22  Once automated treatment planning has been val...          \n",
       "31  Yes, if the navigation intervention is effecti...          \n",
       "44  It would help with development of Rebecsinib, ...          \n",
       "53  Additional research will advance the technolog...          \n",
       "59                                                NaN          \n",
       "70  Once automated treatment planning has been val...          \n",
       "81  Yes, if the navigator intervention is effectiv...          \n",
       "\n",
       "                                Participated in Pedal  \\\n",
       "22  I participated in 2018 as a walker, 2019-20 as...   \n",
       "31                                                yes   \n",
       "44                                    Yes as a rider.   \n",
       "53                                                No.   \n",
       "59                                                NaN   \n",
       "70               Participated as a rider before COVID   \n",
       "81                                                Yes   \n",
       "\n",
       "   Further Research Contributions Success Stories  \\\n",
       "22                             No              No   \n",
       "31                            Yes             Yes   \n",
       "44                            Yes             Yes   \n",
       "53                             No              No   \n",
       "59                             No              No   \n",
       "70                             No              No   \n",
       "81                            Yes             Yes   \n",
       "\n",
       "   Major Scientific Breakthroughs  \\\n",
       "22                            NaN   \n",
       "31                            Yes   \n",
       "44                            Yes   \n",
       "53                            NaN   \n",
       "59                            NaN   \n",
       "70                            NaN   \n",
       "81                            Yes   \n",
       "\n",
       "                                  Additional Comments  Complete  \\\n",
       "22  The seed funding received from Padres Pedal th...      True   \n",
       "31  Missing Cancer Control and Population Sciences...      True   \n",
       "44                                         Thank you.      True   \n",
       "53                                                NaN      True   \n",
       "59                                                NaN      True   \n",
       "70                                                NaN      True   \n",
       "81  Please see Dr. Aristizabal's report.  She is t...      True   \n",
       "\n",
       "   Publication Status 1                          First DOI #  \\\n",
       "22            Published         10.1016/j.brachy.2020.04.008   \n",
       "31             Accepted                  10.1200/EDBK_320499   \n",
       "44                  NaN                                  NaN   \n",
       "53             Accepted                             10.21873   \n",
       "59                  NaN                                  NaN   \n",
       "70            Published         10.1016/j.brachy.2020.04.008   \n",
       "81            Published  Please see Dr. Aristizabal's report   \n",
       "\n",
       "   Publication Status 2                         Second DOI #  \\\n",
       "22            Published      10.1016/j.semradonc.2020.05.009   \n",
       "31             Accepted    10.1001/jamanetworkopen.2021.9038   \n",
       "44                  NaN                                  NaN   \n",
       "53          In progress                                  NaN   \n",
       "59                  NaN                                  NaN   \n",
       "70            Published      10.1016/j.semradonc.2020.05.009   \n",
       "81            Published  Please see Dr. Aristizabal's report   \n",
       "\n",
       "   Publication Status 3                          Third DOI #  \\\n",
       "22            Published         10.1016/j.brachy.2021.08.010   \n",
       "31             Accepted                    10.1002/pbc.28296   \n",
       "44                  NaN                                  NaN   \n",
       "53                  NaN                                  NaN   \n",
       "59                  NaN                                  NaN   \n",
       "70            Published         10.1016/j.brachy.2021.08.010   \n",
       "81            Published  Please see Dr. Aristizabal's report   \n",
       "\n",
       "                                        Project Title  \n",
       "22  Knowledge-based planning and treatment decisio...  \n",
       "31  Development and Implementation of a Peer-Navig...  \n",
       "44  Deciphering the role of RNA editing in leukemi...  \n",
       "53          Precision Interception of Gastric Cancers  \n",
       "59  A pilot trial to test the benefit of real time...  \n",
       "70  Knowledge-based planning and treatment decisio...  \n",
       "81  Development and Implementation of a Peer-Navig...  "
      ]
     },
     "execution_count": 65,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pr[pr[\"Healthcare Professionals (pol)\"]]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Save cleaned dataframes to csv files in interim\n",
    "# Caution: examine directory before uncomment/run this cell to prevent duplicate\n",
    "# files or unintentional modifications to files\n",
    "\n",
    "wp = os.path.join('interim', 'tableau-datasets', '2022_Pedal_Prog_Rep.csv')\n",
    "pr.to_csv(wp)\n",
    "\n",
    "# wp = os.path.join('interim', '2022_Pedal_Progress_Report.csv')\n",
    "# prog_r.to_csv(wp)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 67,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Prevention and diagnostic tools                   34\n",
       "Novel approaches and new therapeutic platforms    66\n",
       "Immunotherapies and personalized vaccines         35\n",
       "Addressing cancer disparities                      3\n",
       "Pediatric cancers                                 46\n",
       "dtype: int64"
      ]
     },
     "execution_count": 67,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "test = roi_adj[['Prevention and diagnostic tools', 'Novel approaches and new therapeutic platforms', \\\n",
    "    'Immunotherapies and personalized vaccines', 'Addressing cancer disparities',\n",
    "    'Pediatric cancers']]\n",
    "test.sum()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 68,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\phuro\\AppData\\Local\\Temp\\ipykernel_47384\\1983725501.py:1: FutureWarning:\n",
      "\n",
      "Dropping invalid columns in DataFrameGroupBy.max is deprecated. In a future version, a TypeError will be raised. Before calling .max, select only columns which should be valid for the function.\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "Prevention and diagnostic tools                   13\n",
       "Novel approaches and new therapeutic platforms    26\n",
       "Immunotherapies and personalized vaccines         14\n",
       "Addressing cancer disparities                      2\n",
       "Pediatric cancers                                 16\n",
       "dtype: int64"
      ]
     },
     "execution_count": 68,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "test = roi_adj.groupby('Project Title').max()\n",
    "test = test[['Prevention and diagnostic tools', 'Novel approaches and new therapeutic platforms', \\\n",
    "    'Immunotherapies and personalized vaccines', 'Addressing cancer disparities',\n",
    "    'Pediatric cancers']]\n",
    "test.sum()"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Fix mission pillars pie chart"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\phuro\\AppData\\Local\\Temp\\ipykernel_47384\\2230836996.py:1: FutureWarning:\n",
      "\n",
      "Dropping invalid columns in DataFrameGroupBy.max is deprecated. In a future version, a TypeError will be raised. Before calling .max, select only columns which should be valid for the function.\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Prevention and diagnostic tools</th>\n",
       "      <th>Novel approaches and new therapeutic platforms</th>\n",
       "      <th>Immunotherapies and personalized vaccines</th>\n",
       "      <th>Addressing cancer disparities</th>\n",
       "      <th>Pediatric cancers</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Project Title</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>A National Phase I Study of Cabozantinib in Combination with 13-cis-Retinoic Acid in Children with Relapsed or Refractory Solid Tumors</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>A Novel Role for Histidine Kinase Activity in Neuroblastoma Pathogenesis</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>A Phase 1B, Nonrandomized Trial Investigating Docetaxel Combined with Cirmtuzumab in Patients with Metastatic Castration Resistant Prostate Cancer</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>A Phase 1b Safety and Feasibility Study of Personalized Immunotherapy in Adults with Advanced Cancers</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>A Phase 1b pilot clinical trial of cirmtuzumab, an anti-ROR1 monoclonal antibody, in combination with paclitaxel for the treatment of patients with metastatic, or locally advanced, unresectable breast cancer</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>A pilot trial to test the benefit of real time drug screening to determine individualized treatment plans for children and young adults with relapsed or refractory medulloblastoma</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>An Open-Label, Phase 2 Efficacy Study of Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>An over-expressed GPCR in pancreatic cancer associated fibroblasts as a novel therapeutic target</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Applying p38 MAPK inhibitors to tackle breast cancer metastasis</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Characterization of a GOLPH3 Pathway Inhibitor to Enable a Hit-to-Lead Grant to Develop a Novel Cancer Therapeutic</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Cytotoxic Breast Cancer Treatment Effects on Aging</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Deciphering the role of RNA editing in leukemia stem cell generation and pediatric acute leukemia relapse</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Decoding Colon Cancers Using Boolean Principles</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Defining the mechanisms of pancreatic cancer susceptibility in patient-derived organoid models</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Demonstrating the Clinical Utility of Whole Exome Sequencing for Cancer Patients</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Detecting Correlates of Vaccine Responses in Allogeneic Hematopoietic Stem Cell Transplant Recipients</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Detecting dysregulated genes in neuroblastoma using allele-specific expression</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Developing targeted therapy for Ewing sarcoma metastasis</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Development and Implementation of a Peer-Navigation Intervention to Improve Research Literacy in Pediatric Cancer Trials</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Discovery of non-coding oncogenic mutations in pediatric acute lymphoblastic leukemia using ATAC-seq and Hi-C</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Elucidating the role of Syk kinase and Syk inhibitors combined with Radiation therapy in Neuroblastoma</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Enhanced Breast Cancer Risk Prediction from Imputed Gene Expression</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Epigenetic basis of platinum drug resistance in ovarian cancer</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Epigenetic profiling of endometrial cancer</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Evaluation of carcinogen exposure via genome-wide DNA-adduct signatures</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Examination of inhibitors of the ULK1 autophagy kinase as therapeutics in NSCLC</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Functional Roles for Histidine Kinase Signaling in Neuroblastoma</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Highly selective, synthetic, cleavage specificity-based nanobiosensors for tumorigenic and anti-tumorigenic MMPs</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Identification of genes critical for the production of T cells from human pluripotent stem cells for development of \"off-the-shelf\" T cell immunotherapies</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Identification of regulatory programs for glioblastoma cellular hierarchy using single-cell multi-omic profiling</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Identification of therapeutic targets of B-ALL using Boolean logic</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Impact of Metformin on Clonal Hematopoiesis and Clinical Outcomes in Breast Cancer</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Improved Echocardiographic Diagnosis of Anthracycline-Related Cardiac Dysfunction Using Global Longitudinal Strain</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>In Vivo Modeling of Anti-Tumor Responses of Human Melanoma Patients and their Responses to Checkpoint Immunotherapy</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Inducing Cytosolic Chromatin Fragments in Cancer Cells to Turn Cold Tumors Hot</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Inhibiting Liver Cancer Stem Cells to Improve Response to Thermal Ablation</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Investigating the Efficacy of radium-223 with Olaparib in Men with Metastatic Castration-resistant Prostate Cancer</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Irreversible electroporation as an In Situ vaccine for pancreatic cancer</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>KRAS Addiction and Protein Biomarkers of Response to anti-KRAS Therapy in NSCLC Patient Derived Xenografts</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Knowledge-based planning and treatment decision-making for gynecologic brachytherapy</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Low Dose Chemotherapy for Immuno-activation in Lung Cancer</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Mechanisms Linking Prolonged Nightly Fasting with Cancer Risk</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Microbe-Associated Colorectal Cancer (M.A.C.S)</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Natural Killer Cells for Treatment of Medulloblastoma</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Neoantigen-specific T cell responses in exceptional responders to immunotherapy in NSCLC</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>New Therapies for Myeloid Leukemia</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Novel Pathways Regulated by NME1 in Neuroblastoma</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Novel kinase inhibitors in combination with retinoic acide for neuroblastoma</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Oncogenic Regulation of B-Lymphomagenesis by the Chromatin Modulator DOT1L</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Peptide Targeted Delivery of Epigenetic Therapies in Pancreatic Cancer</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Precision Interception of Gastric Cancers</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Protein Kinase C as a Novel Biomarker and Target in Pancreatic Cancer</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Responses of Melanoma Patients to Checkpoint Immunotherapy</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Science</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Small molecule screen for inhibitors of the GOLPH3 pathway</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Stromal reprogramming to enhance the effectiveness of pancreatic cancer therapy</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Targeting A Therapeutic Vulnerability in PTEN-Deficient Brain Tumors</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Targeting CD114 Signaling in Pediatric Medulloblastoma</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Targeting FZD7 in human cancers</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Targeting KRAS mutant lung cancer with biphosphonated/statins and rapamycin analogs</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Targeting Stem Cell Signals in Cancer Development and Progression</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Targeting cellular mechanotransduction in breast cancer metastasis</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Targeting fibroblast heterogeneity to improve surgical outcomes in pancreatic cancer</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Targeting imatinib-resistant, KIT-negative cells in human GISTs</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>The GNAS-PKA Onco-Signaling Network in Colorectal Malignancies</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Therapeutic Reprogramming of Pancreatic Cancer Stroma Via Modulation of p62 and p53 (YEAR 1)</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Tissue-specific role of SMARCB1 in pediatric rhabdoid tumors</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Transcriptomic, epigenomic profiling to reveal TIL, microglia functional phenotype, and clonality in pediatric brain tumors</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>UCSD-UCSF Specialized Program of Research Excellence (SPORE) in Head and Neck Cancer</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Understanding and Targeting NRF2 in Pancreatic Cancer</th>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                    Prevention and diagnostic tools  \\\n",
       "Project Title                                                                         \n",
       "A National Phase I Study of Cabozantinib in Com...                            False   \n",
       "A Novel Role for Histidine Kinase Activity in N...                            False   \n",
       "A Phase 1B, Nonrandomized Trial Investigating D...                            False   \n",
       "A Phase 1b Safety and Feasibility Study of Pers...                            False   \n",
       "A Phase 1b pilot clinical trial of cirmtuzumab,...                            False   \n",
       "A pilot trial to test the benefit of real time ...                            False   \n",
       "An Open-Label, Phase 2 Efficacy Study of Temozo...                            False   \n",
       "An over-expressed GPCR in pancreatic cancer ass...                            False   \n",
       "Applying p38 MAPK inhibitors to tackle breast c...                            False   \n",
       "Characterization of a GOLPH3 Pathway Inhibitor ...                            False   \n",
       "Cytotoxic Breast Cancer Treatment Effects on Aging                             True   \n",
       "Deciphering the role of RNA editing in leukemia...                            False   \n",
       "Decoding Colon Cancers Using Boolean Principles                                True   \n",
       "Defining the mechanisms of pancreatic cancer su...                             True   \n",
       "Demonstrating the Clinical Utility of Whole Exo...                             True   \n",
       "Detecting Correlates of Vaccine Responses in Al...                             True   \n",
       "Detecting dysregulated genes in neuroblastoma u...                            False   \n",
       "Developing targeted therapy for Ewing sarcoma m...                            False   \n",
       "Development and Implementation of a Peer-Naviga...                            False   \n",
       "Discovery of non-coding oncogenic mutations in ...                            False   \n",
       "Elucidating the role of Syk kinase and Syk inhi...                            False   \n",
       "Enhanced Breast Cancer Risk Prediction from Imp...                             True   \n",
       "Epigenetic basis of platinum drug resistance in...                             True   \n",
       "Epigenetic profiling of endometrial cancer                                     True   \n",
       "Evaluation of carcinogen exposure via genome-wi...                             True   \n",
       "Examination of inhibitors of the ULK1 autophagy...                            False   \n",
       "FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma                              False   \n",
       "Functional Roles for Histidine Kinase Signaling...                            False   \n",
       "Highly selective, synthetic, cleavage specifici...                             True   \n",
       "Identification of genes critical for the produc...                            False   \n",
       "Identification of regulatory programs for gliob...                            False   \n",
       "Identification of therapeutic targets of B-ALL ...                            False   \n",
       "Impact of Metformin on Clonal Hematopoiesis and...                             True   \n",
       "Improved Echocardiographic Diagnosis of Anthrac...                            False   \n",
       "In Vivo Modeling of Anti-Tumor Responses of Hum...                            False   \n",
       "Inducing Cytosolic Chromatin Fragments in Cance...                            False   \n",
       "Inhibiting Liver Cancer Stem Cells to Improve R...                            False   \n",
       "Investigating the Efficacy of radium-223 with O...                            False   \n",
       "Irreversible electroporation as an In Situ vacc...                            False   \n",
       "KRAS Addiction and Protein Biomarkers of Respon...                            False   \n",
       "Knowledge-based planning and treatment decision...                             True   \n",
       "Low Dose Chemotherapy for Immuno-activation in ...                            False   \n",
       "Mechanisms Linking Prolonged Nightly Fasting wi...                             True   \n",
       "Microbe-Associated Colorectal Cancer (M.A.C.S)                                False   \n",
       "Natural Killer Cells for Treatment of Medullobl...                            False   \n",
       "Neoantigen-specific T cell responses in excepti...                            False   \n",
       "New Therapies for Myeloid Leukemia                                            False   \n",
       "Novel Pathways Regulated by NME1 in Neuroblastoma                             False   \n",
       "Novel kinase inhibitors in combination with ret...                            False   \n",
       "Oncogenic Regulation of B-Lymphomagenesis by th...                            False   \n",
       "Peptide Targeted Delivery of Epigenetic Therapi...                            False   \n",
       "Precision Interception of Gastric Cancers                                     False   \n",
       "Protein Kinase C as a Novel Biomarker and Targe...                            False   \n",
       "Responses of Melanoma Patients to Checkpoint Im...                            False   \n",
       "Science                                                                       False   \n",
       "Small molecule screen for inhibitors of the GOL...                            False   \n",
       "Stromal reprogramming to enhance the effectiven...                            False   \n",
       "Targeting A Therapeutic Vulnerability in PTEN-D...                            False   \n",
       "Targeting CD114 Signaling in Pediatric Medullob...                            False   \n",
       "Targeting FZD7 in human cancers                                               False   \n",
       "Targeting KRAS mutant lung cancer with biphosph...                            False   \n",
       "Targeting Stem Cell Signals in Cancer Developme...                            False   \n",
       "Targeting cellular mechanotransduction in breas...                            False   \n",
       "Targeting fibroblast heterogeneity to improve s...                            False   \n",
       "Targeting imatinib-resistant, KIT-negative cell...                            False   \n",
       "The GNAS-PKA Onco-Signaling Network in Colorect...                            False   \n",
       "Therapeutic Reprogramming of Pancreatic Cancer ...                            False   \n",
       "Tissue-specific role of SMARCB1 in pediatric rh...                            False   \n",
       "Transcriptomic, epigenomic profiling to reveal ...                            False   \n",
       "UCSD-UCSF Specialized Program of Research Excel...                            False   \n",
       "Understanding and Targeting NRF2 in Pancreatic ...                            False   \n",
       "\n",
       "                                                    Novel approaches and new therapeutic platforms  \\\n",
       "Project Title                                                                                        \n",
       "A National Phase I Study of Cabozantinib in Com...                                           False   \n",
       "A Novel Role for Histidine Kinase Activity in N...                                           False   \n",
       "A Phase 1B, Nonrandomized Trial Investigating D...                                            True   \n",
       "A Phase 1b Safety and Feasibility Study of Pers...                                           False   \n",
       "A Phase 1b pilot clinical trial of cirmtuzumab,...                                           False   \n",
       "A pilot trial to test the benefit of real time ...                                           False   \n",
       "An Open-Label, Phase 2 Efficacy Study of Temozo...                                            True   \n",
       "An over-expressed GPCR in pancreatic cancer ass...                                            True   \n",
       "Applying p38 MAPK inhibitors to tackle breast c...                                            True   \n",
       "Characterization of a GOLPH3 Pathway Inhibitor ...                                            True   \n",
       "Cytotoxic Breast Cancer Treatment Effects on Aging                                           False   \n",
       "Deciphering the role of RNA editing in leukemia...                                           False   \n",
       "Decoding Colon Cancers Using Boolean Principles                                              False   \n",
       "Defining the mechanisms of pancreatic cancer su...                                           False   \n",
       "Demonstrating the Clinical Utility of Whole Exo...                                           False   \n",
       "Detecting Correlates of Vaccine Responses in Al...                                           False   \n",
       "Detecting dysregulated genes in neuroblastoma u...                                           False   \n",
       "Developing targeted therapy for Ewing sarcoma m...                                           False   \n",
       "Development and Implementation of a Peer-Naviga...                                           False   \n",
       "Discovery of non-coding oncogenic mutations in ...                                           False   \n",
       "Elucidating the role of Syk kinase and Syk inhi...                                           False   \n",
       "Enhanced Breast Cancer Risk Prediction from Imp...                                           False   \n",
       "Epigenetic basis of platinum drug resistance in...                                           False   \n",
       "Epigenetic profiling of endometrial cancer                                                   False   \n",
       "Evaluation of carcinogen exposure via genome-wi...                                           False   \n",
       "Examination of inhibitors of the ULK1 autophagy...                                            True   \n",
       "FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma                                             False   \n",
       "Functional Roles for Histidine Kinase Signaling...                                           False   \n",
       "Highly selective, synthetic, cleavage specifici...                                           False   \n",
       "Identification of genes critical for the produc...                                           False   \n",
       "Identification of regulatory programs for gliob...                                            True   \n",
       "Identification of therapeutic targets of B-ALL ...                                           False   \n",
       "Impact of Metformin on Clonal Hematopoiesis and...                                           False   \n",
       "Improved Echocardiographic Diagnosis of Anthrac...                                           False   \n",
       "In Vivo Modeling of Anti-Tumor Responses of Hum...                                           False   \n",
       "Inducing Cytosolic Chromatin Fragments in Cance...                                           False   \n",
       "Inhibiting Liver Cancer Stem Cells to Improve R...                                            True   \n",
       "Investigating the Efficacy of radium-223 with O...                                            True   \n",
       "Irreversible electroporation as an In Situ vacc...                                           False   \n",
       "KRAS Addiction and Protein Biomarkers of Respon...                                            True   \n",
       "Knowledge-based planning and treatment decision...                                           False   \n",
       "Low Dose Chemotherapy for Immuno-activation in ...                                           False   \n",
       "Mechanisms Linking Prolonged Nightly Fasting wi...                                           False   \n",
       "Microbe-Associated Colorectal Cancer (M.A.C.S)                                                True   \n",
       "Natural Killer Cells for Treatment of Medullobl...                                           False   \n",
       "Neoantigen-specific T cell responses in excepti...                                           False   \n",
       "New Therapies for Myeloid Leukemia                                                            True   \n",
       "Novel Pathways Regulated by NME1 in Neuroblastoma                                            False   \n",
       "Novel kinase inhibitors in combination with ret...                                           False   \n",
       "Oncogenic Regulation of B-Lymphomagenesis by th...                                            True   \n",
       "Peptide Targeted Delivery of Epigenetic Therapi...                                           False   \n",
       "Precision Interception of Gastric Cancers                                                     True   \n",
       "Protein Kinase C as a Novel Biomarker and Targe...                                            True   \n",
       "Responses of Melanoma Patients to Checkpoint Im...                                           False   \n",
       "Science                                                                                      False   \n",
       "Small molecule screen for inhibitors of the GOL...                                            True   \n",
       "Stromal reprogramming to enhance the effectiven...                                            True   \n",
       "Targeting A Therapeutic Vulnerability in PTEN-D...                                            True   \n",
       "Targeting CD114 Signaling in Pediatric Medullob...                                           False   \n",
       "Targeting FZD7 in human cancers                                                              False   \n",
       "Targeting KRAS mutant lung cancer with biphosph...                                            True   \n",
       "Targeting Stem Cell Signals in Cancer Developme...                                            True   \n",
       "Targeting cellular mechanotransduction in breas...                                            True   \n",
       "Targeting fibroblast heterogeneity to improve s...                                            True   \n",
       "Targeting imatinib-resistant, KIT-negative cell...                                            True   \n",
       "The GNAS-PKA Onco-Signaling Network in Colorect...                                            True   \n",
       "Therapeutic Reprogramming of Pancreatic Cancer ...                                            True   \n",
       "Tissue-specific role of SMARCB1 in pediatric rh...                                           False   \n",
       "Transcriptomic, epigenomic profiling to reveal ...                                           False   \n",
       "UCSD-UCSF Specialized Program of Research Excel...                                           False   \n",
       "Understanding and Targeting NRF2 in Pancreatic ...                                            True   \n",
       "\n",
       "                                                    Immunotherapies and personalized vaccines  \\\n",
       "Project Title                                                                                   \n",
       "A National Phase I Study of Cabozantinib in Com...                                      False   \n",
       "A Novel Role for Histidine Kinase Activity in N...                                      False   \n",
       "A Phase 1B, Nonrandomized Trial Investigating D...                                      False   \n",
       "A Phase 1b Safety and Feasibility Study of Pers...                                       True   \n",
       "A Phase 1b pilot clinical trial of cirmtuzumab,...                                       True   \n",
       "A pilot trial to test the benefit of real time ...                                      False   \n",
       "An Open-Label, Phase 2 Efficacy Study of Temozo...                                      False   \n",
       "An over-expressed GPCR in pancreatic cancer ass...                                      False   \n",
       "Applying p38 MAPK inhibitors to tackle breast c...                                      False   \n",
       "Characterization of a GOLPH3 Pathway Inhibitor ...                                      False   \n",
       "Cytotoxic Breast Cancer Treatment Effects on Aging                                      False   \n",
       "Deciphering the role of RNA editing in leukemia...                                      False   \n",
       "Decoding Colon Cancers Using Boolean Principles                                         False   \n",
       "Defining the mechanisms of pancreatic cancer su...                                      False   \n",
       "Demonstrating the Clinical Utility of Whole Exo...                                      False   \n",
       "Detecting Correlates of Vaccine Responses in Al...                                      False   \n",
       "Detecting dysregulated genes in neuroblastoma u...                                      False   \n",
       "Developing targeted therapy for Ewing sarcoma m...                                      False   \n",
       "Development and Implementation of a Peer-Naviga...                                      False   \n",
       "Discovery of non-coding oncogenic mutations in ...                                      False   \n",
       "Elucidating the role of Syk kinase and Syk inhi...                                      False   \n",
       "Enhanced Breast Cancer Risk Prediction from Imp...                                      False   \n",
       "Epigenetic basis of platinum drug resistance in...                                      False   \n",
       "Epigenetic profiling of endometrial cancer                                              False   \n",
       "Evaluation of carcinogen exposure via genome-wi...                                      False   \n",
       "Examination of inhibitors of the ULK1 autophagy...                                      False   \n",
       "FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma                                        False   \n",
       "Functional Roles for Histidine Kinase Signaling...                                      False   \n",
       "Highly selective, synthetic, cleavage specifici...                                      False   \n",
       "Identification of genes critical for the produc...                                       True   \n",
       "Identification of regulatory programs for gliob...                                      False   \n",
       "Identification of therapeutic targets of B-ALL ...                                      False   \n",
       "Impact of Metformin on Clonal Hematopoiesis and...                                      False   \n",
       "Improved Echocardiographic Diagnosis of Anthrac...                                      False   \n",
       "In Vivo Modeling of Anti-Tumor Responses of Hum...                                       True   \n",
       "Inducing Cytosolic Chromatin Fragments in Cance...                                       True   \n",
       "Inhibiting Liver Cancer Stem Cells to Improve R...                                      False   \n",
       "Investigating the Efficacy of radium-223 with O...                                      False   \n",
       "Irreversible electroporation as an In Situ vacc...                                       True   \n",
       "KRAS Addiction and Protein Biomarkers of Respon...                                      False   \n",
       "Knowledge-based planning and treatment decision...                                      False   \n",
       "Low Dose Chemotherapy for Immuno-activation in ...                                       True   \n",
       "Mechanisms Linking Prolonged Nightly Fasting wi...                                      False   \n",
       "Microbe-Associated Colorectal Cancer (M.A.C.S)                                          False   \n",
       "Natural Killer Cells for Treatment of Medullobl...                                       True   \n",
       "Neoantigen-specific T cell responses in excepti...                                       True   \n",
       "New Therapies for Myeloid Leukemia                                                      False   \n",
       "Novel Pathways Regulated by NME1 in Neuroblastoma                                       False   \n",
       "Novel kinase inhibitors in combination with ret...                                      False   \n",
       "Oncogenic Regulation of B-Lymphomagenesis by th...                                      False   \n",
       "Peptide Targeted Delivery of Epigenetic Therapi...                                       True   \n",
       "Precision Interception of Gastric Cancers                                               False   \n",
       "Protein Kinase C as a Novel Biomarker and Targe...                                      False   \n",
       "Responses of Melanoma Patients to Checkpoint Im...                                       True   \n",
       "Science                                                                                 False   \n",
       "Small molecule screen for inhibitors of the GOL...                                      False   \n",
       "Stromal reprogramming to enhance the effectiven...                                      False   \n",
       "Targeting A Therapeutic Vulnerability in PTEN-D...                                      False   \n",
       "Targeting CD114 Signaling in Pediatric Medullob...                                      False   \n",
       "Targeting FZD7 in human cancers                                                          True   \n",
       "Targeting KRAS mutant lung cancer with biphosph...                                      False   \n",
       "Targeting Stem Cell Signals in Cancer Developme...                                      False   \n",
       "Targeting cellular mechanotransduction in breas...                                      False   \n",
       "Targeting fibroblast heterogeneity to improve s...                                      False   \n",
       "Targeting imatinib-resistant, KIT-negative cell...                                      False   \n",
       "The GNAS-PKA Onco-Signaling Network in Colorect...                                      False   \n",
       "Therapeutic Reprogramming of Pancreatic Cancer ...                                      False   \n",
       "Tissue-specific role of SMARCB1 in pediatric rh...                                      False   \n",
       "Transcriptomic, epigenomic profiling to reveal ...                                       True   \n",
       "UCSD-UCSF Specialized Program of Research Excel...                                       True   \n",
       "Understanding and Targeting NRF2 in Pancreatic ...                                      False   \n",
       "\n",
       "                                                    Addressing cancer disparities  \\\n",
       "Project Title                                                                       \n",
       "A National Phase I Study of Cabozantinib in Com...                          False   \n",
       "A Novel Role for Histidine Kinase Activity in N...                          False   \n",
       "A Phase 1B, Nonrandomized Trial Investigating D...                          False   \n",
       "A Phase 1b Safety and Feasibility Study of Pers...                          False   \n",
       "A Phase 1b pilot clinical trial of cirmtuzumab,...                          False   \n",
       "A pilot trial to test the benefit of real time ...                          False   \n",
       "An Open-Label, Phase 2 Efficacy Study of Temozo...                          False   \n",
       "An over-expressed GPCR in pancreatic cancer ass...                          False   \n",
       "Applying p38 MAPK inhibitors to tackle breast c...                          False   \n",
       "Characterization of a GOLPH3 Pathway Inhibitor ...                          False   \n",
       "Cytotoxic Breast Cancer Treatment Effects on Aging                          False   \n",
       "Deciphering the role of RNA editing in leukemia...                          False   \n",
       "Decoding Colon Cancers Using Boolean Principles                             False   \n",
       "Defining the mechanisms of pancreatic cancer su...                          False   \n",
       "Demonstrating the Clinical Utility of Whole Exo...                          False   \n",
       "Detecting Correlates of Vaccine Responses in Al...                          False   \n",
       "Detecting dysregulated genes in neuroblastoma u...                          False   \n",
       "Developing targeted therapy for Ewing sarcoma m...                          False   \n",
       "Development and Implementation of a Peer-Naviga...                           True   \n",
       "Discovery of non-coding oncogenic mutations in ...                          False   \n",
       "Elucidating the role of Syk kinase and Syk inhi...                          False   \n",
       "Enhanced Breast Cancer Risk Prediction from Imp...                          False   \n",
       "Epigenetic basis of platinum drug resistance in...                          False   \n",
       "Epigenetic profiling of endometrial cancer                                  False   \n",
       "Evaluation of carcinogen exposure via genome-wi...                          False   \n",
       "Examination of inhibitors of the ULK1 autophagy...                          False   \n",
       "FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma                            False   \n",
       "Functional Roles for Histidine Kinase Signaling...                          False   \n",
       "Highly selective, synthetic, cleavage specifici...                          False   \n",
       "Identification of genes critical for the produc...                          False   \n",
       "Identification of regulatory programs for gliob...                          False   \n",
       "Identification of therapeutic targets of B-ALL ...                          False   \n",
       "Impact of Metformin on Clonal Hematopoiesis and...                          False   \n",
       "Improved Echocardiographic Diagnosis of Anthrac...                          False   \n",
       "In Vivo Modeling of Anti-Tumor Responses of Hum...                          False   \n",
       "Inducing Cytosolic Chromatin Fragments in Cance...                          False   \n",
       "Inhibiting Liver Cancer Stem Cells to Improve R...                          False   \n",
       "Investigating the Efficacy of radium-223 with O...                          False   \n",
       "Irreversible electroporation as an In Situ vacc...                          False   \n",
       "KRAS Addiction and Protein Biomarkers of Respon...                          False   \n",
       "Knowledge-based planning and treatment decision...                          False   \n",
       "Low Dose Chemotherapy for Immuno-activation in ...                          False   \n",
       "Mechanisms Linking Prolonged Nightly Fasting wi...                          False   \n",
       "Microbe-Associated Colorectal Cancer (M.A.C.S)                              False   \n",
       "Natural Killer Cells for Treatment of Medullobl...                          False   \n",
       "Neoantigen-specific T cell responses in excepti...                          False   \n",
       "New Therapies for Myeloid Leukemia                                          False   \n",
       "Novel Pathways Regulated by NME1 in Neuroblastoma                           False   \n",
       "Novel kinase inhibitors in combination with ret...                          False   \n",
       "Oncogenic Regulation of B-Lymphomagenesis by th...                          False   \n",
       "Peptide Targeted Delivery of Epigenetic Therapi...                          False   \n",
       "Precision Interception of Gastric Cancers                                   False   \n",
       "Protein Kinase C as a Novel Biomarker and Targe...                          False   \n",
       "Responses of Melanoma Patients to Checkpoint Im...                          False   \n",
       "Science                                                                      True   \n",
       "Small molecule screen for inhibitors of the GOL...                          False   \n",
       "Stromal reprogramming to enhance the effectiven...                          False   \n",
       "Targeting A Therapeutic Vulnerability in PTEN-D...                          False   \n",
       "Targeting CD114 Signaling in Pediatric Medullob...                          False   \n",
       "Targeting FZD7 in human cancers                                             False   \n",
       "Targeting KRAS mutant lung cancer with biphosph...                          False   \n",
       "Targeting Stem Cell Signals in Cancer Developme...                          False   \n",
       "Targeting cellular mechanotransduction in breas...                          False   \n",
       "Targeting fibroblast heterogeneity to improve s...                          False   \n",
       "Targeting imatinib-resistant, KIT-negative cell...                          False   \n",
       "The GNAS-PKA Onco-Signaling Network in Colorect...                          False   \n",
       "Therapeutic Reprogramming of Pancreatic Cancer ...                          False   \n",
       "Tissue-specific role of SMARCB1 in pediatric rh...                          False   \n",
       "Transcriptomic, epigenomic profiling to reveal ...                          False   \n",
       "UCSD-UCSF Specialized Program of Research Excel...                          False   \n",
       "Understanding and Targeting NRF2 in Pancreatic ...                          False   \n",
       "\n",
       "                                                    Pediatric cancers  \n",
       "Project Title                                                          \n",
       "A National Phase I Study of Cabozantinib in Com...               True  \n",
       "A Novel Role for Histidine Kinase Activity in N...               True  \n",
       "A Phase 1B, Nonrandomized Trial Investigating D...              False  \n",
       "A Phase 1b Safety and Feasibility Study of Pers...              False  \n",
       "A Phase 1b pilot clinical trial of cirmtuzumab,...              False  \n",
       "A pilot trial to test the benefit of real time ...               True  \n",
       "An Open-Label, Phase 2 Efficacy Study of Temozo...              False  \n",
       "An over-expressed GPCR in pancreatic cancer ass...              False  \n",
       "Applying p38 MAPK inhibitors to tackle breast c...              False  \n",
       "Characterization of a GOLPH3 Pathway Inhibitor ...              False  \n",
       "Cytotoxic Breast Cancer Treatment Effects on Aging              False  \n",
       "Deciphering the role of RNA editing in leukemia...               True  \n",
       "Decoding Colon Cancers Using Boolean Principles                 False  \n",
       "Defining the mechanisms of pancreatic cancer su...              False  \n",
       "Demonstrating the Clinical Utility of Whole Exo...              False  \n",
       "Detecting Correlates of Vaccine Responses in Al...              False  \n",
       "Detecting dysregulated genes in neuroblastoma u...               True  \n",
       "Developing targeted therapy for Ewing sarcoma m...               True  \n",
       "Development and Implementation of a Peer-Naviga...              False  \n",
       "Discovery of non-coding oncogenic mutations in ...               True  \n",
       "Elucidating the role of Syk kinase and Syk inhi...               True  \n",
       "Enhanced Breast Cancer Risk Prediction from Imp...              False  \n",
       "Epigenetic basis of platinum drug resistance in...              False  \n",
       "Epigenetic profiling of endometrial cancer                      False  \n",
       "Evaluation of carcinogen exposure via genome-wi...              False  \n",
       "Examination of inhibitors of the ULK1 autophagy...              False  \n",
       "FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma                 True  \n",
       "Functional Roles for Histidine Kinase Signaling...               True  \n",
       "Highly selective, synthetic, cleavage specifici...              False  \n",
       "Identification of genes critical for the produc...              False  \n",
       "Identification of regulatory programs for gliob...              False  \n",
       "Identification of therapeutic targets of B-ALL ...               True  \n",
       "Impact of Metformin on Clonal Hematopoiesis and...              False  \n",
       "Improved Echocardiographic Diagnosis of Anthrac...               True  \n",
       "In Vivo Modeling of Anti-Tumor Responses of Hum...              False  \n",
       "Inducing Cytosolic Chromatin Fragments in Cance...              False  \n",
       "Inhibiting Liver Cancer Stem Cells to Improve R...              False  \n",
       "Investigating the Efficacy of radium-223 with O...              False  \n",
       "Irreversible electroporation as an In Situ vacc...              False  \n",
       "KRAS Addiction and Protein Biomarkers of Respon...              False  \n",
       "Knowledge-based planning and treatment decision...              False  \n",
       "Low Dose Chemotherapy for Immuno-activation in ...              False  \n",
       "Mechanisms Linking Prolonged Nightly Fasting wi...              False  \n",
       "Microbe-Associated Colorectal Cancer (M.A.C.S)                  False  \n",
       "Natural Killer Cells for Treatment of Medullobl...              False  \n",
       "Neoantigen-specific T cell responses in excepti...              False  \n",
       "New Therapies for Myeloid Leukemia                              False  \n",
       "Novel Pathways Regulated by NME1 in Neuroblastoma                True  \n",
       "Novel kinase inhibitors in combination with ret...               True  \n",
       "Oncogenic Regulation of B-Lymphomagenesis by th...              False  \n",
       "Peptide Targeted Delivery of Epigenetic Therapi...              False  \n",
       "Precision Interception of Gastric Cancers                       False  \n",
       "Protein Kinase C as a Novel Biomarker and Targe...              False  \n",
       "Responses of Melanoma Patients to Checkpoint Im...              False  \n",
       "Science                                                         False  \n",
       "Small molecule screen for inhibitors of the GOL...              False  \n",
       "Stromal reprogramming to enhance the effectiven...              False  \n",
       "Targeting A Therapeutic Vulnerability in PTEN-D...              False  \n",
       "Targeting CD114 Signaling in Pediatric Medullob...               True  \n",
       "Targeting FZD7 in human cancers                                 False  \n",
       "Targeting KRAS mutant lung cancer with biphosph...              False  \n",
       "Targeting Stem Cell Signals in Cancer Developme...              False  \n",
       "Targeting cellular mechanotransduction in breas...              False  \n",
       "Targeting fibroblast heterogeneity to improve s...              False  \n",
       "Targeting imatinib-resistant, KIT-negative cell...              False  \n",
       "The GNAS-PKA Onco-Signaling Network in Colorect...              False  \n",
       "Therapeutic Reprogramming of Pancreatic Cancer ...              False  \n",
       "Tissue-specific role of SMARCB1 in pediatric rh...               True  \n",
       "Transcriptomic, epigenomic profiling to reveal ...              False  \n",
       "UCSD-UCSF Specialized Program of Research Excel...              False  \n",
       "Understanding and Targeting NRF2 in Pancreatic ...              False  "
      ]
     },
     "execution_count": 69,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pillar_status = roi_adj.groupby('Project Title').max()[[ 'Prevention and diagnostic tools', 'Novel approaches and new therapeutic platforms', \\\n",
    "    'Immunotherapies and personalized vaccines', 'Addressing cancer disparities',\n",
    "    'Pediatric cancers']]\n",
    "pillar_status"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 70,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(71, 5)"
      ]
     },
     "execution_count": 70,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pillar_status.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 71,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "False"
      ]
     },
     "execution_count": 71,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pillar_status.loc['Understanding and Targeting NRF2 in Pancreatic Cancer', 'Pediatric cancers']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 72,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "checked_titles = []\n",
    "def adj_pillar_cnt(row, pillar):\n",
    "    title = row['Project Title']\n",
    "    if title not in checked_titles:\n",
    "        checked_titles.append(title)\n",
    "        return pillar_status.loc[title, pillar]\n",
    "    else:\n",
    "        return False\n",
    "\n",
    "for pillar in pillar_status.columns:\n",
    "    checked_titles = []\n",
    "    roi_adj[pillar] = roi_adj.apply(adj_pillar_cnt, args=[pillar], axis=1)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 73,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Award ID</th>\n",
       "      <th>Project Title</th>\n",
       "      <th>PI Institution</th>\n",
       "      <th>Other Institution</th>\n",
       "      <th>Prevention and diagnostic tools</th>\n",
       "      <th>Novel approaches and new therapeutic platforms</th>\n",
       "      <th>Immunotherapies and personalized vaccines</th>\n",
       "      <th>Addressing cancer disparities</th>\n",
       "      <th>Pediatric cancers</th>\n",
       "      <th>Specific Aims</th>\n",
       "      <th>Aim 1</th>\n",
       "      <th>Aim 2</th>\n",
       "      <th>Aim 3</th>\n",
       "      <th>Aim 4</th>\n",
       "      <th>Aim 5</th>\n",
       "      <th>Aim 6</th>\n",
       "      <th>Public Health Significance</th>\n",
       "      <th>Award Amount</th>\n",
       "      <th>Grant Start Date:</th>\n",
       "      <th>Grant End Date:</th>\n",
       "      <th>Complete</th>\n",
       "      <th>SR - None</th>\n",
       "      <th>SR - Biobehaviorial MCC</th>\n",
       "      <th>SR - Biorepository &amp; Tissue Tech. MCC</th>\n",
       "      <th>SR - Biostatistics MCC</th>\n",
       "      <th>SR - Clinical Trials Office MCC</th>\n",
       "      <th>SR - Flow Cytometry MCC</th>\n",
       "      <th>SR - Genomics &amp; Computational Bio. MCC</th>\n",
       "      <th>SR - In Vivo Imaging MCC</th>\n",
       "      <th>SR - Microscopy MCC</th>\n",
       "      <th>SR - Radiation Medicine MCC</th>\n",
       "      <th>SR - Transgenic Mouse MCC</th>\n",
       "      <th>SR - Gene Transfer/Targeting/Therap Salk</th>\n",
       "      <th>SR - Transgenic Salk</th>\n",
       "      <th>SR - Mass Spect - Proteom/Metabol Salk</th>\n",
       "      <th>SR - Chemical Library Screening SBPMDI</th>\n",
       "      <th>SR - Functional Genomics SBPMDI</th>\n",
       "      <th>Cancer Metabolism SBPMDI</th>\n",
       "      <th>Pedal Importance (recruitment, retention, advancement)</th>\n",
       "      <th>If yes, please specify</th>\n",
       "      <th>If no, please specify</th>\n",
       "      <th>Clinical Trials Resulted</th>\n",
       "      <th>First Clinical Trial</th>\n",
       "      <th>First Clinical Trial Patient Count</th>\n",
       "      <th>Second Clinical Trial</th>\n",
       "      <th>Second Clinical Trial Patient Count</th>\n",
       "      <th>Companies Founded</th>\n",
       "      <th>Patents Filed</th>\n",
       "      <th>Patent Details</th>\n",
       "      <th>Peer-Reviewed Publications Count</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>52.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>52.1</td>\n",
       "      <td>Discovery of non-coding oncogenic mutations in...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Discover non-coding regulatory mutations in AL...</td>\n",
       "      <td>Discover large-scale structural mutations and ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Acute Lymphoblastic Leukemia (ALL) is the most...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The funding for this project and the data gene...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>131.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>52.2</td>\n",
       "      <td>Discovery of non-coding oncogenic mutations in...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Discover non-coding regulatory mutations in AL...</td>\n",
       "      <td>Discover large-scale structural mutations and ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Acute Lymphoblastic Leukemia (ALL) is the most...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Obtaining funding is important for career adva...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>132.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>52.3</td>\n",
       "      <td>Discovery of non-coding oncogenic mutations in...</td>\n",
       "      <td>Rady Children's</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Discover non-coding regulatory mutations in AL...</td>\n",
       "      <td>Discover large-scale structural mutations and ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Acute Lymphoblastic Leukemia (ALL) is the most...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Funding for this project enhanced innovative c...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>200.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>200.1</td>\n",
       "      <td>Discovery of non-coding oncogenic mutations in...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Discover non-coding regulatory mutations in AL...</td>\n",
       "      <td>Discover large-scale structural mutations and ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Acute Lymphoblastic Leukemia (ALL) is the most...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>201.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>200.2</td>\n",
       "      <td>Discovery of non-coding oncogenic mutations in...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Discover non-coding regulatory mutations in AL...</td>\n",
       "      <td>Discover large-scale structural mutations and ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Acute Lymphoblastic Leukemia (ALL) is the most...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "      ID Event Name  Award ID  \\\n",
       "0   52.0    Initial      52.1   \n",
       "1  131.0    Initial      52.2   \n",
       "2  132.0    Initial      52.3   \n",
       "3  200.0    Initial     200.1   \n",
       "4  201.0    Initial     200.2   \n",
       "\n",
       "                                       Project Title   PI Institution  \\\n",
       "0  Discovery of non-coding oncogenic mutations in...   Salk Institute   \n",
       "1  Discovery of non-coding oncogenic mutations in...   Salk Institute   \n",
       "2  Discovery of non-coding oncogenic mutations in...  Rady Children's   \n",
       "3  Discovery of non-coding oncogenic mutations in...   Salk Institute   \n",
       "4  Discovery of non-coding oncogenic mutations in...   Salk Institute   \n",
       "\n",
       "  Other Institution  Prevention and diagnostic tools  \\\n",
       "0               NaN                            False   \n",
       "1               NaN                            False   \n",
       "2               NaN                            False   \n",
       "3               NaN                            False   \n",
       "4               NaN                            False   \n",
       "\n",
       "   Novel approaches and new therapeutic platforms  \\\n",
       "0                                           False   \n",
       "1                                           False   \n",
       "2                                           False   \n",
       "3                                           False   \n",
       "4                                           False   \n",
       "\n",
       "   Immunotherapies and personalized vaccines  Addressing cancer disparities  \\\n",
       "0                                      False                          False   \n",
       "1                                      False                          False   \n",
       "2                                      False                          False   \n",
       "3                                      False                          False   \n",
       "4                                      False                          False   \n",
       "\n",
       "   Pediatric cancers      Specific Aims  \\\n",
       "0               True  Two Specific Aims   \n",
       "1              False  Two Specific Aims   \n",
       "2              False  Two Specific Aims   \n",
       "3              False  Two Specific Aims   \n",
       "4              False  Two Specific Aims   \n",
       "\n",
       "                                               Aim 1  \\\n",
       "0  Discover non-coding regulatory mutations in AL...   \n",
       "1  Discover non-coding regulatory mutations in AL...   \n",
       "2  Discover non-coding regulatory mutations in AL...   \n",
       "3  Discover non-coding regulatory mutations in AL...   \n",
       "4  Discover non-coding regulatory mutations in AL...   \n",
       "\n",
       "                                               Aim 2 Aim 3 Aim 4 Aim 5 Aim 6  \\\n",
       "0  Discover large-scale structural mutations and ...   NaN   NaN   NaN   NaN   \n",
       "1  Discover large-scale structural mutations and ...   NaN   NaN   NaN   NaN   \n",
       "2  Discover large-scale structural mutations and ...   NaN   NaN   NaN   NaN   \n",
       "3  Discover large-scale structural mutations and ...   NaN   NaN   NaN   NaN   \n",
       "4  Discover large-scale structural mutations and ...   NaN   NaN   NaN   NaN   \n",
       "\n",
       "                          Public Health Significance  Award Amount  \\\n",
       "0  Acute Lymphoblastic Leukemia (ALL) is the most...       75000.0   \n",
       "1  Acute Lymphoblastic Leukemia (ALL) is the most...       75000.0   \n",
       "2  Acute Lymphoblastic Leukemia (ALL) is the most...       75000.0   \n",
       "3  Acute Lymphoblastic Leukemia (ALL) is the most...       75000.0   \n",
       "4  Acute Lymphoblastic Leukemia (ALL) is the most...       75000.0   \n",
       "\n",
       "  Grant Start Date: Grant End Date:  Complete SR - None  \\\n",
       "0        2017-06-01      2018-05-31  Complete      True   \n",
       "1        2017-06-01      2018-05-31  Complete      True   \n",
       "2        2017-06-01      2018-05-31  Complete      True   \n",
       "3        2017-06-01      2018-05-31  Complete       NaN   \n",
       "4        2017-06-01      2018-05-31  Complete       NaN   \n",
       "\n",
       "  SR - Biobehaviorial MCC SR - Biorepository & Tissue Tech. MCC  \\\n",
       "0                   False                                 False   \n",
       "1                   False                                 False   \n",
       "2                   False                                 False   \n",
       "3                     NaN                                   NaN   \n",
       "4                     NaN                                   NaN   \n",
       "\n",
       "  SR - Biostatistics MCC SR - Clinical Trials Office MCC  \\\n",
       "0                  False                           False   \n",
       "1                  False                           False   \n",
       "2                  False                           False   \n",
       "3                    NaN                             NaN   \n",
       "4                    NaN                             NaN   \n",
       "\n",
       "  SR - Flow Cytometry MCC SR - Genomics & Computational Bio. MCC  \\\n",
       "0                   False                                  False   \n",
       "1                   False                                  False   \n",
       "2                   False                                  False   \n",
       "3                     NaN                                    NaN   \n",
       "4                     NaN                                    NaN   \n",
       "\n",
       "  SR - In Vivo Imaging MCC SR - Microscopy MCC SR - Radiation Medicine MCC  \\\n",
       "0                    False               False                       False   \n",
       "1                    False               False                       False   \n",
       "2                    False               False                       False   \n",
       "3                      NaN                 NaN                         NaN   \n",
       "4                      NaN                 NaN                         NaN   \n",
       "\n",
       "  SR - Transgenic Mouse MCC SR - Gene Transfer/Targeting/Therap Salk  \\\n",
       "0                     False                                    False   \n",
       "1                     False                                    False   \n",
       "2                     False                                    False   \n",
       "3                       NaN                                      NaN   \n",
       "4                       NaN                                      NaN   \n",
       "\n",
       "  SR - Transgenic Salk SR - Mass Spect - Proteom/Metabol Salk  \\\n",
       "0                False                                  False   \n",
       "1                False                                  False   \n",
       "2                False                                  False   \n",
       "3                  NaN                                    NaN   \n",
       "4                  NaN                                    NaN   \n",
       "\n",
       "  SR - Chemical Library Screening SBPMDI SR - Functional Genomics SBPMDI  \\\n",
       "0                                  False                           False   \n",
       "1                                  False                           False   \n",
       "2                                  False                           False   \n",
       "3                                    NaN                             NaN   \n",
       "4                                    NaN                             NaN   \n",
       "\n",
       "  Cancer Metabolism SBPMDI  \\\n",
       "0                    False   \n",
       "1                    False   \n",
       "2                    False   \n",
       "3                      NaN   \n",
       "4                      NaN   \n",
       "\n",
       "  Pedal Importance (recruitment, retention, advancement)  \\\n",
       "0                                                Yes       \n",
       "1                                                Yes       \n",
       "2                                                Yes       \n",
       "3                                                NaN       \n",
       "4                                                NaN       \n",
       "\n",
       "                              If yes, please specify If no, please specify  \\\n",
       "0  The funding for this project and the data gene...                   NaN   \n",
       "1  Obtaining funding is important for career adva...                   NaN   \n",
       "2  Funding for this project enhanced innovative c...                   NaN   \n",
       "3                                                NaN                   NaN   \n",
       "4                                                NaN                   NaN   \n",
       "\n",
       "   Clinical Trials Resulted First Clinical Trial  \\\n",
       "0                       0.0                  NaN   \n",
       "1                       0.0                  NaN   \n",
       "2                       0.0                  NaN   \n",
       "3                       0.0                  NaN   \n",
       "4                       0.0                  NaN   \n",
       "\n",
       "   First Clinical Trial Patient Count Second Clinical Trial  \\\n",
       "0                                 NaN                   NaN   \n",
       "1                                 NaN                   NaN   \n",
       "2                                 NaN                   NaN   \n",
       "3                                 NaN                   NaN   \n",
       "4                                 NaN                   NaN   \n",
       "\n",
       "   Second Clinical Trial Patient Count Companies Founded Patents Filed  \\\n",
       "0                                  NaN              None            No   \n",
       "1                                  NaN              None            No   \n",
       "2                                  NaN              None            No   \n",
       "3                                  NaN               NaN           NaN   \n",
       "4                                  NaN               NaN           NaN   \n",
       "\n",
       "  Patent Details Peer-Reviewed Publications Count  \n",
       "0            NaN                              Two  \n",
       "1            NaN                              One  \n",
       "2            NaN                              Two  \n",
       "3            NaN                              NaN  \n",
       "4            NaN                              NaN  "
      ]
     },
     "execution_count": 73,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "roi_adj.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 74,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Prevention and diagnostic tools                   13\n",
      "Novel approaches and new therapeutic platforms    26\n",
      "Immunotherapies and personalized vaccines         14\n",
      "Addressing cancer disparities                      2\n",
      "Pediatric cancers                                 16\n",
      "dtype: int64\n",
      "Prevention and diagnostic tools                   13\n",
      "Novel approaches and new therapeutic platforms    26\n",
      "Immunotherapies and personalized vaccines         14\n",
      "Addressing cancer disparities                      2\n",
      "Pediatric cancers                                 16\n",
      "dtype: int64\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\phuro\\AppData\\Local\\Temp\\ipykernel_47384\\3773569758.py:3: FutureWarning:\n",
      "\n",
      "Dropping invalid columns in DataFrameGroupBy.max is deprecated. In a future version, a TypeError will be raised. Before calling .max, select only columns which should be valid for the function.\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# sanity check\n",
    "\n",
    "test = roi_adj.groupby('Project Title').max()\n",
    "test = test[['Prevention and diagnostic tools', 'Novel approaches and new therapeutic platforms', \\\n",
    "    'Immunotherapies and personalized vaccines', 'Addressing cancer disparities',\n",
    "    'Pediatric cancers']]\n",
    "print(test.sum())\n",
    "\n",
    "test1 = roi_adj[['Prevention and diagnostic tools', 'Novel approaches and new therapeutic platforms', \\\n",
    "    'Immunotherapies and personalized vaccines', 'Addressing cancer disparities',\n",
    "    'Pediatric cancers']]\n",
    "print(test1.sum())\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Save cleaned dataframe to csv files in interim\n",
    "# Caution: examine directory before uncomment/run this cell to prevent duplicate\n",
    "# files or unintentional modifications to files\n",
    "\n",
    "wp = os.path.join('interim', 'tableau-datasets', '2022_Pedal_ROI.csv')\n",
    "roi_adj.to_csv(wp)\n",
    "\n",
    "# wp = os.path.join('interim', '2022_Pedal_Progress_Report.csv')\n",
    "# prog_r.to_csv(wp)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 76,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Project Title</th>\n",
       "      <th>Policy Benefits Description</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>Neoantigen-specific T cell responses in except...</td>\n",
       "      <td>Our project could improve guidelines as to how...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>Impact of Metformin on Clonal Hematopoiesis an...</td>\n",
       "      <td>WIll better delineate the burden of clonal hem...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>Knowledge-based planning and treatment decisio...</td>\n",
       "      <td>These tools can help healthcare professionals ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>Development and Implementation of a Peer-Navig...</td>\n",
       "      <td>The navigation intervention could potentially ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>An Open-Label, Phase 2 Efficacy Study of Temoz...</td>\n",
       "      <td>Potential to influence NCCN guidelines.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>Decoding Colon Cancers Using Boolean Principles</td>\n",
       "      <td>E cigarette related policies</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>Deciphering the role of RNA editing in leukemi...</td>\n",
       "      <td>Adding genomics to the EMR in Epic.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>Precision Interception of Gastric Cancers</td>\n",
       "      <td>The development of tumor specific probes for g...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56</th>\n",
       "      <td>Neoantigen-specific T cell responses in except...</td>\n",
       "      <td>Our project could improve guidelines as to how...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70</th>\n",
       "      <td>Knowledge-based planning and treatment decisio...</td>\n",
       "      <td>These tools can help healthcare professionals ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>71</th>\n",
       "      <td>Knowledge-based planning and treatment decisio...</td>\n",
       "      <td>To make brachy more automated and clinical</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>81</th>\n",
       "      <td>Development and Implementation of a Peer-Navig...</td>\n",
       "      <td>The navigator intervention could potentially b...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>85</th>\n",
       "      <td>Investigating the Efficacy of radium-223 with ...</td>\n",
       "      <td>These studies on the immune compartment may le...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                        Project Title  \\\n",
       "9   Neoantigen-specific T cell responses in except...   \n",
       "19  Impact of Metformin on Clonal Hematopoiesis an...   \n",
       "22  Knowledge-based planning and treatment decisio...   \n",
       "31  Development and Implementation of a Peer-Navig...   \n",
       "35  An Open-Label, Phase 2 Efficacy Study of Temoz...   \n",
       "42    Decoding Colon Cancers Using Boolean Principles   \n",
       "44  Deciphering the role of RNA editing in leukemi...   \n",
       "53          Precision Interception of Gastric Cancers   \n",
       "56  Neoantigen-specific T cell responses in except...   \n",
       "70  Knowledge-based planning and treatment decisio...   \n",
       "71  Knowledge-based planning and treatment decisio...   \n",
       "81  Development and Implementation of a Peer-Navig...   \n",
       "85  Investigating the Efficacy of radium-223 with ...   \n",
       "\n",
       "                          Policy Benefits Description  \n",
       "9   Our project could improve guidelines as to how...  \n",
       "19  WIll better delineate the burden of clonal hem...  \n",
       "22  These tools can help healthcare professionals ...  \n",
       "31  The navigation intervention could potentially ...  \n",
       "35            Potential to influence NCCN guidelines.  \n",
       "42                       E cigarette related policies  \n",
       "44                Adding genomics to the EMR in Epic.  \n",
       "53  The development of tumor specific probes for g...  \n",
       "56  Our project could improve guidelines as to how...  \n",
       "70  These tools can help healthcare professionals ...  \n",
       "71        To make brachy more automated and clinical   \n",
       "81  The navigator intervention could potentially b...  \n",
       "85  These studies on the immune compartment may le...  "
      ]
     },
     "execution_count": 76,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# sanity check\n",
    "\n",
    "pr[~pr['Policy Benefits Description'].isna()][['Project Title', 'Policy Benefits Description']]"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Inspect Pedal Significance"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 77,
   "metadata": {},
   "outputs": [],
   "source": [
    "pd.set_option('display.max_rows', 10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 78,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\phuro\\AppData\\Local\\Temp\\ipykernel_47384\\1840511086.py:1: FutureWarning:\n",
      "\n",
      "Dropping invalid columns in DataFrameGroupBy.max is deprecated. In a future version, a TypeError will be raised. Before calling .max, select only columns which should be valid for the function.\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "Prevention and diagnostic tools                   13\n",
       "Novel approaches and new therapeutic platforms    26\n",
       "Immunotherapies and personalized vaccines         14\n",
       "Addressing cancer disparities                      2\n",
       "Pediatric cancers                                 16\n",
       "dtype: int64"
      ]
     },
     "execution_count": 78,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "roi_adj.groupby('Project Title').max()[['Prevention and diagnostic tools', \n",
    "                'Novel approaches and new therapeutic platforms',\n",
    "                'Immunotherapies and personalized vaccines',\n",
    "                'Addressing cancer disparities',\n",
    "                'Pediatric cancers']].sum(axis=0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 79,
   "metadata": {},
   "outputs": [],
   "source": [
    "roi_adj['Pedal Importance (recruitment, retention, advancement)'] = \\\n",
    "    roi_adj['Pedal Importance (recruitment, retention, advancement)'].replace(\n",
    "        {'Yes': True, 'No': False}\n",
    "    )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 80,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\phuro\\AppData\\Local\\Temp\\ipykernel_47384\\844733068.py:1: FutureWarning:\n",
      "\n",
      "Dropping invalid columns in DataFrameGroupBy.max is deprecated. In a future version, a TypeError will be raised. Before calling .max, select only columns which should be valid for the function.\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "True     46\n",
       "False     6\n",
       "Name: Pedal Importance (recruitment, retention, advancement), dtype: int64"
      ]
     },
     "execution_count": 80,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "roi_adj.groupby('Project Title').max()['Pedal Importance (recruitment, retention, advancement)'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 81,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\phuro\\AppData\\Local\\Temp\\ipykernel_47384\\1109639290.py:1: FutureWarning:\n",
      "\n",
      "Dropping invalid columns in DataFrameGroupBy.max is deprecated. In a future version, a TypeError will be raised. Before calling .max, select only columns which should be valid for the function.\n",
      "\n"
     ]
    }
   ],
   "source": [
    "pedal_importance_status = roi_adj.groupby('Project Title').max()['Pedal Importance (recruitment, retention, advancement)']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 82,
   "metadata": {},
   "outputs": [],
   "source": [
    "pedal_importance = roi_adj[['Project Title', 'Pedal Importance (recruitment, retention, advancement)']].copy()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 83,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Project Title\n",
       "A National Phase I Study of Cabozantinib in Combination with 13-cis-Retinoic Acid in Children with Relapsed or Refractory Solid Tumors                                                                              True\n",
       "A Novel Role for Histidine Kinase Activity in Neuroblastoma Pathogenesis                                                                                                                                            True\n",
       "A Phase 1B, Nonrandomized Trial Investigating Docetaxel Combined with Cirmtuzumab in Patients with Metastatic Castration Resistant Prostate Cancer                                                                  True\n",
       "A Phase 1b Safety and Feasibility Study of Personalized Immunotherapy in Adults with Advanced Cancers                                                                                                               True\n",
       "A Phase 1b pilot clinical trial of cirmtuzumab, an anti-ROR1 monoclonal antibody, in combination with paclitaxel for the treatment of patients with metastatic, or locally advanced, unresectable breast cancer     True\n",
       "                                                                                                                                                                                                                   ...  \n",
       "Therapeutic Reprogramming of Pancreatic Cancer Stroma Via Modulation of p62 and p53 (YEAR 1)                                                                                                                         NaN\n",
       "Tissue-specific role of SMARCB1 in pediatric rhabdoid tumors                                                                                                                                                        True\n",
       "Transcriptomic, epigenomic profiling to reveal TIL, microglia functional phenotype, and clonality in pediatric brain tumors                                                                                         True\n",
       "UCSD-UCSF Specialized Program of Research Excellence (SPORE) in Head and Neck Cancer                                                                                                                                True\n",
       "Understanding and Targeting NRF2 in Pancreatic Cancer                                                                                                                                                              False\n",
       "Name: Pedal Importance (recruitment, retention, advancement), Length: 71, dtype: object"
      ]
     },
     "execution_count": 83,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pedal_importance_status"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 84,
   "metadata": {},
   "outputs": [],
   "source": [
    "checked_titles = []\n",
    "def adj_pedal_importance(row, col):\n",
    "    title = row['Project Title']\n",
    "    if title not in checked_titles:\n",
    "        checked_titles.append(title)\n",
    "        return pedal_importance_status.loc[title]\n",
    "    else:\n",
    "        return np.nan\n",
    "\n",
    "checked_titles = []\n",
    "pedal_importance['modified'] = pedal_importance.apply(adj_pedal_importance, \\\n",
    "    args=['Pedal Importance (recruitment, retention, advancement)'], axis=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 85,
   "metadata": {},
   "outputs": [],
   "source": [
    "roi_adj['Pedal Importance (recruitment, retention, advancement)'] = pedal_importance['modified']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 86,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "True     46\n",
       "False     6\n",
       "Name: Pedal Importance (recruitment, retention, advancement), dtype: int64"
      ]
     },
     "execution_count": 86,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "roi_adj['Pedal Importance (recruitment, retention, advancement)'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 87,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "134"
      ]
     },
     "execution_count": 87,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "roi_adj['Pedal Importance (recruitment, retention, advancement)'].isna().sum()"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Clean 'Peer-Reviewed Publications Count' column"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 88,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "One              35\n",
       "Two              26\n",
       "Zero             25\n",
       "Three             6\n",
       "Four              5\n",
       "Six - Ten         4\n",
       "More than Ten     1\n",
       "Name: Peer-Reviewed Publications Count, dtype: int64"
      ]
     },
     "execution_count": 88,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "roi_adj['Peer-Reviewed Publications Count'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 89,
   "metadata": {},
   "outputs": [],
   "source": [
    "roi_adj['Peer-Reviewed Publications Count'] = \\\n",
    "    roi_adj['Peer-Reviewed Publications Count'].replace({\n",
    "        'One': 1,\n",
    "        'Two': 2,\n",
    "        'Zero': 0,\n",
    "        'Three': 3,\n",
    "        'Four': 4,\n",
    "        'Six - Ten': np.NaN,\n",
    "        'More than Ten': np.NaN\n",
    "    })"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 90,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Save cleaned dataframe to csv files in interim\n",
    "# Caution: examine directory before uncomment/run this cell to prevent duplicate\n",
    "# files or unintentional modifications to files\n",
    "\n",
    "wp = os.path.join('interim', 'tableau-datasets', '2022_Pedal_ROI.csv')\n",
    "roi_adj.to_csv(wp)\n",
    "\n",
    "# wp = os.path.join('interim', '2022_Pedal_Progress_Report.csv')\n",
    "# prog_r.to_csv(wp)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 91,
   "metadata": {},
   "outputs": [],
   "source": [
    "pubs_cnt = roi_adj[['Project Title', 'Peer-Reviewed Publications Count']]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 92,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1.0    35\n",
       "2.0    26\n",
       "0.0    25\n",
       "3.0     6\n",
       "4.0     5\n",
       "Name: Peer-Reviewed Publications Count, dtype: int64"
      ]
     },
     "execution_count": 92,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pubs_cnt['Peer-Reviewed Publications Count'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 93,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "125.0"
      ]
     },
     "execution_count": 93,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pubs_cnt['Peer-Reviewed Publications Count'].sum()"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Inspect grant start date column"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 94,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "2017-06-01 00:00:00\n",
      "2017-06-01\n",
      "2019-01-01 00:00:00\n",
      "2019-01-01\n",
      "2018-06-01 00:00:00\n",
      "2018-06-01\n",
      "2020-07-01 00:00:00\n",
      "2020-07-01\n",
      "2016-05-01 00:00:00\n",
      "2016-05-01\n",
      "2015-05-01 00:00:00\n",
      "2015-05-01\n",
      "2019-07-15 00:00:00\n",
      "2019-07-15\n",
      "2014-05-01 00:00:00\n",
      "2014-05-01\n",
      "2020-09-01 00:00:00\n",
      "2020-09-01\n",
      "2019-06-01 00:00:00\n",
      "2019-06-01\n",
      "2021-07-01 00:00:00\n",
      "2021-07-01\n",
      "2017-05-01 00:00:00\n",
      "2017-05-01\n",
      "2020-02-01 00:00:00\n",
      "2020-02-01\n",
      "2018-11-01 00:00:00\n",
      "2018-11-01\n",
      "2019-03-02 00:00:00\n",
      "2019-03-02\n",
      "2019-07-01 00:00:00\n",
      "2019-07-01\n",
      "2020-01-15 00:00:00\n",
      "2020-01-15\n",
      "2014-06-01 00:00:00\n",
      "2014-06-01\n",
      "2014-08-01 00:00:00\n",
      "2014-08-01\n",
      "2020-12-01 00:00:00\n",
      "2020-12-01\n",
      "2018-06-18 00:00:00\n",
      "2018-06-18\n",
      "2020-01-01 00:00:00\n",
      "2020-01-01\n",
      "2022-08-01 00:00:00\n",
      "2022-08-01\n"
     ]
    }
   ],
   "source": [
    "for i in roi_adj['Grant Start Date:'].value_counts().index:\n",
    "    print(pd.to_datetime(i)), print(i)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 95,
   "metadata": {},
   "outputs": [],
   "source": [
    "roi_adj['start'] = [pd.to_datetime(x) for x in roi_adj['Grant Start Date:']]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 96,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[Timestamp('2014-05-01 00:00:00'),\n",
       " Timestamp('2014-05-01 00:00:00'),\n",
       " Timestamp('2014-05-01 00:00:00'),\n",
       " Timestamp('2014-05-01 00:00:00'),\n",
       " Timestamp('2014-05-01 00:00:00'),\n",
       " Timestamp('2014-05-01 00:00:00'),\n",
       " Timestamp('2014-06-01 00:00:00'),\n",
       " Timestamp('2014-06-01 00:00:00'),\n",
       " Timestamp('2014-08-01 00:00:00'),\n",
       " Timestamp('2014-08-01 00:00:00'),\n",
       " Timestamp('2015-05-01 00:00:00'),\n",
       " Timestamp('2015-05-01 00:00:00'),\n",
       " Timestamp('2015-05-01 00:00:00'),\n",
       " Timestamp('2015-05-01 00:00:00'),\n",
       " Timestamp('2015-05-01 00:00:00'),\n",
       " Timestamp('2015-05-01 00:00:00'),\n",
       " Timestamp('2015-05-01 00:00:00'),\n",
       " Timestamp('2015-05-01 00:00:00'),\n",
       " Timestamp('2015-05-01 00:00:00'),\n",
       " Timestamp('2015-05-01 00:00:00'),\n",
       " Timestamp('2015-05-01 00:00:00'),\n",
       " Timestamp('2015-05-01 00:00:00'),\n",
       " Timestamp('2015-05-01 00:00:00'),\n",
       " Timestamp('2016-05-01 00:00:00'),\n",
       " Timestamp('2016-05-01 00:00:00'),\n",
       " Timestamp('2016-05-01 00:00:00'),\n",
       " Timestamp('2016-05-01 00:00:00'),\n",
       " Timestamp('2016-05-01 00:00:00'),\n",
       " Timestamp('2016-05-01 00:00:00'),\n",
       " Timestamp('2016-05-01 00:00:00'),\n",
       " Timestamp('2016-05-01 00:00:00'),\n",
       " Timestamp('2016-05-01 00:00:00'),\n",
       " Timestamp('2016-05-01 00:00:00'),\n",
       " Timestamp('2016-05-01 00:00:00'),\n",
       " Timestamp('2016-05-01 00:00:00'),\n",
       " Timestamp('2016-05-01 00:00:00'),\n",
       " Timestamp('2016-05-01 00:00:00'),\n",
       " Timestamp('2016-05-01 00:00:00'),\n",
       " Timestamp('2017-05-01 00:00:00'),\n",
       " Timestamp('2017-05-01 00:00:00'),\n",
       " Timestamp('2017-05-01 00:00:00'),\n",
       " Timestamp('2017-05-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2017-06-01 00:00:00'),\n",
       " Timestamp('2018-06-01 00:00:00'),\n",
       " Timestamp('2018-06-01 00:00:00'),\n",
       " Timestamp('2018-06-01 00:00:00'),\n",
       " Timestamp('2018-06-01 00:00:00'),\n",
       " Timestamp('2018-06-01 00:00:00'),\n",
       " Timestamp('2018-06-01 00:00:00'),\n",
       " Timestamp('2018-06-01 00:00:00'),\n",
       " Timestamp('2018-06-01 00:00:00'),\n",
       " Timestamp('2018-06-01 00:00:00'),\n",
       " Timestamp('2018-06-01 00:00:00'),\n",
       " Timestamp('2018-06-01 00:00:00'),\n",
       " Timestamp('2018-06-01 00:00:00'),\n",
       " Timestamp('2018-06-01 00:00:00'),\n",
       " Timestamp('2018-06-01 00:00:00'),\n",
       " Timestamp('2018-06-01 00:00:00'),\n",
       " Timestamp('2018-06-01 00:00:00'),\n",
       " Timestamp('2018-06-01 00:00:00'),\n",
       " Timestamp('2018-06-01 00:00:00'),\n",
       " Timestamp('2018-06-01 00:00:00'),\n",
       " Timestamp('2018-06-01 00:00:00'),\n",
       " Timestamp('2018-06-01 00:00:00'),\n",
       " Timestamp('2018-06-01 00:00:00'),\n",
       " Timestamp('2018-06-18 00:00:00'),\n",
       " Timestamp('2018-11-01 00:00:00'),\n",
       " Timestamp('2018-11-01 00:00:00'),\n",
       " Timestamp('2019-01-01 00:00:00'),\n",
       " Timestamp('2019-01-01 00:00:00'),\n",
       " Timestamp('2019-01-01 00:00:00'),\n",
       " Timestamp('2019-01-01 00:00:00'),\n",
       " Timestamp('2019-01-01 00:00:00'),\n",
       " Timestamp('2019-01-01 00:00:00'),\n",
       " Timestamp('2019-01-01 00:00:00'),\n",
       " Timestamp('2019-01-01 00:00:00'),\n",
       " Timestamp('2019-01-01 00:00:00'),\n",
       " Timestamp('2019-01-01 00:00:00'),\n",
       " Timestamp('2019-01-01 00:00:00'),\n",
       " Timestamp('2019-01-01 00:00:00'),\n",
       " Timestamp('2019-01-01 00:00:00'),\n",
       " Timestamp('2019-01-01 00:00:00'),\n",
       " Timestamp('2019-01-01 00:00:00'),\n",
       " Timestamp('2019-01-01 00:00:00'),\n",
       " Timestamp('2019-01-01 00:00:00'),\n",
       " Timestamp('2019-01-01 00:00:00'),\n",
       " Timestamp('2019-01-01 00:00:00'),\n",
       " Timestamp('2019-01-01 00:00:00'),\n",
       " Timestamp('2019-01-01 00:00:00'),\n",
       " Timestamp('2019-01-01 00:00:00'),\n",
       " Timestamp('2019-03-02 00:00:00'),\n",
       " Timestamp('2019-03-02 00:00:00'),\n",
       " Timestamp('2019-06-01 00:00:00'),\n",
       " Timestamp('2019-06-01 00:00:00'),\n",
       " Timestamp('2019-06-01 00:00:00'),\n",
       " Timestamp('2019-06-01 00:00:00'),\n",
       " Timestamp('2019-07-01 00:00:00'),\n",
       " Timestamp('2019-07-01 00:00:00'),\n",
       " Timestamp('2019-07-15 00:00:00'),\n",
       " Timestamp('2019-07-15 00:00:00'),\n",
       " Timestamp('2019-07-15 00:00:00'),\n",
       " Timestamp('2019-07-15 00:00:00'),\n",
       " Timestamp('2019-07-15 00:00:00'),\n",
       " Timestamp('2019-07-15 00:00:00'),\n",
       " Timestamp('2019-07-15 00:00:00'),\n",
       " Timestamp('2019-07-15 00:00:00'),\n",
       " Timestamp('2020-01-01 00:00:00'),\n",
       " Timestamp('2020-01-15 00:00:00'),\n",
       " Timestamp('2020-01-15 00:00:00'),\n",
       " Timestamp('2020-02-01 00:00:00'),\n",
       " Timestamp('2020-02-01 00:00:00'),\n",
       " Timestamp('2020-02-01 00:00:00'),\n",
       " Timestamp('2020-07-01 00:00:00'),\n",
       " Timestamp('2020-07-01 00:00:00'),\n",
       " Timestamp('2020-07-01 00:00:00'),\n",
       " Timestamp('2020-07-01 00:00:00'),\n",
       " Timestamp('2020-07-01 00:00:00'),\n",
       " Timestamp('2020-07-01 00:00:00'),\n",
       " Timestamp('2020-07-01 00:00:00'),\n",
       " Timestamp('2020-07-01 00:00:00'),\n",
       " Timestamp('2020-07-01 00:00:00'),\n",
       " Timestamp('2020-07-01 00:00:00'),\n",
       " Timestamp('2020-07-01 00:00:00'),\n",
       " Timestamp('2020-07-01 00:00:00'),\n",
       " Timestamp('2020-07-01 00:00:00'),\n",
       " Timestamp('2020-07-01 00:00:00'),\n",
       " Timestamp('2020-07-01 00:00:00'),\n",
       " Timestamp('2020-07-01 00:00:00'),\n",
       " Timestamp('2020-07-01 00:00:00'),\n",
       " Timestamp('2020-07-01 00:00:00'),\n",
       " Timestamp('2020-09-01 00:00:00'),\n",
       " Timestamp('2020-09-01 00:00:00'),\n",
       " Timestamp('2020-09-01 00:00:00'),\n",
       " Timestamp('2020-09-01 00:00:00'),\n",
       " Timestamp('2020-09-01 00:00:00'),\n",
       " Timestamp('2020-12-01 00:00:00'),\n",
       " Timestamp('2021-07-01 00:00:00'),\n",
       " Timestamp('2021-07-01 00:00:00'),\n",
       " Timestamp('2021-07-01 00:00:00'),\n",
       " Timestamp('2021-07-01 00:00:00'),\n",
       " Timestamp('2022-08-01 00:00:00')]"
      ]
     },
     "execution_count": 96,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dates = roi_adj['start'].tolist()\n",
    "dates.sort()\n",
    "dates"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 97,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Label grant start dates as before or after peak of COVID-19 pandemic\n",
    "\n",
    "binar = Binarizer(threshold=pd.to_datetime('2020-12-31'))\n",
    "labels = binar.transform([roi_adj['start'].values])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 98,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['2017-06-01T00:00:00.000000000', '2017-06-01T00:00:00.000000000',\n",
       "       '2017-06-01T00:00:00.000000000', '2017-06-01T00:00:00.000000000',\n",
       "       '2017-06-01T00:00:00.000000000', '2017-06-01T00:00:00.000000000',\n",
       "       '2017-06-01T00:00:00.000000000', '2017-06-01T00:00:00.000000000',\n",
       "       '2017-06-01T00:00:00.000000000', '2017-06-01T00:00:00.000000000'],\n",
       "      dtype='datetime64[ns]')"
      ]
     },
     "execution_count": 98,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "roi_adj['start'].values[:10]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 99,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['1970-01-01T00:00:00.000000000', '1970-01-01T00:00:00.000000000',\n",
       "       '1970-01-01T00:00:00.000000000', '1970-01-01T00:00:00.000000000',\n",
       "       '1970-01-01T00:00:00.000000000', '1970-01-01T00:00:00.000000000',\n",
       "       '1970-01-01T00:00:00.000000000', '1970-01-01T00:00:00.000000000',\n",
       "       '1970-01-01T00:00:00.000000000', '1970-01-01T00:00:00.000000000'],\n",
       "      dtype='datetime64[ns]')"
      ]
     },
     "execution_count": 99,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "labels[0][:10]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 100,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0"
      ]
     },
     "execution_count": 100,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "roi_adj['start'].isna().sum()"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Inspect and clean grant start and award amount columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 101,
   "metadata": {},
   "outputs": [],
   "source": [
    "unique_projects = roi_adj.groupby('Project Title').nunique()[['start', 'Award Amount']]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 102,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>start</th>\n",
       "      <th>Award Amount</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Project Title</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>A National Phase I Study of Cabozantinib in Combination with 13-cis-Retinoic Acid in Children with Relapsed or Refractory Solid Tumors</th>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>A Novel Role for Histidine Kinase Activity in Neuroblastoma Pathogenesis</th>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>A Phase 1B, Nonrandomized Trial Investigating Docetaxel Combined with Cirmtuzumab in Patients with Metastatic Castration Resistant Prostate Cancer</th>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>A Phase 1b Safety and Feasibility Study of Personalized Immunotherapy in Adults with Advanced Cancers</th>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>A Phase 1b pilot clinical trial of cirmtuzumab, an anti-ROR1 monoclonal antibody, in combination with paclitaxel for the treatment of patients with metastatic, or locally advanced, unresectable breast cancer</th>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Therapeutic Reprogramming of Pancreatic Cancer Stroma Via Modulation of p62 and p53 (YEAR 1)</th>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Tissue-specific role of SMARCB1 in pediatric rhabdoid tumors</th>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Transcriptomic, epigenomic profiling to reveal TIL, microglia functional phenotype, and clonality in pediatric brain tumors</th>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>UCSD-UCSF Specialized Program of Research Excellence (SPORE) in Head and Neck Cancer</th>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Understanding and Targeting NRF2 in Pancreatic Cancer</th>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>71 rows × 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                    start  Award Amount\n",
       "Project Title                                                          \n",
       "A National Phase I Study of Cabozantinib in Com...      2             1\n",
       "A Novel Role for Histidine Kinase Activity in N...      1             1\n",
       "A Phase 1B, Nonrandomized Trial Investigating D...      1             1\n",
       "A Phase 1b Safety and Feasibility Study of Pers...      1             1\n",
       "A Phase 1b pilot clinical trial of cirmtuzumab,...      1             1\n",
       "...                                                   ...           ...\n",
       "Therapeutic Reprogramming of Pancreatic Cancer ...      1             1\n",
       "Tissue-specific role of SMARCB1 in pediatric rh...      1             1\n",
       "Transcriptomic, epigenomic profiling to reveal ...      1             1\n",
       "UCSD-UCSF Specialized Program of Research Excel...      1             1\n",
       "Understanding and Targeting NRF2 in Pancreatic ...      1             1\n",
       "\n",
       "[71 rows x 2 columns]"
      ]
     },
     "execution_count": 102,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "unique_projects"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 103,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Award ID</th>\n",
       "      <th>Project Title</th>\n",
       "      <th>PI Institution</th>\n",
       "      <th>Other Institution</th>\n",
       "      <th>Prevention and diagnostic tools</th>\n",
       "      <th>Novel approaches and new therapeutic platforms</th>\n",
       "      <th>Immunotherapies and personalized vaccines</th>\n",
       "      <th>Addressing cancer disparities</th>\n",
       "      <th>Pediatric cancers</th>\n",
       "      <th>Specific Aims</th>\n",
       "      <th>Aim 1</th>\n",
       "      <th>Aim 2</th>\n",
       "      <th>Aim 3</th>\n",
       "      <th>Aim 4</th>\n",
       "      <th>Aim 5</th>\n",
       "      <th>Aim 6</th>\n",
       "      <th>Public Health Significance</th>\n",
       "      <th>Award Amount</th>\n",
       "      <th>Grant Start Date:</th>\n",
       "      <th>Grant End Date:</th>\n",
       "      <th>Complete</th>\n",
       "      <th>SR - None</th>\n",
       "      <th>SR - Biobehaviorial MCC</th>\n",
       "      <th>SR - Biorepository &amp; Tissue Tech. MCC</th>\n",
       "      <th>SR - Biostatistics MCC</th>\n",
       "      <th>SR - Clinical Trials Office MCC</th>\n",
       "      <th>SR - Flow Cytometry MCC</th>\n",
       "      <th>SR - Genomics &amp; Computational Bio. MCC</th>\n",
       "      <th>SR - In Vivo Imaging MCC</th>\n",
       "      <th>SR - Microscopy MCC</th>\n",
       "      <th>SR - Radiation Medicine MCC</th>\n",
       "      <th>SR - Transgenic Mouse MCC</th>\n",
       "      <th>SR - Gene Transfer/Targeting/Therap Salk</th>\n",
       "      <th>SR - Transgenic Salk</th>\n",
       "      <th>SR - Mass Spect - Proteom/Metabol Salk</th>\n",
       "      <th>SR - Chemical Library Screening SBPMDI</th>\n",
       "      <th>SR - Functional Genomics SBPMDI</th>\n",
       "      <th>Cancer Metabolism SBPMDI</th>\n",
       "      <th>Pedal Importance (recruitment, retention, advancement)</th>\n",
       "      <th>If yes, please specify</th>\n",
       "      <th>If no, please specify</th>\n",
       "      <th>Clinical Trials Resulted</th>\n",
       "      <th>First Clinical Trial</th>\n",
       "      <th>First Clinical Trial Patient Count</th>\n",
       "      <th>Second Clinical Trial</th>\n",
       "      <th>Second Clinical Trial Patient Count</th>\n",
       "      <th>Companies Founded</th>\n",
       "      <th>Patents Filed</th>\n",
       "      <th>Patent Details</th>\n",
       "      <th>Peer-Reviewed Publications Count</th>\n",
       "      <th>start</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>143</th>\n",
       "      <td>5.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>5.1</td>\n",
       "      <td>A National Phase I Study of Cabozantinib in Co...</td>\n",
       "      <td>Rady Children's</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine the safety, dose-limiting toxicities...</td>\n",
       "      <td>Identify biomarkers predictive of patient resp...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Children with high-risk and recurrent solid tu...</td>\n",
       "      <td>200000.0</td>\n",
       "      <td>2021-07-01</td>\n",
       "      <td>2023-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>The availability of funding from Padres Pedal ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>A National Phase I Study of Cabozantinib in Co...</td>\n",
       "      <td>6.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2021-07-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>144</th>\n",
       "      <td>60.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>5.2</td>\n",
       "      <td>A National Phase I Study of Cabozantinib in Co...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine the safety, dose-limiting toxicities...</td>\n",
       "      <td>Identify biomarkers predictive of patient resp...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Children with high-risk and recurrent solid tu...</td>\n",
       "      <td>200000.0</td>\n",
       "      <td>2020-12-01</td>\n",
       "      <td>2022-11-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2020-12-01</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "       ID Event Name  Award ID  \\\n",
       "143   5.0    Initial       5.1   \n",
       "144  60.0    Initial       5.2   \n",
       "\n",
       "                                         Project Title        PI Institution  \\\n",
       "143  A National Phase I Study of Cabozantinib in Co...       Rady Children's   \n",
       "144  A National Phase I Study of Cabozantinib in Co...  Moores Cancer Center   \n",
       "\n",
       "    Other Institution  Prevention and diagnostic tools  \\\n",
       "143               NaN                            False   \n",
       "144               NaN                            False   \n",
       "\n",
       "     Novel approaches and new therapeutic platforms  \\\n",
       "143                                           False   \n",
       "144                                           False   \n",
       "\n",
       "     Immunotherapies and personalized vaccines  Addressing cancer disparities  \\\n",
       "143                                      False                          False   \n",
       "144                                      False                          False   \n",
       "\n",
       "     Pediatric cancers      Specific Aims  \\\n",
       "143               True  Two Specific Aims   \n",
       "144              False  Two Specific Aims   \n",
       "\n",
       "                                                 Aim 1  \\\n",
       "143  Determine the safety, dose-limiting toxicities...   \n",
       "144  Determine the safety, dose-limiting toxicities...   \n",
       "\n",
       "                                                 Aim 2 Aim 3 Aim 4 Aim 5  \\\n",
       "143  Identify biomarkers predictive of patient resp...   NaN   NaN   NaN   \n",
       "144  Identify biomarkers predictive of patient resp...   NaN   NaN   NaN   \n",
       "\n",
       "    Aim 6                         Public Health Significance  Award Amount  \\\n",
       "143   NaN  Children with high-risk and recurrent solid tu...      200000.0   \n",
       "144   NaN  Children with high-risk and recurrent solid tu...      200000.0   \n",
       "\n",
       "    Grant Start Date: Grant End Date:  Complete SR - None  \\\n",
       "143        2021-07-01      2023-06-30  Complete     False   \n",
       "144        2020-12-01      2022-11-30  Complete       NaN   \n",
       "\n",
       "    SR - Biobehaviorial MCC SR - Biorepository & Tissue Tech. MCC  \\\n",
       "143                   False                                 False   \n",
       "144                     NaN                                   NaN   \n",
       "\n",
       "    SR - Biostatistics MCC SR - Clinical Trials Office MCC  \\\n",
       "143                   True                           False   \n",
       "144                    NaN                             NaN   \n",
       "\n",
       "    SR - Flow Cytometry MCC SR - Genomics & Computational Bio. MCC  \\\n",
       "143                   False                                  False   \n",
       "144                     NaN                                    NaN   \n",
       "\n",
       "    SR - In Vivo Imaging MCC SR - Microscopy MCC SR - Radiation Medicine MCC  \\\n",
       "143                    False               False                       False   \n",
       "144                      NaN                 NaN                         NaN   \n",
       "\n",
       "    SR - Transgenic Mouse MCC SR - Gene Transfer/Targeting/Therap Salk  \\\n",
       "143                     False                                    False   \n",
       "144                       NaN                                      NaN   \n",
       "\n",
       "    SR - Transgenic Salk SR - Mass Spect - Proteom/Metabol Salk  \\\n",
       "143                False                                  False   \n",
       "144                  NaN                                    NaN   \n",
       "\n",
       "    SR - Chemical Library Screening SBPMDI SR - Functional Genomics SBPMDI  \\\n",
       "143                                  False                           False   \n",
       "144                                    NaN                             NaN   \n",
       "\n",
       "    Cancer Metabolism SBPMDI  \\\n",
       "143                    False   \n",
       "144                      NaN   \n",
       "\n",
       "    Pedal Importance (recruitment, retention, advancement)  \\\n",
       "143                                               True       \n",
       "144                                                NaN       \n",
       "\n",
       "                                If yes, please specify If no, please specify  \\\n",
       "143  The availability of funding from Padres Pedal ...                   NaN   \n",
       "144                                                NaN                   NaN   \n",
       "\n",
       "     Clinical Trials Resulted  \\\n",
       "143                       1.0   \n",
       "144                       0.0   \n",
       "\n",
       "                                  First Clinical Trial  \\\n",
       "143  A National Phase I Study of Cabozantinib in Co...   \n",
       "144                                                NaN   \n",
       "\n",
       "     First Clinical Trial Patient Count Second Clinical Trial  \\\n",
       "143                                 6.0                   NaN   \n",
       "144                                 NaN                   NaN   \n",
       "\n",
       "     Second Clinical Trial Patient Count Companies Founded Patents Filed  \\\n",
       "143                                  NaN              None            No   \n",
       "144                                  NaN               NaN           NaN   \n",
       "\n",
       "    Patent Details  Peer-Reviewed Publications Count      start  \n",
       "143            NaN                               1.0 2021-07-01  \n",
       "144            NaN                               NaN 2020-12-01  "
      ]
     },
     "execution_count": 103,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "query_project(roi_adj, 'A National Phase I')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 104,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\phuro\\AppData\\Local\\Temp\\ipykernel_47384\\1699777955.py:3: FutureWarning:\n",
      "\n",
      "Dropping invalid columns in DataFrameGroupBy.min is deprecated. In a future version, a TypeError will be raised. Before calling .min, select only columns which should be valid for the function.\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# Keep projects unique (aka keep only one start date and one award amout per project)\n",
    "\n",
    "unique_projs = roi_adj.groupby('Project Title').min()[['start', 'Award Amount']]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 105,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>start</th>\n",
       "      <th>Award Amount</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Project Title</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>A National Phase I Study of Cabozantinib in Combination with 13-cis-Retinoic Acid in Children with Relapsed or Refractory Solid Tumors</th>\n",
       "      <td>2020-12-01</td>\n",
       "      <td>200000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>A Novel Role for Histidine Kinase Activity in Neuroblastoma Pathogenesis</th>\n",
       "      <td>2018-06-01</td>\n",
       "      <td>100000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>A Phase 1B, Nonrandomized Trial Investigating Docetaxel Combined with Cirmtuzumab in Patients with Metastatic Castration Resistant Prostate Cancer</th>\n",
       "      <td>2020-01-01</td>\n",
       "      <td>150000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>A Phase 1b Safety and Feasibility Study of Personalized Immunotherapy in Adults with Advanced Cancers</th>\n",
       "      <td>2019-01-01</td>\n",
       "      <td>150000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>A Phase 1b pilot clinical trial of cirmtuzumab, an anti-ROR1 monoclonal antibody, in combination with paclitaxel for the treatment of patients with metastatic, or locally advanced, unresectable breast cancer</th>\n",
       "      <td>2019-01-01</td>\n",
       "      <td>300000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Therapeutic Reprogramming of Pancreatic Cancer Stroma Via Modulation of p62 and p53 (YEAR 1)</th>\n",
       "      <td>2015-05-01</td>\n",
       "      <td>300000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Tissue-specific role of SMARCB1 in pediatric rhabdoid tumors</th>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>75000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Transcriptomic, epigenomic profiling to reveal TIL, microglia functional phenotype, and clonality in pediatric brain tumors</th>\n",
       "      <td>2018-06-01</td>\n",
       "      <td>100000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>UCSD-UCSF Specialized Program of Research Excellence (SPORE) in Head and Neck Cancer</th>\n",
       "      <td>2021-07-01</td>\n",
       "      <td>200000.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Understanding and Targeting NRF2 in Pancreatic Cancer</th>\n",
       "      <td>2018-06-01</td>\n",
       "      <td>125000.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>71 rows × 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                        start  Award Amount\n",
       "Project Title                                                              \n",
       "A National Phase I Study of Cabozantinib in Com... 2020-12-01      200000.0\n",
       "A Novel Role for Histidine Kinase Activity in N... 2018-06-01      100000.0\n",
       "A Phase 1B, Nonrandomized Trial Investigating D... 2020-01-01      150000.0\n",
       "A Phase 1b Safety and Feasibility Study of Pers... 2019-01-01      150000.0\n",
       "A Phase 1b pilot clinical trial of cirmtuzumab,... 2019-01-01      300000.0\n",
       "...                                                       ...           ...\n",
       "Therapeutic Reprogramming of Pancreatic Cancer ... 2015-05-01      300000.0\n",
       "Tissue-specific role of SMARCB1 in pediatric rh... 2017-06-01       75000.0\n",
       "Transcriptomic, epigenomic profiling to reveal ... 2018-06-01      100000.0\n",
       "UCSD-UCSF Specialized Program of Research Excel... 2021-07-01      200000.0\n",
       "Understanding and Targeting NRF2 in Pancreatic ... 2018-06-01      125000.0\n",
       "\n",
       "[71 rows x 2 columns]"
      ]
     },
     "execution_count": 105,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "unique_projs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 106,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Label grant start dates as before or after peak of COVID-19 pandemic\n",
    "\n",
    "def get_pandemic_label(row):\n",
    "    date = row['start']\n",
    "    thresh = pd.to_datetime('2020-12-31')\n",
    "    if date <= thresh:\n",
    "        return 'before peak'\n",
    "    return 'after peak'\n",
    "\n",
    "roi_adj['pandemic_label'] = roi_adj[['start']].apply(get_pandemic_label, axis=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 107,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.plotly.v1+json": {
       "config": {
        "plotlyServerURL": "https://plot.ly"
       },
       "data": [
        {
         "alignmentgroup": "True",
         "bingroup": "x",
         "histfunc": "sum",
         "hovertemplate": "grant start: %{x}<br>total award amount: %{y}",
         "legendgroup": "before peak",
         "marker": {
          "color": "#3283FE",
          "pattern": {
           "shape": ""
          }
         },
         "name": "before peak",
         "nbinsx": 16,
         "offsetgroup": "before peak",
         "orientation": "v",
         "showlegend": true,
         "texttemplate": "%{value}",
         "type": "histogram",
         "x": [
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2015-05-01T00:00:00",
          "2015-05-01T00:00:00",
          "2015-05-01T00:00:00",
          "2015-05-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-05-01T00:00:00",
          "2017-05-01T00:00:00",
          "2017-05-01T00:00:00",
          "2017-05-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2019-06-01T00:00:00",
          "2019-06-01T00:00:00",
          "2019-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2019-01-01T00:00:00",
          "2019-01-01T00:00:00",
          "2019-01-01T00:00:00",
          "2018-06-01T00:00:00",
          "2018-06-01T00:00:00",
          "2018-06-01T00:00:00",
          "2015-05-01T00:00:00",
          "2015-05-01T00:00:00",
          "2015-05-01T00:00:00",
          "2019-01-01T00:00:00",
          "2019-01-01T00:00:00",
          "2019-01-01T00:00:00",
          "2019-01-01T00:00:00",
          "2019-01-01T00:00:00",
          "2019-01-01T00:00:00",
          "2019-01-01T00:00:00",
          "2019-01-01T00:00:00",
          "2019-01-01T00:00:00",
          "2019-07-15T00:00:00",
          "2019-07-15T00:00:00",
          "2019-07-15T00:00:00",
          "2016-05-01T00:00:00",
          "2016-05-01T00:00:00",
          "2016-05-01T00:00:00",
          "2020-09-01T00:00:00",
          "2020-09-01T00:00:00",
          "2020-09-01T00:00:00",
          "2020-02-01T00:00:00",
          "2020-02-01T00:00:00",
          "2020-02-01T00:00:00",
          "2016-05-01T00:00:00",
          "2016-05-01T00:00:00",
          "2016-05-01T00:00:00",
          "2020-07-01T00:00:00",
          "2020-07-01T00:00:00",
          "2020-07-01T00:00:00",
          "2016-05-01T00:00:00",
          "2016-05-01T00:00:00",
          "2016-05-01T00:00:00",
          "2020-07-01T00:00:00",
          "2020-07-01T00:00:00",
          "2020-07-01T00:00:00",
          "2020-07-01T00:00:00",
          "2020-07-01T00:00:00",
          "2020-07-01T00:00:00",
          "2020-07-01T00:00:00",
          "2020-07-01T00:00:00",
          "2020-07-01T00:00:00",
          "2015-05-01T00:00:00",
          "2015-05-01T00:00:00",
          "2016-05-01T00:00:00",
          "2016-05-01T00:00:00",
          "2016-05-01T00:00:00",
          "2016-05-01T00:00:00",
          "2018-06-18T00:00:00",
          "2018-06-01T00:00:00",
          "2018-06-01T00:00:00",
          "2018-06-01T00:00:00",
          "2015-05-01T00:00:00",
          "2015-05-01T00:00:00",
          "2020-01-15T00:00:00",
          "2020-01-15T00:00:00",
          "2014-05-01T00:00:00",
          "2014-05-01T00:00:00",
          "2014-08-01T00:00:00",
          "2014-08-01T00:00:00",
          "2014-05-01T00:00:00",
          "2014-05-01T00:00:00",
          "2014-06-01T00:00:00",
          "2014-06-01T00:00:00",
          "2014-05-01T00:00:00",
          "2014-05-01T00:00:00",
          "2016-05-01T00:00:00",
          "2016-05-01T00:00:00",
          "2015-05-01T00:00:00",
          "2015-05-01T00:00:00",
          "2019-07-15T00:00:00",
          "2019-07-15T00:00:00",
          "2019-01-01T00:00:00",
          "2019-01-01T00:00:00",
          "2019-01-01T00:00:00",
          "2019-01-01T00:00:00",
          "2018-11-01T00:00:00",
          "2018-11-01T00:00:00",
          "2020-12-01T00:00:00",
          "2020-09-01T00:00:00",
          "2020-09-01T00:00:00",
          "2020-07-01T00:00:00",
          "2020-07-01T00:00:00",
          "2020-07-01T00:00:00",
          "2020-07-01T00:00:00",
          "2020-07-01T00:00:00",
          "2020-07-01T00:00:00",
          "2019-07-01T00:00:00",
          "2019-07-01T00:00:00",
          "2019-07-15T00:00:00",
          "2019-07-15T00:00:00",
          "2019-01-01T00:00:00",
          "2019-01-01T00:00:00",
          "2019-03-02T00:00:00",
          "2019-03-02T00:00:00",
          "2018-06-01T00:00:00",
          "2018-06-01T00:00:00",
          "2019-01-01T00:00:00",
          "2019-01-01T00:00:00",
          "2018-06-01T00:00:00",
          "2018-06-01T00:00:00",
          "2018-06-01T00:00:00",
          "2018-06-01T00:00:00",
          "2018-06-01T00:00:00",
          "2018-06-01T00:00:00",
          "2018-06-01T00:00:00",
          "2018-06-01T00:00:00",
          "2018-06-01T00:00:00",
          "2018-06-01T00:00:00",
          "2018-06-01T00:00:00",
          "2018-06-01T00:00:00",
          "2018-06-01T00:00:00",
          "2018-06-01T00:00:00",
          "2019-07-15T00:00:00",
          "2019-06-01T00:00:00",
          "2019-01-01T00:00:00",
          "2019-01-01T00:00:00",
          "2017-06-01T00:00:00",
          "2020-01-01T00:00:00"
         ],
         "xaxis": "x",
         "y": [
          75000,
          75000,
          75000,
          75000,
          75000,
          75000,
          75000,
          75000,
          75000,
          75000,
          75000,
          75000,
          75000,
          75000,
          75000,
          75000,
          75000,
          75000,
          75000,
          75000,
          75000,
          75000,
          300000,
          300000,
          300000,
          300000,
          75000,
          75000,
          75000,
          75000,
          75000,
          75000,
          75000,
          75000,
          75000,
          75000,
          75000,
          75000,
          74881,
          74881,
          74881,
          74881,
          75000,
          75000,
          75000,
          75000,
          75000,
          75000,
          75000,
          75000,
          99988,
          99988,
          99988,
          75000,
          75000,
          75000,
          150000,
          150000,
          150000,
          125000,
          125000,
          125000,
          75000,
          75000,
          75000,
          125000,
          125000,
          125000,
          125000,
          125000,
          125000,
          71979,
          71979,
          71979,
          125000,
          125000,
          125000,
          75000,
          75000,
          75000,
          99992,
          99992,
          99992,
          200000,
          200000,
          200000,
          75000,
          75000,
          75000,
          125000,
          125000,
          125000,
          75000,
          75000,
          75000,
          125000,
          125000,
          125000,
          125000,
          125000,
          125000,
          125000,
          125000,
          125000,
          75000,
          75000,
          75000,
          75000,
          74999.51,
          74999.51,
          125000,
          125000,
          100000,
          100000,
          75000,
          75000,
          200000,
          200000,
          75000,
          75000,
          75000,
          75000,
          74757,
          74757,
          75000,
          75000,
          18288,
          18288,
          75000,
          75000,
          75000,
          75000,
          100000,
          100000,
          300000,
          300000,
          150000,
          150000,
          150000,
          150000,
          200000,
          125000,
          125000,
          125000,
          125000,
          100000,
          100000,
          100000,
          100000,
          125000,
          125000,
          125000,
          125000,
          125000,
          125000,
          125000,
          125000,
          125000,
          125000,
          125000,
          125000,
          124972,
          124972,
          119768,
          119768,
          125000,
          125000,
          125000,
          125000,
          125000,
          125000,
          100000,
          100000,
          100000,
          100000,
          100000,
          100000,
          300000,
          300000,
          75000,
          150000
         ],
         "yaxis": "y"
        },
        {
         "alignmentgroup": "True",
         "bingroup": "x",
         "histfunc": "sum",
         "hovertemplate": "grant start: %{x}<br>total award amount: %{y}",
         "legendgroup": "after peak",
         "marker": {
          "color": "#F6222E",
          "pattern": {
           "shape": ""
          }
         },
         "name": "after peak",
         "nbinsx": 16,
         "offsetgroup": "after peak",
         "orientation": "v",
         "showlegend": true,
         "texttemplate": "%{value}",
         "type": "histogram",
         "x": [
          "2021-07-01T00:00:00",
          "2021-07-01T00:00:00",
          "2021-07-01T00:00:00",
          "2021-07-01T00:00:00",
          "2022-08-01T00:00:00"
         ],
         "xaxis": "x",
         "y": [
          200000,
          200000,
          200000,
          200000,
          75000
         ],
         "yaxis": "y"
        }
       ],
       "layout": {
        "barmode": "relative",
        "legend": {
         "title": {
          "text": "status"
         },
         "tracegroupgap": 0
        },
        "template": {
         "data": {
          "bar": [
           {
            "error_x": {
             "color": "#2a3f5f"
            },
            "error_y": {
             "color": "#2a3f5f"
            },
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "bar"
           }
          ],
          "barpolar": [
           {
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "barpolar"
           }
          ],
          "carpet": [
           {
            "aaxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "baxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "type": "carpet"
           }
          ],
          "choropleth": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "choropleth"
           }
          ],
          "contour": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "contour"
           }
          ],
          "contourcarpet": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "contourcarpet"
           }
          ],
          "heatmap": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "heatmap"
           }
          ],
          "heatmapgl": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "heatmapgl"
           }
          ],
          "histogram": [
           {
            "marker": {
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "histogram"
           }
          ],
          "histogram2d": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "histogram2d"
           }
          ],
          "histogram2dcontour": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "histogram2dcontour"
           }
          ],
          "mesh3d": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "mesh3d"
           }
          ],
          "parcoords": [
           {
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "parcoords"
           }
          ],
          "pie": [
           {
            "automargin": true,
            "type": "pie"
           }
          ],
          "scatter": [
           {
            "fillpattern": {
             "fillmode": "overlay",
             "size": 10,
             "solidity": 0.2
            },
            "type": "scatter"
           }
          ],
          "scatter3d": [
           {
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatter3d"
           }
          ],
          "scattercarpet": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattercarpet"
           }
          ],
          "scattergeo": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattergeo"
           }
          ],
          "scattergl": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattergl"
           }
          ],
          "scattermapbox": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattermapbox"
           }
          ],
          "scatterpolar": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterpolar"
           }
          ],
          "scatterpolargl": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterpolargl"
           }
          ],
          "scatterternary": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterternary"
           }
          ],
          "surface": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "surface"
           }
          ],
          "table": [
           {
            "cells": {
             "fill": {
              "color": "#EBF0F8"
             },
             "line": {
              "color": "white"
             }
            },
            "header": {
             "fill": {
              "color": "#C8D4E3"
             },
             "line": {
              "color": "white"
             }
            },
            "type": "table"
           }
          ]
         },
         "layout": {
          "annotationdefaults": {
           "arrowcolor": "#2a3f5f",
           "arrowhead": 0,
           "arrowwidth": 1
          },
          "autotypenumbers": "strict",
          "coloraxis": {
           "colorbar": {
            "outlinewidth": 0,
            "ticks": ""
           }
          },
          "colorscale": {
           "diverging": [
            [
             0,
             "#8e0152"
            ],
            [
             0.1,
             "#c51b7d"
            ],
            [
             0.2,
             "#de77ae"
            ],
            [
             0.3,
             "#f1b6da"
            ],
            [
             0.4,
             "#fde0ef"
            ],
            [
             0.5,
             "#f7f7f7"
            ],
            [
             0.6,
             "#e6f5d0"
            ],
            [
             0.7,
             "#b8e186"
            ],
            [
             0.8,
             "#7fbc41"
            ],
            [
             0.9,
             "#4d9221"
            ],
            [
             1,
             "#276419"
            ]
           ],
           "sequential": [
            [
             0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1,
             "#f0f921"
            ]
           ],
           "sequentialminus": [
            [
             0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1,
             "#f0f921"
            ]
           ]
          },
          "colorway": [
           "#636efa",
           "#EF553B",
           "#00cc96",
           "#ab63fa",
           "#FFA15A",
           "#19d3f3",
           "#FF6692",
           "#B6E880",
           "#FF97FF",
           "#FECB52"
          ],
          "font": {
           "color": "#2a3f5f"
          },
          "geo": {
           "bgcolor": "white",
           "lakecolor": "white",
           "landcolor": "#E5ECF6",
           "showlakes": true,
           "showland": true,
           "subunitcolor": "white"
          },
          "hoverlabel": {
           "align": "left"
          },
          "hovermode": "closest",
          "mapbox": {
           "style": "light"
          },
          "paper_bgcolor": "white",
          "plot_bgcolor": "#E5ECF6",
          "polar": {
           "angularaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "bgcolor": "#E5ECF6",
           "radialaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "scene": {
           "xaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           },
           "yaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           },
           "zaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           }
          },
          "shapedefaults": {
           "line": {
            "color": "#2a3f5f"
           }
          },
          "ternary": {
           "aaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "baxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "bgcolor": "#E5ECF6",
           "caxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "title": {
           "x": 0.05
          },
          "xaxis": {
           "automargin": true,
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "zerolinewidth": 2
          },
          "yaxis": {
           "automargin": true,
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "zerolinewidth": 2
          }
         }
        },
        "title": {
         "text": "Annual Total Award Amounts, before and after peak of COVID-19 Pandemic"
        },
        "xaxis": {
         "anchor": "y",
         "domain": [
          0,
          1
         ],
         "title": {
          "text": "grant start"
         }
        },
        "yaxis": {
         "anchor": "x",
         "domain": [
          0,
          1
         ],
         "title": {
          "text": "total award amount, millions"
         }
        }
       }
      }
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Plot distribution of award amounts across the pandemic\n",
    "\n",
    "awards_fig = px.histogram(roi_adj, x='start', y='Award Amount', \\\n",
    "    color='pandemic_label', nbins=16,\n",
    "    title='Annual Total Award Amounts, before and after peak of COVID-19 Pandemic',\n",
    "    labels={'start': 'grant start', 'pandemic_label': 'status'},\n",
    "    color_discrete_sequence=[blue, red], text_auto=True\n",
    ") \n",
    "\n",
    "awards_fig.update_layout(yaxis_title='total award amount, millions')\n",
    "\n",
    "awards_fig.update_traces(\n",
    "    hovertemplate='grant start: %{x}<br>total award amount: %{y}'\n",
    ")\n",
    "\n",
    "awards_fig"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 108,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'#3283FE'"
      ]
     },
     "execution_count": 108,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "blue"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 109,
   "metadata": {},
   "outputs": [],
   "source": [
    "unique_projs['pandemic_label'] = unique_projs.apply(get_pandemic_label, axis=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 110,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.plotly.v1+json": {
       "config": {
        "plotlyServerURL": "https://plot.ly"
       },
       "data": [
        {
         "alignmentgroup": "True",
         "bingroup": "x",
         "histfunc": "sum",
         "hovertemplate": "grant start: %{x}<br>total award amount: %{y}",
         "legendgroup": "before peak",
         "marker": {
          "color": "#3283FE",
          "pattern": {
           "shape": ""
          }
         },
         "name": "before peak",
         "nbinsx": 16,
         "offsetgroup": "before peak",
         "orientation": "v",
         "showlegend": true,
         "texttemplate": "%{value}",
         "type": "histogram",
         "x": [
          "2020-12-01T00:00:00",
          "2018-06-01T00:00:00",
          "2020-01-01T00:00:00",
          "2019-01-01T00:00:00",
          "2019-01-01T00:00:00",
          "2020-07-01T00:00:00",
          "2019-01-01T00:00:00",
          "2017-05-01T00:00:00",
          "2014-08-01T00:00:00",
          "2019-07-01T00:00:00",
          "2015-05-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2020-07-01T00:00:00",
          "2014-05-01T00:00:00",
          "2016-05-01T00:00:00",
          "2019-07-15T00:00:00",
          "2017-06-01T00:00:00",
          "2018-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2020-07-01T00:00:00",
          "2018-06-01T00:00:00",
          "2016-05-01T00:00:00",
          "2018-06-01T00:00:00",
          "2019-01-01T00:00:00",
          "2020-07-01T00:00:00",
          "2019-06-01T00:00:00",
          "2019-06-01T00:00:00",
          "2015-05-01T00:00:00",
          "2017-06-01T00:00:00",
          "2019-07-15T00:00:00",
          "2017-06-01T00:00:00",
          "2019-03-02T00:00:00",
          "2020-09-01T00:00:00",
          "2015-05-01T00:00:00",
          "2018-06-01T00:00:00",
          "2019-01-01T00:00:00",
          "2018-11-01T00:00:00",
          "2017-06-01T00:00:00",
          "2015-05-01T00:00:00",
          "2019-01-01T00:00:00",
          "2019-01-01T00:00:00",
          "2016-05-01T00:00:00",
          "2019-07-15T00:00:00",
          "2018-06-01T00:00:00",
          "2020-07-01T00:00:00",
          "2020-02-01T00:00:00",
          "2020-07-01T00:00:00",
          "2017-06-01T00:00:00",
          "2017-06-01T00:00:00",
          "2020-09-01T00:00:00",
          "2020-07-01T00:00:00",
          "2020-01-15T00:00:00",
          "2018-06-01T00:00:00",
          "2014-05-01T00:00:00",
          "2014-05-01T00:00:00",
          "2018-06-01T00:00:00",
          "2019-01-01T00:00:00",
          "2019-01-01T00:00:00",
          "2016-05-01T00:00:00",
          "2016-05-01T00:00:00",
          "2017-06-01T00:00:00",
          "2018-06-01T00:00:00",
          "2014-06-01T00:00:00",
          "2016-05-01T00:00:00",
          "2015-05-01T00:00:00",
          "2017-06-01T00:00:00",
          "2018-06-01T00:00:00",
          "2018-06-01T00:00:00"
         ],
         "xaxis": "x",
         "y": [
          200000,
          100000,
          150000,
          150000,
          300000,
          100000,
          300000,
          75000,
          75000,
          125000,
          75000,
          75000,
          75000,
          125000,
          18288,
          74999.51,
          100000,
          75000,
          100000,
          75000,
          125000,
          125000,
          75000,
          125000,
          125000,
          125000,
          99988,
          100000,
          75000,
          75000,
          125000,
          75000,
          125000,
          99992,
          75000,
          124972,
          125000,
          150000,
          75000,
          75000,
          71979,
          150000,
          75000,
          125000,
          125000,
          125000,
          200000,
          100000,
          75000,
          74881,
          125000,
          125000,
          200000,
          119768,
          75000,
          74757,
          125000,
          125000,
          125000,
          75000,
          75000,
          75000,
          125000,
          75000,
          75000,
          300000,
          75000,
          100000,
          125000
         ],
         "yaxis": "y"
        },
        {
         "alignmentgroup": "True",
         "bingroup": "x",
         "histfunc": "sum",
         "hovertemplate": "grant start: %{x}<br>total award amount: %{y}",
         "legendgroup": "after peak",
         "marker": {
          "color": "#F6222E",
          "pattern": {
           "shape": ""
          }
         },
         "name": "after peak",
         "nbinsx": 16,
         "offsetgroup": "after peak",
         "orientation": "v",
         "showlegend": true,
         "texttemplate": "%{value}",
         "type": "histogram",
         "x": [
          "2022-08-01T00:00:00",
          "2021-07-01T00:00:00"
         ],
         "xaxis": "x",
         "y": [
          75000,
          200000
         ],
         "yaxis": "y"
        }
       ],
       "layout": {
        "barmode": "relative",
        "legend": {
         "title": {
          "text": "status"
         },
         "tracegroupgap": 0
        },
        "template": {
         "data": {
          "bar": [
           {
            "error_x": {
             "color": "#2a3f5f"
            },
            "error_y": {
             "color": "#2a3f5f"
            },
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "bar"
           }
          ],
          "barpolar": [
           {
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "barpolar"
           }
          ],
          "carpet": [
           {
            "aaxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "baxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "type": "carpet"
           }
          ],
          "choropleth": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "choropleth"
           }
          ],
          "contour": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "contour"
           }
          ],
          "contourcarpet": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "contourcarpet"
           }
          ],
          "heatmap": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "heatmap"
           }
          ],
          "heatmapgl": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "heatmapgl"
           }
          ],
          "histogram": [
           {
            "marker": {
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "histogram"
           }
          ],
          "histogram2d": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "histogram2d"
           }
          ],
          "histogram2dcontour": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "histogram2dcontour"
           }
          ],
          "mesh3d": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "mesh3d"
           }
          ],
          "parcoords": [
           {
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "parcoords"
           }
          ],
          "pie": [
           {
            "automargin": true,
            "type": "pie"
           }
          ],
          "scatter": [
           {
            "fillpattern": {
             "fillmode": "overlay",
             "size": 10,
             "solidity": 0.2
            },
            "type": "scatter"
           }
          ],
          "scatter3d": [
           {
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatter3d"
           }
          ],
          "scattercarpet": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattercarpet"
           }
          ],
          "scattergeo": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattergeo"
           }
          ],
          "scattergl": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattergl"
           }
          ],
          "scattermapbox": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattermapbox"
           }
          ],
          "scatterpolar": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterpolar"
           }
          ],
          "scatterpolargl": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterpolargl"
           }
          ],
          "scatterternary": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterternary"
           }
          ],
          "surface": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "surface"
           }
          ],
          "table": [
           {
            "cells": {
             "fill": {
              "color": "#EBF0F8"
             },
             "line": {
              "color": "white"
             }
            },
            "header": {
             "fill": {
              "color": "#C8D4E3"
             },
             "line": {
              "color": "white"
             }
            },
            "type": "table"
           }
          ]
         },
         "layout": {
          "annotationdefaults": {
           "arrowcolor": "#2a3f5f",
           "arrowhead": 0,
           "arrowwidth": 1
          },
          "autotypenumbers": "strict",
          "coloraxis": {
           "colorbar": {
            "outlinewidth": 0,
            "ticks": ""
           }
          },
          "colorscale": {
           "diverging": [
            [
             0,
             "#8e0152"
            ],
            [
             0.1,
             "#c51b7d"
            ],
            [
             0.2,
             "#de77ae"
            ],
            [
             0.3,
             "#f1b6da"
            ],
            [
             0.4,
             "#fde0ef"
            ],
            [
             0.5,
             "#f7f7f7"
            ],
            [
             0.6,
             "#e6f5d0"
            ],
            [
             0.7,
             "#b8e186"
            ],
            [
             0.8,
             "#7fbc41"
            ],
            [
             0.9,
             "#4d9221"
            ],
            [
             1,
             "#276419"
            ]
           ],
           "sequential": [
            [
             0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1,
             "#f0f921"
            ]
           ],
           "sequentialminus": [
            [
             0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1,
             "#f0f921"
            ]
           ]
          },
          "colorway": [
           "#636efa",
           "#EF553B",
           "#00cc96",
           "#ab63fa",
           "#FFA15A",
           "#19d3f3",
           "#FF6692",
           "#B6E880",
           "#FF97FF",
           "#FECB52"
          ],
          "font": {
           "color": "#2a3f5f"
          },
          "geo": {
           "bgcolor": "white",
           "lakecolor": "white",
           "landcolor": "#E5ECF6",
           "showlakes": true,
           "showland": true,
           "subunitcolor": "white"
          },
          "hoverlabel": {
           "align": "left"
          },
          "hovermode": "closest",
          "mapbox": {
           "style": "light"
          },
          "paper_bgcolor": "white",
          "plot_bgcolor": "#E5ECF6",
          "polar": {
           "angularaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "bgcolor": "#E5ECF6",
           "radialaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "scene": {
           "xaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           },
           "yaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           },
           "zaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           }
          },
          "shapedefaults": {
           "line": {
            "color": "#2a3f5f"
           }
          },
          "ternary": {
           "aaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "baxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "bgcolor": "#E5ECF6",
           "caxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "title": {
           "x": 0.05
          },
          "xaxis": {
           "automargin": true,
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "zerolinewidth": 2
          },
          "yaxis": {
           "automargin": true,
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "zerolinewidth": 2
          }
         }
        },
        "title": {
         "text": "Annual Total Award Amounts, before and after peak of COVID-19 Pandemic"
        },
        "xaxis": {
         "anchor": "y",
         "domain": [
          0,
          1
         ],
         "title": {
          "text": "grant start"
         }
        },
        "yaxis": {
         "anchor": "x",
         "domain": [
          0,
          1
         ],
         "title": {
          "text": "total award amount, millions"
         }
        }
       }
      }
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Plot distribution of award amounts across the pandemic\n",
    "\n",
    "awards_fig = px.histogram(unique_projs, x='start', y='Award Amount', \\\n",
    "    color='pandemic_label', nbins=16,\n",
    "    title='Annual Total Award Amounts, before and after peak of COVID-19 Pandemic',\n",
    "    labels={'start': 'grant start', 'pandemic_label': 'status'},\n",
    "    color_discrete_sequence=[blue, red], text_auto=True\n",
    ") \n",
    "\n",
    "awards_fig.update_layout(yaxis_title='total award amount, millions')\n",
    "\n",
    "awards_fig.update_traces(\n",
    "    hovertemplate='grant start: %{x}<br>total award amount: %{y}'\n",
    ")\n",
    "\n",
    "awards_fig"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 111,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'C:\\\\Users\\\\phuro\\\\Biokind\\\\curebound-team\\\\curebound\\\\data'"
      ]
     },
     "execution_count": 111,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "working_directory()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 112,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Successfully saved grants_across_covid.csv at: processed\\grants_across_covid.csv\n"
     ]
    }
   ],
   "source": [
    "export_data(wp='processed', df=unique_projs, filename='grants_across_covid.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 113,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>start</th>\n",
       "      <th>Award Amount</th>\n",
       "      <th>pandemic_label</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Project Title</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>An over-expressed GPCR in pancreatic cancer associated fibroblasts as a novel therapeutic target</th>\n",
       "      <td>2017-05-01</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>before peak</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Applying p38 MAPK inhibitors to tackle breast cancer metastasis</th>\n",
       "      <td>2014-08-01</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>before peak</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Cytotoxic Breast Cancer Treatment Effects on Aging</th>\n",
       "      <td>2015-05-01</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>before peak</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Deciphering the role of RNA editing in leukemia stem cell generation and pediatric acute leukemia relapse</th>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>before peak</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Decoding Colon Cancers Using Boolean Principles</th>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>before peak</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Targeting Stem Cell Signals in Cancer Development and Progression</th>\n",
       "      <td>2016-05-01</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>before peak</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Targeting cellular mechanotransduction in breast cancer metastasis</th>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>before peak</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Targeting imatinib-resistant, KIT-negative cells in human GISTs</th>\n",
       "      <td>2014-06-01</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>before peak</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>The GNAS-PKA Onco-Signaling Network in Colorectal Malignancies</th>\n",
       "      <td>2016-05-01</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>before peak</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Tissue-specific role of SMARCB1 in pediatric rhabdoid tumors</th>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>before peak</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>24 rows × 3 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                        start  Award Amount  \\\n",
       "Project Title                                                                 \n",
       "An over-expressed GPCR in pancreatic cancer ass... 2017-05-01       75000.0   \n",
       "Applying p38 MAPK inhibitors to tackle breast c... 2014-08-01       75000.0   \n",
       "Cytotoxic Breast Cancer Treatment Effects on Aging 2015-05-01       75000.0   \n",
       "Deciphering the role of RNA editing in leukemia... 2017-06-01       75000.0   \n",
       "Decoding Colon Cancers Using Boolean Principles    2017-06-01       75000.0   \n",
       "...                                                       ...           ...   \n",
       "Targeting Stem Cell Signals in Cancer Developme... 2016-05-01       75000.0   \n",
       "Targeting cellular mechanotransduction in breas... 2017-06-01       75000.0   \n",
       "Targeting imatinib-resistant, KIT-negative cell... 2014-06-01       75000.0   \n",
       "The GNAS-PKA Onco-Signaling Network in Colorect... 2016-05-01       75000.0   \n",
       "Tissue-specific role of SMARCB1 in pediatric rh... 2017-06-01       75000.0   \n",
       "\n",
       "                                                   pandemic_label  \n",
       "Project Title                                                      \n",
       "An over-expressed GPCR in pancreatic cancer ass...    before peak  \n",
       "Applying p38 MAPK inhibitors to tackle breast c...    before peak  \n",
       "Cytotoxic Breast Cancer Treatment Effects on Aging    before peak  \n",
       "Deciphering the role of RNA editing in leukemia...    before peak  \n",
       "Decoding Colon Cancers Using Boolean Principles       before peak  \n",
       "...                                                           ...  \n",
       "Targeting Stem Cell Signals in Cancer Developme...    before peak  \n",
       "Targeting cellular mechanotransduction in breas...    before peak  \n",
       "Targeting imatinib-resistant, KIT-negative cell...    before peak  \n",
       "The GNAS-PKA Onco-Signaling Network in Colorect...    before peak  \n",
       "Tissue-specific role of SMARCB1 in pediatric rh...    before peak  \n",
       "\n",
       "[24 rows x 3 columns]"
      ]
     },
     "execution_count": 113,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "unique_projs[unique_projs['Award Amount'] == 75000]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 114,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Award ID</th>\n",
       "      <th>Project Title</th>\n",
       "      <th>PI Institution</th>\n",
       "      <th>Other Institution</th>\n",
       "      <th>Prevention and diagnostic tools</th>\n",
       "      <th>Novel approaches and new therapeutic platforms</th>\n",
       "      <th>Immunotherapies and personalized vaccines</th>\n",
       "      <th>Addressing cancer disparities</th>\n",
       "      <th>Pediatric cancers</th>\n",
       "      <th>Specific Aims</th>\n",
       "      <th>Aim 1</th>\n",
       "      <th>Aim 2</th>\n",
       "      <th>Aim 3</th>\n",
       "      <th>Aim 4</th>\n",
       "      <th>Aim 5</th>\n",
       "      <th>Aim 6</th>\n",
       "      <th>Public Health Significance</th>\n",
       "      <th>Award Amount</th>\n",
       "      <th>Grant Start Date:</th>\n",
       "      <th>Grant End Date:</th>\n",
       "      <th>Complete</th>\n",
       "      <th>SR - None</th>\n",
       "      <th>SR - Biobehaviorial MCC</th>\n",
       "      <th>SR - Biorepository &amp; Tissue Tech. MCC</th>\n",
       "      <th>SR - Biostatistics MCC</th>\n",
       "      <th>SR - Clinical Trials Office MCC</th>\n",
       "      <th>SR - Flow Cytometry MCC</th>\n",
       "      <th>SR - Genomics &amp; Computational Bio. MCC</th>\n",
       "      <th>SR - In Vivo Imaging MCC</th>\n",
       "      <th>SR - Microscopy MCC</th>\n",
       "      <th>SR - Radiation Medicine MCC</th>\n",
       "      <th>SR - Transgenic Mouse MCC</th>\n",
       "      <th>SR - Gene Transfer/Targeting/Therap Salk</th>\n",
       "      <th>SR - Transgenic Salk</th>\n",
       "      <th>SR - Mass Spect - Proteom/Metabol Salk</th>\n",
       "      <th>SR - Chemical Library Screening SBPMDI</th>\n",
       "      <th>SR - Functional Genomics SBPMDI</th>\n",
       "      <th>Cancer Metabolism SBPMDI</th>\n",
       "      <th>Pedal Importance (recruitment, retention, advancement)</th>\n",
       "      <th>If yes, please specify</th>\n",
       "      <th>If no, please specify</th>\n",
       "      <th>Clinical Trials Resulted</th>\n",
       "      <th>First Clinical Trial</th>\n",
       "      <th>First Clinical Trial Patient Count</th>\n",
       "      <th>Second Clinical Trial</th>\n",
       "      <th>Second Clinical Trial Patient Count</th>\n",
       "      <th>Companies Founded</th>\n",
       "      <th>Patents Filed</th>\n",
       "      <th>Patent Details</th>\n",
       "      <th>Peer-Reviewed Publications Count</th>\n",
       "      <th>start</th>\n",
       "      <th>pandemic_label</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>49.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>49.1</td>\n",
       "      <td>Decoding Colon Cancers Using Boolean Principles</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Build a virtual colon crypt</td>\n",
       "      <td>Visualize the altered organization of crypts i...</td>\n",
       "      <td>Assess the risk of neoplasia in pre-neoplastic...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Colorectal cancer is the 3rd most common cance...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>my appointment track does not value intramural...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>before peak</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>127.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>49.2</td>\n",
       "      <td>Decoding Colon Cancers Using Boolean Principles</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Build a virtual colon crypt.</td>\n",
       "      <td>Visualize the altered organization of crypts i...</td>\n",
       "      <td>Assess the risk of neoplasia in pre-neoplastic...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Colorectal cancer is the 3rd most common cance...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Pedal the Cause motivated the students.</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2020-135Human-centered drug discovery: A metho...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>before peak</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>128.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>49.3</td>\n",
       "      <td>Decoding Colon Cancers Using Boolean Principles</td>\n",
       "      <td>Sanford Burnum</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Build a virtual colon crypt.</td>\n",
       "      <td>Visualize the altered organization of crypts i...</td>\n",
       "      <td>Assess the risk of neoplasia in pre-neoplastic...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Colorectal cancer is the 3rd most common cance...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Please see description of the atypical situati...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>before peak</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>193.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>193.1</td>\n",
       "      <td>Decoding Colon Cancers Using Boolean Principles</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Build a virtual colon crypt</td>\n",
       "      <td>Visualize the altered organization of crypts i...</td>\n",
       "      <td>Assess the risk of neoplasia in pre-neoplastic...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Colorectal cancer is the 3rd most common cance...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>before peak</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>194.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>193.2</td>\n",
       "      <td>Decoding Colon Cancers Using Boolean Principles</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Build a virtual colon crypt</td>\n",
       "      <td>Visualize the altered organization of crypts i...</td>\n",
       "      <td>Assess the risk of neoplasia in pre-neoplastic...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Colorectal cancer is the 3rd most common cance...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>before peak</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>195.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>193.3</td>\n",
       "      <td>Decoding Colon Cancers Using Boolean Principles</td>\n",
       "      <td>Sanford Burnum</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Build a virtual colon crypt</td>\n",
       "      <td>Visualize the altered organization of crypts i...</td>\n",
       "      <td>Assess the risk of neoplasia in pre-neoplastic...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Colorectal cancer is the 3rd most common cance...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>before peak</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "       ID Event Name  Award ID  \\\n",
       "6    49.0    Initial      49.1   \n",
       "7   127.0    Initial      49.2   \n",
       "8   128.0    Initial      49.3   \n",
       "9   193.0    Initial     193.1   \n",
       "10  194.0    Initial     193.2   \n",
       "11  195.0    Initial     193.3   \n",
       "\n",
       "                                      Project Title        PI Institution  \\\n",
       "6   Decoding Colon Cancers Using Boolean Principles  Moores Cancer Center   \n",
       "7   Decoding Colon Cancers Using Boolean Principles  Moores Cancer Center   \n",
       "8   Decoding Colon Cancers Using Boolean Principles        Sanford Burnum   \n",
       "9   Decoding Colon Cancers Using Boolean Principles  Moores Cancer Center   \n",
       "10  Decoding Colon Cancers Using Boolean Principles  Moores Cancer Center   \n",
       "11  Decoding Colon Cancers Using Boolean Principles        Sanford Burnum   \n",
       "\n",
       "   Other Institution  Prevention and diagnostic tools  \\\n",
       "6                NaN                             True   \n",
       "7                NaN                            False   \n",
       "8                NaN                            False   \n",
       "9                NaN                            False   \n",
       "10               NaN                            False   \n",
       "11               NaN                            False   \n",
       "\n",
       "    Novel approaches and new therapeutic platforms  \\\n",
       "6                                            False   \n",
       "7                                            False   \n",
       "8                                            False   \n",
       "9                                            False   \n",
       "10                                           False   \n",
       "11                                           False   \n",
       "\n",
       "    Immunotherapies and personalized vaccines  Addressing cancer disparities  \\\n",
       "6                                       False                          False   \n",
       "7                                       False                          False   \n",
       "8                                       False                          False   \n",
       "9                                       False                          False   \n",
       "10                                      False                          False   \n",
       "11                                      False                          False   \n",
       "\n",
       "    Pediatric cancers        Specific Aims                         Aim 1  \\\n",
       "6               False  Three Specific Aims   Build a virtual colon crypt   \n",
       "7               False  Three Specific Aims  Build a virtual colon crypt.   \n",
       "8               False  Three Specific Aims  Build a virtual colon crypt.   \n",
       "9               False  Three Specific Aims   Build a virtual colon crypt   \n",
       "10              False  Three Specific Aims   Build a virtual colon crypt   \n",
       "11              False  Three Specific Aims   Build a virtual colon crypt   \n",
       "\n",
       "                                                Aim 2  \\\n",
       "6   Visualize the altered organization of crypts i...   \n",
       "7   Visualize the altered organization of crypts i...   \n",
       "8   Visualize the altered organization of crypts i...   \n",
       "9   Visualize the altered organization of crypts i...   \n",
       "10  Visualize the altered organization of crypts i...   \n",
       "11  Visualize the altered organization of crypts i...   \n",
       "\n",
       "                                                Aim 3 Aim 4 Aim 5 Aim 6  \\\n",
       "6   Assess the risk of neoplasia in pre-neoplastic...   NaN   NaN   NaN   \n",
       "7   Assess the risk of neoplasia in pre-neoplastic...   NaN   NaN   NaN   \n",
       "8   Assess the risk of neoplasia in pre-neoplastic...   NaN   NaN   NaN   \n",
       "9   Assess the risk of neoplasia in pre-neoplastic...   NaN   NaN   NaN   \n",
       "10  Assess the risk of neoplasia in pre-neoplastic...   NaN   NaN   NaN   \n",
       "11  Assess the risk of neoplasia in pre-neoplastic...   NaN   NaN   NaN   \n",
       "\n",
       "                           Public Health Significance  Award Amount  \\\n",
       "6   Colorectal cancer is the 3rd most common cance...       75000.0   \n",
       "7   Colorectal cancer is the 3rd most common cance...       75000.0   \n",
       "8   Colorectal cancer is the 3rd most common cance...       75000.0   \n",
       "9   Colorectal cancer is the 3rd most common cance...       75000.0   \n",
       "10  Colorectal cancer is the 3rd most common cance...       75000.0   \n",
       "11  Colorectal cancer is the 3rd most common cance...       75000.0   \n",
       "\n",
       "   Grant Start Date: Grant End Date:  Complete SR - None  \\\n",
       "6         2017-06-01      2018-05-31  Complete      True   \n",
       "7         2017-06-01      2018-05-31  Complete      True   \n",
       "8         2017-06-01      2018-05-31  Complete     False   \n",
       "9         2017-06-01      2018-05-31  Complete       NaN   \n",
       "10        2017-06-01      2018-05-31  Complete       NaN   \n",
       "11        2017-06-01      2018-05-31  Complete       NaN   \n",
       "\n",
       "   SR - Biobehaviorial MCC SR - Biorepository & Tissue Tech. MCC  \\\n",
       "6                    False                                 False   \n",
       "7                    False                                 False   \n",
       "8                    False                                  True   \n",
       "9                      NaN                                   NaN   \n",
       "10                     NaN                                   NaN   \n",
       "11                     NaN                                   NaN   \n",
       "\n",
       "   SR - Biostatistics MCC SR - Clinical Trials Office MCC  \\\n",
       "6                   False                           False   \n",
       "7                   False                           False   \n",
       "8                   False                           False   \n",
       "9                     NaN                             NaN   \n",
       "10                    NaN                             NaN   \n",
       "11                    NaN                             NaN   \n",
       "\n",
       "   SR - Flow Cytometry MCC SR - Genomics & Computational Bio. MCC  \\\n",
       "6                    False                                  False   \n",
       "7                    False                                  False   \n",
       "8                    False                                   True   \n",
       "9                      NaN                                    NaN   \n",
       "10                     NaN                                    NaN   \n",
       "11                     NaN                                    NaN   \n",
       "\n",
       "   SR - In Vivo Imaging MCC SR - Microscopy MCC SR - Radiation Medicine MCC  \\\n",
       "6                     False               False                       False   \n",
       "7                     False               False                       False   \n",
       "8                     False               False                       False   \n",
       "9                       NaN                 NaN                         NaN   \n",
       "10                      NaN                 NaN                         NaN   \n",
       "11                      NaN                 NaN                         NaN   \n",
       "\n",
       "   SR - Transgenic Mouse MCC SR - Gene Transfer/Targeting/Therap Salk  \\\n",
       "6                      False                                    False   \n",
       "7                      False                                    False   \n",
       "8                      False                                    False   \n",
       "9                        NaN                                      NaN   \n",
       "10                       NaN                                      NaN   \n",
       "11                       NaN                                      NaN   \n",
       "\n",
       "   SR - Transgenic Salk SR - Mass Spect - Proteom/Metabol Salk  \\\n",
       "6                 False                                  False   \n",
       "7                 False                                  False   \n",
       "8                 False                                  False   \n",
       "9                   NaN                                    NaN   \n",
       "10                  NaN                                    NaN   \n",
       "11                  NaN                                    NaN   \n",
       "\n",
       "   SR - Chemical Library Screening SBPMDI SR - Functional Genomics SBPMDI  \\\n",
       "6                                   False                           False   \n",
       "7                                   False                           False   \n",
       "8                                   False                           False   \n",
       "9                                     NaN                             NaN   \n",
       "10                                    NaN                             NaN   \n",
       "11                                    NaN                             NaN   \n",
       "\n",
       "   Cancer Metabolism SBPMDI  \\\n",
       "6                     False   \n",
       "7                     False   \n",
       "8                     False   \n",
       "9                       NaN   \n",
       "10                      NaN   \n",
       "11                      NaN   \n",
       "\n",
       "   Pedal Importance (recruitment, retention, advancement)  \\\n",
       "6                                                True       \n",
       "7                                                 NaN       \n",
       "8                                                 NaN       \n",
       "9                                                 NaN       \n",
       "10                                                NaN       \n",
       "11                                                NaN       \n",
       "\n",
       "                     If yes, please specify  \\\n",
       "6                                       NaN   \n",
       "7   Pedal the Cause motivated the students.   \n",
       "8                                       NaN   \n",
       "9                                       NaN   \n",
       "10                                      NaN   \n",
       "11                                      NaN   \n",
       "\n",
       "                                If no, please specify  \\\n",
       "6   my appointment track does not value intramural...   \n",
       "7                                                 NaN   \n",
       "8   Please see description of the atypical situati...   \n",
       "9                                                 NaN   \n",
       "10                                                NaN   \n",
       "11                                                NaN   \n",
       "\n",
       "    Clinical Trials Resulted First Clinical Trial  \\\n",
       "6                        0.0                  NaN   \n",
       "7                        0.0                  NaN   \n",
       "8                        0.0                  NaN   \n",
       "9                        0.0                  NaN   \n",
       "10                       0.0                  NaN   \n",
       "11                       0.0                  NaN   \n",
       "\n",
       "    First Clinical Trial Patient Count Second Clinical Trial  \\\n",
       "6                                  NaN                   NaN   \n",
       "7                                  NaN                   NaN   \n",
       "8                                  NaN                   NaN   \n",
       "9                                  NaN                   NaN   \n",
       "10                                 NaN                   NaN   \n",
       "11                                 NaN                   NaN   \n",
       "\n",
       "    Second Clinical Trial Patient Count Companies Founded Patents Filed  \\\n",
       "6                                   NaN               NaN            No   \n",
       "7                                   NaN              None           Yes   \n",
       "8                                   NaN              None            No   \n",
       "9                                   NaN               NaN           NaN   \n",
       "10                                  NaN               NaN           NaN   \n",
       "11                                  NaN               NaN           NaN   \n",
       "\n",
       "                                       Patent Details  \\\n",
       "6                                                 NaN   \n",
       "7   2020-135Human-centered drug discovery: A metho...   \n",
       "8                                                 NaN   \n",
       "9                                                 NaN   \n",
       "10                                                NaN   \n",
       "11                                                NaN   \n",
       "\n",
       "    Peer-Reviewed Publications Count      start pandemic_label  \n",
       "6                                NaN 2017-06-01    before peak  \n",
       "7                                2.0 2017-06-01    before peak  \n",
       "8                                0.0 2017-06-01    before peak  \n",
       "9                                NaN 2017-06-01    before peak  \n",
       "10                               NaN 2017-06-01    before peak  \n",
       "11                               NaN 2017-06-01    before peak  "
      ]
     },
     "execution_count": 114,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "query_project(roi_adj, 'Decoding')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 115,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Publication Status 4</th>\n",
       "      <th>Fourth DOI #</th>\n",
       "      <th>Publication Status 5</th>\n",
       "      <th>Fifth DOI #</th>\n",
       "      <th>Publication Status 6</th>\n",
       "      <th>Sixth DOI #</th>\n",
       "      <th>Publication Status 7</th>\n",
       "      <th>Seventh DOI #</th>\n",
       "      <th>Publication Status 8</th>\n",
       "      <th>Eighth DOI #</th>\n",
       "      <th>Publication Status 9</th>\n",
       "      <th>Ninth DOI #</th>\n",
       "      <th>Publication Status 10</th>\n",
       "      <th>Tenth DOI #</th>\n",
       "      <th>Pedal Non-Peer Pubs</th>\n",
       "      <th>Other Accomplishments</th>\n",
       "      <th>Health Benefits</th>\n",
       "      <th>International</th>\n",
       "      <th>National</th>\n",
       "      <th>Local</th>\n",
       "      <th>General Public</th>\n",
       "      <th>Healthcare Professionals</th>\n",
       "      <th>Patients</th>\n",
       "      <th>Patient Families</th>\n",
       "      <th>Health Benefits Description</th>\n",
       "      <th>Policy Influence</th>\n",
       "      <th>International (pol)</th>\n",
       "      <th>National (pol)</th>\n",
       "      <th>Local (pol)</th>\n",
       "      <th>General Public (pol)</th>\n",
       "      <th>Healthcare Professionals (pol)</th>\n",
       "      <th>Patients (pol)</th>\n",
       "      <th>Patient Families (pol)</th>\n",
       "      <th>Policy Benefits Description</th>\n",
       "      <th>Economic Benefits</th>\n",
       "      <th>International (econ)</th>\n",
       "      <th>National (econ)</th>\n",
       "      <th>Local (econ)</th>\n",
       "      <th>General Public (econ)</th>\n",
       "      <th>Healthcare Professionals (econ)</th>\n",
       "      <th>Patients (econ)</th>\n",
       "      <th>Patient Families (econ)</th>\n",
       "      <th>Economic Benefits Description</th>\n",
       "      <th>Equity Benefits</th>\n",
       "      <th>International (equity)</th>\n",
       "      <th>National (equity)</th>\n",
       "      <th>Local (equity)</th>\n",
       "      <th>General Public (equity)</th>\n",
       "      <th>Healthcare Professionals (equity)</th>\n",
       "      <th>Patients (equity)</th>\n",
       "      <th>Patient Families (equity)</th>\n",
       "      <th>Equity Benefits Description</th>\n",
       "      <th>Additional Funding Achieved</th>\n",
       "      <th>First AFS Status</th>\n",
       "      <th>First AFS Name and Project Title</th>\n",
       "      <th>First AFS Amount</th>\n",
       "      <th>Second AFS Status</th>\n",
       "      <th>Second AFS Name and Project Title</th>\n",
       "      <th>Second AFS Amount</th>\n",
       "      <th>Third AFS Status</th>\n",
       "      <th>Third AFS Name and Project Title</th>\n",
       "      <th>Third AGS Amount</th>\n",
       "      <th>Fourth AFS Status</th>\n",
       "      <th>Fourth AFS Name and Project Title</th>\n",
       "      <th>Fourth AFS Amount</th>\n",
       "      <th>Additional Funding Source #5 Agency/Sponsor Name and Project Title</th>\n",
       "      <th>Fifth AFS Status</th>\n",
       "      <th>Fifth AFS Amount</th>\n",
       "      <th>Additional Pedal Funding Impact</th>\n",
       "      <th>Additional Funding Benefits Description</th>\n",
       "      <th>Additional Pedal Funding Impact (clinical stages)</th>\n",
       "      <th>Additional Funding Benefits Description (clinical stages)</th>\n",
       "      <th>Participated in Pedal</th>\n",
       "      <th>Further Research Contributions</th>\n",
       "      <th>Success Stories</th>\n",
       "      <th>Major Scientific Breakthroughs</th>\n",
       "      <th>Additional Comments</th>\n",
       "      <th>Complete</th>\n",
       "      <th>Publication Status 1</th>\n",
       "      <th>First DOI #</th>\n",
       "      <th>Publication Status 2</th>\n",
       "      <th>Second DOI #</th>\n",
       "      <th>Publication Status 3</th>\n",
       "      <th>Third DOI #</th>\n",
       "      <th>Project Title</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>49.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>10.1016/j.jbc.2021.100493</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>10.1016/j.isci.2021.102035</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>One of the studies showed the harmful effects ...</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>E cigarette related policies</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>NIH NCATS UG3TR002968 Network-Based Novel Ther...</td>\n",
       "      <td>820000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>NIH NCATS UG3TR003355 Precision therapeutics o...</td>\n",
       "      <td>890000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>we have 2 new directions that have emerged fro...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>targets discovered in the studies could be dev...</td>\n",
       "      <td>i have donated money.</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>10.26508/lsa.201900481</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>10.1038/s41467-021-24470-5</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>10.1016/bs.acr.2021.02.005</td>\n",
       "      <td>Decoding Colon Cancers Using Boolean Principles</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>92</th>\n",
       "      <td>127.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Improved understanding of colorectal cancer.</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>R01 GM138385 - Annotation of cell types in hum...</td>\n",
       "      <td>1420781.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>R01AI155696 Macrophage Polarization in Respons...</td>\n",
       "      <td>1906469.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Can help identify prognostic biomarkers of col...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Can move clinical diagnostic markers forward.</td>\n",
       "      <td>Rider</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>Published</td>\n",
       "      <td>10.1038/s41467-021-24470-5</td>\n",
       "      <td>Published</td>\n",
       "      <td>10.1053/j.gastro.2021.10.006</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Decoding Colon Cancers Using Boolean Principles</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>93</th>\n",
       "      <td>128.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>The granted project helped to increase the qua...</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Spanish Ministry of Health grant FIS, Alteraci...</td>\n",
       "      <td>200000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Spanish Ministry of Health, FIS Epigenetics in...</td>\n",
       "      <td>250000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>I am so sorry not being more helpful, but I ex...</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Decoding Colon Cancers Using Boolean Principles</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "       ID          Event Name Publication Status 4               Fourth DOI #  \\\n",
       "42   49.0  Progress Report #1             Accepted  10.1016/j.jbc.2021.100493   \n",
       "92  127.0  Progress Report #1                  NaN                        NaN   \n",
       "93  128.0  Progress Report #1                  NaN                        NaN   \n",
       "\n",
       "   Publication Status 5                 Fifth DOI # Publication Status 6  \\\n",
       "42             Accepted  10.1016/j.isci.2021.102035            Submitted   \n",
       "92                  NaN                         NaN                  NaN   \n",
       "93                  NaN                         NaN                  NaN   \n",
       "\n",
       "   Sixth DOI # Publication Status 7 Seventh DOI # Publication Status 8  \\\n",
       "42         NaN            Submitted           NaN          In progress   \n",
       "92         NaN                  NaN           NaN                  NaN   \n",
       "93         NaN                  NaN           NaN                  NaN   \n",
       "\n",
       "   Eighth DOI # Publication Status 9 Ninth DOI # Publication Status 10  \\\n",
       "42          NaN          In progress         NaN           In progress   \n",
       "92          NaN                  NaN         NaN                   NaN   \n",
       "93          NaN                  NaN         NaN                   NaN   \n",
       "\n",
       "   Tenth DOI # Pedal Non-Peer Pubs  \\\n",
       "42         NaN                 NaN   \n",
       "92         NaN                 NaN   \n",
       "93         NaN                None   \n",
       "\n",
       "                                Other Accomplishments Health Benefits  \\\n",
       "42                                                NaN             Yes   \n",
       "92                                                NaN             Yes   \n",
       "93  The granted project helped to increase the qua...              No   \n",
       "\n",
       "    International  National  Local  General Public  Healthcare Professionals  \\\n",
       "42           True     False  False            True                      True   \n",
       "92          False     False  False            True                     False   \n",
       "93          False     False  False           False                     False   \n",
       "\n",
       "    Patients  Patient Families  \\\n",
       "42      True             False   \n",
       "92     False             False   \n",
       "93     False             False   \n",
       "\n",
       "                          Health Benefits Description  Policy Influence  \\\n",
       "42  One of the studies showed the harmful effects ...              True   \n",
       "92       Improved understanding of colorectal cancer.              True   \n",
       "93                                                NaN              True   \n",
       "\n",
       "    International (pol)  National (pol)  Local (pol)  General Public (pol)  \\\n",
       "42                False           False        False                  True   \n",
       "92                False           False        False                 False   \n",
       "93                False           False        False                 False   \n",
       "\n",
       "    Healthcare Professionals (pol)  Patients (pol)  Patient Families (pol)  \\\n",
       "42                           False           False                   False   \n",
       "92                           False           False                   False   \n",
       "93                           False           False                   False   \n",
       "\n",
       "     Policy Benefits Description Economic Benefits  International (econ)  \\\n",
       "42  E cigarette related policies                No                 False   \n",
       "92                           NaN                No                 False   \n",
       "93                           NaN                No                 False   \n",
       "\n",
       "    National (econ)  Local (econ)  General Public (econ)  \\\n",
       "42            False         False                  False   \n",
       "92            False         False                  False   \n",
       "93            False         False                  False   \n",
       "\n",
       "    Healthcare Professionals (econ)  Patients (econ)  Patient Families (econ)  \\\n",
       "42                            False            False                    False   \n",
       "92                            False            False                    False   \n",
       "93                            False            False                    False   \n",
       "\n",
       "   Economic Benefits Description Equity Benefits  International (equity)  \\\n",
       "42                           NaN              No                   False   \n",
       "92                           NaN              No                   False   \n",
       "93                           NaN              No                   False   \n",
       "\n",
       "    National (equity)  Local (equity)  General Public (equity)  \\\n",
       "42              False           False                    False   \n",
       "92              False           False                    False   \n",
       "93              False           False                    False   \n",
       "\n",
       "    Healthcare Professionals (equity)  Patients (equity)  \\\n",
       "42                              False              False   \n",
       "92                              False              False   \n",
       "93                              False              False   \n",
       "\n",
       "    Patient Families (equity) Equity Benefits Description  \\\n",
       "42                      False                         NaN   \n",
       "92                      False                         NaN   \n",
       "93                      False                         NaN   \n",
       "\n",
       "   Additional Funding Achieved First AFS Status  \\\n",
       "42                         Two          Awarded   \n",
       "92                         Two          Awarded   \n",
       "93                         Two          Awarded   \n",
       "\n",
       "                     First AFS Name and Project Title  First AFS Amount  \\\n",
       "42  NIH NCATS UG3TR002968 Network-Based Novel Ther...          820000.0   \n",
       "92  R01 GM138385 - Annotation of cell types in hum...         1420781.0   \n",
       "93  Spanish Ministry of Health grant FIS, Alteraci...          200000.0   \n",
       "\n",
       "   Second AFS Status                  Second AFS Name and Project Title  \\\n",
       "42           Awarded  NIH NCATS UG3TR003355 Precision therapeutics o...   \n",
       "92           Awarded  R01AI155696 Macrophage Polarization in Respons...   \n",
       "93           Awarded  Spanish Ministry of Health, FIS Epigenetics in...   \n",
       "\n",
       "    Second AFS Amount Third AFS Status Third AFS Name and Project Title  \\\n",
       "42           890000.0              NaN                              NaN   \n",
       "92          1906469.0              NaN                              NaN   \n",
       "93           250000.0              NaN                              NaN   \n",
       "\n",
       "    Third AGS Amount Fourth AFS Status Fourth AFS Name and Project Title  \\\n",
       "42               NaN               NaN                               NaN   \n",
       "92               NaN               NaN                               NaN   \n",
       "93               NaN               NaN                               NaN   \n",
       "\n",
       "    Fourth AFS Amount  \\\n",
       "42                NaN   \n",
       "92                NaN   \n",
       "93                NaN   \n",
       "\n",
       "   Additional Funding Source #5 Agency/Sponsor Name and Project Title  \\\n",
       "42                                                NaN                   \n",
       "92                                                NaN                   \n",
       "93                                                NaN                   \n",
       "\n",
       "   Fifth AFS Status  Fifth AFS Amount Additional Pedal Funding Impact  \\\n",
       "42              NaN               NaN                             Yes   \n",
       "92              NaN               NaN                             Yes   \n",
       "93              NaN               NaN                              No   \n",
       "\n",
       "              Additional Funding Benefits Description  \\\n",
       "42  we have 2 new directions that have emerged fro...   \n",
       "92  Can help identify prognostic biomarkers of col...   \n",
       "93                                                NaN   \n",
       "\n",
       "   Additional Pedal Funding Impact (clinical stages)  \\\n",
       "42                                               Yes   \n",
       "92                                               Yes   \n",
       "93                                                No   \n",
       "\n",
       "   Additional Funding Benefits Description (clinical stages)  \\\n",
       "42  targets discovered in the studies could be dev...          \n",
       "92      Can move clinical diagnostic markers forward.          \n",
       "93                                                NaN          \n",
       "\n",
       "    Participated in Pedal Further Research Contributions Success Stories  \\\n",
       "42  i have donated money.                             No              No   \n",
       "92                  Rider                             No              No   \n",
       "93                     No                             No              No   \n",
       "\n",
       "   Major Scientific Breakthroughs  \\\n",
       "42                            NaN   \n",
       "92                            NaN   \n",
       "93                            NaN   \n",
       "\n",
       "                                  Additional Comments  Complete  \\\n",
       "42                                                NaN      True   \n",
       "92                                                NaN      True   \n",
       "93  I am so sorry not being more helpful, but I ex...      True   \n",
       "\n",
       "   Publication Status 1                 First DOI # Publication Status 2  \\\n",
       "42             Accepted      10.26508/lsa.201900481             Accepted   \n",
       "92            Published  10.1038/s41467-021-24470-5            Published   \n",
       "93                  NaN                         NaN                  NaN   \n",
       "\n",
       "                    Second DOI # Publication Status 3  \\\n",
       "42    10.1038/s41467-021-24470-5             Accepted   \n",
       "92  10.1053/j.gastro.2021.10.006                  NaN   \n",
       "93                           NaN                  NaN   \n",
       "\n",
       "                   Third DOI #  \\\n",
       "42  10.1016/bs.acr.2021.02.005   \n",
       "92                         NaN   \n",
       "93                         NaN   \n",
       "\n",
       "                                      Project Title  \n",
       "42  Decoding Colon Cancers Using Boolean Principles  \n",
       "92  Decoding Colon Cancers Using Boolean Principles  \n",
       "93  Decoding Colon Cancers Using Boolean Principles  "
      ]
     },
     "execution_count": 115,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "query_project(pr, 'Decoding')"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Inspect additional funding achieved"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 116,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "No additional funding sources    49\n",
       "One                              33\n",
       "Two                              10\n",
       "Five                              5\n",
       "Three                             3\n",
       "Four                              1\n",
       "Name: Additional Funding Achieved, dtype: int64"
      ]
     },
     "execution_count": 116,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pr['Additional Funding Achieved'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 117,
   "metadata": {},
   "outputs": [],
   "source": [
    "pr['Additional Funding Achieved'] = pr['Additional Funding Achieved'].replace({\n",
    "    'No additional funding sources': 0,\n",
    "    'One': 1, \n",
    "    'Two': 2,\n",
    "    'Five': 5,\n",
    "    'Three': 3,\n",
    "    'Four': 4\n",
    "})"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 118,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.7307692307692307"
      ]
     },
     "execution_count": 118,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Get percentage of projects that achieved additional funding\n",
    "\n",
    "afs_cnt = pr.groupby('Project Title').sum()['Additional Funding Achieved']\n",
    "afs_prop = len(afs_cnt[afs_cnt != 0]) / len(afs_cnt)\n",
    "afs_prop"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 119,
   "metadata": {},
   "outputs": [],
   "source": [
    "pr.rename(columns={'Third AGS Amount': 'Third AFS Amount'}, inplace=True)\n",
    "afs = query_by_columns(pr, r'[AFS]{3}\\s{1}Status|[AFS]{3}\\s{1}Amount')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 120,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>First AFS Status</th>\n",
       "      <th>First AFS Amount</th>\n",
       "      <th>Second AFS Status</th>\n",
       "      <th>Second AFS Amount</th>\n",
       "      <th>Third AFS Status</th>\n",
       "      <th>Third AFS Amount</th>\n",
       "      <th>Fourth AFS Status</th>\n",
       "      <th>Fourth AFS Amount</th>\n",
       "      <th>Fifth AFS Status</th>\n",
       "      <th>Fifth AFS Amount</th>\n",
       "      <th>Project Title</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>1500000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Detecting dysregulated genes in neuroblastoma ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>300000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>100000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>750000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>150000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>500000.0</td>\n",
       "      <td>Functional Roles for Histidine Kinase Signalin...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>250000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A National Phase I Study of Cabozantinib in Co...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Submitted</td>\n",
       "      <td>2500000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>377000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A Phase 1B, Nonrandomized Trial Investigating ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>97</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Identification of therapeutic targets of B-ALL...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>98</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Developing targeted therapy for Ewing sarcoma ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>99</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Defining the mechanisms of pancreatic cancer s...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>100</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>300000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>100000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>100000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>750000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>150000.0</td>\n",
       "      <td>A Novel Role for Histidine Kinase Activity in ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>101</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A Novel Role for Histidine Kinase Activity in ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>102 rows × 11 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    First AFS Status  First AFS Amount Second AFS Status  Second AFS Amount  \\\n",
       "0            Awarded         1500000.0               NaN                NaN   \n",
       "1            Awarded          300000.0           Awarded           100000.0   \n",
       "2            Awarded          250000.0               NaN                NaN   \n",
       "3          Submitted         2500000.0               NaN                NaN   \n",
       "4            Awarded          377000.0               NaN                NaN   \n",
       "..               ...               ...               ...                ...   \n",
       "97               NaN               NaN               NaN                NaN   \n",
       "98               NaN               NaN               NaN                NaN   \n",
       "99               NaN               NaN               NaN                NaN   \n",
       "100          Awarded          300000.0           Awarded           100000.0   \n",
       "101              NaN               NaN               NaN                NaN   \n",
       "\n",
       "    Third AFS Status  Third AFS Amount Fourth AFS Status  Fourth AFS Amount  \\\n",
       "0                NaN               NaN               NaN                NaN   \n",
       "1          Submitted          750000.0         Submitted           150000.0   \n",
       "2                NaN               NaN               NaN                NaN   \n",
       "3                NaN               NaN               NaN                NaN   \n",
       "4                NaN               NaN               NaN                NaN   \n",
       "..               ...               ...               ...                ...   \n",
       "97               NaN               NaN               NaN                NaN   \n",
       "98               NaN               NaN               NaN                NaN   \n",
       "99               NaN               NaN               NaN                NaN   \n",
       "100          Awarded          100000.0         Submitted           750000.0   \n",
       "101              NaN               NaN               NaN                NaN   \n",
       "\n",
       "    Fifth AFS Status  Fifth AFS Amount  \\\n",
       "0                NaN               NaN   \n",
       "1          Submitted          500000.0   \n",
       "2                NaN               NaN   \n",
       "3                NaN               NaN   \n",
       "4                NaN               NaN   \n",
       "..               ...               ...   \n",
       "97               NaN               NaN   \n",
       "98               NaN               NaN   \n",
       "99               NaN               NaN   \n",
       "100        Submitted          150000.0   \n",
       "101              NaN               NaN   \n",
       "\n",
       "                                         Project Title  \n",
       "0    Detecting dysregulated genes in neuroblastoma ...  \n",
       "1    Functional Roles for Histidine Kinase Signalin...  \n",
       "2    A National Phase I Study of Cabozantinib in Co...  \n",
       "3    UCSD-UCSF Specialized Program of Research Exce...  \n",
       "4    A Phase 1B, Nonrandomized Trial Investigating ...  \n",
       "..                                                 ...  \n",
       "97   Identification of therapeutic targets of B-ALL...  \n",
       "98   Developing targeted therapy for Ewing sarcoma ...  \n",
       "99   Defining the mechanisms of pancreatic cancer s...  \n",
       "100  A Novel Role for Histidine Kinase Activity in ...  \n",
       "101  A Novel Role for Histidine Kinase Activity in ...  \n",
       "\n",
       "[102 rows x 11 columns]"
      ]
     },
     "execution_count": 120,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "afs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 121,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>First AFS Status</th>\n",
       "      <th>First AFS Amount</th>\n",
       "      <th>Second AFS Status</th>\n",
       "      <th>Second AFS Amount</th>\n",
       "      <th>Third AFS Status</th>\n",
       "      <th>Third AFS Amount</th>\n",
       "      <th>Fourth AFS Status</th>\n",
       "      <th>Fourth AFS Amount</th>\n",
       "      <th>Fifth AFS Status</th>\n",
       "      <th>Fifth AFS Amount</th>\n",
       "      <th>Project Title</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>250000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A National Phase I Study of Cabozantinib in Co...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>101</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A Novel Role for Histidine Kinase Activity in ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>100</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>300000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>100000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>100000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>750000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>150000.0</td>\n",
       "      <td>A Novel Role for Histidine Kinase Activity in ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>377000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A Phase 1B, Nonrandomized Trial Investigating ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>750000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A Phase 1b Safety and Feasibility Study of Per...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>83</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A Phase 1b pilot clinical trial of cirmtuzumab...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A Phase 1b pilot clinical trial of cirmtuzumab...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>59</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A pilot trial to test the benefit of real time...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A pilot trial to test the benefit of real time...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>84</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>499999.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>An Open-Label, Phase 2 Efficacy Study of Temoz...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>1500000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>500000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>An Open-Label, Phase 2 Efficacy Study of Temoz...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>89</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>An over-expressed GPCR in pancreatic cancer as...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>250000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>100000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>An over-expressed GPCR in pancreatic cancer as...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>3310103.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Characterization of a GOLPH3 Pathway Inhibitor...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>3310103.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>3500000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>80689.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Characterization of a GOLPH3 Pathway Inhibitor...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>600000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>2000000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>1000000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Deciphering the role of RNA editing in leukemi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>820000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>890000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Decoding Colon Cancers Using Boolean Principles</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>92</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>1420781.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>1906469.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Decoding Colon Cancers Using Boolean Principles</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>93</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>200000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>250000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Decoding Colon Cancers Using Boolean Principles</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Defining the mechanisms of pancreatic cancer s...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Defining the mechanisms of pancreatic cancer s...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>99</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Defining the mechanisms of pancreatic cancer s...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>61</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Detecting dysregulated genes in neuroblastoma ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>1500000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Detecting dysregulated genes in neuroblastoma ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>500000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Developing targeted therapy for Ewing sarcoma ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>98</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Developing targeted therapy for Ewing sarcoma ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>81</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Development and Implementation of a Peer-Navig...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>1000000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>1000000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>125000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>125000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>1250000.0</td>\n",
       "      <td>Development and Implementation of a Peer-Navig...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Discovery of non-coding oncogenic mutations in...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Discovery of non-coding oncogenic mutations in...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>96</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Discovery of non-coding oncogenic mutations in...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>58</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Elucidating the role of Syk kinase and Syk inh...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>1900000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Elucidating the role of Syk kinase and Syk inh...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>150000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Enhanced Breast Cancer Risk Prediction from Im...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>77</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Enhanced Breast Cancer Risk Prediction from Im...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>80</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Epigenetic profiling of endometrial cancer</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Epigenetic profiling of endometrial cancer</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>64</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Evaluation of carcinogen exposure via genome-w...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Evaluation of carcinogen exposure via genome-w...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>55</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Examination of inhibitors of the ULK1 autophag...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>54</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Examination of inhibitors of the ULK1 autophag...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Examination of inhibitors of the ULK1 autophag...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>67</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>3827000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>66</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>3000000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>2047950.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>300000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>100000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>750000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>150000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>500000.0</td>\n",
       "      <td>Functional Roles for Histidine Kinase Signalin...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>90</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Identification of genes critical for the produ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>63</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>2000000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Identification of regulatory programs for glio...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>67000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Identification of regulatory programs for glio...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>1420781.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>1906469.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Identification of therapeutic targets of B-ALL...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>97</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Identification of therapeutic targets of B-ALL...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>65</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>100000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Impact of Metformin on Clonal Hematopoiesis an...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Impact of Metformin on Clonal Hematopoiesis an...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>60</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>250000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Improved Echocardiographic Diagnosis of Anthra...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Improved Echocardiographic Diagnosis of Anthra...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>536250.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inducing Cytosolic Chromatin Fragments in Canc...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inducing Cytosolic Chromatin Fragments in Canc...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>250000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>200000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inhibiting Liver Cancer Stem Cells to Improve ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>68</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inhibiting Liver Cancer Stem Cells to Improve ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>69</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inhibiting Liver Cancer Stem Cells to Improve ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>200000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Investigating the Efficacy of radium-223 with ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>85</th>\n",
       "      <td>Planned</td>\n",
       "      <td>2000000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Investigating the Efficacy of radium-223 with ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>1480000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>11000000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Irreversible electroporation as an In Situ vac...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>87</th>\n",
       "      <td>Submitted</td>\n",
       "      <td>2750000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Irreversible electroporation as an In Situ vac...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Knowledge-based planning and treatment decisio...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>71</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Knowledge-based planning and treatment decisio...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Knowledge-based planning and treatment decisio...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>86</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>565000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Low Dose Chemotherapy for Immuno-activation in...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Low Dose Chemotherapy for Immuno-activation in...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>Planned</td>\n",
       "      <td>1500000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Microbe-Associated Colorectal Cancer (M.A.C.S)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>79</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Microbe-Associated Colorectal Cancer (M.A.C.S)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>73</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>125000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Natural Killer Cells for Treatment of Medullob...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Neoantigen-specific T cell responses in except...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Neoantigen-specific T cell responses in except...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>New Therapies for Myeloid Leukemia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>New Therapies for Myeloid Leukemia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>New Therapies for Myeloid Leukemia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>300000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>750000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>150000.0</td>\n",
       "      <td>Planned</td>\n",
       "      <td>2000000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Novel Pathways Regulated by NME1 in Neuroblastoma</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>300000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>100000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>265000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>50000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>50000.0</td>\n",
       "      <td>Novel kinase inhibitors in combination with re...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>88</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>660000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Oncogenic Regulation of B-Lymphomagenesis by t...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>660000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Oncogenic Regulation of B-Lymphomagenesis by t...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>5000000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Peptide Targeted Delivery of Epigenetic Therap...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>Planned</td>\n",
       "      <td>100000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Peptide Targeted Delivery of Epigenetic Therap...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>2264206.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Precision Interception of Gastric Cancers</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>1800000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Precision Interception of Gastric Cancers</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>100000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>584200.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Responses of Melanoma Patients to Checkpoint I...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>76</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Responses of Melanoma Patients to Checkpoint I...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Targeting A Therapeutic Vulnerability in PTEN-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>Submitted</td>\n",
       "      <td>150000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>160000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>2000000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>350000.0</td>\n",
       "      <td>Planned</td>\n",
       "      <td>2500000.0</td>\n",
       "      <td>Targeting CD114 Signaling in Pediatric Medullo...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>72</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Targeting CD114 Signaling in Pediatric Medullo...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>74</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>200000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Targeting FZD7 in human cancers</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>100000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>1200000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Targeting FZD7 in human cancers</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>91</th>\n",
       "      <td>Submitted</td>\n",
       "      <td>3000000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Targeting cellular mechanotransduction in brea...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>1818865.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>1449402.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>50000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Targeting cellular mechanotransduction in brea...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Tissue-specific role of SMARCB1 in pediatric r...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>94</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Tissue-specific role of SMARCB1 in pediatric r...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>82</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Transcriptomic, epigenomic profiling to reveal...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>825000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Transcriptomic, epigenomic profiling to reveal...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Submitted</td>\n",
       "      <td>2500000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>78</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Understanding and Targeting NRF2 in Pancreatic...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Understanding and Targeting NRF2 in Pancreatic...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    First AFS Status  First AFS Amount Second AFS Status  Second AFS Amount  \\\n",
       "2            Awarded          250000.0               NaN                NaN   \n",
       "101              NaN               NaN               NaN                NaN   \n",
       "100          Awarded          300000.0           Awarded           100000.0   \n",
       "4            Awarded          377000.0               NaN                NaN   \n",
       "33           Awarded          750000.0               NaN                NaN   \n",
       "83               NaN               NaN               NaN                NaN   \n",
       "34               NaN               NaN               NaN                NaN   \n",
       "59               NaN               NaN               NaN                NaN   \n",
       "12               NaN               NaN               NaN                NaN   \n",
       "84           Awarded          499999.0               NaN                NaN   \n",
       "35           Awarded         1500000.0           Awarded           500000.0   \n",
       "89               NaN               NaN               NaN                NaN   \n",
       "40           Awarded          250000.0           Awarded           100000.0   \n",
       "62           Awarded         3310103.0               NaN                NaN   \n",
       "15           Awarded         3310103.0           Awarded          3500000.0   \n",
       "44           Awarded          600000.0           Awarded          2000000.0   \n",
       "42           Awarded          820000.0           Awarded           890000.0   \n",
       "92           Awarded         1420781.0           Awarded          1906469.0   \n",
       "93           Awarded          200000.0           Awarded           250000.0   \n",
       "57               NaN               NaN               NaN                NaN   \n",
       "10               NaN               NaN               NaN                NaN   \n",
       "99               NaN               NaN               NaN                NaN   \n",
       "61               NaN               NaN               NaN                NaN   \n",
       "0            Awarded         1500000.0               NaN                NaN   \n",
       "47           Awarded          500000.0               NaN                NaN   \n",
       "98               NaN               NaN               NaN                NaN   \n",
       "81               NaN               NaN               NaN                NaN   \n",
       "31           Awarded         1000000.0         Submitted          1000000.0   \n",
       "45               NaN               NaN               NaN                NaN   \n",
       "95               NaN               NaN               NaN                NaN   \n",
       "96               NaN               NaN               NaN                NaN   \n",
       "58               NaN               NaN               NaN                NaN   \n",
       "11           Awarded         1900000.0               NaN                NaN   \n",
       "27           Awarded          150000.0               NaN                NaN   \n",
       "77               NaN               NaN               NaN                NaN   \n",
       "80               NaN               NaN               NaN                NaN   \n",
       "30               NaN               NaN               NaN                NaN   \n",
       "64               NaN               NaN               NaN                NaN   \n",
       "18               NaN               NaN               NaN                NaN   \n",
       "55               NaN               NaN               NaN                NaN   \n",
       "54               NaN               NaN               NaN                NaN   \n",
       "8                NaN               NaN               NaN                NaN   \n",
       "67           Awarded         3827000.0               NaN                NaN   \n",
       "66           Awarded         3000000.0               NaN                NaN   \n",
       "20           Awarded         2047950.0               NaN                NaN   \n",
       "1            Awarded          300000.0           Awarded           100000.0   \n",
       "90               NaN               NaN               NaN                NaN   \n",
       "63           Awarded         2000000.0               NaN                NaN   \n",
       "17           Awarded           67000.0               NaN                NaN   \n",
       "46           Awarded         1420781.0           Awarded          1906469.0   \n",
       "97               NaN               NaN               NaN                NaN   \n",
       "65           Awarded          100000.0               NaN                NaN   \n",
       "19               NaN               NaN               NaN                NaN   \n",
       "60           Awarded          250000.0               NaN                NaN   \n",
       "13               NaN               NaN               NaN                NaN   \n",
       "75           Awarded          536250.0               NaN                NaN   \n",
       "25               NaN               NaN               NaN                NaN   \n",
       "21           Awarded          250000.0         Submitted           200000.0   \n",
       "68               NaN               NaN               NaN                NaN   \n",
       "69               NaN               NaN               NaN                NaN   \n",
       "36           Awarded          200000.0               NaN                NaN   \n",
       "85           Planned         2000000.0               NaN                NaN   \n",
       "38           Awarded         1480000.0         Submitted         11000000.0   \n",
       "87         Submitted         2750000.0               NaN                NaN   \n",
       "22               NaN               NaN               NaN                NaN   \n",
       "71               NaN               NaN               NaN                NaN   \n",
       "70               NaN               NaN               NaN                NaN   \n",
       "86           Awarded          565000.0               NaN                NaN   \n",
       "37               NaN               NaN               NaN                NaN   \n",
       "16           Planned         1500000.0               NaN                NaN   \n",
       "79               NaN               NaN               NaN                NaN   \n",
       "73           Awarded          125000.0               NaN                NaN   \n",
       "56               NaN               NaN               NaN                NaN   \n",
       "9                NaN               NaN               NaN                NaN   \n",
       "5                NaN               NaN               NaN                NaN   \n",
       "50               NaN               NaN               NaN                NaN   \n",
       "51               NaN               NaN               NaN                NaN   \n",
       "14           Awarded          300000.0         Submitted           750000.0   \n",
       "48           Awarded          300000.0           Awarded           100000.0   \n",
       "88           Awarded          660000.0               NaN                NaN   \n",
       "39           Awarded          660000.0               NaN                NaN   \n",
       "6            Awarded         5000000.0               NaN                NaN   \n",
       "52           Planned          100000.0               NaN                NaN   \n",
       "53           Awarded         2264206.0               NaN                NaN   \n",
       "7            Awarded         1800000.0               NaN                NaN   \n",
       "26           Awarded          100000.0           Awarded           584200.0   \n",
       "76               NaN               NaN               NaN                NaN   \n",
       "29               NaN               NaN               NaN                NaN   \n",
       "23         Submitted          150000.0         Submitted           160000.0   \n",
       "72               NaN               NaN               NaN                NaN   \n",
       "74           Awarded          200000.0               NaN                NaN   \n",
       "24           Awarded          100000.0           Awarded          1200000.0   \n",
       "91         Submitted         3000000.0               NaN                NaN   \n",
       "41           Awarded         1818865.0           Awarded          1449402.0   \n",
       "43               NaN               NaN               NaN                NaN   \n",
       "94               NaN               NaN               NaN                NaN   \n",
       "82               NaN               NaN               NaN                NaN   \n",
       "32           Awarded          825000.0               NaN                NaN   \n",
       "3          Submitted         2500000.0               NaN                NaN   \n",
       "49               NaN               NaN               NaN                NaN   \n",
       "78               NaN               NaN               NaN                NaN   \n",
       "28               NaN               NaN               NaN                NaN   \n",
       "\n",
       "    Third AFS Status  Third AFS Amount Fourth AFS Status  Fourth AFS Amount  \\\n",
       "2                NaN               NaN               NaN                NaN   \n",
       "101              NaN               NaN               NaN                NaN   \n",
       "100          Awarded          100000.0         Submitted           750000.0   \n",
       "4                NaN               NaN               NaN                NaN   \n",
       "33               NaN               NaN               NaN                NaN   \n",
       "83               NaN               NaN               NaN                NaN   \n",
       "34               NaN               NaN               NaN                NaN   \n",
       "59               NaN               NaN               NaN                NaN   \n",
       "12               NaN               NaN               NaN                NaN   \n",
       "84               NaN               NaN               NaN                NaN   \n",
       "35               NaN               NaN               NaN                NaN   \n",
       "89               NaN               NaN               NaN                NaN   \n",
       "40               NaN               NaN               NaN                NaN   \n",
       "62               NaN               NaN               NaN                NaN   \n",
       "15           Awarded           80689.0               NaN                NaN   \n",
       "44           Awarded         1000000.0               NaN                NaN   \n",
       "42               NaN               NaN               NaN                NaN   \n",
       "92               NaN               NaN               NaN                NaN   \n",
       "93               NaN               NaN               NaN                NaN   \n",
       "57               NaN               NaN               NaN                NaN   \n",
       "10               NaN               NaN               NaN                NaN   \n",
       "99               NaN               NaN               NaN                NaN   \n",
       "61               NaN               NaN               NaN                NaN   \n",
       "0                NaN               NaN               NaN                NaN   \n",
       "47               NaN               NaN               NaN                NaN   \n",
       "98               NaN               NaN               NaN                NaN   \n",
       "81               NaN               NaN               NaN                NaN   \n",
       "31           Awarded          125000.0           Awarded           125000.0   \n",
       "45               NaN               NaN               NaN                NaN   \n",
       "95               NaN               NaN               NaN                NaN   \n",
       "96               NaN               NaN               NaN                NaN   \n",
       "58               NaN               NaN               NaN                NaN   \n",
       "11               NaN               NaN               NaN                NaN   \n",
       "27               NaN               NaN               NaN                NaN   \n",
       "77               NaN               NaN               NaN                NaN   \n",
       "80               NaN               NaN               NaN                NaN   \n",
       "30               NaN               NaN               NaN                NaN   \n",
       "64               NaN               NaN               NaN                NaN   \n",
       "18               NaN               NaN               NaN                NaN   \n",
       "55               NaN               NaN               NaN                NaN   \n",
       "54               NaN               NaN               NaN                NaN   \n",
       "8                NaN               NaN               NaN                NaN   \n",
       "67               NaN               NaN               NaN                NaN   \n",
       "66               NaN               NaN               NaN                NaN   \n",
       "20               NaN               NaN               NaN                NaN   \n",
       "1          Submitted          750000.0         Submitted           150000.0   \n",
       "90               NaN               NaN               NaN                NaN   \n",
       "63               NaN               NaN               NaN                NaN   \n",
       "17               NaN               NaN               NaN                NaN   \n",
       "46               NaN               NaN               NaN                NaN   \n",
       "97               NaN               NaN               NaN                NaN   \n",
       "65               NaN               NaN               NaN                NaN   \n",
       "19               NaN               NaN               NaN                NaN   \n",
       "60               NaN               NaN               NaN                NaN   \n",
       "13               NaN               NaN               NaN                NaN   \n",
       "75               NaN               NaN               NaN                NaN   \n",
       "25               NaN               NaN               NaN                NaN   \n",
       "21               NaN               NaN               NaN                NaN   \n",
       "68               NaN               NaN               NaN                NaN   \n",
       "69               NaN               NaN               NaN                NaN   \n",
       "36               NaN               NaN               NaN                NaN   \n",
       "85               NaN               NaN               NaN                NaN   \n",
       "38               NaN               NaN               NaN                NaN   \n",
       "87               NaN               NaN               NaN                NaN   \n",
       "22               NaN               NaN               NaN                NaN   \n",
       "71               NaN               NaN               NaN                NaN   \n",
       "70               NaN               NaN               NaN                NaN   \n",
       "86               NaN               NaN               NaN                NaN   \n",
       "37               NaN               NaN               NaN                NaN   \n",
       "16               NaN               NaN               NaN                NaN   \n",
       "79               NaN               NaN               NaN                NaN   \n",
       "73               NaN               NaN               NaN                NaN   \n",
       "56               NaN               NaN               NaN                NaN   \n",
       "9                NaN               NaN               NaN                NaN   \n",
       "5                NaN               NaN               NaN                NaN   \n",
       "50               NaN               NaN               NaN                NaN   \n",
       "51               NaN               NaN               NaN                NaN   \n",
       "14         Submitted          150000.0           Planned          2000000.0   \n",
       "48           Awarded          265000.0           Awarded            50000.0   \n",
       "88               NaN               NaN               NaN                NaN   \n",
       "39               NaN               NaN               NaN                NaN   \n",
       "6                NaN               NaN               NaN                NaN   \n",
       "52               NaN               NaN               NaN                NaN   \n",
       "53               NaN               NaN               NaN                NaN   \n",
       "7                NaN               NaN               NaN                NaN   \n",
       "26               NaN               NaN               NaN                NaN   \n",
       "76               NaN               NaN               NaN                NaN   \n",
       "29               NaN               NaN               NaN                NaN   \n",
       "23         Submitted         2000000.0         Submitted           350000.0   \n",
       "72               NaN               NaN               NaN                NaN   \n",
       "74               NaN               NaN               NaN                NaN   \n",
       "24               NaN               NaN               NaN                NaN   \n",
       "91               NaN               NaN               NaN                NaN   \n",
       "41           Awarded           50000.0               NaN                NaN   \n",
       "43               NaN               NaN               NaN                NaN   \n",
       "94               NaN               NaN               NaN                NaN   \n",
       "82               NaN               NaN               NaN                NaN   \n",
       "32               NaN               NaN               NaN                NaN   \n",
       "3                NaN               NaN               NaN                NaN   \n",
       "49               NaN               NaN               NaN                NaN   \n",
       "78               NaN               NaN               NaN                NaN   \n",
       "28               NaN               NaN               NaN                NaN   \n",
       "\n",
       "    Fifth AFS Status  Fifth AFS Amount  \\\n",
       "2                NaN               NaN   \n",
       "101              NaN               NaN   \n",
       "100        Submitted          150000.0   \n",
       "4                NaN               NaN   \n",
       "33               NaN               NaN   \n",
       "83               NaN               NaN   \n",
       "34               NaN               NaN   \n",
       "59               NaN               NaN   \n",
       "12               NaN               NaN   \n",
       "84               NaN               NaN   \n",
       "35               NaN               NaN   \n",
       "89               NaN               NaN   \n",
       "40               NaN               NaN   \n",
       "62               NaN               NaN   \n",
       "15               NaN               NaN   \n",
       "44               NaN               NaN   \n",
       "42               NaN               NaN   \n",
       "92               NaN               NaN   \n",
       "93               NaN               NaN   \n",
       "57               NaN               NaN   \n",
       "10               NaN               NaN   \n",
       "99               NaN               NaN   \n",
       "61               NaN               NaN   \n",
       "0                NaN               NaN   \n",
       "47               NaN               NaN   \n",
       "98               NaN               NaN   \n",
       "81               NaN               NaN   \n",
       "31           Awarded         1250000.0   \n",
       "45               NaN               NaN   \n",
       "95               NaN               NaN   \n",
       "96               NaN               NaN   \n",
       "58               NaN               NaN   \n",
       "11               NaN               NaN   \n",
       "27               NaN               NaN   \n",
       "77               NaN               NaN   \n",
       "80               NaN               NaN   \n",
       "30               NaN               NaN   \n",
       "64               NaN               NaN   \n",
       "18               NaN               NaN   \n",
       "55               NaN               NaN   \n",
       "54               NaN               NaN   \n",
       "8                NaN               NaN   \n",
       "67               NaN               NaN   \n",
       "66               NaN               NaN   \n",
       "20               NaN               NaN   \n",
       "1          Submitted          500000.0   \n",
       "90               NaN               NaN   \n",
       "63               NaN               NaN   \n",
       "17               NaN               NaN   \n",
       "46               NaN               NaN   \n",
       "97               NaN               NaN   \n",
       "65               NaN               NaN   \n",
       "19               NaN               NaN   \n",
       "60               NaN               NaN   \n",
       "13               NaN               NaN   \n",
       "75               NaN               NaN   \n",
       "25               NaN               NaN   \n",
       "21               NaN               NaN   \n",
       "68               NaN               NaN   \n",
       "69               NaN               NaN   \n",
       "36               NaN               NaN   \n",
       "85               NaN               NaN   \n",
       "38               NaN               NaN   \n",
       "87               NaN               NaN   \n",
       "22               NaN               NaN   \n",
       "71               NaN               NaN   \n",
       "70               NaN               NaN   \n",
       "86               NaN               NaN   \n",
       "37               NaN               NaN   \n",
       "16               NaN               NaN   \n",
       "79               NaN               NaN   \n",
       "73               NaN               NaN   \n",
       "56               NaN               NaN   \n",
       "9                NaN               NaN   \n",
       "5                NaN               NaN   \n",
       "50               NaN               NaN   \n",
       "51               NaN               NaN   \n",
       "14         Submitted               NaN   \n",
       "48           Awarded           50000.0   \n",
       "88               NaN               NaN   \n",
       "39               NaN               NaN   \n",
       "6                NaN               NaN   \n",
       "52               NaN               NaN   \n",
       "53               NaN               NaN   \n",
       "7                NaN               NaN   \n",
       "26               NaN               NaN   \n",
       "76               NaN               NaN   \n",
       "29               NaN               NaN   \n",
       "23           Planned         2500000.0   \n",
       "72               NaN               NaN   \n",
       "74               NaN               NaN   \n",
       "24               NaN               NaN   \n",
       "91               NaN               NaN   \n",
       "41               NaN               NaN   \n",
       "43               NaN               NaN   \n",
       "94               NaN               NaN   \n",
       "82               NaN               NaN   \n",
       "32               NaN               NaN   \n",
       "3                NaN               NaN   \n",
       "49               NaN               NaN   \n",
       "78               NaN               NaN   \n",
       "28               NaN               NaN   \n",
       "\n",
       "                                         Project Title  \n",
       "2    A National Phase I Study of Cabozantinib in Co...  \n",
       "101  A Novel Role for Histidine Kinase Activity in ...  \n",
       "100  A Novel Role for Histidine Kinase Activity in ...  \n",
       "4    A Phase 1B, Nonrandomized Trial Investigating ...  \n",
       "33   A Phase 1b Safety and Feasibility Study of Per...  \n",
       "83   A Phase 1b pilot clinical trial of cirmtuzumab...  \n",
       "34   A Phase 1b pilot clinical trial of cirmtuzumab...  \n",
       "59   A pilot trial to test the benefit of real time...  \n",
       "12   A pilot trial to test the benefit of real time...  \n",
       "84   An Open-Label, Phase 2 Efficacy Study of Temoz...  \n",
       "35   An Open-Label, Phase 2 Efficacy Study of Temoz...  \n",
       "89   An over-expressed GPCR in pancreatic cancer as...  \n",
       "40   An over-expressed GPCR in pancreatic cancer as...  \n",
       "62   Characterization of a GOLPH3 Pathway Inhibitor...  \n",
       "15   Characterization of a GOLPH3 Pathway Inhibitor...  \n",
       "44   Deciphering the role of RNA editing in leukemi...  \n",
       "42     Decoding Colon Cancers Using Boolean Principles  \n",
       "92     Decoding Colon Cancers Using Boolean Principles  \n",
       "93     Decoding Colon Cancers Using Boolean Principles  \n",
       "57   Defining the mechanisms of pancreatic cancer s...  \n",
       "10   Defining the mechanisms of pancreatic cancer s...  \n",
       "99   Defining the mechanisms of pancreatic cancer s...  \n",
       "61   Detecting dysregulated genes in neuroblastoma ...  \n",
       "0    Detecting dysregulated genes in neuroblastoma ...  \n",
       "47   Developing targeted therapy for Ewing sarcoma ...  \n",
       "98   Developing targeted therapy for Ewing sarcoma ...  \n",
       "81   Development and Implementation of a Peer-Navig...  \n",
       "31   Development and Implementation of a Peer-Navig...  \n",
       "45   Discovery of non-coding oncogenic mutations in...  \n",
       "95   Discovery of non-coding oncogenic mutations in...  \n",
       "96   Discovery of non-coding oncogenic mutations in...  \n",
       "58   Elucidating the role of Syk kinase and Syk inh...  \n",
       "11   Elucidating the role of Syk kinase and Syk inh...  \n",
       "27   Enhanced Breast Cancer Risk Prediction from Im...  \n",
       "77   Enhanced Breast Cancer Risk Prediction from Im...  \n",
       "80          Epigenetic profiling of endometrial cancer  \n",
       "30          Epigenetic profiling of endometrial cancer  \n",
       "64   Evaluation of carcinogen exposure via genome-w...  \n",
       "18   Evaluation of carcinogen exposure via genome-w...  \n",
       "55   Examination of inhibitors of the ULK1 autophag...  \n",
       "54   Examination of inhibitors of the ULK1 autophag...  \n",
       "8    Examination of inhibitors of the ULK1 autophag...  \n",
       "67    FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma  \n",
       "66    FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma  \n",
       "20    FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma  \n",
       "1    Functional Roles for Histidine Kinase Signalin...  \n",
       "90   Identification of genes critical for the produ...  \n",
       "63   Identification of regulatory programs for glio...  \n",
       "17   Identification of regulatory programs for glio...  \n",
       "46   Identification of therapeutic targets of B-ALL...  \n",
       "97   Identification of therapeutic targets of B-ALL...  \n",
       "65   Impact of Metformin on Clonal Hematopoiesis an...  \n",
       "19   Impact of Metformin on Clonal Hematopoiesis an...  \n",
       "60   Improved Echocardiographic Diagnosis of Anthra...  \n",
       "13   Improved Echocardiographic Diagnosis of Anthra...  \n",
       "75   Inducing Cytosolic Chromatin Fragments in Canc...  \n",
       "25   Inducing Cytosolic Chromatin Fragments in Canc...  \n",
       "21   Inhibiting Liver Cancer Stem Cells to Improve ...  \n",
       "68   Inhibiting Liver Cancer Stem Cells to Improve ...  \n",
       "69   Inhibiting Liver Cancer Stem Cells to Improve ...  \n",
       "36   Investigating the Efficacy of radium-223 with ...  \n",
       "85   Investigating the Efficacy of radium-223 with ...  \n",
       "38   Irreversible electroporation as an In Situ vac...  \n",
       "87   Irreversible electroporation as an In Situ vac...  \n",
       "22   Knowledge-based planning and treatment decisio...  \n",
       "71   Knowledge-based planning and treatment decisio...  \n",
       "70   Knowledge-based planning and treatment decisio...  \n",
       "86   Low Dose Chemotherapy for Immuno-activation in...  \n",
       "37   Low Dose Chemotherapy for Immuno-activation in...  \n",
       "16      Microbe-Associated Colorectal Cancer (M.A.C.S)  \n",
       "79      Microbe-Associated Colorectal Cancer (M.A.C.S)  \n",
       "73   Natural Killer Cells for Treatment of Medullob...  \n",
       "56   Neoantigen-specific T cell responses in except...  \n",
       "9    Neoantigen-specific T cell responses in except...  \n",
       "5                   New Therapies for Myeloid Leukemia  \n",
       "50                  New Therapies for Myeloid Leukemia  \n",
       "51                  New Therapies for Myeloid Leukemia  \n",
       "14   Novel Pathways Regulated by NME1 in Neuroblastoma  \n",
       "48   Novel kinase inhibitors in combination with re...  \n",
       "88   Oncogenic Regulation of B-Lymphomagenesis by t...  \n",
       "39   Oncogenic Regulation of B-Lymphomagenesis by t...  \n",
       "6    Peptide Targeted Delivery of Epigenetic Therap...  \n",
       "52   Peptide Targeted Delivery of Epigenetic Therap...  \n",
       "53           Precision Interception of Gastric Cancers  \n",
       "7            Precision Interception of Gastric Cancers  \n",
       "26   Responses of Melanoma Patients to Checkpoint I...  \n",
       "76   Responses of Melanoma Patients to Checkpoint I...  \n",
       "29   Targeting A Therapeutic Vulnerability in PTEN-...  \n",
       "23   Targeting CD114 Signaling in Pediatric Medullo...  \n",
       "72   Targeting CD114 Signaling in Pediatric Medullo...  \n",
       "74                     Targeting FZD7 in human cancers  \n",
       "24                     Targeting FZD7 in human cancers  \n",
       "91   Targeting cellular mechanotransduction in brea...  \n",
       "41   Targeting cellular mechanotransduction in brea...  \n",
       "43   Tissue-specific role of SMARCB1 in pediatric r...  \n",
       "94   Tissue-specific role of SMARCB1 in pediatric r...  \n",
       "82   Transcriptomic, epigenomic profiling to reveal...  \n",
       "32   Transcriptomic, epigenomic profiling to reveal...  \n",
       "3    UCSD-UCSF Specialized Program of Research Exce...  \n",
       "49   UCSD-UCSF Specialized Program of Research Exce...  \n",
       "78   Understanding and Targeting NRF2 in Pancreatic...  \n",
       "28   Understanding and Targeting NRF2 in Pancreatic...  "
      ]
     },
     "execution_count": 121,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pd.set_option('display.max_rows', None)\n",
    "afs.sort_values(by='Project Title')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 122,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Get distribution of afs status\n",
    "\n",
    "afs_status = []\n",
    "afs_amt = []\n",
    "for col in afs.columns[:-1]:\n",
    "  if 'Amount' in col:\n",
    "    afs_amt += afs[col].tolist()\n",
    "    continue\n",
    "  afs_status += afs[col].tolist()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 123,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Awarded      69\n",
       "Submitted    18\n",
       "Planned       5\n",
       "dtype: int64"
      ]
     },
     "execution_count": 123,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pd.Series(afs_status).value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 124,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "100927267.0"
      ]
     },
     "execution_count": 124,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "np.sum(pd.Series(afs_amt).fillna(0))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 125,
   "metadata": {},
   "outputs": [],
   "source": [
    "afs_status = query_by_columns(afs, r'[AFS]{3}\\s{1}Status').drop(columns=['Project Title'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 126,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>First AFS Status</th>\n",
       "      <th>Second AFS Status</th>\n",
       "      <th>Third AFS Status</th>\n",
       "      <th>Fourth AFS Status</th>\n",
       "      <th>Fifth AFS Status</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>Submitted</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Submitted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>Planned</td>\n",
       "      <td>Submitted</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>Planned</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>Submitted</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>Planned</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Awarded</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Awarded</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>Planned</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>54</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>55</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>58</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>59</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>60</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>61</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>63</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>64</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>65</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>66</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>67</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>68</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>69</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>71</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>72</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>73</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>74</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>76</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>77</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>78</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>79</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>80</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>81</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>82</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>83</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>84</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>85</th>\n",
       "      <td>Planned</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>86</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>87</th>\n",
       "      <td>Submitted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>88</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>89</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>90</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>91</th>\n",
       "      <td>Submitted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>92</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>93</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>94</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>96</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>97</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>98</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>99</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>100</th>\n",
       "      <td>Awarded</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>Submitted</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>101</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    First AFS Status Second AFS Status Third AFS Status Fourth AFS Status  \\\n",
       "0            Awarded               NaN              NaN               NaN   \n",
       "1            Awarded           Awarded        Submitted         Submitted   \n",
       "2            Awarded               NaN              NaN               NaN   \n",
       "3          Submitted               NaN              NaN               NaN   \n",
       "4            Awarded               NaN              NaN               NaN   \n",
       "5                NaN               NaN              NaN               NaN   \n",
       "6            Awarded               NaN              NaN               NaN   \n",
       "7            Awarded               NaN              NaN               NaN   \n",
       "8                NaN               NaN              NaN               NaN   \n",
       "9                NaN               NaN              NaN               NaN   \n",
       "10               NaN               NaN              NaN               NaN   \n",
       "11           Awarded               NaN              NaN               NaN   \n",
       "12               NaN               NaN              NaN               NaN   \n",
       "13               NaN               NaN              NaN               NaN   \n",
       "14           Awarded         Submitted        Submitted           Planned   \n",
       "15           Awarded           Awarded          Awarded               NaN   \n",
       "16           Planned               NaN              NaN               NaN   \n",
       "17           Awarded               NaN              NaN               NaN   \n",
       "18               NaN               NaN              NaN               NaN   \n",
       "19               NaN               NaN              NaN               NaN   \n",
       "20           Awarded               NaN              NaN               NaN   \n",
       "21           Awarded         Submitted              NaN               NaN   \n",
       "22               NaN               NaN              NaN               NaN   \n",
       "23         Submitted         Submitted        Submitted         Submitted   \n",
       "24           Awarded           Awarded              NaN               NaN   \n",
       "25               NaN               NaN              NaN               NaN   \n",
       "26           Awarded           Awarded              NaN               NaN   \n",
       "27           Awarded               NaN              NaN               NaN   \n",
       "28               NaN               NaN              NaN               NaN   \n",
       "29               NaN               NaN              NaN               NaN   \n",
       "30               NaN               NaN              NaN               NaN   \n",
       "31           Awarded         Submitted          Awarded           Awarded   \n",
       "32           Awarded               NaN              NaN               NaN   \n",
       "33           Awarded               NaN              NaN               NaN   \n",
       "34               NaN               NaN              NaN               NaN   \n",
       "35           Awarded           Awarded              NaN               NaN   \n",
       "36           Awarded               NaN              NaN               NaN   \n",
       "37               NaN               NaN              NaN               NaN   \n",
       "38           Awarded         Submitted              NaN               NaN   \n",
       "39           Awarded               NaN              NaN               NaN   \n",
       "40           Awarded           Awarded              NaN               NaN   \n",
       "41           Awarded           Awarded          Awarded               NaN   \n",
       "42           Awarded           Awarded              NaN               NaN   \n",
       "43               NaN               NaN              NaN               NaN   \n",
       "44           Awarded           Awarded          Awarded               NaN   \n",
       "45               NaN               NaN              NaN               NaN   \n",
       "46           Awarded           Awarded              NaN               NaN   \n",
       "47           Awarded               NaN              NaN               NaN   \n",
       "48           Awarded           Awarded          Awarded           Awarded   \n",
       "49               NaN               NaN              NaN               NaN   \n",
       "50               NaN               NaN              NaN               NaN   \n",
       "51               NaN               NaN              NaN               NaN   \n",
       "52           Planned               NaN              NaN               NaN   \n",
       "53           Awarded               NaN              NaN               NaN   \n",
       "54               NaN               NaN              NaN               NaN   \n",
       "55               NaN               NaN              NaN               NaN   \n",
       "56               NaN               NaN              NaN               NaN   \n",
       "57               NaN               NaN              NaN               NaN   \n",
       "58               NaN               NaN              NaN               NaN   \n",
       "59               NaN               NaN              NaN               NaN   \n",
       "60           Awarded               NaN              NaN               NaN   \n",
       "61               NaN               NaN              NaN               NaN   \n",
       "62           Awarded               NaN              NaN               NaN   \n",
       "63           Awarded               NaN              NaN               NaN   \n",
       "64               NaN               NaN              NaN               NaN   \n",
       "65           Awarded               NaN              NaN               NaN   \n",
       "66           Awarded               NaN              NaN               NaN   \n",
       "67           Awarded               NaN              NaN               NaN   \n",
       "68               NaN               NaN              NaN               NaN   \n",
       "69               NaN               NaN              NaN               NaN   \n",
       "70               NaN               NaN              NaN               NaN   \n",
       "71               NaN               NaN              NaN               NaN   \n",
       "72               NaN               NaN              NaN               NaN   \n",
       "73           Awarded               NaN              NaN               NaN   \n",
       "74           Awarded               NaN              NaN               NaN   \n",
       "75           Awarded               NaN              NaN               NaN   \n",
       "76               NaN               NaN              NaN               NaN   \n",
       "77               NaN               NaN              NaN               NaN   \n",
       "78               NaN               NaN              NaN               NaN   \n",
       "79               NaN               NaN              NaN               NaN   \n",
       "80               NaN               NaN              NaN               NaN   \n",
       "81               NaN               NaN              NaN               NaN   \n",
       "82               NaN               NaN              NaN               NaN   \n",
       "83               NaN               NaN              NaN               NaN   \n",
       "84           Awarded               NaN              NaN               NaN   \n",
       "85           Planned               NaN              NaN               NaN   \n",
       "86           Awarded               NaN              NaN               NaN   \n",
       "87         Submitted               NaN              NaN               NaN   \n",
       "88           Awarded               NaN              NaN               NaN   \n",
       "89               NaN               NaN              NaN               NaN   \n",
       "90               NaN               NaN              NaN               NaN   \n",
       "91         Submitted               NaN              NaN               NaN   \n",
       "92           Awarded           Awarded              NaN               NaN   \n",
       "93           Awarded           Awarded              NaN               NaN   \n",
       "94               NaN               NaN              NaN               NaN   \n",
       "95               NaN               NaN              NaN               NaN   \n",
       "96               NaN               NaN              NaN               NaN   \n",
       "97               NaN               NaN              NaN               NaN   \n",
       "98               NaN               NaN              NaN               NaN   \n",
       "99               NaN               NaN              NaN               NaN   \n",
       "100          Awarded           Awarded          Awarded         Submitted   \n",
       "101              NaN               NaN              NaN               NaN   \n",
       "\n",
       "    Fifth AFS Status  \n",
       "0                NaN  \n",
       "1          Submitted  \n",
       "2                NaN  \n",
       "3                NaN  \n",
       "4                NaN  \n",
       "5                NaN  \n",
       "6                NaN  \n",
       "7                NaN  \n",
       "8                NaN  \n",
       "9                NaN  \n",
       "10               NaN  \n",
       "11               NaN  \n",
       "12               NaN  \n",
       "13               NaN  \n",
       "14         Submitted  \n",
       "15               NaN  \n",
       "16               NaN  \n",
       "17               NaN  \n",
       "18               NaN  \n",
       "19               NaN  \n",
       "20               NaN  \n",
       "21               NaN  \n",
       "22               NaN  \n",
       "23           Planned  \n",
       "24               NaN  \n",
       "25               NaN  \n",
       "26               NaN  \n",
       "27               NaN  \n",
       "28               NaN  \n",
       "29               NaN  \n",
       "30               NaN  \n",
       "31           Awarded  \n",
       "32               NaN  \n",
       "33               NaN  \n",
       "34               NaN  \n",
       "35               NaN  \n",
       "36               NaN  \n",
       "37               NaN  \n",
       "38               NaN  \n",
       "39               NaN  \n",
       "40               NaN  \n",
       "41               NaN  \n",
       "42               NaN  \n",
       "43               NaN  \n",
       "44               NaN  \n",
       "45               NaN  \n",
       "46               NaN  \n",
       "47               NaN  \n",
       "48           Awarded  \n",
       "49               NaN  \n",
       "50               NaN  \n",
       "51               NaN  \n",
       "52               NaN  \n",
       "53               NaN  \n",
       "54               NaN  \n",
       "55               NaN  \n",
       "56               NaN  \n",
       "57               NaN  \n",
       "58               NaN  \n",
       "59               NaN  \n",
       "60               NaN  \n",
       "61               NaN  \n",
       "62               NaN  \n",
       "63               NaN  \n",
       "64               NaN  \n",
       "65               NaN  \n",
       "66               NaN  \n",
       "67               NaN  \n",
       "68               NaN  \n",
       "69               NaN  \n",
       "70               NaN  \n",
       "71               NaN  \n",
       "72               NaN  \n",
       "73               NaN  \n",
       "74               NaN  \n",
       "75               NaN  \n",
       "76               NaN  \n",
       "77               NaN  \n",
       "78               NaN  \n",
       "79               NaN  \n",
       "80               NaN  \n",
       "81               NaN  \n",
       "82               NaN  \n",
       "83               NaN  \n",
       "84               NaN  \n",
       "85               NaN  \n",
       "86               NaN  \n",
       "87               NaN  \n",
       "88               NaN  \n",
       "89               NaN  \n",
       "90               NaN  \n",
       "91               NaN  \n",
       "92               NaN  \n",
       "93               NaN  \n",
       "94               NaN  \n",
       "95               NaN  \n",
       "96               NaN  \n",
       "97               NaN  \n",
       "98               NaN  \n",
       "99               NaN  \n",
       "100        Submitted  \n",
       "101              NaN  "
      ]
     },
     "execution_count": 126,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "afs_status"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 127,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.plotly.v1+json": {
       "config": {
        "plotlyServerURL": "https://plot.ly"
       },
       "data": [
        {
         "alignmentgroup": "True",
         "bingroup": "x",
         "hovertemplate": "Additional Funding Source #=First AFS Status<br>status=%{x}<br>count=%{y}<extra></extra>",
         "legendgroup": "First AFS Status",
         "marker": {
          "color": "#3283FE",
          "opacity": 0.8,
          "pattern": {
           "shape": ""
          }
         },
         "name": "First AFS Status",
         "offsetgroup": "First AFS Status",
         "orientation": "v",
         "showlegend": true,
         "type": "histogram",
         "x": [
          "Awarded",
          "Awarded",
          "Awarded",
          "Submitted",
          "Awarded",
          null,
          "Awarded",
          "Awarded",
          null,
          null,
          null,
          "Awarded",
          null,
          null,
          "Awarded",
          "Awarded",
          "Planned",
          "Awarded",
          null,
          null,
          "Awarded",
          "Awarded",
          null,
          "Submitted",
          "Awarded",
          null,
          "Awarded",
          "Awarded",
          null,
          null,
          null,
          "Awarded",
          "Awarded",
          "Awarded",
          null,
          "Awarded",
          "Awarded",
          null,
          "Awarded",
          "Awarded",
          "Awarded",
          "Awarded",
          "Awarded",
          null,
          "Awarded",
          null,
          "Awarded",
          "Awarded",
          "Awarded",
          null,
          null,
          null,
          "Planned",
          "Awarded",
          null,
          null,
          null,
          null,
          null,
          null,
          "Awarded",
          null,
          "Awarded",
          "Awarded",
          null,
          "Awarded",
          "Awarded",
          "Awarded",
          null,
          null,
          null,
          null,
          null,
          "Awarded",
          "Awarded",
          "Awarded",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Awarded",
          "Planned",
          "Awarded",
          "Submitted",
          "Awarded",
          null,
          null,
          "Submitted",
          "Awarded",
          "Awarded",
          null,
          null,
          null,
          null,
          null,
          null,
          "Awarded",
          null
         ],
         "xaxis": "x",
         "yaxis": "y"
        },
        {
         "alignmentgroup": "True",
         "bingroup": "x",
         "hovertemplate": "Additional Funding Source #=Second AFS Status<br>status=%{x}<br>count=%{y}<extra></extra>",
         "legendgroup": "Second AFS Status",
         "marker": {
          "color": "#F6222E",
          "opacity": 0.8,
          "pattern": {
           "shape": ""
          }
         },
         "name": "Second AFS Status",
         "offsetgroup": "Second AFS Status",
         "orientation": "v",
         "showlegend": true,
         "type": "histogram",
         "x": [
          null,
          "Awarded",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Submitted",
          "Awarded",
          null,
          null,
          null,
          null,
          null,
          "Submitted",
          null,
          "Submitted",
          "Awarded",
          null,
          "Awarded",
          null,
          null,
          null,
          null,
          "Submitted",
          null,
          null,
          null,
          "Awarded",
          null,
          null,
          "Submitted",
          null,
          "Awarded",
          "Awarded",
          "Awarded",
          null,
          "Awarded",
          null,
          "Awarded",
          null,
          "Awarded",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Awarded",
          "Awarded",
          null,
          null,
          null,
          null,
          null,
          null,
          "Awarded",
          null
         ],
         "xaxis": "x",
         "yaxis": "y"
        },
        {
         "alignmentgroup": "True",
         "bingroup": "x",
         "hovertemplate": "Additional Funding Source #=Third AFS Status<br>status=%{x}<br>count=%{y}<extra></extra>",
         "legendgroup": "Third AFS Status",
         "marker": {
          "color": "#DEA0FD",
          "opacity": 0.8,
          "pattern": {
           "shape": ""
          }
         },
         "name": "Third AFS Status",
         "offsetgroup": "Third AFS Status",
         "orientation": "v",
         "showlegend": true,
         "type": "histogram",
         "x": [
          null,
          "Submitted",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Submitted",
          "Awarded",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Submitted",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Awarded",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Awarded",
          null,
          null,
          "Awarded",
          null,
          null,
          null,
          "Awarded",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Awarded",
          null
         ],
         "xaxis": "x",
         "yaxis": "y"
        },
        {
         "alignmentgroup": "True",
         "bingroup": "x",
         "hovertemplate": "Additional Funding Source #=Fourth AFS Status<br>status=%{x}<br>count=%{y}<extra></extra>",
         "legendgroup": "Fourth AFS Status",
         "marker": {
          "color": "#FE00FA",
          "opacity": 0.8,
          "pattern": {
           "shape": ""
          }
         },
         "name": "Fourth AFS Status",
         "offsetgroup": "Fourth AFS Status",
         "orientation": "v",
         "showlegend": true,
         "type": "histogram",
         "x": [
          null,
          "Submitted",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Planned",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Submitted",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Awarded",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Awarded",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Submitted",
          null
         ],
         "xaxis": "x",
         "yaxis": "y"
        },
        {
         "alignmentgroup": "True",
         "bingroup": "x",
         "hovertemplate": "Additional Funding Source #=Fifth AFS Status<br>status=%{x}<br>count=%{y}<extra></extra>",
         "legendgroup": "Fifth AFS Status",
         "marker": {
          "color": "#325A9B",
          "opacity": 0.8,
          "pattern": {
           "shape": ""
          }
         },
         "name": "Fifth AFS Status",
         "offsetgroup": "Fifth AFS Status",
         "orientation": "v",
         "showlegend": true,
         "type": "histogram",
         "x": [
          null,
          "Submitted",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Submitted",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Planned",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Awarded",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Awarded",
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          null,
          "Submitted",
          null
         ],
         "xaxis": "x",
         "yaxis": "y"
        }
       ],
       "layout": {
        "barmode": "relative",
        "legend": {
         "title": {
          "text": "Additional Funding Source #"
         },
         "tracegroupgap": 0
        },
        "template": {
         "data": {
          "bar": [
           {
            "error_x": {
             "color": "#2a3f5f"
            },
            "error_y": {
             "color": "#2a3f5f"
            },
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "bar"
           }
          ],
          "barpolar": [
           {
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "barpolar"
           }
          ],
          "carpet": [
           {
            "aaxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "baxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "type": "carpet"
           }
          ],
          "choropleth": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "choropleth"
           }
          ],
          "contour": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "contour"
           }
          ],
          "contourcarpet": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "contourcarpet"
           }
          ],
          "heatmap": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "heatmap"
           }
          ],
          "heatmapgl": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "heatmapgl"
           }
          ],
          "histogram": [
           {
            "marker": {
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "histogram"
           }
          ],
          "histogram2d": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "histogram2d"
           }
          ],
          "histogram2dcontour": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "histogram2dcontour"
           }
          ],
          "mesh3d": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "mesh3d"
           }
          ],
          "parcoords": [
           {
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "parcoords"
           }
          ],
          "pie": [
           {
            "automargin": true,
            "type": "pie"
           }
          ],
          "scatter": [
           {
            "fillpattern": {
             "fillmode": "overlay",
             "size": 10,
             "solidity": 0.2
            },
            "type": "scatter"
           }
          ],
          "scatter3d": [
           {
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatter3d"
           }
          ],
          "scattercarpet": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattercarpet"
           }
          ],
          "scattergeo": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattergeo"
           }
          ],
          "scattergl": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattergl"
           }
          ],
          "scattermapbox": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattermapbox"
           }
          ],
          "scatterpolar": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterpolar"
           }
          ],
          "scatterpolargl": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterpolargl"
           }
          ],
          "scatterternary": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterternary"
           }
          ],
          "surface": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "surface"
           }
          ],
          "table": [
           {
            "cells": {
             "fill": {
              "color": "#EBF0F8"
             },
             "line": {
              "color": "white"
             }
            },
            "header": {
             "fill": {
              "color": "#C8D4E3"
             },
             "line": {
              "color": "white"
             }
            },
            "type": "table"
           }
          ]
         },
         "layout": {
          "annotationdefaults": {
           "arrowcolor": "#2a3f5f",
           "arrowhead": 0,
           "arrowwidth": 1
          },
          "autotypenumbers": "strict",
          "coloraxis": {
           "colorbar": {
            "outlinewidth": 0,
            "ticks": ""
           }
          },
          "colorscale": {
           "diverging": [
            [
             0,
             "#8e0152"
            ],
            [
             0.1,
             "#c51b7d"
            ],
            [
             0.2,
             "#de77ae"
            ],
            [
             0.3,
             "#f1b6da"
            ],
            [
             0.4,
             "#fde0ef"
            ],
            [
             0.5,
             "#f7f7f7"
            ],
            [
             0.6,
             "#e6f5d0"
            ],
            [
             0.7,
             "#b8e186"
            ],
            [
             0.8,
             "#7fbc41"
            ],
            [
             0.9,
             "#4d9221"
            ],
            [
             1,
             "#276419"
            ]
           ],
           "sequential": [
            [
             0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1,
             "#f0f921"
            ]
           ],
           "sequentialminus": [
            [
             0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1,
             "#f0f921"
            ]
           ]
          },
          "colorway": [
           "#636efa",
           "#EF553B",
           "#00cc96",
           "#ab63fa",
           "#FFA15A",
           "#19d3f3",
           "#FF6692",
           "#B6E880",
           "#FF97FF",
           "#FECB52"
          ],
          "font": {
           "color": "#2a3f5f"
          },
          "geo": {
           "bgcolor": "white",
           "lakecolor": "white",
           "landcolor": "#E5ECF6",
           "showlakes": true,
           "showland": true,
           "subunitcolor": "white"
          },
          "hoverlabel": {
           "align": "left"
          },
          "hovermode": "closest",
          "mapbox": {
           "style": "light"
          },
          "paper_bgcolor": "white",
          "plot_bgcolor": "#E5ECF6",
          "polar": {
           "angularaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "bgcolor": "#E5ECF6",
           "radialaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "scene": {
           "xaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           },
           "yaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           },
           "zaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           }
          },
          "shapedefaults": {
           "line": {
            "color": "#2a3f5f"
           }
          },
          "ternary": {
           "aaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "baxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "bgcolor": "#E5ECF6",
           "caxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "title": {
           "x": 0.05
          },
          "xaxis": {
           "automargin": true,
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "zerolinewidth": 2
          },
          "yaxis": {
           "automargin": true,
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "zerolinewidth": 2
          }
         }
        },
        "title": {
         "text": "Additional Funding Achieved by Status<br><sup>Percentage of projects w/ additional funding (planned, submitted, awarded): 73% | Total Amount: $100,927,267</sup>"
        },
        "xaxis": {
         "anchor": "y",
         "domain": [
          0,
          1
         ],
         "title": {
          "text": "status"
         }
        },
        "yaxis": {
         "anchor": "x",
         "domain": [
          0,
          1
         ],
         "title": {
          "text": "count"
         }
        }
       }
      }
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Plot distribution \n",
    "\n",
    "# How many additional funding sources have you planned, submitted, or been awarded (directly or indirectly) as a result of this Padres Pedal the Cause support? (e.g., grants of any type, awards, philanthropy, etc.)?\n",
    "\n",
    "afs_status_fig = px.histogram(afs_status, \\\n",
    "    title='Additional Funding Achieved by Status<br><sup>Percentage of projects w/ additional funding (planned, submitted, awarded): 73% | Total Amount: $100,927,267</sup>',\n",
    "    color_discrete_sequence=[blue, red]+ px.colors.qualitative.Alphabet[11:],\n",
    "    opacity=0.80,\n",
    "    labels={'value': 'status', 'variable': 'Additional Funding Source #'})\n",
    "afs_status_fig"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 128,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Successfully saved additional_funding.csv at: processed\\additional_funding.csv\n"
     ]
    }
   ],
   "source": [
    "# Export to plot in Tableau\n",
    "\n",
    "# afs_status.set_index('Project Title', drop=True, inplace=True)\n",
    "export_data('processed', afs_status, 'additional_funding.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 129,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1    71\n",
       "dtype: int64"
      ]
     },
     "execution_count": 129,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pillar_status.sum(axis=1).value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 130,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Policy Influence</th>\n",
       "      <th>International (pol)</th>\n",
       "      <th>National (pol)</th>\n",
       "      <th>Local (pol)</th>\n",
       "      <th>General Public (pol)</th>\n",
       "      <th>Healthcare Professionals (pol)</th>\n",
       "      <th>Patients (pol)</th>\n",
       "      <th>Patient Families (pol)</th>\n",
       "      <th>Policy Benefits Description</th>\n",
       "      <th>Project Title</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Detecting dysregulated genes in neuroblastoma ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Functional Roles for Histidine Kinase Signalin...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A National Phase I Study of Cabozantinib in Co...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A Phase 1B, Nonrandomized Trial Investigating ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>New Therapies for Myeloid Leukemia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Peptide Targeted Delivery of Epigenetic Therap...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Precision Interception of Gastric Cancers</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Examination of inhibitors of the ULK1 autophag...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Our project could improve guidelines as to how...</td>\n",
       "      <td>Neoantigen-specific T cell responses in except...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Defining the mechanisms of pancreatic cancer s...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Elucidating the role of Syk kinase and Syk inh...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A pilot trial to test the benefit of real time...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Improved Echocardiographic Diagnosis of Anthra...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Novel Pathways Regulated by NME1 in Neuroblastoma</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Characterization of a GOLPH3 Pathway Inhibitor...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Microbe-Associated Colorectal Cancer (M.A.C.S)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Identification of regulatory programs for glio...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Evaluation of carcinogen exposure via genome-w...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>WIll better delineate the burden of clonal hem...</td>\n",
       "      <td>Impact of Metformin on Clonal Hematopoiesis an...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inhibiting Liver Cancer Stem Cells to Improve ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>These tools can help healthcare professionals ...</td>\n",
       "      <td>Knowledge-based planning and treatment decisio...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Targeting CD114 Signaling in Pediatric Medullo...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Targeting FZD7 in human cancers</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inducing Cytosolic Chromatin Fragments in Canc...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Responses of Melanoma Patients to Checkpoint I...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Enhanced Breast Cancer Risk Prediction from Im...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Understanding and Targeting NRF2 in Pancreatic...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Targeting A Therapeutic Vulnerability in PTEN-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Epigenetic profiling of endometrial cancer</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>The navigation intervention could potentially ...</td>\n",
       "      <td>Development and Implementation of a Peer-Navig...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Transcriptomic, epigenomic profiling to reveal...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A Phase 1b Safety and Feasibility Study of Per...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A Phase 1b pilot clinical trial of cirmtuzumab...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Potential to influence NCCN guidelines.</td>\n",
       "      <td>An Open-Label, Phase 2 Efficacy Study of Temoz...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Investigating the Efficacy of radium-223 with ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Low Dose Chemotherapy for Immuno-activation in...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Irreversible electroporation as an In Situ vac...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Oncogenic Regulation of B-Lymphomagenesis by t...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>An over-expressed GPCR in pancreatic cancer as...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Targeting cellular mechanotransduction in brea...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>E cigarette related policies</td>\n",
       "      <td>Decoding Colon Cancers Using Boolean Principles</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Tissue-specific role of SMARCB1 in pediatric r...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Adding genomics to the EMR in Epic.</td>\n",
       "      <td>Deciphering the role of RNA editing in leukemi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Discovery of non-coding oncogenic mutations in...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Identification of therapeutic targets of B-ALL...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Developing targeted therapy for Ewing sarcoma ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Novel kinase inhibitors in combination with re...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>New Therapies for Myeloid Leukemia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>New Therapies for Myeloid Leukemia</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Peptide Targeted Delivery of Epigenetic Therap...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>The development of tumor specific probes for g...</td>\n",
       "      <td>Precision Interception of Gastric Cancers</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>54</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Examination of inhibitors of the ULK1 autophag...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>55</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Examination of inhibitors of the ULK1 autophag...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Our project could improve guidelines as to how...</td>\n",
       "      <td>Neoantigen-specific T cell responses in except...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Defining the mechanisms of pancreatic cancer s...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>58</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Elucidating the role of Syk kinase and Syk inh...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>59</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A pilot trial to test the benefit of real time...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>60</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Improved Echocardiographic Diagnosis of Anthra...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>61</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Detecting dysregulated genes in neuroblastoma ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Characterization of a GOLPH3 Pathway Inhibitor...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>63</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Identification of regulatory programs for glio...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>64</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Evaluation of carcinogen exposure via genome-w...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>65</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Impact of Metformin on Clonal Hematopoiesis an...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>66</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>67</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>68</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inhibiting Liver Cancer Stem Cells to Improve ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>69</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inhibiting Liver Cancer Stem Cells to Improve ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>These tools can help healthcare professionals ...</td>\n",
       "      <td>Knowledge-based planning and treatment decisio...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>71</th>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>To make brachy more automated and clinical</td>\n",
       "      <td>Knowledge-based planning and treatment decisio...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>72</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Targeting CD114 Signaling in Pediatric Medullo...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>73</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Natural Killer Cells for Treatment of Medullob...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>74</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Targeting FZD7 in human cancers</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inducing Cytosolic Chromatin Fragments in Canc...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>76</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Responses of Melanoma Patients to Checkpoint I...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>77</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Enhanced Breast Cancer Risk Prediction from Im...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>78</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Understanding and Targeting NRF2 in Pancreatic...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>79</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Microbe-Associated Colorectal Cancer (M.A.C.S)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>80</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Epigenetic profiling of endometrial cancer</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>81</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>The navigator intervention could potentially b...</td>\n",
       "      <td>Development and Implementation of a Peer-Navig...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>82</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Transcriptomic, epigenomic profiling to reveal...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>83</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A Phase 1b pilot clinical trial of cirmtuzumab...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>84</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>An Open-Label, Phase 2 Efficacy Study of Temoz...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>85</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>These studies on the immune compartment may le...</td>\n",
       "      <td>Investigating the Efficacy of radium-223 with ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>86</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Low Dose Chemotherapy for Immuno-activation in...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>87</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Irreversible electroporation as an In Situ vac...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>88</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Oncogenic Regulation of B-Lymphomagenesis by t...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>89</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>An over-expressed GPCR in pancreatic cancer as...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>90</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Identification of genes critical for the produ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>91</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Targeting cellular mechanotransduction in brea...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>92</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Decoding Colon Cancers Using Boolean Principles</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>93</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Decoding Colon Cancers Using Boolean Principles</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>94</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Tissue-specific role of SMARCB1 in pediatric r...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Discovery of non-coding oncogenic mutations in...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>96</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Discovery of non-coding oncogenic mutations in...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>97</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Identification of therapeutic targets of B-ALL...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>98</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Developing targeted therapy for Ewing sarcoma ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>99</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Defining the mechanisms of pancreatic cancer s...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>100</th>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A Novel Role for Histidine Kinase Activity in ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>101</th>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A Novel Role for Histidine Kinase Activity in ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     Policy Influence  International (pol)  National (pol)  Local (pol)  \\\n",
       "0                True                False           False        False   \n",
       "1                True                False           False        False   \n",
       "2                True                False           False        False   \n",
       "3                True                False           False        False   \n",
       "4                True                False           False        False   \n",
       "5                True                False           False        False   \n",
       "6                True                False           False        False   \n",
       "7                True                False           False        False   \n",
       "8                True                False           False        False   \n",
       "9                True                False           False        False   \n",
       "10               True                False           False        False   \n",
       "11               True                False           False        False   \n",
       "12               True                False           False        False   \n",
       "13               True                False           False        False   \n",
       "14               True                False           False        False   \n",
       "15               True                False           False        False   \n",
       "16               True                False           False        False   \n",
       "17               True                False           False        False   \n",
       "18               True                False           False        False   \n",
       "19               True                 True           False        False   \n",
       "20               True                False           False        False   \n",
       "21               True                False           False        False   \n",
       "22               True                 True            True         True   \n",
       "23               True                False           False        False   \n",
       "24               True                False           False        False   \n",
       "25               True                False           False        False   \n",
       "26               True                False           False        False   \n",
       "27               True                False           False        False   \n",
       "28               True                False           False        False   \n",
       "29               True                False           False        False   \n",
       "30               True                False           False        False   \n",
       "31               True                False            True         True   \n",
       "32               True                False           False        False   \n",
       "33               True                False           False        False   \n",
       "34               True                False           False        False   \n",
       "35               True                False            True        False   \n",
       "36               True                False           False        False   \n",
       "37               True                False           False        False   \n",
       "38               True                False           False        False   \n",
       "39               True                False           False        False   \n",
       "40               True                False           False        False   \n",
       "41               True                False           False        False   \n",
       "42               True                False           False        False   \n",
       "43               True                False           False        False   \n",
       "44               True                False           False        False   \n",
       "45               True                False           False        False   \n",
       "46               True                False           False        False   \n",
       "47               True                False           False        False   \n",
       "48               True                False           False        False   \n",
       "49               True                False           False        False   \n",
       "50               True                False           False        False   \n",
       "51               True                False           False        False   \n",
       "52               True                False           False        False   \n",
       "53               True                 True            True        False   \n",
       "54               True                False           False        False   \n",
       "55               True                False           False        False   \n",
       "56               True                False           False        False   \n",
       "57               True                False           False        False   \n",
       "58               True                False           False        False   \n",
       "59               True                 True            True         True   \n",
       "60               True                False           False        False   \n",
       "61               True                False           False        False   \n",
       "62               True                False           False        False   \n",
       "63               True                False           False        False   \n",
       "64               True                False           False        False   \n",
       "65               True                False           False        False   \n",
       "66               True                False           False        False   \n",
       "67               True                False           False        False   \n",
       "68               True                False           False        False   \n",
       "69               True                False           False        False   \n",
       "70               True                 True            True         True   \n",
       "71               True                 True            True         True   \n",
       "72               True                False           False        False   \n",
       "73               True                False           False        False   \n",
       "74               True                False           False        False   \n",
       "75               True                False           False        False   \n",
       "76               True                False           False        False   \n",
       "77               True                False           False        False   \n",
       "78               True                False           False        False   \n",
       "79               True                False           False        False   \n",
       "80               True                False           False        False   \n",
       "81               True                False            True         True   \n",
       "82               True                False           False        False   \n",
       "83               True                False           False        False   \n",
       "84               True                False           False        False   \n",
       "85               True                False            True        False   \n",
       "86               True                False           False        False   \n",
       "87               True                False           False        False   \n",
       "88               True                False           False        False   \n",
       "89               True                False           False        False   \n",
       "90               True                False           False        False   \n",
       "91               True                False           False        False   \n",
       "92               True                False           False        False   \n",
       "93               True                False           False        False   \n",
       "94               True                False           False        False   \n",
       "95               True                False           False        False   \n",
       "96               True                False           False        False   \n",
       "97               True                False           False        False   \n",
       "98               True                False           False        False   \n",
       "99               True                False           False        False   \n",
       "100              True                False           False        False   \n",
       "101             False                False           False        False   \n",
       "\n",
       "     General Public (pol)  Healthcare Professionals (pol)  Patients (pol)  \\\n",
       "0                   False                           False           False   \n",
       "1                   False                           False           False   \n",
       "2                   False                           False           False   \n",
       "3                   False                           False           False   \n",
       "4                   False                           False           False   \n",
       "5                   False                           False           False   \n",
       "6                   False                           False           False   \n",
       "7                   False                           False           False   \n",
       "8                   False                           False           False   \n",
       "9                    True                           False            True   \n",
       "10                  False                           False           False   \n",
       "11                  False                           False           False   \n",
       "12                  False                           False           False   \n",
       "13                  False                           False           False   \n",
       "14                  False                           False           False   \n",
       "15                  False                           False           False   \n",
       "16                  False                           False           False   \n",
       "17                  False                           False           False   \n",
       "18                  False                           False           False   \n",
       "19                  False                           False           False   \n",
       "20                  False                           False           False   \n",
       "21                  False                           False           False   \n",
       "22                  False                            True            True   \n",
       "23                  False                           False           False   \n",
       "24                  False                           False           False   \n",
       "25                  False                           False           False   \n",
       "26                  False                           False           False   \n",
       "27                  False                           False           False   \n",
       "28                  False                           False           False   \n",
       "29                  False                           False           False   \n",
       "30                  False                           False           False   \n",
       "31                   True                            True            True   \n",
       "32                  False                           False           False   \n",
       "33                  False                           False           False   \n",
       "34                  False                           False           False   \n",
       "35                  False                           False           False   \n",
       "36                  False                           False           False   \n",
       "37                  False                           False           False   \n",
       "38                  False                           False           False   \n",
       "39                  False                           False           False   \n",
       "40                  False                           False           False   \n",
       "41                  False                           False           False   \n",
       "42                   True                           False           False   \n",
       "43                  False                           False           False   \n",
       "44                  False                            True           False   \n",
       "45                  False                           False           False   \n",
       "46                  False                           False           False   \n",
       "47                  False                           False           False   \n",
       "48                  False                           False           False   \n",
       "49                  False                           False           False   \n",
       "50                  False                           False           False   \n",
       "51                  False                           False           False   \n",
       "52                  False                           False           False   \n",
       "53                  False                            True            True   \n",
       "54                  False                           False           False   \n",
       "55                  False                           False           False   \n",
       "56                   True                           False            True   \n",
       "57                  False                           False           False   \n",
       "58                  False                           False           False   \n",
       "59                  False                            True           False   \n",
       "60                  False                           False           False   \n",
       "61                  False                           False           False   \n",
       "62                  False                           False           False   \n",
       "63                  False                           False           False   \n",
       "64                  False                           False           False   \n",
       "65                  False                           False           False   \n",
       "66                  False                           False           False   \n",
       "67                  False                           False           False   \n",
       "68                  False                           False           False   \n",
       "69                  False                           False           False   \n",
       "70                  False                            True            True   \n",
       "71                   True                           False           False   \n",
       "72                  False                           False           False   \n",
       "73                  False                           False           False   \n",
       "74                  False                           False           False   \n",
       "75                  False                           False           False   \n",
       "76                  False                           False           False   \n",
       "77                  False                           False           False   \n",
       "78                  False                           False           False   \n",
       "79                  False                           False           False   \n",
       "80                  False                           False           False   \n",
       "81                   True                            True            True   \n",
       "82                  False                           False           False   \n",
       "83                  False                           False           False   \n",
       "84                  False                           False           False   \n",
       "85                  False                           False           False   \n",
       "86                  False                           False           False   \n",
       "87                  False                           False           False   \n",
       "88                  False                           False           False   \n",
       "89                  False                           False           False   \n",
       "90                  False                           False           False   \n",
       "91                  False                           False           False   \n",
       "92                  False                           False           False   \n",
       "93                  False                           False           False   \n",
       "94                  False                           False           False   \n",
       "95                  False                           False           False   \n",
       "96                  False                           False           False   \n",
       "97                  False                           False           False   \n",
       "98                  False                           False           False   \n",
       "99                  False                           False           False   \n",
       "100                 False                           False           False   \n",
       "101                 False                           False           False   \n",
       "\n",
       "     Patient Families (pol)  \\\n",
       "0                     False   \n",
       "1                     False   \n",
       "2                     False   \n",
       "3                     False   \n",
       "4                     False   \n",
       "5                     False   \n",
       "6                     False   \n",
       "7                     False   \n",
       "8                     False   \n",
       "9                     False   \n",
       "10                    False   \n",
       "11                    False   \n",
       "12                    False   \n",
       "13                    False   \n",
       "14                    False   \n",
       "15                    False   \n",
       "16                    False   \n",
       "17                    False   \n",
       "18                    False   \n",
       "19                    False   \n",
       "20                    False   \n",
       "21                    False   \n",
       "22                    False   \n",
       "23                    False   \n",
       "24                    False   \n",
       "25                    False   \n",
       "26                    False   \n",
       "27                    False   \n",
       "28                    False   \n",
       "29                    False   \n",
       "30                    False   \n",
       "31                     True   \n",
       "32                    False   \n",
       "33                    False   \n",
       "34                    False   \n",
       "35                    False   \n",
       "36                    False   \n",
       "37                    False   \n",
       "38                    False   \n",
       "39                    False   \n",
       "40                    False   \n",
       "41                    False   \n",
       "42                    False   \n",
       "43                    False   \n",
       "44                    False   \n",
       "45                    False   \n",
       "46                    False   \n",
       "47                    False   \n",
       "48                    False   \n",
       "49                    False   \n",
       "50                    False   \n",
       "51                    False   \n",
       "52                    False   \n",
       "53                    False   \n",
       "54                    False   \n",
       "55                    False   \n",
       "56                    False   \n",
       "57                    False   \n",
       "58                    False   \n",
       "59                    False   \n",
       "60                    False   \n",
       "61                    False   \n",
       "62                    False   \n",
       "63                    False   \n",
       "64                    False   \n",
       "65                    False   \n",
       "66                    False   \n",
       "67                    False   \n",
       "68                    False   \n",
       "69                    False   \n",
       "70                    False   \n",
       "71                    False   \n",
       "72                    False   \n",
       "73                    False   \n",
       "74                    False   \n",
       "75                    False   \n",
       "76                    False   \n",
       "77                    False   \n",
       "78                    False   \n",
       "79                    False   \n",
       "80                    False   \n",
       "81                     True   \n",
       "82                    False   \n",
       "83                    False   \n",
       "84                    False   \n",
       "85                    False   \n",
       "86                    False   \n",
       "87                    False   \n",
       "88                    False   \n",
       "89                    False   \n",
       "90                    False   \n",
       "91                    False   \n",
       "92                    False   \n",
       "93                    False   \n",
       "94                    False   \n",
       "95                    False   \n",
       "96                    False   \n",
       "97                    False   \n",
       "98                    False   \n",
       "99                    False   \n",
       "100                   False   \n",
       "101                   False   \n",
       "\n",
       "                           Policy Benefits Description  \\\n",
       "0                                                  NaN   \n",
       "1                                                  NaN   \n",
       "2                                                  NaN   \n",
       "3                                                  NaN   \n",
       "4                                                  NaN   \n",
       "5                                                  NaN   \n",
       "6                                                  NaN   \n",
       "7                                                  NaN   \n",
       "8                                                  NaN   \n",
       "9    Our project could improve guidelines as to how...   \n",
       "10                                                 NaN   \n",
       "11                                                 NaN   \n",
       "12                                                 NaN   \n",
       "13                                                 NaN   \n",
       "14                                                 NaN   \n",
       "15                                                 NaN   \n",
       "16                                                 NaN   \n",
       "17                                                 NaN   \n",
       "18                                                 NaN   \n",
       "19   WIll better delineate the burden of clonal hem...   \n",
       "20                                                 NaN   \n",
       "21                                                 NaN   \n",
       "22   These tools can help healthcare professionals ...   \n",
       "23                                                 NaN   \n",
       "24                                                 NaN   \n",
       "25                                                 NaN   \n",
       "26                                                 NaN   \n",
       "27                                                 NaN   \n",
       "28                                                 NaN   \n",
       "29                                                 NaN   \n",
       "30                                                 NaN   \n",
       "31   The navigation intervention could potentially ...   \n",
       "32                                                 NaN   \n",
       "33                                                 NaN   \n",
       "34                                                 NaN   \n",
       "35             Potential to influence NCCN guidelines.   \n",
       "36                                                 NaN   \n",
       "37                                                 NaN   \n",
       "38                                                 NaN   \n",
       "39                                                 NaN   \n",
       "40                                                 NaN   \n",
       "41                                                 NaN   \n",
       "42                        E cigarette related policies   \n",
       "43                                                 NaN   \n",
       "44                 Adding genomics to the EMR in Epic.   \n",
       "45                                                 NaN   \n",
       "46                                                 NaN   \n",
       "47                                                 NaN   \n",
       "48                                                 NaN   \n",
       "49                                                 NaN   \n",
       "50                                                 NaN   \n",
       "51                                                 NaN   \n",
       "52                                                 NaN   \n",
       "53   The development of tumor specific probes for g...   \n",
       "54                                                 NaN   \n",
       "55                                                 NaN   \n",
       "56   Our project could improve guidelines as to how...   \n",
       "57                                                 NaN   \n",
       "58                                                 NaN   \n",
       "59                                                 NaN   \n",
       "60                                                 NaN   \n",
       "61                                                 NaN   \n",
       "62                                                 NaN   \n",
       "63                                                 NaN   \n",
       "64                                                 NaN   \n",
       "65                                                 NaN   \n",
       "66                                                 NaN   \n",
       "67                                                 NaN   \n",
       "68                                                 NaN   \n",
       "69                                                 NaN   \n",
       "70   These tools can help healthcare professionals ...   \n",
       "71         To make brachy more automated and clinical    \n",
       "72                                                 NaN   \n",
       "73                                                 NaN   \n",
       "74                                                 NaN   \n",
       "75                                                 NaN   \n",
       "76                                                 NaN   \n",
       "77                                                 NaN   \n",
       "78                                                 NaN   \n",
       "79                                                 NaN   \n",
       "80                                                 NaN   \n",
       "81   The navigator intervention could potentially b...   \n",
       "82                                                 NaN   \n",
       "83                                                 NaN   \n",
       "84                                                 NaN   \n",
       "85   These studies on the immune compartment may le...   \n",
       "86                                                 NaN   \n",
       "87                                                 NaN   \n",
       "88                                                 NaN   \n",
       "89                                                 NaN   \n",
       "90                                                 NaN   \n",
       "91                                                 NaN   \n",
       "92                                                 NaN   \n",
       "93                                                 NaN   \n",
       "94                                                 NaN   \n",
       "95                                                 NaN   \n",
       "96                                                 NaN   \n",
       "97                                                 NaN   \n",
       "98                                                 NaN   \n",
       "99                                                 NaN   \n",
       "100                                                NaN   \n",
       "101                                                NaN   \n",
       "\n",
       "                                         Project Title  \n",
       "0    Detecting dysregulated genes in neuroblastoma ...  \n",
       "1    Functional Roles for Histidine Kinase Signalin...  \n",
       "2    A National Phase I Study of Cabozantinib in Co...  \n",
       "3    UCSD-UCSF Specialized Program of Research Exce...  \n",
       "4    A Phase 1B, Nonrandomized Trial Investigating ...  \n",
       "5                   New Therapies for Myeloid Leukemia  \n",
       "6    Peptide Targeted Delivery of Epigenetic Therap...  \n",
       "7            Precision Interception of Gastric Cancers  \n",
       "8    Examination of inhibitors of the ULK1 autophag...  \n",
       "9    Neoantigen-specific T cell responses in except...  \n",
       "10   Defining the mechanisms of pancreatic cancer s...  \n",
       "11   Elucidating the role of Syk kinase and Syk inh...  \n",
       "12   A pilot trial to test the benefit of real time...  \n",
       "13   Improved Echocardiographic Diagnosis of Anthra...  \n",
       "14   Novel Pathways Regulated by NME1 in Neuroblastoma  \n",
       "15   Characterization of a GOLPH3 Pathway Inhibitor...  \n",
       "16      Microbe-Associated Colorectal Cancer (M.A.C.S)  \n",
       "17   Identification of regulatory programs for glio...  \n",
       "18   Evaluation of carcinogen exposure via genome-w...  \n",
       "19   Impact of Metformin on Clonal Hematopoiesis an...  \n",
       "20    FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma  \n",
       "21   Inhibiting Liver Cancer Stem Cells to Improve ...  \n",
       "22   Knowledge-based planning and treatment decisio...  \n",
       "23   Targeting CD114 Signaling in Pediatric Medullo...  \n",
       "24                     Targeting FZD7 in human cancers  \n",
       "25   Inducing Cytosolic Chromatin Fragments in Canc...  \n",
       "26   Responses of Melanoma Patients to Checkpoint I...  \n",
       "27   Enhanced Breast Cancer Risk Prediction from Im...  \n",
       "28   Understanding and Targeting NRF2 in Pancreatic...  \n",
       "29   Targeting A Therapeutic Vulnerability in PTEN-...  \n",
       "30          Epigenetic profiling of endometrial cancer  \n",
       "31   Development and Implementation of a Peer-Navig...  \n",
       "32   Transcriptomic, epigenomic profiling to reveal...  \n",
       "33   A Phase 1b Safety and Feasibility Study of Per...  \n",
       "34   A Phase 1b pilot clinical trial of cirmtuzumab...  \n",
       "35   An Open-Label, Phase 2 Efficacy Study of Temoz...  \n",
       "36   Investigating the Efficacy of radium-223 with ...  \n",
       "37   Low Dose Chemotherapy for Immuno-activation in...  \n",
       "38   Irreversible electroporation as an In Situ vac...  \n",
       "39   Oncogenic Regulation of B-Lymphomagenesis by t...  \n",
       "40   An over-expressed GPCR in pancreatic cancer as...  \n",
       "41   Targeting cellular mechanotransduction in brea...  \n",
       "42     Decoding Colon Cancers Using Boolean Principles  \n",
       "43   Tissue-specific role of SMARCB1 in pediatric r...  \n",
       "44   Deciphering the role of RNA editing in leukemi...  \n",
       "45   Discovery of non-coding oncogenic mutations in...  \n",
       "46   Identification of therapeutic targets of B-ALL...  \n",
       "47   Developing targeted therapy for Ewing sarcoma ...  \n",
       "48   Novel kinase inhibitors in combination with re...  \n",
       "49   UCSD-UCSF Specialized Program of Research Exce...  \n",
       "50                  New Therapies for Myeloid Leukemia  \n",
       "51                  New Therapies for Myeloid Leukemia  \n",
       "52   Peptide Targeted Delivery of Epigenetic Therap...  \n",
       "53           Precision Interception of Gastric Cancers  \n",
       "54   Examination of inhibitors of the ULK1 autophag...  \n",
       "55   Examination of inhibitors of the ULK1 autophag...  \n",
       "56   Neoantigen-specific T cell responses in except...  \n",
       "57   Defining the mechanisms of pancreatic cancer s...  \n",
       "58   Elucidating the role of Syk kinase and Syk inh...  \n",
       "59   A pilot trial to test the benefit of real time...  \n",
       "60   Improved Echocardiographic Diagnosis of Anthra...  \n",
       "61   Detecting dysregulated genes in neuroblastoma ...  \n",
       "62   Characterization of a GOLPH3 Pathway Inhibitor...  \n",
       "63   Identification of regulatory programs for glio...  \n",
       "64   Evaluation of carcinogen exposure via genome-w...  \n",
       "65   Impact of Metformin on Clonal Hematopoiesis an...  \n",
       "66    FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma  \n",
       "67    FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma  \n",
       "68   Inhibiting Liver Cancer Stem Cells to Improve ...  \n",
       "69   Inhibiting Liver Cancer Stem Cells to Improve ...  \n",
       "70   Knowledge-based planning and treatment decisio...  \n",
       "71   Knowledge-based planning and treatment decisio...  \n",
       "72   Targeting CD114 Signaling in Pediatric Medullo...  \n",
       "73   Natural Killer Cells for Treatment of Medullob...  \n",
       "74                     Targeting FZD7 in human cancers  \n",
       "75   Inducing Cytosolic Chromatin Fragments in Canc...  \n",
       "76   Responses of Melanoma Patients to Checkpoint I...  \n",
       "77   Enhanced Breast Cancer Risk Prediction from Im...  \n",
       "78   Understanding and Targeting NRF2 in Pancreatic...  \n",
       "79      Microbe-Associated Colorectal Cancer (M.A.C.S)  \n",
       "80          Epigenetic profiling of endometrial cancer  \n",
       "81   Development and Implementation of a Peer-Navig...  \n",
       "82   Transcriptomic, epigenomic profiling to reveal...  \n",
       "83   A Phase 1b pilot clinical trial of cirmtuzumab...  \n",
       "84   An Open-Label, Phase 2 Efficacy Study of Temoz...  \n",
       "85   Investigating the Efficacy of radium-223 with ...  \n",
       "86   Low Dose Chemotherapy for Immuno-activation in...  \n",
       "87   Irreversible electroporation as an In Situ vac...  \n",
       "88   Oncogenic Regulation of B-Lymphomagenesis by t...  \n",
       "89   An over-expressed GPCR in pancreatic cancer as...  \n",
       "90   Identification of genes critical for the produ...  \n",
       "91   Targeting cellular mechanotransduction in brea...  \n",
       "92     Decoding Colon Cancers Using Boolean Principles  \n",
       "93     Decoding Colon Cancers Using Boolean Principles  \n",
       "94   Tissue-specific role of SMARCB1 in pediatric r...  \n",
       "95   Discovery of non-coding oncogenic mutations in...  \n",
       "96   Discovery of non-coding oncogenic mutations in...  \n",
       "97   Identification of therapeutic targets of B-ALL...  \n",
       "98   Developing targeted therapy for Ewing sarcoma ...  \n",
       "99   Defining the mechanisms of pancreatic cancer s...  \n",
       "100  A Novel Role for Histidine Kinase Activity in ...  \n",
       "101  A Novel Role for Histidine Kinase Activity in ...  "
      ]
     },
     "execution_count": 130,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "poli"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 141,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Award ID</th>\n",
       "      <th>Project Title</th>\n",
       "      <th>PI Institution</th>\n",
       "      <th>Other Institution</th>\n",
       "      <th>Prevention and diagnostic tools</th>\n",
       "      <th>Novel approaches and new therapeutic platforms</th>\n",
       "      <th>Immunotherapies and personalized vaccines</th>\n",
       "      <th>Addressing cancer disparities</th>\n",
       "      <th>Pediatric cancers</th>\n",
       "      <th>Specific Aims</th>\n",
       "      <th>Aim 1</th>\n",
       "      <th>Aim 2</th>\n",
       "      <th>Aim 3</th>\n",
       "      <th>Aim 4</th>\n",
       "      <th>Aim 5</th>\n",
       "      <th>Aim 6</th>\n",
       "      <th>Public Health Significance</th>\n",
       "      <th>Award Amount</th>\n",
       "      <th>Grant Start Date:</th>\n",
       "      <th>Grant End Date:</th>\n",
       "      <th>Complete</th>\n",
       "      <th>SR - None</th>\n",
       "      <th>SR - Biobehaviorial MCC</th>\n",
       "      <th>SR - Biorepository &amp; Tissue Tech. MCC</th>\n",
       "      <th>SR - Biostatistics MCC</th>\n",
       "      <th>SR - Clinical Trials Office MCC</th>\n",
       "      <th>SR - Flow Cytometry MCC</th>\n",
       "      <th>SR - Genomics &amp; Computational Bio. MCC</th>\n",
       "      <th>SR - In Vivo Imaging MCC</th>\n",
       "      <th>SR - Microscopy MCC</th>\n",
       "      <th>SR - Radiation Medicine MCC</th>\n",
       "      <th>SR - Transgenic Mouse MCC</th>\n",
       "      <th>SR - Gene Transfer/Targeting/Therap Salk</th>\n",
       "      <th>SR - Transgenic Salk</th>\n",
       "      <th>SR - Mass Spect - Proteom/Metabol Salk</th>\n",
       "      <th>SR - Chemical Library Screening SBPMDI</th>\n",
       "      <th>SR - Functional Genomics SBPMDI</th>\n",
       "      <th>Cancer Metabolism SBPMDI</th>\n",
       "      <th>Pedal Importance (recruitment, retention, advancement)</th>\n",
       "      <th>If yes, please specify</th>\n",
       "      <th>If no, please specify</th>\n",
       "      <th>Clinical Trials Resulted</th>\n",
       "      <th>First Clinical Trial</th>\n",
       "      <th>First Clinical Trial Patient Count</th>\n",
       "      <th>Second Clinical Trial</th>\n",
       "      <th>Second Clinical Trial Patient Count</th>\n",
       "      <th>Companies Founded</th>\n",
       "      <th>Patents Filed</th>\n",
       "      <th>Patent Details</th>\n",
       "      <th>Peer-Reviewed Publications Count</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>293</th>\n",
       "      <td>207.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Science</td>\n",
       "      <td>UCSD - not a member of Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>science project</td>\n",
       "      <td>Health Project</td>\n",
       "      <td>Both</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>diana</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2022-08-01</td>\n",
       "      <td>2022-08-31</td>\n",
       "      <td>Incomplete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        ID Event Name  Award ID Project Title  \\\n",
       "293  207.0    Initial       NaN       Science   \n",
       "\n",
       "                                  PI Institution Other Institution  \\\n",
       "293  UCSD - not a member of Moores Cancer Center               NaN   \n",
       "\n",
       "     Prevention and diagnostic tools  \\\n",
       "293                            False   \n",
       "\n",
       "     Novel approaches and new therapeutic platforms  \\\n",
       "293                                           False   \n",
       "\n",
       "     Immunotherapies and personalized vaccines  Addressing cancer disparities  \\\n",
       "293                                      False                           True   \n",
       "\n",
       "     Pediatric cancers        Specific Aims            Aim 1           Aim 2  \\\n",
       "293              False  Three Specific Aims  science project  Health Project   \n",
       "\n",
       "    Aim 3 Aim 4 Aim 5 Aim 6 Public Health Significance  Award Amount  \\\n",
       "293  Both   NaN   NaN   NaN                      diana       75000.0   \n",
       "\n",
       "    Grant Start Date: Grant End Date:    Complete SR - None  \\\n",
       "293        2022-08-01      2022-08-31  Incomplete       NaN   \n",
       "\n",
       "    SR - Biobehaviorial MCC SR - Biorepository & Tissue Tech. MCC  \\\n",
       "293                     NaN                                   NaN   \n",
       "\n",
       "    SR - Biostatistics MCC SR - Clinical Trials Office MCC  \\\n",
       "293                    NaN                             NaN   \n",
       "\n",
       "    SR - Flow Cytometry MCC SR - Genomics & Computational Bio. MCC  \\\n",
       "293                     NaN                                    NaN   \n",
       "\n",
       "    SR - In Vivo Imaging MCC SR - Microscopy MCC SR - Radiation Medicine MCC  \\\n",
       "293                      NaN                 NaN                         NaN   \n",
       "\n",
       "    SR - Transgenic Mouse MCC SR - Gene Transfer/Targeting/Therap Salk  \\\n",
       "293                       NaN                                      NaN   \n",
       "\n",
       "    SR - Transgenic Salk SR - Mass Spect - Proteom/Metabol Salk  \\\n",
       "293                  NaN                                    NaN   \n",
       "\n",
       "    SR - Chemical Library Screening SBPMDI SR - Functional Genomics SBPMDI  \\\n",
       "293                                    NaN                             NaN   \n",
       "\n",
       "    Cancer Metabolism SBPMDI  \\\n",
       "293                      NaN   \n",
       "\n",
       "    Pedal Importance (recruitment, retention, advancement)  \\\n",
       "293                                                NaN       \n",
       "\n",
       "    If yes, please specify If no, please specify  Clinical Trials Resulted  \\\n",
       "293                    NaN                   NaN                       0.0   \n",
       "\n",
       "    First Clinical Trial  First Clinical Trial Patient Count  \\\n",
       "293                  NaN                                 NaN   \n",
       "\n",
       "    Second Clinical Trial  Second Clinical Trial Patient Count  \\\n",
       "293                   NaN                                  NaN   \n",
       "\n",
       "    Companies Founded Patents Filed Patent Details  \\\n",
       "293               NaN           NaN            NaN   \n",
       "\n",
       "    Peer-Reviewed Publications Count  \n",
       "293                              NaN  "
      ]
     },
     "execution_count": 141,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "query_data(roi, 'Grant Start Date:', '2022')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.2"
  },
  "orig_nbformat": 4
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
